data_5zew_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5zew _Structure_validation_residue.Date_analyzed 2019-02-22 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.423 ' HG2' ' H ' ' A' ' 2' ' ' LYS . 26.7 ttt . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 1' ' ' MET . 58.3 mttm -75.65 140.99 42.87 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.099 -1.0 . . . . 0.0 110.613 162.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.81 159.84 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.056 1.742 . . . . 0.0 109.961 175.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -113.8 139.57 49.02 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.961 1.304 . . . . 0.0 110.36 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 tt -126.82 141.81 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.676 0.79 . . . . 0.0 111.357 174.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 t -124.65 85.36 56.7 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 125.547 1.539 . . . . 0.0 109.862 -177.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.07 121.37 5.33 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.289 2.66 . . . . 0.0 111.528 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.29 52.77 1.65 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.38 1.472 . . . . 0.0 113.406 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -150.45 147.02 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.054 1.342 . . . . 0.0 111.809 -176.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.39 29.18 74.4 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.436 1.017 . . . . 0.0 114.958 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.49 68.37 1.52 Allowed Glycine 0 CA--C 1.532 1.143 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -167.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.26 137.02 42.85 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.49 1.043 . . . . 0.0 114.372 -170.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.1 m -148.48 152.64 38.86 Favored Pre-proline 0 N--CA 1.474 0.735 0 C-N-CA 126.298 1.839 . . . . 0.0 110.813 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -65.86 143.51 73.63 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.936 2.424 . . . . 0.0 112.45 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.9 tp -139.55 129.0 24.24 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.357 1.463 . . . . 0.0 111.118 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -82.97 144.62 29.86 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.304 1.041 . . . . 0.0 112.783 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -152.38 146.97 25.75 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.297 1.439 . . . . 0.0 111.625 168.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -81.42 135.74 35.66 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.739 0.816 . . . . 0.0 111.191 171.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.6 m -134.16 156.56 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.484 1.114 . . . . 0.0 112.279 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.82 152.07 93.81 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 124.382 1.073 . . . . 0.0 112.608 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.09 -23.74 60.32 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.119 2.546 . . . . 0.0 113.279 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -85.43 10.7 12.12 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.249 1.42 . . . . 0.0 113.739 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.99 155.44 27.5 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.079 0.854 . . . . 0.0 112.515 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.6 m -144.39 135.37 25.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.265 1.426 . . . . 0.0 110.669 -171.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.7 t -61.28 -40.27 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.367 0.667 . . . . 0.0 111.953 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.34 -39.13 97.35 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.431 -0.649 . . . . 0.0 113.37 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.69 -37.59 82.52 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 118.342 1.071 . . . . 0.0 112.489 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.48 -44.56 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.543 -0.723 . . . . 0.0 110.37 172.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -60.94 -52.61 64.28 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.02 0.928 . . . . 0.0 111.925 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.2 p -64.53 -36.07 83.02 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 118.358 -0.829 . . . . 0.0 112.852 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -58.47 -45.01 89.49 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.558 1.072 . . . . 0.0 112.084 172.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 51.9 t -69.82 -42.81 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.082 0.856 . . . . 0.0 111.87 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 88.3 m -56.74 -42.32 79.05 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.908 1.231 . . . . 0.0 112.263 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.19 -41.31 81.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.922 0.889 . . . . 0.0 112.626 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.2 ttt -71.49 -36.78 71.23 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.897 0.879 . . . . 0.0 113.07 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -77.37 -13.78 59.86 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.075 1.35 . . . . 0.0 113.295 171.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 55.1 46.39 24.14 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.485 1.914 . . . . 0.0 112.109 -176.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.1 mt -133.14 146.12 59.73 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.424 1.49 . . . . 0.0 112.956 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.18 162.07 43.66 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.974 3.116 . . . . 0.0 113.473 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.48 -7.68 16.81 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.833 3.022 . . . . 0.0 114.273 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.3 -24.64 57.51 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.794 -1.191 . . . . 0.0 113.139 170.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 74.7 p -123.13 0.87 9.11 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.806 1.243 . . . . 0.0 114.204 -174.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.7 m -146.93 125.34 12.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.301 1.441 . . . . 0.0 109.998 172.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -145.36 149.55 34.97 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.734 1.214 . . . . 0.0 113.218 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.3 tp -105.13 144.59 31.72 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.129 1.772 . . . . 0.0 111.229 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.5 p -131.71 154.6 48.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.003 1.321 . . . . 0.0 111.451 170.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -143.03 125.29 15.49 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.434 1.894 . . . . 0.0 109.479 -174.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt 53.24 31.46 11.67 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.714 1.206 . . . . 0.0 113.351 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.41 -4.58 55.12 Favored Glycine 0 CA--C 1.542 1.769 0 C-N-CA 125.529 1.538 . . . . 0.0 116.094 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -94.41 153.15 18.1 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.771 1.628 . . . . 0.0 111.993 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.25 127.67 32.63 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 157.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.5 mt -142.59 151.28 41.36 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.43 1.492 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -154.51 -48.99 0.09 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.369 1.068 . . . . 0.0 113.693 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -83.52 39.13 0.65 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.734 1.614 . . . . 0.0 113.651 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.9 m -72.53 -22.72 60.98 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.844 1.258 . . . . 0.0 113.328 -172.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 63.36 -54.09 0.2 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.71 2.804 . . . . 0.0 115.558 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -160.71 140.8 11.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.868 2.467 . . . . 0.0 108.853 168.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -73.53 -34.71 65.35 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.023 0.829 . . . . 0.0 112.242 171.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -65.75 -27.94 68.67 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -173.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.4 m -67.0 -18.23 65.29 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.9 mp -107.87 -42.16 4.78 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.142 1.377 . . . . 0.0 112.155 175.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.63 93.86 0.1 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.575 1.56 . . . . 0.0 111.771 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.1 p -76.4 149.39 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.045 0.938 . . . . 0.0 110.994 173.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -141.94 178.56 7.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.477 1.111 . . . . 0.0 113.435 -172.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -97.86 137.53 36.57 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.395 1.878 . . . . 0.0 111.31 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.94 19.6 67.18 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 115.562 0.985 . . . . 0.0 115.562 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -65.09 143.57 57.81 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.581 1.191 . . . . 0.0 111.602 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -127.61 132.84 49.72 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -166.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -121.35 141.01 51.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.061 1.744 . . . . 0.0 111.296 -175.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.6 t -124.14 122.48 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.979 0.911 . . . . 0.0 109.835 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -112.42 112.02 23.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.022 1.329 . . . . 0.0 109.062 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.9 mt -101.5 140.26 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.715 1.606 . . . . 0.0 109.921 -176.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.8 p -133.51 157.37 45.83 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.894 1.277 . . . . 0.0 112.375 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 . . . . . 0 N--CA 1.476 0.874 0 C-N-CA 127.017 2.127 . . . . 0.0 111.475 178.872 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 121.246 0.546 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -82.92 149.71 26.9 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.201 -0.937 . . . . 0.0 110.536 166.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.2 pt -139.85 160.41 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.554 1.942 . . . . 0.0 110.009 169.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -118.88 107.81 14.04 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.872 0.869 . . . . 0.0 111.243 172.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.9 tt -90.13 140.17 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.037 0.535 . . . . 0.0 110.933 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 t -125.84 88.94 53.38 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 125.148 1.379 . . . . 0.0 109.899 -175.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -82.41 124.06 4.06 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.448 2.765 . . . . 0.0 112.509 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.19 35.86 0.18 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.87 1.668 . . . . 0.0 114.039 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.0 m -79.42 51.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 126.793 2.037 . . . . 0.0 113.315 -171.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.96 53.01 7.39 Favored Glycine 0 CA--C 1.533 1.218 0 O-C-N 121.276 -0.89 . . . . 0.0 112.877 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.97 23.89 36.83 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.405 1.002 . . . . 0.0 114.747 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.19 138.72 45.75 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 118.18 0.99 . . . . 0.0 113.554 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.5 p -84.1 155.13 64.04 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 125.427 1.491 . . . . 0.0 112.969 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -62.04 145.15 96.72 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.256 2.637 . . . . 0.0 111.825 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.91 127.05 29.91 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.814 1.246 . . . . 0.0 111.392 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -75.53 130.74 39.34 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.724 1.209 . . . . 0.0 111.291 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.94 149.49 41.91 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.611 1.564 . . . . 0.0 111.143 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -85.48 141.8 29.66 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.089 1.356 . . . . 0.0 111.2 169.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.45 142.17 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.482 1.113 . . . . 0.0 112.897 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.97 150.32 61.38 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.187 1.395 . . . . 0.0 112.674 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.15 -23.58 60.09 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.55 2.833 . . . . 0.0 113.619 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -78.82 0.92 25.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.226 1.41 . . . . 0.0 113.872 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.11 140.23 56.06 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.259 0.936 . . . . 0.0 111.972 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.2 m -119.5 131.96 55.68 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.134 1.374 . . . . 0.0 110.23 -174.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.8 m -61.55 -31.96 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -174.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.64 -37.22 92.33 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 123.776 0.703 . . . . 0.0 113.292 173.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.15 -41.9 73.25 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.214 1.007 . . . . 0.0 111.689 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.46 -45.31 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.549 0.739 . . . . 0.0 111.041 175.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -55.36 -49.07 73.23 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.644 1.177 . . . . 0.0 111.239 172.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 90.5 m -65.26 -40.2 93.66 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.226 0.61 . . . . 0.0 111.849 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -59.61 -46.95 87.45 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.252 1.021 . . . . 0.0 111.638 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 36.0 t -61.64 -46.92 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.162 0.985 . . . . 0.0 111.865 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.6 m -63.93 -38.49 91.29 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.4 0.68 . . . . 0.0 112.283 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.26 -41.81 84.95 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.823 0.849 . . . . 0.0 112.421 174.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -66.08 -41.47 90.64 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.329 1.051 . . . . 0.0 112.832 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -85.28 -9.44 57.7 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.79 12.97 1.84 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 127.646 2.379 . . . . 0.0 115.063 -174.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.9 mp -118.66 153.61 52.29 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 126.743 2.017 . . . . 0.0 111.537 -175.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.06 163.87 37.73 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 124.245 3.297 . . . . 0.0 114.235 -173.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -64.91 -14.6 46.05 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.257 2.638 . . . . 0.0 114.026 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -68.58 -26.89 65.62 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.345 1.058 . . . . 0.0 113.215 171.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 34.6 p -109.01 -21.4 12.64 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.078 1.351 . . . . 0.0 113.573 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.3 m -126.54 126.03 43.01 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.145 0.978 . . . . 0.0 110.899 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -141.97 166.25 25.22 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.844 1.258 . . . . 0.0 113.354 -169.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.0 tp -136.93 140.33 42.19 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.869 1.668 . . . . 0.0 111.278 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.8 p -137.29 156.67 47.98 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.181 1.392 . . . . 0.0 112.767 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -152.53 131.92 12.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.441 2.297 . . . . 0.0 110.144 -174.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.35 40.01 17.52 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.357 1.463 . . . . 0.0 113.444 174.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.29 8.7 87.62 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 125.132 1.348 . . . . 0.0 116.334 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -133.89 160.78 36.64 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.707 1.603 . . . . 0.0 112.619 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.41 155.52 29.93 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.274 0.629 . . . . 0.0 110.866 160.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.6 mt -116.86 133.58 55.83 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.55 1.14 . . . . 0.0 111.065 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.2 141.65 18.7 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.926 1.29 . . . . 0.0 111.403 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.5 t0 55.09 33.58 20.71 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.776 1.63 . . . . 0.0 114.789 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.0 p -83.43 -29.48 28.06 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.565 1.146 . . . . 0.0 113.595 -171.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 61.42 -23.45 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 129.107 2.963 . . . . 0.0 116.979 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.1 p -149.09 161.58 41.68 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.796 2.039 . . . . 0.0 111.25 171.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 65.8 mt -77.01 -20.95 55.37 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.738 -0.601 . . . . 0.0 112.595 164.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -63.67 -36.24 83.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.164 0.986 . . . . 0.0 112.421 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.8 m -69.95 -19.2 63.38 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 174.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.1 mt -90.11 -24.74 21.02 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.731 1.213 . . . . 0.0 113.48 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.97 41.09 72.78 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 123.643 0.64 . . . . 0.0 113.158 -174.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.0 p -55.64 149.19 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.907 1.283 . . . . 0.0 112.22 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.79 151.27 30.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.211 1.004 . . . . 0.0 112.182 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -64.22 128.62 36.58 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.67 0.788 . . . . 0.0 111.195 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.78 8.65 76.09 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.013 1.292 . . . . 0.0 115.858 -176.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -62.08 152.04 33.85 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.665 1.733 . . . . 0.0 113.6 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -103.39 154.15 19.72 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.685 1.194 . . . . 0.0 114.179 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -135.78 143.2 45.1 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.119 2.168 . . . . 0.0 109.679 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.9 t -121.7 126.22 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.745 0.818 . . . . 0.0 110.34 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 tt -111.86 122.31 47.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.733 1.613 . . . . 0.0 109.194 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -113.92 142.74 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.722 1.609 . . . . 0.0 110.061 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.7 t -136.87 150.66 48.4 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.092 1.357 . . . . 0.0 112.052 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 . . . . . 0 N--CA 1.475 0.811 0 C-N-CA 126.681 1.993 . . . . 0.0 110.154 -176.251 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.913 0.387 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -102.71 152.23 21.46 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.739 1.215 . . . . 0.0 112.315 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -133.44 154.46 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.283 1.833 . . . . 0.0 109.608 173.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -98.12 146.26 25.74 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.235 0.614 . . . . 0.0 110.549 161.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.4 tt -123.5 136.74 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 124.473 1.109 . . . . 0.0 109.62 165.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -123.46 78.85 54.46 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.943 1.297 . . . . 0.0 109.359 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -81.56 138.02 10.57 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.882 2.388 . . . . 0.0 112.556 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.29 35.7 0.18 Allowed 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.676 1.59 . . . . 0.0 114.394 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.85 160.89 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 126.517 1.927 . . . . 0.0 111.701 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.45 -117.94 12.88 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 123.876 0.75 . . . . 0.0 112.144 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.79 -18.2 72.08 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 123.905 0.764 . . . . 0.0 114.745 174.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.89 11.82 58.74 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-N 118.747 1.273 . . . . 0.0 115.095 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.2 p -106.85 160.14 27.37 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.846 2.058 . . . . 0.0 112.765 -168.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.38 137.37 55.36 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.926 2.417 . . . . 0.0 112.076 171.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 mp -124.1 137.09 54.61 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.319 1.448 . . . . 0.0 110.427 167.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -99.82 135.08 41.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.626 1.17 . . . . 0.0 111.844 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.7 mt -142.23 147.61 36.79 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.039 1.736 . . . . 0.0 111.778 -173.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -81.05 144.06 32.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.284 1.034 . . . . 0.0 110.834 166.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.1 p -144.71 145.24 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.777 0.831 . . . . 0.0 112.514 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 148.09 91.45 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.537 1.135 . . . . 0.0 112.6 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.84 -23.1 41.81 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.202 2.601 . . . . 0.0 113.182 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -81.91 5.79 17.9 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.443 1.497 . . . . 0.0 113.858 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.77 140.47 51.5 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.211 -0.931 . . . . 0.0 112.149 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.6 p -120.05 149.6 41.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.307 1.043 . . . . 0.0 112.109 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.8 m -60.79 -36.06 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.853 0.861 . . . . 0.0 112.519 175.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.83 -44.49 91.96 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 123.893 0.759 . . . . 0.0 112.357 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.75 -47.72 79.89 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 117.767 0.783 . . . . 0.0 112.06 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.4 t -63.14 -48.11 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.466 0.575 . . . . 0.0 111.316 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -59.71 -48.11 82.98 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.71 0.804 . . . . 0.0 111.66 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.5 m -68.62 -36.48 78.7 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.761 -0.587 . . . . 0.0 111.851 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -66.98 -38.78 86.67 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.862 0.865 . . . . 0.0 112.337 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.0 t -56.29 -51.8 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.725 0.81 . . . . 0.0 110.956 167.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.2 m -62.41 -37.18 84.8 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.19 -44.38 84.14 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.024 0.929 . . . . 0.0 112.565 174.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 96.4 mtp -68.63 -39.39 80.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.807 0.843 . . . . 0.0 113.11 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -80.67 -12.56 59.47 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 175.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 58.59 17.43 5.0 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 127.165 2.186 . . . . 0.0 114.162 -173.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 mp -130.04 152.02 79.3 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 127.156 2.183 . . . . 0.0 110.702 -171.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.21 164.74 32.84 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 124.111 3.207 . . . . 0.0 114.115 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.59 -12.28 34.28 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.334 2.689 . . . . 0.0 114.014 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -66.03 -36.84 84.32 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.976 -1.078 . . . . 0.0 112.059 170.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.5 p -90.66 -19.66 23.38 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 89.5 m -136.44 124.83 23.36 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.533 1.515 . . . . 0.0 111.732 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -125.86 157.73 36.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.861 1.665 . . . . 0.0 112.221 -173.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.0 tp -125.98 136.49 53.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.445 1.898 . . . . 0.0 111.308 -173.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.0 p -134.37 153.22 52.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.405 1.082 . . . . 0.0 112.543 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -152.26 136.13 16.34 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.186 1.795 . . . . 0.0 110.059 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt 51.54 33.61 10.86 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.756 1.622 . . . . 0.0 114.362 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.32 19.36 77.47 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.125 0.869 . . . . 0.0 115.091 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -129.02 160.96 31.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.048 2.139 . . . . 0.0 111.24 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -88.58 131.97 34.73 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.696 0.798 . . . . 0.0 110.113 160.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.5 tp -96.94 112.63 24.3 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.148 0.979 . . . . 0.0 110.464 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -154.04 151.14 28.99 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.996 1.318 . . . . 0.0 112.33 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.6 t0 56.18 29.58 14.98 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.928 2.091 . . . . 0.0 115.037 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.0 p -88.36 -20.11 25.75 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 58.09 -64.79 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.87 2.068 . . . . 0.0 114.266 -163.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.7 p -144.01 150.03 37.61 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.16 1.384 . . . . 0.0 111.989 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.51 -30.8 71.61 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.686 0.794 . . . . 0.0 112.631 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.68 -22.51 65.28 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.231 -0.918 . . . . 0.0 113.26 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.7 p -69.44 -26.53 64.65 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 56.6 mt -98.02 -6.35 32.09 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.117 1.767 . . . . 0.0 113.16 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.33 115.39 1.46 Allowed Glycine 0 CA--C 1.536 1.347 0 C-N-CA 126.206 1.86 . . . . 0.0 112.385 -171.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 m -74.43 154.45 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.75 1.22 . . . . 0.0 112.684 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -147.81 160.06 43.16 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.317 1.847 . . . . 0.0 110.319 170.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -93.09 147.49 22.82 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.821 0.848 . . . . 0.0 112.485 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.82 30.78 59.07 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 115.068 0.787 . . . . 0.0 115.068 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.29 148.34 51.86 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.631 1.215 . . . . 0.0 111.891 173.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -120.74 111.75 17.99 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.367 1.067 . . . . 0.0 111.563 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -94.04 144.23 25.66 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.126 1.37 . . . . 0.0 111.222 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.08 128.34 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.484 1.114 . . . . 0.0 109.664 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.3 tp -115.16 123.21 48.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.026 0.93 . . . . 0.0 110.967 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.4 123.56 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.408 1.483 . . . . 0.0 109.708 -171.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.2 t -111.57 141.19 45.48 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.257 1.023 . . . . 0.0 111.76 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? . . . . . 0 N--CA 1.469 0.498 0 C-N-CA 125.557 1.543 . . . . 0.0 110.475 175.737 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 mmt . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.668 0.271 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.88 148.92 27.04 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.651 -1.28 . . . . 0.0 112.298 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.22 155.97 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.883 1.673 . . . . 0.0 110.434 172.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -111.19 119.36 38.7 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.414 1.086 . . . . 0.0 111.083 169.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 tp -86.98 137.82 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 165.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 t -128.81 77.99 76.82 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 124.718 1.207 . . . . 0.0 109.789 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.09 136.74 10.43 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.317 2.678 . . . . 0.0 112.114 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.46 36.49 0.16 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.679 1.592 . . . . 0.0 113.463 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.6 t -138.32 147.56 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.106 1.762 . . . . 0.0 110.641 -170.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.11 -117.71 10.81 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 123.969 0.795 . . . . 0.0 111.967 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.53 -19.58 71.02 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 123.85 0.738 . . . . 0.0 114.519 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.51 3.66 41.38 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 124.87 1.224 . . . . 0.0 115.667 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.0 p -91.31 157.22 42.85 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 126.583 1.953 . . . . 0.0 113.203 -171.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -64.23 145.36 88.7 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.992 2.461 . . . . 0.0 111.784 168.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 tt -137.07 122.48 19.5 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.95 1.3 . . . . 0.0 110.313 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -90.52 137.81 32.06 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.226 1.01 . . . . 0.0 113.017 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.0 mt -144.72 148.17 33.86 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.984 1.714 . . . . 0.0 111.826 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -80.65 138.2 36.39 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.641 1.176 . . . . 0.0 110.382 166.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.4 m -140.0 153.33 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.458 1.103 . . . . 0.0 112.33 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.85 150.49 96.47 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.04 0.936 . . . . 0.0 112.197 175.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.64 -21.01 52.68 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.082 2.521 . . . . 0.0 112.957 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.88 15.68 2.15 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.853 1.661 . . . . 0.0 114.015 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.18 142.49 54.29 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.163 -0.961 . . . . 0.0 112.128 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.3 m -133.56 138.58 46.11 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.241 1.416 . . . . 0.0 111.046 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.9 t -57.49 -47.76 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.339 1.055 . . . . 0.0 112.587 -173.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.6 -38.33 96.22 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.674 -0.515 . . . . 0.0 112.968 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.18 -46.07 78.64 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 117.986 0.893 . . . . 0.0 111.814 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -60.8 -49.14 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.805 0.842 . . . . 0.0 110.971 176.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -62.42 -46.37 88.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.264 0.626 . . . . 0.0 111.777 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.6 m -59.62 -43.92 93.63 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.475 0.71 . . . . 0.0 111.51 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -66.32 -37.7 85.98 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.576 0.751 . . . . 0.0 112.469 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.02 -46.59 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.502 0.592 . . . . 0.0 111.794 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.2 m -58.6 -40.44 83.26 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.501 1.046 . . . . 0.0 112.144 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.72 -41.51 87.8 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.893 0.877 . . . . 0.0 112.715 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.6 tpt -68.28 -41.25 81.27 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.515 1.126 . . . . 0.0 112.767 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -74.77 -24.62 58.71 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.511 1.524 . . . . 0.0 113.137 172.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.79 30.25 19.55 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.805 2.042 . . . . 0.0 113.221 -171.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 mp -120.32 153.83 56.06 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.948 2.099 . . . . 0.0 111.454 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.74 162.54 38.98 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.899 3.066 . . . . 0.0 113.496 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -67.58 -16.22 46.53 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.537 2.825 . . . . 0.0 114.819 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -79.79 -29.6 40.4 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.675 1.125 . . . . 0.0 113.613 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.7 p -86.64 9.55 18.31 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.702 1.201 . . . . 0.0 113.69 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 t -135.85 144.81 45.84 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.36 1.464 . . . . 0.0 110.897 176.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -133.52 148.01 51.63 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.505 1.922 . . . . 0.0 110.4 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.3 tp -139.67 121.24 15.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.34 1.456 . . . . 0.0 110.563 -169.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.7 m -132.71 141.11 48.42 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.596 1.158 . . . . 0.0 112.342 -169.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -143.75 131.94 21.89 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.779 2.032 . . . . 0.0 110.608 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt 50.14 37.64 15.07 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.008 1.323 . . . . 0.0 113.82 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.18 17.35 79.57 Favored Glycine 0 CA--C 1.541 1.683 0 C-N-CA 124.718 1.151 . . . . 0.0 115.788 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -136.7 154.13 50.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.675 1.99 . . . . 0.0 112.881 -175.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.41 129.27 34.57 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.82 0.848 . . . . 0.0 110.521 165.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.1 130.72 34.84 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.989 0.916 . . . . 0.0 110.223 169.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -162.23 141.94 9.72 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.513 1.525 . . . . 0.0 111.637 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 t0 56.55 25.34 9.71 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 172.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.1 p -82.96 -16.03 48.94 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.839 -1.163 . . . . 0.0 113.234 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 62.67 -56.1 0.15 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 128.775 2.83 . . . . 0.0 115.02 -171.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 21.5 p -148.93 148.21 29.55 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.344 1.858 . . . . 0.0 111.593 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.69 -25.46 68.22 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.689 0.796 . . . . 0.0 112.991 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -62.01 -27.36 68.82 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.065 -1.022 . . . . 0.0 113.084 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.5 m -69.11 -23.93 64.05 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.114 0.966 . . . . 0.0 113.162 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.6 mt -93.45 -22.87 18.63 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.238 1.415 . . . . 0.0 112.724 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.53 114.03 3.01 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.47 1.986 . . . . 0.0 111.344 -167.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.2 t -72.74 143.18 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.717 1.207 . . . . 0.0 111.314 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -138.55 146.14 41.52 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.549 1.54 . . . . 0.0 110.38 168.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -78.38 147.38 34.14 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.289 -0.882 . . . . 0.0 112.411 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.7 21.81 78.07 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 115.044 0.778 . . . . 0.0 115.044 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -56.98 140.0 50.26 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.728 1.264 . . . . 0.0 111.309 170.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -121.44 137.04 54.89 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.856 0.862 . . . . 0.0 112.138 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -119.0 121.87 40.88 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.463 1.505 . . . . 0.0 109.731 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.5 t -91.81 130.59 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.326 0.65 . . . . 0.0 109.428 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 tp -120.31 123.45 43.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.151 0.98 . . . . 0.0 110.892 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -113.28 129.18 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.411 1.485 . . . . 0.0 110.014 -172.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.6 t -94.37 145.88 24.45 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.497 1.119 . . . . 0.0 111.787 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.773 0 C-N-CA 124.633 1.173 . . . . 0.0 110.615 171.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.979 0.419 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -121.52 147.45 45.77 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.737 1.215 . . . . 0.0 112.544 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.12 166.44 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.542 1.937 . . . . 0.0 110.265 172.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -128.38 100.78 5.93 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.894 0.878 . . . . 0.0 111.287 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.5 tt -86.55 141.8 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.77 0.828 . . . . 0.0 111.209 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.6 t -128.84 80.89 71.9 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 125.491 1.517 . . . . 0.0 109.483 -176.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.5 142.7 33.37 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.952 2.434 . . . . 0.0 111.94 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.62 23.29 0.23 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.399 1.48 . . . . 0.0 113.908 174.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -155.8 160.55 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 127.246 2.218 . . . . 0.0 109.889 -172.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.43 34.81 53.62 Favored Glycine 0 CA--C 1.535 1.292 0 O-C-N 121.389 -0.819 . . . . 0.0 113.998 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.33 -9.17 64.89 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.575 1.559 . . . . 0.0 114.887 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.7 -0.44 43.75 Favored Glycine 0 CA--C 1.54 1.598 0 N-CA-C 116.555 1.382 . . . . 0.0 116.555 170.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.4 m -80.38 152.34 73.1 Favored Pre-proline 0 N--CA 1.472 0.629 0 C-N-CA 124.676 1.19 . . . . 0.0 113.053 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -64.43 145.34 87.76 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.067 2.511 . . . . 0.0 111.845 170.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.7 mt -131.68 121.86 24.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.503 1.521 . . . . 0.0 110.58 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -88.89 132.77 34.54 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.553 1.141 . . . . 0.0 111.284 178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 mt -149.81 143.49 25.39 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.347 1.059 . . . . 0.0 111.624 -173.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -69.82 150.97 46.28 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.351 0.66 . . . . 0.0 111.98 168.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 p -146.37 140.15 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.349 1.06 . . . . 0.0 111.538 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.56 145.27 78.73 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.021 0.928 . . . . 0.0 111.956 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.2 -20.88 49.11 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.833 2.355 . . . . 0.0 113.198 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -75.72 -7.18 53.73 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.2 157.76 30.55 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.162 0.892 . . . . 0.0 112.847 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.85 145.9 51.82 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.95 1.3 . . . . 0.0 110.885 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.1 t -66.37 -34.05 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 121.373 -0.829 . . . . 0.0 111.295 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.25 -43.7 99.05 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.439 1.018 . . . . 0.0 113.054 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.87 -45.47 85.88 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.98 0.89 . . . . 0.0 111.717 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.3 t -60.92 -49.3 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.012 0.925 . . . . 0.0 111.99 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.9 ptt85 -64.08 -39.52 94.24 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.123 0.874 . . . . 0.0 112.07 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.7 m -62.69 -41.22 98.99 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.596 0.758 . . . . 0.0 111.376 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -42.57 97.17 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.708 0.803 . . . . 0.0 112.191 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 70.2 t -74.67 -35.74 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.541 0.736 . . . . 0.0 112.559 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 87.1 m -60.25 -45.51 93.01 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.589 -0.694 . . . . 0.0 111.465 170.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.46 -41.1 89.56 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.984 0.914 . . . . 0.0 112.829 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 57.7 ttm -61.69 -43.84 98.09 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.396 1.078 . . . . 0.0 112.849 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -85.94 -6.38 59.07 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.4 tptm 53.54 53.67 11.21 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.059 2.144 . . . . 0.0 112.451 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.7 mt -133.16 148.38 68.98 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.612 1.565 . . . . 0.0 112.164 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -69.49 160.42 49.83 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.563 2.842 . . . . 0.0 112.444 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.07 -26.01 73.43 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.741 2.294 . . . . 0.0 113.13 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -70.09 -3.19 15.41 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.492 -1.38 . . . . 0.0 114.604 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.8 p -127.7 14.67 6.99 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.368 1.467 . . . . 0.0 113.075 165.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 m -154.53 110.69 3.23 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.031 1.733 . . . . 0.0 110.868 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.2 mtt-85 -132.15 155.22 48.56 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.557 1.143 . . . . 0.0 112.886 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.0 tp -127.37 131.53 50.33 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.255 1.822 . . . . 0.0 110.596 -174.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.8 p -136.84 152.16 49.95 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.415 1.086 . . . . 0.0 113.371 -175.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -142.26 134.5 27.65 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.575 1.95 . . . . 0.0 110.382 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 tptm 51.68 33.31 10.68 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.465 1.506 . . . . 0.0 114.191 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.75 10.09 84.67 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 125.285 1.422 . . . . 0.0 115.931 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -127.34 149.94 49.82 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.792 1.637 . . . . 0.0 112.678 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.12 88.51 6.55 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.735 1.214 . . . . 0.0 110.844 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.2 mp -65.39 147.55 53.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.916 0.886 . . . . 0.0 111.68 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -158.07 -51.05 0.07 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.888 1.275 . . . . 0.0 113.437 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -84.53 40.25 0.78 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.492 1.517 . . . . 0.0 113.295 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.0 m -73.82 -27.26 61.02 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.41 1.084 . . . . 0.0 112.808 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 62.0 -61.92 0.1 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 128.035 2.534 . . . . 0.0 114.776 -174.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.4 p -147.29 150.57 35.05 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.217 1.407 . . . . 0.0 111.319 170.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.07 -20.61 62.34 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.122 0.569 . . . . 0.0 112.471 167.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.09 -54.35 39.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.575 1.55 . . . . 0.0 112.346 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.3 m -69.27 -28.47 66.34 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.9 tp -74.68 -27.84 60.58 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.989 0.916 . . . . 0.0 112.788 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.61 54.24 6.12 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.383 0.992 . . . . 0.0 113.042 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.6 p -56.62 151.88 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.633 1.173 . . . . 0.0 112.905 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.83 161.07 33.83 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.01 1.324 . . . . 0.0 112.945 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -60.95 129.81 43.28 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.099 1.36 . . . . 0.0 112.29 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.46 4.97 59.27 Favored Glycine 0 CA--C 1.535 1.281 0 N-CA-C 115.99 1.156 . . . . 0.0 115.99 171.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -64.68 138.02 58.15 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.179 1.49 . . . . 0.0 110.649 168.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -132.98 134.46 44.51 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -167.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -124.32 136.55 54.19 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.698 1.199 . . . . 0.0 111.484 -167.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t -100.73 132.29 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.725 0.81 . . . . 0.0 109.864 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 tt -120.43 103.44 9.19 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.845 0.858 . . . . 0.0 110.299 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -86.71 141.41 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 126.25 1.82 . . . . 0.0 109.867 -176.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.8 t -146.67 156.55 43.27 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.16 0.984 . . . . 0.0 111.899 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 125.024 1.33 . . . . 0.0 112.573 -171.116 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -101.82 140.06 36.62 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.0 -1.688 . . . . 0.0 112.458 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.83 171.1 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 127.297 2.239 . . . . 0.0 110.399 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -127.2 149.95 49.75 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.809 1.244 . . . . 0.0 110.962 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.1 tt -129.38 142.47 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.119 0.968 . . . . 0.0 110.777 172.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.83 77.85 76.12 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 125.292 1.437 . . . . 0.0 109.779 -173.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.84 133.91 15.87 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.163 2.575 . . . . 0.0 111.497 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.7 41.47 0.27 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.253 1.421 . . . . 0.0 113.314 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.4 t -139.22 147.28 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.031 1.732 . . . . 0.0 110.718 -170.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.13 -119.92 16.37 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 123.898 0.761 . . . . 0.0 111.947 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.34 -18.41 71.43 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 123.684 0.659 . . . . 0.0 114.678 174.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.84 3.19 41.68 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 124.966 1.27 . . . . 0.0 115.748 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.5 p -82.33 155.72 69.14 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.996 1.718 . . . . 0.0 113.363 -174.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -67.34 152.18 79.49 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.302 2.668 . . . . 0.0 112.097 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.1 tp -141.31 125.3 17.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.797 1.239 . . . . 0.0 111.759 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -71.08 142.01 50.84 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.21 1.404 . . . . 0.0 112.327 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.75 151.78 37.73 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.382 1.473 . . . . 0.0 110.351 174.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -111.68 128.68 56.15 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.776 1.23 . . . . 0.0 110.465 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.5 m -140.53 155.1 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.206 1.402 . . . . 0.0 112.483 -165.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.98 150.29 97.64 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 123.82 0.848 . . . . 0.0 111.788 171.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.2 -25.34 57.76 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.966 2.444 . . . . 0.0 112.971 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -76.34 12.57 1.17 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.908 1.683 . . . . 0.0 114.728 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.55 105.12 0.73 Allowed 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.916 -1.115 . . . . 0.0 111.917 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.0 m -75.61 130.1 38.24 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.476 1.11 . . . . 0.0 111.15 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.9 t -60.93 -35.2 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.994 0.918 . . . . 0.0 112.925 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.59 -40.0 97.23 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 121.319 -0.863 . . . . 0.0 113.223 172.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.66 -34.76 77.57 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 117.975 0.887 . . . . 0.0 112.324 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.2 t -60.48 -44.39 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 O-C-N 121.505 -0.747 . . . . 0.0 110.814 172.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -61.42 -54.21 46.47 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.323 173.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 66.4 p -63.17 -34.44 77.63 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.41 1.005 . . . . 0.0 112.853 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -61.06 -47.5 86.09 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.739 0.816 . . . . 0.0 111.751 173.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.0 t -66.6 -41.87 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.805 176.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 92.4 m -57.84 -41.87 83.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.46 1.027 . . . . 0.0 112.087 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.51 -41.5 88.77 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.696 0.798 . . . . 0.0 112.849 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.5 mtt -67.29 -39.49 86.01 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.04 0.936 . . . . 0.0 113.106 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.453 ' HE3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -79.14 -23.22 44.13 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.879 1.272 . . . . 0.0 113.647 176.635 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt 58.78 31.3 21.07 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.419 1.888 . . . . 0.0 113.189 -167.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 mp -114.24 150.58 43.92 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 126.249 1.82 . . . . 0.0 111.035 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -69.54 161.84 44.32 Favored 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.702 2.935 . . . . 0.0 112.726 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -65.18 -20.18 62.77 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.22 2.613 . . . . 0.0 113.674 176.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -67.65 -31.56 71.64 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.149 -0.969 . . . . 0.0 113.309 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 47.8 p -94.41 20.17 8.65 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.382 1.473 . . . . 0.0 113.704 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 t -145.68 152.55 39.8 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.334 1.054 . . . . 0.0 112.373 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 88.0 mmt-85 -139.36 145.55 39.15 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.924 1.69 . . . . 0.0 111.283 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.8 tp -134.71 127.9 31.91 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.441 1.896 . . . . 0.0 109.834 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.6 p -140.67 155.48 46.48 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.418 1.087 . . . . 0.0 112.772 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -146.41 140.49 26.35 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.101 1.76 . . . . 0.0 110.013 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.1 tptt 50.95 34.8 11.17 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.644 1.578 . . . . 0.0 114.035 -177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.87 14.94 81.17 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.757 1.17 . . . . 0.0 115.292 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -130.71 145.45 51.94 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.129 1.772 . . . . 0.0 111.739 -173.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.84 119.4 23.86 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.739 0.815 . . . . 0.0 110.655 171.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.1 mp -93.37 135.42 34.62 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.25 1.02 . . . . 0.0 110.212 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -160.64 149.7 16.97 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.227 1.811 . . . . 0.0 110.127 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 56.18 27.43 11.61 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.601 1.561 . . . . 0.0 114.823 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -73.23 -26.09 60.99 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.52 1.128 . . . . 0.0 113.638 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 61.04 -43.85 0.12 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.73 2.812 . . . . 0.0 115.079 -167.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.8 t -155.05 145.43 22.05 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.121 1.768 . . . . 0.0 110.62 174.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.72 -18.85 65.39 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.671 -0.643 . . . . 0.0 111.938 172.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.66 -24.11 67.47 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.033 -1.042 . . . . 0.0 112.772 173.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.7 t -68.25 -36.89 80.15 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.808 0.843 . . . . 0.0 112.283 172.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.4 mt -85.66 -20.67 29.08 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.972 1.309 . . . . 0.0 113.323 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.64 115.77 3.75 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.757 2.123 . . . . 0.0 111.856 -172.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.6 m -77.7 151.86 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.851 1.261 . . . . 0.0 113.364 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.89 163.61 39.77 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.407 1.883 . . . . 0.0 110.755 169.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -90.89 150.23 21.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.166 0.987 . . . . 0.0 112.806 172.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.67 81.67 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.739 1.161 . . . . 0.0 114.804 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -62.19 120.95 11.91 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.531 1.165 . . . . 0.0 110.745 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -106.15 114.87 29.26 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.045 0.938 . . . . 0.0 112.075 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -93.61 125.8 38.42 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.575 1.55 . . . . 0.0 110.545 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.0 t -96.39 133.26 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.724 0.81 . . . . 0.0 109.433 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.5 tt -130.37 123.49 30.03 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.851 0.86 . . . . 0.0 111.232 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.4 mm -117.07 122.01 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.112 1.365 . . . . 0.0 110.163 -171.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -81.66 143.35 31.97 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.328 0.651 . . . . 0.0 110.949 167.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 . . . . . 0 N--CA 1.472 0.659 0 C-N-CA 123.753 0.821 . . . . 0.0 110.335 167.657 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.5 mtt . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -79.76 149.28 31.17 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.16 -0.962 . . . . 0.0 111.559 166.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.97 140.26 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.918 2.087 . . . . 0.0 109.08 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -100.24 110.41 22.66 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.856 1.262 . . . . 0.0 110.951 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.3 tt -90.56 138.47 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.766 -0.584 . . . . 0.0 110.354 171.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.7 t -127.37 81.89 69.24 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 125.134 1.373 . . . . 0.0 109.65 -175.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -84.06 135.55 6.52 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.892 2.395 . . . . 0.0 113.02 -177.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.1 37.23 0.25 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.771 1.628 . . . . 0.0 114.109 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.84 157.16 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.681 1.593 . . . . 0.0 111.148 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.58 -115.48 7.38 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.207 0.908 . . . . 0.0 111.863 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.35 -21.93 70.75 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 123.736 0.684 . . . . 0.0 114.376 174.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.33 23.7 70.22 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 118.539 1.169 . . . . 0.0 114.576 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -133.14 155.88 80.54 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 125.822 1.649 . . . . 0.0 112.964 -163.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.1 138.16 55.39 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.991 2.46 . . . . 0.0 112.564 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.2 mt -131.36 122.8 26.97 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.734 1.614 . . . . 0.0 110.205 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -79.71 141.39 36.43 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.709 0.804 . . . . 0.0 111.894 173.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 tp -150.25 144.69 25.75 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.954 1.301 . . . . 0.0 111.229 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -86.05 136.54 33.19 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.98 0.912 . . . . 0.0 111.017 170.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 t -142.98 142.53 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.426 1.09 . . . . 0.0 111.019 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.49 152.14 96.5 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.689 1.196 . . . . 0.0 113.192 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.07 -20.23 50.58 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.379 2.719 . . . . 0.0 113.492 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -72.02 6.0 2.38 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.87 1.668 . . . . 0.0 114.354 172.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.3 131.05 47.04 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.572 1.078 . . . . 0.0 112.496 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.0 m -116.47 133.25 56.23 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.469 1.508 . . . . 0.0 109.798 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.0 t -59.67 -41.0 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.304 0.642 . . . . 0.0 112.155 -175.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.71 -36.54 91.91 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.522 -0.599 . . . . 0.0 113.413 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.9 -44.22 73.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.381 1.091 . . . . 0.0 111.945 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.66 -47.01 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.591 0.756 . . . . 0.0 111.169 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -61.63 -43.55 98.64 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.457 1.103 . . . . 0.0 111.944 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 88.3 m -62.52 -42.6 99.62 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.655 0.662 . . . . 0.0 111.696 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.67 -43.78 98.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.004 0.921 . . . . 0.0 111.489 176.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.79 -52.86 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.236 1.015 . . . . 0.0 111.504 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 85.1 m -61.06 -35.88 78.11 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.778 0.717 . . . . 0.0 112.599 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.82 -44.25 81.68 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.824 0.849 . . . . 0.0 112.911 173.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 71.7 mtm -68.97 -39.06 79.68 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.527 -0.733 . . . . 0.0 112.928 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -15.63 58.87 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.82 1.248 . . . . 0.0 113.426 176.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? 57.18 32.53 21.87 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.597 1.959 . . . . 0.0 112.447 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 32.0 mt -148.42 152.06 37.84 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 126.268 1.827 . . . . 0.0 112.311 -165.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.58 164.03 35.96 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 124.395 3.397 . . . . 0.0 114.44 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.95 -5.21 15.12 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.651 2.901 . . . . 0.0 114.476 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -75.05 -32.39 61.53 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.796 -1.19 . . . . 0.0 113.287 168.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.7 p -95.15 -20.35 19.33 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.1 m -135.16 130.4 35.33 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.308 1.043 . . . . 0.0 111.055 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -132.02 159.33 39.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.816 1.647 . . . . 0.0 112.598 -173.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.8 tp -127.61 137.0 52.43 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.184 1.794 . . . . 0.0 110.752 -176.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.5 p -132.64 151.45 51.95 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.028 0.931 . . . . 0.0 111.993 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -138.3 128.98 26.55 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.005 1.722 . . . . 0.0 109.984 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt 50.28 37.05 14.1 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.114 1.366 . . . . 0.0 114.076 172.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.22 11.49 80.71 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.447 1.499 . . . . 0.0 116.248 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -137.34 155.02 49.91 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.222 1.511 . . . . 0.0 113.59 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.14 99.52 11.57 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.57 1.148 . . . . 0.0 110.249 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.58 141.28 57.89 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.187 0.995 . . . . 0.0 110.994 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -166.6 154.48 9.91 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.649 1.58 . . . . 0.0 111.954 173.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.9 t0 57.41 28.72 15.82 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.973 1.709 . . . . 0.0 115.468 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.6 p -84.45 -24.73 29.38 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -174.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 59.49 -46.52 0.08 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 128.287 2.635 . . . . 0.0 115.803 -167.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 t -151.67 142.71 23.12 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.312 1.445 . . . . 0.0 111.229 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.4 tp -70.04 -22.86 63.04 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.699 0.799 . . . . 0.0 112.645 174.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.83 -33.6 75.08 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.085 -1.009 . . . . 0.0 113.168 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.4 t -64.81 -33.89 77.05 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.469 0.708 . . . . 0.0 112.32 174.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 87.0 mt -84.98 -3.98 58.97 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.548 1.539 . . . . 0.0 113.504 173.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.74 113.76 0.49 Allowed Glycine 0 CA--C 1.536 1.397 0 C-N-CA 126.026 1.774 . . . . 0.0 112.825 -170.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 m -70.79 157.56 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.206 1.002 . . . . 0.0 112.196 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -138.12 -169.07 2.49 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.084 1.754 . . . . 0.0 110.874 174.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -138.07 150.59 47.04 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.274 1.029 . . . . 0.0 112.58 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.82 21.75 75.22 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 123.32 0.486 . . . . 0.0 113.9 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -60.86 153.34 24.93 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.835 1.254 . . . . 0.0 112.858 176.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -134.41 136.69 43.47 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.094 0.958 . . . . 0.0 113.028 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -125.69 136.13 52.87 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.189 1.795 . . . . 0.0 109.411 -174.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.8 t -117.38 124.21 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.571 0.749 . . . . 0.0 110.079 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tp -104.39 125.99 51.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.692 0.797 . . . . 0.0 110.332 176.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.5 pt -116.5 146.27 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.348 1.459 . . . . 0.0 110.336 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.8 t -139.43 146.89 40.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.037 0.935 . . . . 0.0 111.548 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 55.6 ttt-85 . . . . . 0 N--CA 1.469 0.498 0 C-N-CA 126.331 1.852 . . . . 0.0 110.475 -169.382 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.503 ' HB2' ' OD1' ' A' ' 65' ' ' ASP . 15.8 mmt . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 mtmm -86.33 143.23 27.97 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.915 0.886 . . . . 0.0 110.283 162.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.3 157.54 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.009 1.723 . . . . 0.0 109.687 172.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -122.45 102.07 7.87 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.085 0.954 . . . . 0.0 110.88 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 tt -87.26 141.66 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 122.791 0.436 . . . . 0.0 110.71 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.3 t -130.73 81.78 66.47 Favored Pre-proline 0 N--CA 1.47 0.56 0 C-N-CA 125.276 1.43 . . . . 0.0 109.48 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.41 134.22 12.43 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.685 2.257 . . . . 0.0 112.046 178.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.18 40.65 0.21 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.024 1.33 . . . . 0.0 113.515 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.2 t -137.97 147.11 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.044 1.738 . . . . 0.0 110.814 -170.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.13 -121.55 21.55 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.845 0.736 . . . . 0.0 111.961 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.05 -17.31 71.67 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.671 0.653 . . . . 0.0 114.59 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.36 3.34 61.56 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.778 1.18 . . . . 0.0 115.402 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 m -72.65 152.13 91.47 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.103 1.361 . . . . 0.0 113.717 -172.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -64.97 152.64 81.67 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.706 2.271 . . . . 0.0 111.81 164.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.3 tp -142.64 124.52 15.16 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.785 1.234 . . . . 0.0 111.323 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -82.77 135.11 35.08 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.951 0.901 . . . . 0.0 111.899 175.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.3 mt -142.7 141.25 31.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.14 1.776 . . . . 0.0 110.761 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -76.78 144.61 39.07 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.626 0.77 . . . . 0.0 111.832 166.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.9 m -142.11 153.79 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.854 1.262 . . . . 0.0 111.452 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.76 150.7 88.69 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.218 0.607 . . . . 0.0 111.692 169.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -65.29 -20.92 62.14 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.781 2.321 . . . . 0.0 112.889 173.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -80.22 7.53 9.21 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.026 1.73 . . . . 0.0 114.185 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.18 117.53 4.5 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.691 1.197 . . . . 0.0 112.963 -174.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.9 m -91.34 141.27 28.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.36 1.464 . . . . 0.0 111.684 -176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.48 -44.22 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.556 -0.715 . . . . 0.0 111.986 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.2 -36.83 93.0 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.513 0.577 . . . . 0.0 113.681 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.82 -43.67 83.19 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.167 0.983 . . . . 0.0 111.797 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 82.3 t -63.7 -44.81 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.854 0.862 . . . . 0.0 111.252 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -64.02 -38.02 89.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.286 1.035 . . . . 0.0 111.966 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.0 m -66.34 -44.95 81.85 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.19 0.996 . . . . 0.0 111.423 174.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -58.17 -45.04 88.2 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.0 0.92 . . . . 0.0 112.139 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.8 t -59.67 -53.24 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.086 0.955 . . . . 0.0 111.112 173.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.3 t -61.08 -41.52 96.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.357 0.663 . . . . 0.0 112.535 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.9 73.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.065 0.946 . . . . 0.0 112.79 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.9 ttp -73.42 -22.57 60.19 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.6 mmpm? -93.23 -15.39 25.94 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.959 1.304 . . . . 0.0 113.688 170.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt 55.71 24.85 7.6 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.933 2.493 . . . . 0.0 114.613 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.86 153.97 61.65 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.857 1.663 . . . . 0.0 111.644 -173.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -71.12 156.66 59.25 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.897 3.065 . . . . 0.0 113.243 -175.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.75 -14.5 45.19 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.824 3.016 . . . . 0.0 114.491 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -64.22 -24.99 67.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.824 0.85 . . . . 0.0 113.09 170.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 38.8 p -98.17 -26.86 14.42 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.416 1.087 . . . . 0.0 113.441 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 84.9 m -138.76 116.94 11.8 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.284 1.034 . . . . 0.0 111.61 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -109.59 162.84 14.02 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.875 1.67 . . . . 0.0 112.984 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.4 tp -129.66 140.52 51.13 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.039 1.736 . . . . 0.0 111.303 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.4 p -136.26 157.71 46.16 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.597 1.159 . . . . 0.0 112.537 171.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -139.5 131.2 27.36 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.857 2.063 . . . . 0.0 109.789 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? 47.74 37.21 6.66 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.591 1.556 . . . . 0.0 114.485 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.09 14.95 81.76 Favored Glycine 0 CA--C 1.54 1.632 0 N-CA-C 115.715 1.046 . . . . 0.0 115.715 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -134.32 159.85 39.72 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.759 1.623 . . . . 0.0 111.761 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.12 133.16 34.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.407 0.683 . . . . 0.0 111.332 169.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.0 mt -86.41 127.55 34.84 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.822 0.849 . . . . 0.0 110.457 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.33 131.89 9.52 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.306 1.442 . . . . 0.0 110.541 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.0 t0 55.26 29.18 12.39 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.703 1.601 . . . . 0.0 115.094 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.2 p -84.5 -11.99 55.08 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.762 -1.211 . . . . 0.0 113.95 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 63.6 -54.15 0.22 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.893 2.477 . . . . 0.0 115.388 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.1 p -147.33 158.09 43.83 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.312 1.845 . . . . 0.0 111.516 176.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.4 -34.17 77.56 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.721 -0.612 . . . . 0.0 112.066 168.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.6 tm-20 -63.14 -33.54 75.69 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.832 0.853 . . . . 0.0 113.034 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 p -63.75 -27.65 69.34 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.4 mt -98.07 4.75 49.17 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.858 1.663 . . . . 0.0 113.17 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.16 100.11 0.76 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.367 1.46 . . . . 0.0 112.141 -172.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.5 p -73.65 150.68 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.869 1.267 . . . . 0.0 111.813 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.69 -171.86 3.33 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.041 1.736 . . . . 0.0 111.041 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.503 ' OD1' ' HB2' ' A' ' 1' ' ' MET . 14.2 t0 -121.88 145.2 48.32 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.453 1.101 . . . . 0.0 111.647 174.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.01 20.6 77.5 Favored Glycine 0 CA--C 1.539 1.533 0 CA-C-O 119.705 -0.497 . . . . 0.0 114.333 -174.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -58.47 136.48 57.51 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.432 1.116 . . . . 0.0 111.835 172.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -112.25 140.68 46.76 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -123.66 132.64 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.151 1.781 . . . . 0.0 109.295 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.7 t -123.58 121.3 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 118.719 0.69 . . . . 0.0 110.873 -173.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 tp -96.32 137.72 34.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.379 1.072 . . . . 0.0 110.178 175.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.32 125.43 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.485 1.114 . . . . 0.0 109.027 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.7 t -118.1 142.04 47.84 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.711 1.204 . . . . 0.0 112.141 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 . . . . . 0 N--CA 1.472 0.66 0 C-N-CA 124.912 1.285 . . . . 0.0 111.478 171.204 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 121.344 0.592 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -92.75 139.31 30.68 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.652 1.181 . . . . 0.0 111.197 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pp -137.0 162.84 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.773 1.629 . . . . 0.0 110.849 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -126.79 138.73 53.4 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.203 1.001 . . . . 0.0 112.153 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.9 mt -121.18 133.91 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.936 1.295 . . . . 0.0 109.096 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.23 92.87 37.71 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.692 1.197 . . . . 0.0 110.831 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -88.25 130.87 2.5 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.915 2.41 . . . . 0.0 112.493 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.23 29.95 0.12 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.514 1.526 . . . . 0.0 114.507 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.3 m -73.95 73.87 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 126.471 1.908 . . . . 0.0 112.767 -173.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.0 38.91 63.89 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.143 0.878 . . . . 0.0 113.192 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.55 29.46 29.8 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.311 0.958 . . . . 0.0 114.289 -174.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.78 141.22 48.1 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 124.622 1.106 . . . . 0.0 114.103 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 m -80.03 154.62 75.16 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 125.107 1.363 . . . . 0.0 113.418 -176.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -62.89 147.43 94.62 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.075 2.517 . . . . 0.0 111.997 166.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.86 138.03 35.39 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.64 1.576 . . . . 0.0 110.813 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -87.73 140.34 29.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.069 1.348 . . . . 0.0 112.122 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 mp -140.85 164.94 28.88 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.083 1.753 . . . . 0.0 111.459 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -116.39 137.53 52.08 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.52 1.528 . . . . 0.0 110.217 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.3 158.99 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.743 1.217 . . . . 0.0 111.879 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.2 149.13 98.62 Favored Pre-proline 0 CA--C 1.551 0.984 0 O-C-N 121.767 -0.583 . . . . 0.0 111.498 170.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.46 -24.32 56.94 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.944 2.429 . . . . 0.0 113.221 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -82.95 33.35 0.44 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.925 1.69 . . . . 0.0 113.638 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.41 117.76 5.64 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.184 -0.948 . . . . 0.0 111.199 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.2 m -97.46 129.36 44.66 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.732 1.213 . . . . 0.0 110.888 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.8 -44.0 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.917 0.887 . . . . 0.0 112.226 -175.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.46 -36.47 93.42 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.517 0.579 . . . . 0.0 113.51 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.92 -37.98 76.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.38 1.09 . . . . 0.0 112.378 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.7 t -68.65 -43.93 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.276 1.03 . . . . 0.0 111.24 174.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -63.84 -37.39 87.2 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.022 0.929 . . . . 0.0 112.241 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.9 m -64.17 -39.77 94.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.661 0.785 . . . . 0.0 111.328 170.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.24 -47.95 83.81 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.872 0.869 . . . . 0.0 111.281 174.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.4 t -56.9 -50.22 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.04 1.336 . . . . 0.0 111.342 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.5 t -59.93 -44.71 94.17 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.756 0.822 . . . . 0.0 112.109 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.84 86.17 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.994 0.918 . . . . 0.0 113.177 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.4 mtt -68.64 -42.49 77.94 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.107 0.963 . . . . 0.0 112.748 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.98 -23.28 41.71 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.01 26.24 15.53 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.962 1.705 . . . . 0.0 113.275 -174.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.79 153.91 70.39 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 126.845 2.058 . . . . 0.0 111.317 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.47 163.63 38.16 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 124.293 3.329 . . . . 0.0 114.247 -173.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.57 -15.78 51.75 Favored 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 123.421 2.747 . . . . 0.0 113.992 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -67.67 -28.86 68.05 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.138 -0.976 . . . . 0.0 113.208 173.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.1 p -102.95 -10.16 19.23 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.087 1.355 . . . . 0.0 113.872 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.4 m -148.63 123.49 9.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.836 1.254 . . . . 0.0 111.263 172.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -110.49 160.39 16.66 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.718 1.207 . . . . 0.0 113.447 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.6 tp -126.43 132.52 51.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.798 2.039 . . . . 0.0 110.391 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.5 p -137.11 158.36 44.62 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.362 1.065 . . . . 0.0 111.966 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -133.44 126.58 31.51 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.137 2.175 . . . . 0.0 109.378 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt 51.49 30.66 6.55 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.17 0.988 . . . . 0.0 113.382 -174.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.34 2.28 73.15 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 125.26 1.409 . . . . 0.0 115.958 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.44 146.3 29.68 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.948 2.099 . . . . 0.0 111.357 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.8 122.15 25.68 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.576 -0.703 . . . . 0.0 110.968 169.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.2 mt -83.35 134.17 34.92 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.201 1.0 . . . . 0.0 111.097 171.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -160.38 144.76 14.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.456 1.502 . . . . 0.0 110.578 170.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.9 t0 52.69 27.99 5.8 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.778 1.631 . . . . 0.0 115.021 174.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.9 m -83.04 -23.82 33.04 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.078 1.351 . . . . 0.0 112.926 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 61.63 -52.85 0.13 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 128.403 2.681 . . . . 0.0 115.544 -172.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.0 t -159.15 142.27 14.5 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.031 1.332 . . . . 0.0 111.641 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.16 -26.75 67.57 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.538 0.735 . . . . 0.0 112.314 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.43 -20.01 64.62 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.755 1.161 . . . . 0.0 113.361 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.7 t -74.91 -38.19 61.89 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.112 0.965 . . . . 0.0 112.374 173.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.47 -35.73 14.94 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.887 1.275 . . . . 0.0 112.929 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 140.42 87.77 0.13 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.042 1.782 . . . . 0.0 112.267 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.3 p -76.72 147.36 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.011 1.324 . . . . 0.0 112.357 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.19 156.13 37.98 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.894 1.278 . . . . 0.0 112.483 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -67.65 147.09 53.17 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.339 -0.851 . . . . 0.0 111.287 162.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.78 14.32 77.95 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 123.867 0.746 . . . . 0.0 114.493 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -55.4 132.91 49.36 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.729 1.264 . . . . 0.0 110.579 168.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.48 131.95 45.41 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.268 1.027 . . . . 0.0 112.443 -165.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -128.07 132.1 49.06 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.432 1.493 . . . . 0.0 110.637 -169.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.74 133.96 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.166 0.987 . . . . 0.0 110.752 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 tp -109.93 115.47 29.85 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.313 1.045 . . . . 0.0 110.049 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.2 mm -105.32 94.09 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.256 1.023 . . . . 0.0 108.983 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -79.22 152.02 30.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.259 1.424 . . . . 0.0 111.243 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 . . . . . 0 N--CA 1.474 0.759 0 C-N-CA 124.74 1.216 . . . . 0.0 112.197 -177.892 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 110.583 -0.154 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -86.13 145.4 27.04 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.179 -1.575 . . . . 0.0 112.944 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.4 mm -136.48 140.12 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 127.873 2.469 . . . . 0.0 108.641 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -91.84 140.2 29.91 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.177 0.591 . . . . 0.0 110.596 167.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.6 pt -118.78 139.78 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.888 0.875 . . . . 0.0 110.317 168.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 t -129.95 73.71 81.18 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 124.602 1.161 . . . . 0.0 110.371 -175.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -78.62 134.34 12.22 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.508 2.805 . . . . 0.0 112.014 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.05 35.17 0.2 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.603 1.561 . . . . 0.0 114.545 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.4 m -138.94 161.59 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 126.09 1.756 . . . . 0.0 111.874 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.87 -119.97 18.31 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 123.687 0.661 . . . . 0.0 111.467 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.09 -17.85 74.18 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 123.684 0.659 . . . . 0.0 114.691 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.48 2.48 35.01 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.206 1.384 . . . . 0.0 115.229 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.6 p -85.63 156.55 58.8 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.392 1.877 . . . . 0.0 113.591 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.32 153.08 79.4 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.051 2.5 . . . . 0.0 112.4 170.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.8 tp -143.19 130.04 20.48 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.185 1.394 . . . . 0.0 111.671 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -80.35 134.97 36.1 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.41 1.084 . . . . 0.0 111.967 172.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.4 mt -142.93 149.53 38.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.118 1.767 . . . . 0.0 111.409 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -90.58 134.32 34.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.502 1.121 . . . . 0.0 110.809 169.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.59 154.64 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.612 1.165 . . . . 0.0 112.299 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.64 152.12 89.35 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.361 1.064 . . . . 0.0 112.585 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.11 -17.98 55.74 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.364 2.709 . . . . 0.0 113.544 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -80.59 4.81 17.3 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.521 1.528 . . . . 0.0 113.928 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.67 125.99 25.81 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.495 1.043 . . . . 0.0 112.565 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 m -94.21 131.27 39.96 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.045 1.338 . . . . 0.0 110.814 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.6 t -60.6 -41.54 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 O-C-N 121.348 -0.845 . . . . 0.0 111.962 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.86 -33.93 88.57 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 123.827 0.727 . . . . 0.0 113.767 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.97 -42.66 76.31 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.389 1.095 . . . . 0.0 111.463 174.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.59 -48.03 88.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.77 0.828 . . . . 0.0 110.876 174.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.4 mmm-85 -58.14 -45.99 86.43 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.792 0.837 . . . . 0.0 112.115 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.7 m -60.34 -44.53 95.43 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.332 0.653 . . . . 0.0 111.902 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -42.85 99.44 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.149 0.979 . . . . 0.0 111.568 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.0 t -67.18 -47.76 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.589 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 97.8 m -57.67 -42.32 83.31 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.025 1.284 . . . . 0.0 112.087 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.94 -41.18 91.64 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.79 0.836 . . . . 0.0 112.797 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.7 ttt -70.85 -41.68 71.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.257 1.023 . . . . 0.0 112.815 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -29.11 63.85 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.762 1.225 . . . . 0.0 112.641 173.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? 68.65 31.75 4.51 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 127.247 2.219 . . . . 0.0 113.208 -173.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mp -128.98 153.65 80.26 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.193 1.797 . . . . 0.0 111.824 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.14 159.62 53.13 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.836 3.024 . . . . 0.0 113.245 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.51 -15.25 48.91 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.923 3.082 . . . . 0.0 114.408 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -70.23 -25.14 63.24 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.475 1.034 . . . . 0.0 113.031 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.4 m -93.46 0.65 56.84 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.962 1.305 . . . . 0.0 113.22 -175.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.0 t -137.34 140.21 41.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.939 1.296 . . . . 0.0 112.056 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -134.16 140.8 46.79 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.72 1.608 . . . . 0.0 110.772 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.4 tp -131.63 129.92 41.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.508 1.523 . . . . 0.0 110.907 -171.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -139.7 153.82 47.33 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.48 1.112 . . . . 0.0 112.948 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -143.72 138.64 29.01 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.263 1.825 . . . . 0.0 110.24 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 55.03 30.89 15.04 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.863 1.265 . . . . 0.0 113.777 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.45 18.19 79.28 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 124.786 1.184 . . . . 0.0 114.952 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -134.15 142.78 47.58 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.373 1.869 . . . . 0.0 111.132 -170.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.91 135.55 40.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.762 0.825 . . . . 0.0 111.919 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.4 mt -103.91 136.81 42.88 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.486 1.114 . . . . 0.0 110.798 173.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.48 149.65 18.94 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.119 1.368 . . . . 0.0 111.164 171.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.0 t0 54.23 27.67 8.16 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.778 1.631 . . . . 0.0 114.88 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -75.24 -24.88 57.72 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.388 1.075 . . . . 0.0 113.287 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 60.53 -56.01 0.08 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 128.584 2.754 . . . . 0.0 114.898 -169.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 p -146.92 133.57 19.91 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.934 1.694 . . . . 0.0 111.205 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.79 -32.8 74.53 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.871 0.869 . . . . 0.0 112.882 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -62.09 -26.83 68.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.145 0.978 . . . . 0.0 113.383 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.6 m -71.05 -28.15 64.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.385 1.074 . . . . 0.0 113.445 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 72.3 mt -99.76 -32.21 11.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.74 1.216 . . . . 0.0 112.966 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 138.39 81.55 0.09 OUTLIER Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.516 1.532 . . . . 0.0 112.162 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.4 p -70.52 147.07 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.268 1.027 . . . . 0.0 111.633 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -146.36 167.96 22.29 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.619 1.568 . . . . 0.0 111.863 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -106.48 145.69 31.49 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.375 1.47 . . . . 0.0 113.446 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.53 13.45 82.93 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 123.798 0.714 . . . . 0.0 114.463 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -65.03 159.92 22.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.412 1.085 . . . . 0.0 111.796 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.72 130.96 28.44 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -101.43 138.5 38.36 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.242 1.417 . . . . 0.0 111.093 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.87 134.47 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.263 1.025 . . . . 0.0 109.574 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.0 tt -130.84 125.46 33.7 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.759 0.824 . . . . 0.0 111.514 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.0 mm -113.41 135.78 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.123 1.769 . . . . 0.0 110.476 -170.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.2 t -102.05 143.48 31.84 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.803 1.241 . . . . 0.0 111.346 172.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.862 0 C-N-CA 124.626 1.17 . . . . 0.0 111.055 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ttt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 120.657 0.265 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -68.56 147.52 51.84 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.624 -1.297 . . . . 0.0 111.072 158.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -143.95 166.11 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 127.568 2.347 . . . . 0.0 110.165 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -125.69 134.9 51.66 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.062 0.945 . . . . 0.0 111.355 167.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 54.5 mt -121.53 131.03 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.999 1.319 . . . . 0.0 108.669 177.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 p -121.49 98.11 46.48 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 124.563 1.145 . . . . 0.0 110.77 173.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -84.58 144.11 9.98 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.298 2.666 . . . . 0.0 111.38 172.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.34 34.38 0.11 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 125.687 1.595 . . . . 0.0 113.553 173.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.3 t -134.29 144.32 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.263 1.825 . . . . 0.0 110.684 -167.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.24 -113.76 6.21 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.05 0.833 . . . . 0.0 112.234 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.73 -20.22 70.05 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 123.984 0.802 . . . . 0.0 114.548 174.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.37 12.86 64.26 Favored Glycine 0 CA--C 1.54 1.606 0 CA-C-N 118.547 1.173 . . . . 0.0 115.47 175.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.0 p -111.86 155.97 42.39 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 126.254 1.822 . . . . 0.0 113.003 -167.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.6 145.11 91.3 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.977 2.451 . . . . 0.0 112.317 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.92 129.62 34.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.6 1.56 . . . . 0.0 109.998 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.84 135.21 43.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.654 1.181 . . . . 0.0 111.543 173.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.13 168.59 19.38 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.832 1.653 . . . . 0.0 110.602 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.2 143.56 49.95 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.909 1.284 . . . . 0.0 111.086 166.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.5 m -141.45 158.12 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.033 1.333 . . . . 0.0 112.109 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.64 149.23 98.35 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.238 1.015 . . . . 0.0 112.179 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -67.69 -17.71 47.81 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.623 2.882 . . . . 0.0 113.837 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.48 -6.7 59.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.205 1.402 . . . . 0.0 114.136 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.76 141.5 52.74 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.471 1.032 . . . . 0.0 111.282 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.9 t -130.83 145.94 52.13 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.365 1.066 . . . . 0.0 111.328 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.24 -35.28 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.439 0.696 . . . . 0.0 111.807 -169.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.57 -35.98 91.93 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 121.736 -0.603 . . . . 0.0 113.84 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.89 -41.91 67.41 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.596 1.198 . . . . 0.0 112.045 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.79 -44.44 99.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.561 0.744 . . . . 0.0 110.685 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -60.35 -47.16 87.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.373 1.069 . . . . 0.0 111.523 174.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.1 m -59.85 -45.77 91.4 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.937 0.895 . . . . 0.0 111.813 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -60.2 -43.31 96.02 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.705 0.802 . . . . 0.0 112.505 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.51 -41.32 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.777 0.717 . . . . 0.0 112.105 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 87.5 m -60.53 -37.16 80.3 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.527 1.058 . . . . 0.0 112.31 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.0 77.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.252 1.021 . . . . 0.0 113.122 174.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.3 mmt -66.83 -38.32 86.21 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.325 -0.859 . . . . 0.0 112.524 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -23.1 58.56 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.991 1.316 . . . . 0.0 113.385 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.5 mtpt 51.04 45.02 28.36 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.958 2.103 . . . . 0.0 112.435 -167.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.2 mt -136.17 151.34 73.33 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.786 1.634 . . . . 0.0 112.245 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -70.77 162.44 42.58 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 124.004 3.136 . . . . 0.0 113.526 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.69 -11.58 29.72 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 123.662 2.908 . . . . 0.0 114.305 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -72.07 -32.85 67.44 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.694 1.197 . . . . 0.0 113.123 173.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.6 p -105.11 -5.23 20.99 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.156 1.382 . . . . 0.0 113.858 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.0 m -147.63 125.18 11.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.137 1.775 . . . . 0.0 110.077 176.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -140.47 147.19 39.24 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.1 tp -108.85 140.17 42.67 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.587 1.955 . . . . 0.0 111.028 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.9 t -141.88 157.33 45.12 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.263 1.425 . . . . 0.0 111.485 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -132.0 129.99 40.83 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.67 1.588 . . . . 0.0 110.359 -174.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp 51.36 29.06 4.79 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.61 14.84 82.07 Favored Glycine 0 CA--C 1.541 1.709 0 C-N-CA 125.288 1.423 . . . . 0.0 116.09 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.47 129.26 30.81 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.781 1.632 . . . . 0.0 111.267 -177.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.76 131.65 46.83 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.332 0.653 . . . . 0.0 112.501 -175.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.1 mt -131.68 153.9 49.53 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.461 1.504 . . . . 0.0 111.607 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -161.08 -48.83 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.978 1.711 . . . . 0.0 111.268 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -81.54 27.82 0.42 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.688 1.995 . . . . 0.0 114.115 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.8 m -68.09 -27.56 66.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.25 1.42 . . . . 0.0 113.277 -172.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 64.5 -63.43 0.17 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.231 2.612 . . . . 0.0 114.895 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.6 p -149.08 146.99 27.99 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.249 1.819 . . . . 0.0 110.485 168.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.4 mt -74.08 -27.4 60.88 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.538 -0.726 . . . . 0.0 112.068 171.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -58.53 -36.21 73.51 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.227 1.011 . . . . 0.0 113.079 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.8 p -63.71 -20.01 65.39 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.5 mt -105.6 -2.44 23.48 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.034 1.733 . . . . 0.0 113.294 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.26 113.84 0.35 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.629 1.585 . . . . 0.0 112.578 -171.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.67 146.04 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.976 1.31 . . . . 0.0 111.676 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -145.71 174.74 10.94 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.672 1.589 . . . . 0.0 111.797 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -78.29 162.05 26.8 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.027 0.931 . . . . 0.0 110.903 162.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.67 14.81 81.68 Favored Glycine 0 CA--C 1.536 1.406 0 N-CA-C 115.844 1.098 . . . . 0.0 115.844 174.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.59 127.25 31.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.852 1.326 . . . . 0.0 110.613 165.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -129.03 130.4 46.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.882 1.273 . . . . 0.0 111.981 -166.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -125.51 133.24 52.44 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.798 1.639 . . . . 0.0 111.195 -170.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.6 t -118.1 129.54 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.814 1.245 . . . . 0.0 109.152 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.38 120.57 34.39 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.263 1.025 . . . . 0.0 110.108 -176.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.4 mt -116.19 130.03 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.82 1.248 . . . . 0.0 109.12 -172.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.8 p -120.02 158.46 26.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.19 1.396 . . . . 0.0 111.053 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 . . . . . 0 N--CA 1.475 0.787 0 C-N-CA 124.433 1.093 . . . . 0.0 111.37 -175.807 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptm . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -86.44 149.61 24.87 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.127 -1.608 . . . . 0.0 111.812 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.4 pt -130.74 166.08 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.764 2.025 . . . . 0.0 111.117 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -131.07 112.46 12.91 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.577 1.151 . . . . 0.0 110.079 170.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.3 tt -94.81 139.69 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 122.779 0.432 . . . . 0.0 110.652 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 t -126.92 81.43 69.63 Favored Pre-proline 0 N--CA 1.471 0.609 0 C-N-CA 125.247 1.419 . . . . 0.0 109.649 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.53 136.39 12.34 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.474 2.116 . . . . 0.0 112.473 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.83 41.1 0.15 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.133 1.373 . . . . 0.0 113.194 171.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.4 t -135.86 142.66 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.348 1.859 . . . . 0.0 110.35 -169.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.43 -116.5 9.44 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.949 0.785 . . . . 0.0 112.533 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.82 -14.9 68.38 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.212 0.911 . . . . 0.0 115.081 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.69 7.37 47.66 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 118.885 1.342 . . . . 0.0 115.929 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.6 m -94.43 155.48 39.65 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.696 1.598 . . . . 0.0 113.166 -170.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -63.01 147.23 94.74 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.212 2.608 . . . . 0.0 112.18 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 tt -138.75 122.61 17.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.414 1.486 . . . . 0.0 110.391 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -82.27 143.39 31.35 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.958 0.903 . . . . 0.0 112.783 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 tp -152.2 153.81 34.55 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.535 1.134 . . . . 0.0 111.657 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -85.22 150.43 24.8 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.374 -0.829 . . . . 0.0 111.338 163.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p -148.16 149.66 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.101 0.961 . . . . 0.0 111.643 174.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.06 149.91 98.23 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.992 0.917 . . . . 0.0 112.482 176.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.56 -21.09 46.57 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.278 2.652 . . . . 0.0 113.023 175.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -78.76 16.45 0.87 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.954 1.702 . . . . 0.0 113.648 175.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.35 121.94 10.04 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.391 1.076 . . . . 0.0 112.003 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.6 m -107.83 130.23 55.01 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.283 1.433 . . . . 0.0 109.861 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.1 t -58.94 -42.93 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.383 0.673 . . . . 0.0 111.637 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.77 -37.48 92.51 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.619 1.104 . . . . 0.0 113.578 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.02 -45.12 71.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.326 1.063 . . . . 0.0 111.705 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.32 -50.68 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.814 0.846 . . . . 0.0 111.581 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.27 -37.15 86.47 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.683 -0.636 . . . . 0.0 112.468 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.1 m -67.13 -42.03 85.14 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.522 0.601 . . . . 0.0 111.451 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -40.2 93.72 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.996 0.919 . . . . 0.0 111.887 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -62.18 -52.54 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.555 1.142 . . . . 0.0 111.502 172.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 88.3 m -62.24 -35.51 79.14 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.51 0.596 . . . . 0.0 112.23 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.64 86.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.404 1.081 . . . . 0.0 112.752 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -43.95 87.16 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.726 0.81 . . . . 0.0 112.365 174.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 36' ' ' LYS . 8.0 mmpt? -73.71 -20.48 60.52 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.704 1.202 . . . . 0.0 113.99 177.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? 55.92 27.84 11.69 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.59 1.956 . . . . 0.0 113.075 -170.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.24 154.74 70.25 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.486 1.914 . . . . 0.0 111.394 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.69 165.07 33.24 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.425 3.417 . . . . 0.0 114.225 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.34 -17.5 58.14 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.312 2.675 . . . . 0.0 114.091 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -64.64 -28.91 69.93 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.829 -1.169 . . . . 0.0 112.796 173.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.0 p -98.48 -14.05 20.23 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.271 1.428 . . . . 0.0 114.328 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 100.0 m -142.66 117.03 9.61 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 119.899 1.227 . . . . 0.0 111.919 174.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.5 167.74 10.62 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.003 1.721 . . . . 0.0 113.137 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.8 tp -142.63 136.42 29.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.03 1.732 . . . . 0.0 111.372 -173.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.4 p -135.57 158.31 44.69 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.54 1.136 . . . . 0.0 113.213 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -147.62 130.39 16.08 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.3 2.24 . . . . 0.0 110.052 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? 50.67 31.36 5.75 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.323 1.449 . . . . 0.0 113.78 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.86 7.35 88.37 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.01 1.291 . . . . 0.0 115.96 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -120.54 158.97 26.16 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.581 1.552 . . . . 0.0 112.409 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.39 127.76 32.5 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.649 0.78 . . . . 0.0 110.534 165.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.7 mt -75.46 138.12 41.4 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.376 0.671 . . . . 0.0 110.762 169.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -163.28 142.5 8.46 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.427 1.491 . . . . 0.0 111.464 170.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t0 57.19 21.39 6.52 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.3 m -70.84 -26.92 63.49 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.857 1.263 . . . . 0.0 112.9 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 63.65 -56.0 0.21 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 128.619 2.767 . . . . 0.0 115.01 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.3 p -145.06 144.46 30.98 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.274 1.429 . . . . 0.0 111.48 170.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.4 -28.54 68.01 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.558 -0.714 . . . . 0.0 112.271 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -65.29 -26.87 68.26 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.362 -0.836 . . . . 0.0 113.167 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.5 t -63.07 -37.49 87.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.738 0.815 . . . . 0.0 112.614 172.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.0 mt -90.68 -10.33 43.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.936 1.294 . . . . 0.0 113.689 174.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.51 118.14 2.49 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 126.471 1.986 . . . . 0.0 112.545 -172.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.7 t -73.51 144.89 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.811 1.244 . . . . 0.0 111.219 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.06 156.55 38.04 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.635 1.574 . . . . 0.0 110.551 166.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -88.77 146.92 24.73 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.152 -0.967 . . . . 0.0 112.522 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.0 26.59 66.29 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.631 0.613 . . . . 0.0 114.631 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -61.8 140.11 58.27 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.499 1.149 . . . . 0.0 111.869 175.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -119.13 134.23 55.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.711 0.804 . . . . 0.0 112.581 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -122.28 138.25 54.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.427 1.491 . . . . 0.0 110.755 -174.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.83 123.07 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.591 0.757 . . . . 0.0 110.594 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tp -97.92 134.97 40.32 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.4 1.08 . . . . 0.0 110.637 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.08 111.7 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.719 1.208 . . . . 0.0 109.711 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.4 t -90.74 152.39 20.83 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.83 1.252 . . . . 0.0 111.292 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 . . . . . 0 N--CA 1.476 0.835 0 C-N-CA 125.673 1.589 . . . . 0.0 111.004 172.862 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 121.188 0.518 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -114.05 149.02 36.08 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.195 1.398 . . . . 0.0 111.414 170.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -128.52 155.32 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.865 1.666 . . . . 0.0 110.047 173.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -118.86 93.81 4.23 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.854 1.262 . . . . 0.0 110.22 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 tt -79.71 140.47 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.783 -0.573 . . . . 0.0 110.743 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.7 t -131.51 82.31 61.97 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 125.261 1.425 . . . . 0.0 109.842 -172.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.39 136.45 9.94 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.631 2.22 . . . . 0.0 113.098 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.96 39.22 0.18 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.592 1.557 . . . . 0.0 113.564 172.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.6 t -137.99 145.87 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.987 1.715 . . . . 0.0 110.691 -171.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.44 -119.58 17.33 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.054 0.835 . . . . 0.0 112.429 176.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.9 -14.42 67.87 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 124.088 0.851 . . . . 0.0 114.903 175.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.27 6.22 46.23 Favored Glycine 0 CA--C 1.541 1.71 0 CA-C-N 118.812 1.306 . . . . 0.0 115.87 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.2 m -90.83 153.57 45.35 Favored Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 125.369 1.468 . . . . 0.0 113.334 -171.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -66.25 152.98 79.79 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 123.403 2.735 . . . . 0.0 112.646 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 tp -140.1 118.72 12.32 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.427 1.491 . . . . 0.0 111.586 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -69.51 137.56 52.61 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.436 1.094 . . . . 0.0 111.575 169.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.3 tp -150.64 136.9 18.6 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.532 1.133 . . . . 0.0 111.51 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.02 143.33 43.6 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.612 0.765 . . . . 0.0 111.626 171.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.17 147.95 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.232 1.013 . . . . 0.0 112.1 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.79 150.89 95.28 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.143 0.977 . . . . 0.0 112.537 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.58 -27.12 53.67 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.043 2.496 . . . . 0.0 113.048 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -77.35 14.39 0.97 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.398 1.479 . . . . 0.0 114.134 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.13 100.29 0.32 Allowed 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.844 -1.16 . . . . 0.0 112.212 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.7 t -73.62 148.77 42.54 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.427 1.091 . . . . 0.0 110.858 168.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.6 m -57.75 -31.55 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.85 0.86 . . . . 0.0 112.485 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.33 -41.78 99.37 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.576 0.608 . . . . 0.0 112.732 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.2 -44.82 82.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.771 0.828 . . . . 0.0 111.75 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.2 t -62.98 -49.46 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.879 0.871 . . . . 0.0 110.924 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -35.92 78.26 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.853 1.261 . . . . 0.0 112.369 -177.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.6 m -66.79 -45.44 78.44 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.551 0.74 . . . . 0.0 111.435 172.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -63.18 -39.28 94.19 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.702 0.683 . . . . 0.0 111.928 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -56.94 -52.0 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.51 1.124 . . . . 0.0 111.385 170.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 51.8 t -60.86 -42.78 98.52 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.123 0.569 . . . . 0.0 112.207 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.23 -40.72 86.37 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.972 0.909 . . . . 0.0 113.254 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.8 tpp -67.73 -44.07 78.46 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.808 1.243 . . . . 0.0 112.094 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -76.63 -24.03 53.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.691 0.796 . . . . 0.0 113.043 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.3 ttpp 59.67 27.25 16.45 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.457 2.303 . . . . 0.0 114.144 -173.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.01 154.49 81.38 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 126.192 1.797 . . . . 0.0 112.033 -175.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.81 159.95 50.98 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.904 3.069 . . . . 0.0 113.974 -171.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.57 -10.24 28.46 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.269 3.312 . . . . 0.0 114.978 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -73.46 -21.56 60.41 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.195 -0.941 . . . . 0.0 112.601 167.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.9 m -108.48 -37.26 6.0 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.018 1.327 . . . . 0.0 112.844 -172.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.2 t -97.52 139.09 33.97 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.69 0.796 . . . . 0.0 111.728 170.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -136.54 154.11 50.81 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.592 1.557 . . . . 0.0 111.476 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.8 tp -138.23 132.9 32.5 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.472 1.509 . . . . 0.0 111.217 -171.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.2 p -140.17 155.12 47.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.26 1.024 . . . . 0.0 113.526 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -149.01 131.64 15.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.788 2.035 . . . . 0.0 110.302 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.0 tptt 54.27 29.05 10.04 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.166 1.386 . . . . 0.0 114.319 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.73 3.33 87.11 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.382 1.468 . . . . 0.0 115.562 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -112.55 161.26 16.97 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.821 2.048 . . . . 0.0 111.334 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.03 142.25 28.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.61 0.764 . . . . 0.0 110.64 161.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.16 118.82 34.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.134 0.974 . . . . 0.0 111.053 172.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.39 145.72 22.97 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.489 1.516 . . . . 0.0 111.109 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 54.63 23.52 4.77 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.589 1.956 . . . . 0.0 116.137 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 p -75.94 -24.02 55.46 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 120.818 -1.176 . . . . 0.0 113.69 -176.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 63.79 -40.15 0.21 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 128.739 2.816 . . . . 0.0 115.122 -172.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 t -152.22 154.6 36.1 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.188 1.795 . . . . 0.0 111.656 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.66 -25.14 68.08 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.211 1.005 . . . . 0.0 112.899 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.92 -27.84 69.42 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.3 m -65.0 -28.04 69.23 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.994 0.918 . . . . 0.0 112.963 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 mp -96.71 -10.06 27.71 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.468 1.507 . . . . 0.0 112.745 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.5 28.9 74.07 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.43 1.014 . . . . 0.0 114.468 177.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.8 m -65.97 151.79 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.515 1.126 . . . . 0.0 113.949 -170.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.08 179.07 7.03 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.238 1.415 . . . . 0.0 112.657 173.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -73.58 152.04 40.71 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 121.112 -0.992 . . . . 0.0 111.631 165.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.37 29.23 53.82 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 115.856 1.103 . . . . 0.0 115.856 172.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -62.11 155.33 24.54 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.772 1.286 . . . . 0.0 112.263 172.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -125.81 136.62 53.33 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.877 0.871 . . . . 0.0 112.347 173.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -122.23 133.53 54.71 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.855 1.262 . . . . 0.0 110.548 -173.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.9 t -103.24 129.42 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.209 0.603 . . . . 0.0 110.338 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 tp -105.57 131.17 53.29 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.087 0.955 . . . . 0.0 110.572 172.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -115.84 146.32 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.621 1.569 . . . . 0.0 109.53 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.6 t -127.34 164.94 20.69 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.167 1.387 . . . . 0.0 112.085 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 . . . . . 0 N--CA 1.475 0.777 0 C-N-CA 126.964 2.106 . . . . 0.0 110.44 -179.037 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 mmt . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.0 140.23 45.34 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.469 -1.395 . . . . 0.0 111.145 160.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pp -131.01 166.58 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.657 1.983 . . . . 0.0 110.311 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -120.99 102.66 8.48 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.458 1.103 . . . . 0.0 110.795 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.6 tt -77.84 143.14 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.859 -0.525 . . . . 0.0 110.067 173.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.5 79.93 72.61 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 124.824 1.249 . . . . 0.0 109.551 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.39 134.27 15.39 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.723 2.949 . . . . 0.0 112.32 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.32 28.76 0.15 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.558 1.543 . . . . 0.0 114.377 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.1 m -138.39 162.89 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 126.181 1.792 . . . . 0.0 111.699 -176.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.76 -128.78 35.32 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 123.602 0.62 . . . . 0.0 111.806 -175.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.73 -15.1 73.31 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 174.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.74 -1.09 54.85 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 124.97 1.271 . . . . 0.0 115.798 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -71.69 151.79 93.48 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 125.278 1.431 . . . . 0.0 113.195 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -64.17 150.54 88.11 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.716 2.278 . . . . 0.0 111.448 166.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.7 tp -142.8 132.86 24.39 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.252 1.021 . . . . 0.0 111.961 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -78.23 133.85 37.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.123 0.969 . . . . 0.0 112.335 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mp -139.82 143.6 36.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.479 1.512 . . . . 0.0 110.763 169.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -81.1 136.42 35.92 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.519 0.728 . . . . 0.0 110.26 166.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.8 142.67 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.733 0.813 . . . . 0.0 112.154 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.29 147.94 96.48 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.864 0.866 . . . . 0.0 112.498 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.49 -19.61 65.28 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.444 2.763 . . . . 0.0 113.67 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -78.91 4.65 13.55 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.868 1.667 . . . . 0.0 114.659 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 124.83 21.5 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.568 1.076 . . . . 0.0 112.649 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.2 m -107.89 138.58 43.89 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.557 1.543 . . . . 0.0 111.305 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.0 t -56.62 -47.29 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.023 0.929 . . . . 0.0 112.547 -175.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.5 -41.5 98.71 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.429 0.537 . . . . 0.0 112.926 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.13 -45.74 79.99 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.006 0.903 . . . . 0.0 112.139 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.48 -52.84 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.9 0.88 . . . . 0.0 110.849 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -62.33 -45.68 92.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.903 0.881 . . . . 0.0 111.606 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 84.6 m -61.17 -41.34 96.6 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.359 0.663 . . . . 0.0 111.917 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -63.43 -40.68 97.83 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.003 0.819 . . . . 0.0 112.416 176.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.6 t -67.68 -43.75 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.201 0.91 . . . . 0.0 111.53 174.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 93.9 m -56.88 -43.1 80.93 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.478 1.036 . . . . 0.0 112.081 174.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.19 89.09 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.111 0.964 . . . . 0.0 112.803 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.3 tpt -67.83 -39.59 83.87 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.869 0.868 . . . . 0.0 112.496 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -19.02 56.42 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.28 1.432 . . . . 0.0 113.916 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt 58.28 29.05 17.5 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.733 2.013 . . . . 0.0 113.328 -169.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mp -128.08 154.83 78.61 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 126.275 1.83 . . . . 0.0 111.82 -174.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.37 165.33 32.05 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 124.399 3.4 . . . . 0.0 115.102 -171.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -63.15 -15.85 50.69 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.644 2.896 . . . . 0.0 113.928 170.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -68.66 -21.16 64.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.236 1.014 . . . . 0.0 113.136 171.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.9 p -114.86 -38.73 3.86 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.051 1.34 . . . . 0.0 113.183 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 81.7 m -92.84 124.67 37.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.29 1.436 . . . . 0.0 111.001 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -149.27 146.22 27.46 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -171.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.18 148.08 34.81 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.245 1.818 . . . . 0.0 111.91 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.0 m -143.04 143.15 31.77 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.834 1.654 . . . . 0.0 111.836 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -144.49 133.54 22.75 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.357 1.863 . . . . 0.0 110.635 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? 52.78 30.49 9.05 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.805 1.242 . . . . 0.0 113.488 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.31 16.57 78.73 Favored Glycine 0 CA--C 1.54 1.627 0 C-N-CA 124.852 1.215 . . . . 0.0 115.218 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 -135.68 155.32 50.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.526 1.93 . . . . 0.0 111.757 -173.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.01 132.32 44.11 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.634 -0.666 . . . . 0.0 111.775 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.35 127.62 37.9 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.58 1.152 . . . . 0.0 109.86 167.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -164.46 147.32 8.94 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.802 1.641 . . . . 0.0 111.162 174.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 56.1 23.96 7.42 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.3 p -75.39 -17.79 60.11 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 120.859 -1.15 . . . . 0.0 113.478 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 61.64 -56.09 0.12 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 128.408 2.683 . . . . 0.0 114.144 -166.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.5 p -147.53 157.51 43.59 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.781 1.632 . . . . 0.0 111.048 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.27 -32.82 74.46 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.459 -0.776 . . . . 0.0 111.304 168.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -63.06 -31.55 72.72 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.407 -0.808 . . . . 0.0 113.074 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.2 t -64.89 -23.88 67.36 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.113 0.965 . . . . 0.0 113.325 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.4 mt -106.31 -33.31 7.81 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.091 1.357 . . . . 0.0 113.486 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.41 85.9 0.19 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.098 1.808 . . . . 0.0 111.739 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.9 p -72.87 146.93 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.556 1.142 . . . . 0.0 112.181 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -149.85 -179.45 7.15 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.347 1.459 . . . . 0.0 112.178 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -97.68 150.06 21.6 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.807 1.643 . . . . 0.0 111.741 167.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.74 5.14 90.07 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.77 1.176 . . . . 0.0 115.545 176.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -61.23 145.64 50.52 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.357 1.079 . . . . 0.0 110.755 170.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.87 134.2 46.58 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -171.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -125.1 113.8 18.21 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.417 1.087 . . . . 0.0 110.64 -169.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -83.58 128.9 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.49 0.716 . . . . 0.0 109.704 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.5 tp -113.04 118.37 34.6 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.371 1.468 . . . . 0.0 109.421 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.1 pt -110.27 154.43 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.89 1.276 . . . . 0.0 111.993 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -139.16 165.73 26.38 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.644 1.577 . . . . 0.0 111.298 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.7 ttt85 . . . . . 0 N--CA 1.473 0.696 0 C-N-CA 125.551 1.541 . . . . 0.0 111.016 -168.289 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -80.68 142.65 33.72 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.049 -1.657 . . . . 0.0 112.476 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.9 pt -131.3 162.29 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 127.103 2.161 . . . . 0.0 110.415 170.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -123.88 92.74 3.74 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.035 1.334 . . . . 0.0 110.627 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.5 tt -78.71 141.13 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 122.13 -0.356 . . . . 0.0 110.356 174.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.8 t -130.6 79.82 71.32 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.383 1.473 . . . . 0.0 109.426 -174.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.85 137.03 13.75 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.253 1.969 . . . . 0.0 112.509 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.0 41.53 0.16 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.718 1.607 . . . . 0.0 112.63 170.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -139.14 142.51 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.539 1.936 . . . . 0.0 109.907 -167.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.48 -115.15 7.51 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 123.754 0.692 . . . . 0.0 112.479 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.44 -18.16 71.36 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.127 0.87 . . . . 0.0 114.972 176.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.95 6.45 56.33 Favored Glycine 0 CA--C 1.541 1.68 0 CA-C-N 118.737 1.268 . . . . 0.0 115.627 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.1 p -95.34 158.91 33.89 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.485 1.914 . . . . 0.0 113.561 -169.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.49 143.25 75.03 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.163 2.575 . . . . 0.0 112.115 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.5 mt -131.28 115.83 16.81 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.017 1.727 . . . . 0.0 110.515 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -74.4 125.58 28.83 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.836 0.855 . . . . 0.0 111.238 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt -138.17 149.05 45.49 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.606 1.563 . . . . 0.0 111.119 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -97.13 130.3 44.41 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.837 1.255 . . . . 0.0 110.156 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.9 149.71 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.922 1.289 . . . . 0.0 112.903 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.11 153.56 88.9 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.8 1.24 . . . . 0.0 112.471 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.13 -25.25 50.95 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.306 2.67 . . . . 0.0 113.635 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -80.51 37.57 0.41 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.013 1.725 . . . . 0.0 112.985 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.06 67.73 3.96 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.981 1.713 . . . . 0.0 112.622 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 55.9 m -63.76 141.34 58.8 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.683 1.193 . . . . 0.0 112.275 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.1 t -60.07 -44.09 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.072 0.949 . . . . 0.0 112.161 -174.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.98 -36.4 92.18 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.498 0.57 . . . . 0.0 113.231 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.93 -50.33 64.79 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 117.992 0.896 . . . . 0.0 111.796 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.2 p -66.78 -36.86 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.867 0.758 . . . . 0.0 112.046 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -59.06 -48.1 82.84 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.475 1.11 . . . . 0.0 111.837 173.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.2 m -66.47 -39.9 89.05 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.375 0.67 . . . . 0.0 112.099 175.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -44.48 96.96 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.893 0.877 . . . . 0.0 111.755 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.9 t -61.48 -48.33 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.136 1.374 . . . . 0.0 111.362 172.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.6 -44.53 93.36 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.458 0.703 . . . . 0.0 111.967 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.49 88.51 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.204 1.002 . . . . 0.0 112.924 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.5 ttm -65.76 -43.5 88.69 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.534 1.133 . . . . 0.0 112.232 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -75.38 -29.53 59.87 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.846 1.258 . . . . 0.0 113.394 177.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.2 tptm 57.41 31.29 19.97 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.746 2.018 . . . . 0.0 113.098 -169.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.52 151.16 56.81 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 126.316 1.846 . . . . 0.0 111.082 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.88 159.18 51.19 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.943 3.095 . . . . 0.0 113.594 -173.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.17 -13.07 35.74 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.99 3.127 . . . . 0.0 114.778 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -66.29 -22.25 66.29 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.136 -0.978 . . . . 0.0 113.355 170.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.2 p -103.07 -25.84 13.27 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.71 1.204 . . . . 0.0 113.709 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.1 m -140.07 126.87 20.6 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.954 1.301 . . . . 0.0 110.928 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -134.44 166.61 22.45 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.125 1.37 . . . . 0.0 112.897 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.4 tp -137.07 135.33 37.41 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.455 1.502 . . . . 0.0 111.497 -168.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.5 p -136.49 158.54 44.19 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.491 1.116 . . . . 0.0 112.519 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -139.09 128.73 24.6 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.606 2.363 . . . . 0.0 109.701 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.62 31.97 11.01 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.643 1.177 . . . . 0.0 113.515 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.94 8.79 87.63 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 124.945 1.26 . . . . 0.0 115.943 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -122.01 151.1 41.18 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.404 1.881 . . . . 0.0 112.261 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.12 126.24 30.52 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.85 -0.531 . . . . 0.0 110.46 165.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.2 mt -74.41 137.65 42.83 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.579 0.752 . . . . 0.0 110.726 170.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.24 140.4 7.5 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.117 1.367 . . . . 0.0 111.335 170.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t0 55.72 26.45 9.43 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.957 1.703 . . . . 0.0 115.191 175.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.9 m -78.03 -15.19 59.13 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.016 1.326 . . . . 0.0 113.732 -171.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 59.4 -70.84 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.601 2.361 . . . . 0.0 114.441 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.2 p -146.38 154.23 41.4 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.158 1.383 . . . . 0.0 111.97 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.22 -20.37 60.88 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.768 -0.583 . . . . 0.0 112.391 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.66 -30.72 71.59 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.192 -0.942 . . . . 0.0 112.659 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.0 t -63.59 -24.3 67.74 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.63 0.772 . . . . 0.0 112.762 173.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.4 mt -92.68 -12.42 31.54 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.46 1.504 . . . . 0.0 113.304 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.54 17.15 64.13 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.185 1.374 . . . . 0.0 115.014 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.1 p -76.44 145.0 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.778 1.231 . . . . 0.0 113.424 -169.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.6 -177.29 5.76 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.869 1.667 . . . . 0.0 113.774 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -68.47 164.4 21.21 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.299 1.44 . . . . 0.0 113.214 172.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.83 11.62 60.16 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.587 1.089 . . . . 0.0 115.033 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -62.19 143.83 56.27 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.436 1.118 . . . . 0.0 111.552 171.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -127.18 132.64 50.44 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.101 0.96 . . . . 0.0 112.235 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -125.27 132.61 52.9 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.866 1.266 . . . . 0.0 109.944 -171.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 p -110.73 120.73 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.024 0.829 . . . . 0.0 111.123 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.99 121.11 40.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.954 1.302 . . . . 0.0 109.136 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.0 tt -119.7 131.07 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.447 1.099 . . . . 0.0 111.063 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.6 t -114.61 150.87 34.4 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.309 1.844 . . . . 0.0 111.353 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 . . . . . 0 N--CA 1.471 0.606 0 C-N-CA 126.179 1.792 . . . . 0.0 109.959 172.984 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.28 0.562 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -108.98 141.68 40.74 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.074 1.35 . . . . 0.0 111.331 174.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.0 pt -121.56 163.05 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.07 1.748 . . . . 0.0 110.457 170.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -125.69 105.57 9.09 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.15 0.98 . . . . 0.0 110.875 174.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.4 mt -86.79 137.88 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -126.0 76.25 71.6 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 124.951 1.3 . . . . 0.0 110.086 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.97 136.59 16.68 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.92 2.413 . . . . 0.0 111.261 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.25 31.91 0.1 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.627 1.571 . . . . 0.0 114.173 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.5 t -139.52 147.67 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 126.62 1.968 . . . . 0.0 109.871 -171.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.5 30.75 70.97 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 121.642 -0.661 . . . . 0.0 114.543 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.65 -8.36 40.02 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.615 1.578 . . . . 0.0 115.11 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.32 5.36 76.91 Favored Glycine 0 CA--C 1.54 1.637 0 N-CA-C 116.355 1.302 . . . . 0.0 116.355 170.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.9 m -75.14 150.32 85.41 Favored Pre-proline 0 N--CA 1.475 0.804 0 CA-C-N 118.649 1.225 . . . . 0.0 113.432 -174.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.77 145.7 76.03 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.378 2.719 . . . . 0.0 111.898 169.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.1 mt -131.71 111.72 11.92 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.725 1.61 . . . . 0.0 110.492 178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -79.27 134.22 36.64 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.355 1.062 . . . . 0.0 111.807 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 tt -152.43 141.98 21.76 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.347 1.059 . . . . 0.0 112.349 -175.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -80.93 133.92 35.63 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.659 1.184 . . . . 0.0 112.289 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -139.1 155.51 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.878 1.271 . . . . 0.0 113.01 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.75 152.45 91.31 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.623 1.169 . . . . 0.0 112.271 172.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.02 -19.05 57.85 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.365 2.71 . . . . 0.0 113.419 174.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -78.76 5.77 10.5 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.643 1.577 . . . . 0.0 114.117 176.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.37 130.52 47.11 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.391 0.996 . . . . 0.0 112.284 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.9 m -109.7 134.73 51.65 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.47 1.508 . . . . 0.0 110.874 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.32 -40.94 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.073 0.949 . . . . 0.0 112.31 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.61 -34.93 91.0 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 123.775 0.702 . . . . 0.0 113.5 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.87 -43.23 75.79 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.339 1.07 . . . . 0.0 111.645 174.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.9 t -61.27 -46.67 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.005 0.922 . . . . 0.0 111.138 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -56.49 -51.42 68.56 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.542 1.137 . . . . 0.0 111.735 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.4 m -60.16 -42.03 94.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.505 0.722 . . . . 0.0 111.818 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.67 -50.76 72.7 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.949 0.9 . . . . 0.0 111.239 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.4 t -68.21 -41.37 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.412 0.685 . . . . 0.0 112.132 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 95.9 m -59.67 -40.41 87.7 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.335 0.971 . . . . 0.0 112.202 173.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.57 -41.99 78.95 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.55 0.74 . . . . 0.0 112.77 174.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 84.2 mtp -66.37 -39.73 89.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.353 1.061 . . . . 0.0 112.871 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -84.46 -18.27 36.44 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.718 1.207 . . . . 0.0 113.86 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp 57.75 30.03 18.31 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.457 1.903 . . . . 0.0 113.728 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.92 150.49 43.56 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 126.129 1.771 . . . . 0.0 111.141 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.64 159.85 50.75 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 123.713 2.942 . . . . 0.0 112.796 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.07 -9.89 26.67 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 124.007 3.138 . . . . 0.0 115.063 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -80.12 -36.16 35.69 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.193 1.397 . . . . 0.0 113.296 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 34.6 p -85.81 8.13 21.2 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.203 1.401 . . . . 0.0 113.827 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.0 t -144.2 142.72 30.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.679 1.591 . . . . 0.0 111.972 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 -141.02 148.51 40.39 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.465 1.506 . . . . 0.0 112.658 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.7 tp -127.48 129.41 47.38 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.008 2.123 . . . . 0.0 110.108 -177.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.8 p -140.06 155.52 47.0 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.41 1.084 . . . . 0.0 112.516 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -145.0 138.69 26.95 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.168 1.787 . . . . 0.0 110.167 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp 54.13 30.4 12.03 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.935 1.294 . . . . 0.0 114.062 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.96 16.85 80.33 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.037 1.304 . . . . 0.0 115.259 -175.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -134.13 150.86 51.16 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.085 1.754 . . . . 0.0 112.252 -171.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.1 115.95 20.79 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.945 0.898 . . . . 0.0 110.962 172.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.2 mp -86.35 131.96 34.08 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.38 1.072 . . . . 0.0 110.297 171.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.78 149.91 11.45 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.388 1.475 . . . . 0.0 110.903 171.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.7 t0 55.77 27.66 11.13 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.732 1.613 . . . . 0.0 115.073 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.6 p -78.85 -22.02 46.72 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.985 1.314 . . . . 0.0 113.523 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 62.34 -53.26 0.15 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 128.51 2.724 . . . . 0.0 115.005 -170.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 61.4 p -144.71 152.31 40.22 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.726 1.61 . . . . 0.0 111.599 172.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.7 mt -70.28 -36.27 74.27 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.344 0.658 . . . . 0.0 111.79 172.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.91 -33.67 76.23 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.6 m -68.45 -26.49 65.53 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 66.3 mt -99.29 -26.72 14.07 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.531 1.132 . . . . 0.0 113.471 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 130.76 83.93 0.3 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.839 1.685 . . . . 0.0 111.946 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.68 148.49 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.641 1.177 . . . . 0.0 111.662 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.29 158.26 43.78 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.216 1.406 . . . . 0.0 111.922 176.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -73.35 142.65 47.05 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.336 1.054 . . . . 0.0 111.69 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.91 19.55 78.7 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.414 0.926 . . . . 0.0 115.414 174.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.61 136.94 57.75 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.849 1.324 . . . . 0.0 111.384 171.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -132.9 132.11 41.68 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -172.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -119.7 97.67 5.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.251 1.421 . . . . 0.0 110.405 -161.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.65 137.47 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.889 -0.507 . . . . 0.0 110.45 174.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tt -139.47 109.0 6.18 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.623 0.769 . . . . 0.0 110.179 -170.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.3 tt -101.94 142.6 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.998 1.319 . . . . 0.0 111.348 -173.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.4 p -130.29 157.05 43.58 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.22 1.408 . . . . 0.0 110.46 173.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 . . . . . 0 N--CA 1.479 0.992 0 C-N-CA 123.87 0.868 . . . . 0.0 112.172 178.879 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mmt . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 121.347 0.594 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -68.59 148.67 50.17 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.976 0.91 . . . . 0.0 112.28 165.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.4 mm -142.23 143.62 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 128.034 2.534 . . . . 0.0 109.176 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -100.4 144.28 29.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.194 0.997 . . . . 0.0 111.056 162.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.7 tt -133.72 134.52 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.443 1.097 . . . . 0.0 110.474 167.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 p -123.34 103.12 35.84 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.592 1.157 . . . . 0.0 110.679 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -92.89 140.69 1.89 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.721 2.28 . . . . 0.0 112.255 176.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.17 48.36 0.61 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.463 1.505 . . . . 0.0 113.522 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 p -154.34 155.3 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.437 1.495 . . . . 0.0 111.529 -172.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.93 -112.4 4.64 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.704 0.669 . . . . 0.0 112.671 174.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.13 -19.85 72.43 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 124.082 0.848 . . . . 0.0 114.799 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.24 32.85 82.18 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 118.782 1.291 . . . . 0.0 114.448 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 t -144.68 145.6 28.84 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.163 1.385 . . . . 0.0 112.103 -162.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -60.51 140.38 91.07 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.526 2.818 . . . . 0.0 113.096 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.0 tp -124.9 134.06 52.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.343 1.857 . . . . 0.0 110.44 175.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -82.79 135.05 35.08 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.676 0.791 . . . . 0.0 110.752 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.3 mt -142.21 175.09 10.02 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.873 2.069 . . . . 0.0 110.872 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -136.41 134.6 37.94 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.613 1.565 . . . . 0.0 109.962 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 m -136.03 155.19 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.136 0.974 . . . . 0.0 113.0 -173.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.24 149.87 73.33 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.853 0.861 . . . . 0.0 111.675 169.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -64.93 -21.64 63.74 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.287 2.658 . . . . 0.0 112.865 172.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -74.06 -0.94 18.03 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.925 1.69 . . . . 0.0 114.134 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.66 121.18 10.38 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.287 0.948 . . . . 0.0 111.814 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.0 p -86.16 150.73 24.2 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.773 0.829 . . . . 0.0 111.502 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.3 t -64.39 -36.6 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.812 -0.555 . . . . 0.0 110.647 173.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.35 -51.4 57.86 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.083 0.849 . . . . 0.0 112.74 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.75 93.13 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.004 0.902 . . . . 0.0 112.865 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.5 t -63.93 -47.29 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 121.833 -0.542 . . . . 0.0 111.013 175.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -63.18 -42.4 99.37 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.273 1.029 . . . . 0.0 112.074 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.8 p -69.63 -38.16 77.1 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 118.329 -0.843 . . . . 0.0 112.582 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -61.95 -43.97 97.74 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.898 1.226 . . . . 0.0 111.844 172.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.2 t -61.53 -48.27 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.832 0.742 . . . . 0.0 111.477 175.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.3 t -59.24 -44.57 92.36 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.938 0.895 . . . . 0.0 111.876 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.63 -40.93 80.12 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.255 1.022 . . . . 0.0 112.951 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 59.3 ttp -71.35 -41.04 70.26 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.14 1.376 . . . . 0.0 112.989 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -82.51 -14.59 54.71 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp 58.34 29.93 18.86 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.708 2.003 . . . . 0.0 112.995 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.2 mt -141.02 147.92 49.81 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.877 1.671 . . . . 0.0 112.378 -168.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.95 161.05 47.4 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.222 3.281 . . . . 0.0 114.582 -171.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -66.05 -16.01 50.73 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.763 2.975 . . . . 0.0 114.71 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -67.58 -45.49 75.4 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.946 -1.096 . . . . 0.0 111.756 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.2 t -88.36 -22.59 23.72 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.195 1.398 . . . . 0.0 112.955 -174.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.6 m -127.82 119.12 25.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.453 1.501 . . . . 0.0 112.204 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -133.06 160.9 35.84 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.345 1.858 . . . . 0.0 113.202 -173.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.1 tp -134.94 138.86 44.45 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.785 2.034 . . . . 0.0 110.854 -172.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.3 m -139.22 146.09 40.06 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.43 1.492 . . . . 0.0 111.388 -176.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -142.56 134.6 27.26 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.499 1.519 . . . . 0.0 110.226 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 tptm 52.91 32.69 13.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.159 1.383 . . . . 0.0 113.407 -176.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.45 14.53 74.7 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 124.495 1.045 . . . . 0.0 115.34 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.41 141.95 51.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.685 1.994 . . . . 0.0 111.4 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.45 125.84 31.54 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.874 0.87 . . . . 0.0 110.348 167.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.0 mp -82.13 138.66 34.71 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.684 0.794 . . . . 0.0 110.354 172.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 136.76 6.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.725 1.61 . . . . 0.0 110.289 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.3 t0 55.61 26.92 9.75 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.577 1.551 . . . . 0.0 114.471 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 m -78.19 -29.39 48.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.839 1.256 . . . . 0.0 113.782 -169.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 62.24 -36.59 0.12 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 128.692 2.797 . . . . 0.0 117.554 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 t -156.01 146.29 21.6 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.292 1.437 . . . . 0.0 111.123 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.27 -18.13 64.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.882 0.873 . . . . 0.0 112.86 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -68.35 -19.95 64.68 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 171.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.1 t -69.46 -41.1 76.65 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.968 0.907 . . . . 0.0 112.017 178.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.8 mp -82.47 -14.56 54.84 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.843 1.257 . . . . 0.0 112.82 170.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.99 37.25 91.98 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.475 1.036 . . . . 0.0 113.364 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.6 m -64.56 152.97 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.313 1.045 . . . . 0.0 113.802 -168.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.86 -178.38 6.83 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.197 1.399 . . . . 0.0 112.965 174.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -80.34 153.07 28.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.609 1.163 . . . . 0.0 112.231 165.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.6 26.12 61.65 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 115.351 0.9 . . . . 0.0 115.351 173.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -61.55 156.46 19.59 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.278 1.039 . . . . 0.0 112.769 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -124.7 108.66 12.23 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.175 1.39 . . . . 0.0 111.132 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -93.58 144.71 25.12 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.272 1.429 . . . . 0.0 110.998 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.0 m -124.47 133.49 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.139 0.976 . . . . 0.0 110.767 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.58 131.98 56.49 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.439 1.096 . . . . 0.0 110.781 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.64 136.59 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.948 1.699 . . . . 0.0 108.936 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.0 t -142.8 129.05 19.88 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.859 0.864 . . . . 0.0 111.408 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.1 mmt-85 . . . . . 0 N--CA 1.476 0.835 0 C-N-CA 125.851 1.66 . . . . 0.0 112.325 178.676 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ttt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -130.07 153.07 48.83 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.39 1.476 . . . . 0.0 111.917 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -133.1 158.82 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 126.8 2.04 . . . . 0.0 110.807 173.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -103.42 147.88 26.58 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.587 1.555 . . . . 0.0 110.036 164.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.2 tt -135.93 135.38 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.148 0.979 . . . . 0.0 110.396 169.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.6 p -128.26 96.75 30.27 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.82 1.248 . . . . 0.0 111.042 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -81.74 138.96 10.86 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.342 2.695 . . . . 0.0 111.683 170.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.98 40.31 0.15 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.586 1.554 . . . . 0.0 112.968 170.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.3 t -138.73 144.38 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.364 1.866 . . . . 0.0 110.037 -169.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.95 -112.4 4.79 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.965 0.793 . . . . 0.0 112.141 175.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.83 -16.8 68.62 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.223 0.916 . . . . 0.0 115.046 175.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.55 20.71 66.15 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 118.747 1.274 . . . . 0.0 115.362 171.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.4 m -129.35 153.58 80.55 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 125.6 1.56 . . . . 0.0 112.962 -164.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.92 146.19 82.14 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.293 2.662 . . . . 0.0 113.384 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.4 mt -132.5 138.4 47.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.418 1.887 . . . . 0.0 111.094 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -78.75 135.67 37.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.987 1.315 . . . . 0.0 111.87 172.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mp -142.96 150.8 40.17 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.882 1.273 . . . . 0.0 111.925 169.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -85.38 143.92 28.34 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.963 0.905 . . . . 0.0 110.471 160.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.17 148.96 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.503 1.521 . . . . 0.0 110.994 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.72 149.9 88.38 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.69 0.796 . . . . 0.0 111.658 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.42 -19.03 61.31 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.02 2.48 . . . . 0.0 112.927 171.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -77.92 -0.74 28.7 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.029 1.732 . . . . 0.0 114.441 171.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.06 142.66 56.48 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 119.415 1.007 . . . . 0.0 111.055 172.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.11 152.01 40.33 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.412 1.085 . . . . 0.0 111.411 -175.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -60.94 -32.91 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 121.566 -0.709 . . . . 0.0 112.433 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.9 -50.26 59.0 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 123.96 0.791 . . . . 0.0 111.917 173.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.4 -40.11 95.42 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.091 0.956 . . . . 0.0 112.73 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.1 t -63.02 -49.6 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.661 -0.649 . . . . 0.0 110.525 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -63.36 -45.33 91.69 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 121.566 -0.709 . . . . 0.0 112.467 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.5 p -67.75 -37.61 82.38 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.479 1.036 . . . . 0.0 112.161 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -58.1 -47.19 83.98 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.265 0.939 . . . . 0.0 111.024 172.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.9 t -63.44 -47.35 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.325 1.05 . . . . 0.0 111.414 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 93.8 m -61.63 -41.83 98.04 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.24 85.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.839 0.856 . . . . 0.0 113.113 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.5 ttt -66.64 -41.18 88.69 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.283 1.033 . . . . 0.0 112.486 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.459 ' HE3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -74.9 -24.21 58.49 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.434 1.094 . . . . 0.0 113.352 172.584 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt 59.09 28.51 17.81 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.385 2.274 . . . . 0.0 113.912 -167.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 mp -116.35 155.44 48.44 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.14 1.776 . . . . 0.0 111.634 -177.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.69 157.72 60.7 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 123.52 2.813 . . . . 0.0 112.437 178.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.48 -25.34 63.06 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.402 2.735 . . . . 0.0 114.406 -173.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -71.64 -17.59 62.25 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.696 1.134 . . . . 0.0 113.634 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.2 m -84.45 -1.04 55.02 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.684 -1.26 . . . . 0.0 112.993 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.3 t -136.13 158.01 45.45 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.49 1.516 . . . . 0.0 112.244 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -141.79 140.12 32.94 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.029 1.732 . . . . 0.0 111.2 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.5 tp -113.31 130.84 56.15 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.433 1.893 . . . . 0.0 110.143 173.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.3 p -136.8 155.63 49.57 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.956 0.902 . . . . 0.0 112.428 172.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -151.74 135.13 16.06 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.303 1.841 . . . . 0.0 110.11 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.92 35.96 20.54 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.215 1.406 . . . . 0.0 113.353 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.83 15.91 79.44 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 124.48 1.038 . . . . 0.0 115.212 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -129.58 151.9 49.69 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.643 1.977 . . . . 0.0 111.637 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.08 135.26 38.59 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.862 -0.524 . . . . 0.0 109.673 160.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.7 tp -107.98 115.89 30.96 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.899 0.88 . . . . 0.0 109.865 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -150.1 141.13 22.97 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.915 1.286 . . . . 0.0 111.613 -169.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.6 t0 54.95 26.46 7.96 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.864 1.665 . . . . 0.0 114.836 174.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.4 p -75.28 -26.52 58.83 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.133 1.373 . . . . 0.0 113.005 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 64.04 -46.7 0.28 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 129.015 2.926 . . . . 0.0 114.892 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -152.94 139.01 18.21 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.35 1.86 . . . . 0.0 111.588 175.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.91 -37.36 87.4 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.877 0.871 . . . . 0.0 111.994 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -65.58 -18.19 65.14 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.9 m -75.61 -27.14 58.35 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.134 0.974 . . . . 0.0 113.15 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.37 -39.8 8.62 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.858 1.263 . . . . 0.0 112.036 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 145.67 93.32 0.14 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.518 1.532 . . . . 0.0 111.459 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.2 p -75.04 147.49 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.338 1.055 . . . . 0.0 111.75 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -147.09 164.82 31.82 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.458 1.503 . . . . 0.0 111.837 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -94.88 146.09 24.46 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.816 1.246 . . . . 0.0 112.841 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.03 19.46 72.51 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 123.86 0.743 . . . . 0.0 114.8 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.31 144.04 54.62 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.458 1.129 . . . . 0.0 111.498 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.25 110.96 17.62 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.674 1.19 . . . . 0.0 111.534 -177.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -92.47 131.66 37.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.787 1.235 . . . . 0.0 111.353 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -109.57 127.2 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.283 1.033 . . . . 0.0 110.298 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.28 121.16 43.59 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.71 1.604 . . . . 0.0 110.357 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.0 mm -114.93 125.38 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.902 1.281 . . . . 0.0 109.903 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.8 t -98.24 155.95 16.94 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.503 1.121 . . . . 0.0 111.622 172.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? . . . . . 0 N--CA 1.476 0.849 0 C-N-CA 125.192 1.397 . . . . 0.0 111.187 171.268 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.843 ' HB2' ' OD1' ' A' ' 65' ' ' ASP . 26.3 mmt . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 121.668 0.747 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 141.17 32.38 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.464 1.506 . . . . 0.0 111.045 174.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.4 mt -128.22 141.98 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.786 1.634 . . . . 0.0 109.803 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -105.55 102.23 11.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.862 1.265 . . . . 0.0 110.25 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.4 pt -78.92 143.51 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.436 -0.79 . . . . 0.0 110.326 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 t -130.61 80.18 70.57 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.907 1.283 . . . . 0.0 109.847 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.55 131.46 16.17 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.021 2.481 . . . . 0.0 112.256 175.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.44 41.07 0.18 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.878 1.271 . . . . 0.0 112.749 167.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.9 t -138.91 145.49 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 126.503 1.921 . . . . 0.0 110.202 -169.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.72 -121.19 22.97 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.721 0.677 . . . . 0.0 111.858 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.21 -18.27 72.95 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 123.952 0.787 . . . . 0.0 114.935 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.09 -0.8 57.98 Favored Glycine 0 CA--C 1.542 1.763 0 C-N-CA 124.981 1.276 . . . . 0.0 115.769 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 m -73.92 153.43 88.94 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 125.523 1.529 . . . . 0.0 113.793 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -63.55 149.37 91.18 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.729 2.286 . . . . 0.0 111.467 163.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 tt -141.4 127.07 19.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.881 1.272 . . . . 0.0 111.311 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -85.38 128.89 34.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.827 1.251 . . . . 0.0 112.581 -174.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.9 mt -141.7 146.17 35.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.561 1.544 . . . . 0.0 112.439 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -84.7 146.33 27.48 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.144 0.977 . . . . 0.0 111.112 163.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.6 m -143.6 157.87 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.291 1.436 . . . . 0.0 111.201 174.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.36 151.95 96.89 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.646 0.778 . . . . 0.0 111.824 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -65.99 -20.49 57.46 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.149 2.566 . . . . 0.0 113.027 173.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -83.98 22.16 1.21 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.482 1.913 . . . . 0.0 113.083 175.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.76 108.98 2.28 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.531 -1.355 . . . . 0.0 111.578 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.2 m -77.92 129.97 36.0 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.402 1.081 . . . . 0.0 110.954 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.1 t -57.57 -44.9 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.028 0.931 . . . . 0.0 111.719 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.24 -35.64 91.86 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.48 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.75 -42.31 77.72 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.883 1.342 . . . . 0.0 112.037 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.0 -49.05 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.448 0.699 . . . . 0.0 110.527 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -62.71 -41.66 99.25 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.513 0.725 . . . . 0.0 111.583 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.1 m -62.41 -42.0 99.11 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.651 0.78 . . . . 0.0 111.591 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -58.58 -45.64 88.61 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.359 0.981 . . . . 0.0 111.733 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 83.1 t -63.34 -47.16 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.938 0.895 . . . . 0.0 111.376 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 83.2 m -63.24 -39.9 95.9 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.067 0.547 . . . . 0.0 112.4 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.44 -39.47 77.79 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.297 1.039 . . . . 0.0 112.719 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 63.9 ttp -67.1 -40.44 86.92 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.148 0.979 . . . . 0.0 112.159 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -83.02 -10.42 58.76 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 173.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.38 25.15 12.51 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 127.29 2.236 . . . . 0.0 114.418 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mp -131.98 155.0 81.89 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 126.326 1.85 . . . . 0.0 112.169 -174.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.48 162.54 41.96 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.305 3.337 . . . . 0.0 114.215 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.67 -16.75 56.6 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 124.194 3.263 . . . . 0.0 114.792 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -66.01 -26.65 67.63 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.026 -1.047 . . . . 0.0 112.434 170.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 26.2 m -91.23 -36.59 13.83 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.492 0.717 . . . . 0.0 112.407 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.3 m -130.21 126.76 38.16 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.245 1.018 . . . . 0.0 112.162 -171.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -131.46 161.8 31.69 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.844 1.658 . . . . 0.0 112.997 -168.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.7 tp -129.29 134.54 47.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.473 2.309 . . . . 0.0 110.654 -174.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.2 p -138.52 156.8 47.19 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.724 1.21 . . . . 0.0 113.033 174.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -147.68 132.76 18.25 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.269 1.828 . . . . 0.0 110.447 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm 52.05 40.58 28.75 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.226 1.41 . . . . 0.0 113.374 173.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.49 9.17 84.57 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 125.167 1.365 . . . . 0.0 115.723 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 65.3 mtp180 -127.6 152.08 48.1 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.457 1.903 . . . . 0.0 111.958 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.36 128.06 34.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.034 0.934 . . . . 0.0 110.116 166.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.2 mt -86.35 140.56 29.93 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.829 0.852 . . . . 0.0 110.988 174.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -162.69 152.76 16.25 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.853 1.661 . . . . 0.0 111.331 171.397 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 53.91 19.89 2.16 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.629 1.972 . . . . 0.0 116.239 171.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -75.91 -29.95 58.6 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.008 1.323 . . . . 0.0 112.576 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 62.46 -53.94 0.15 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 128.006 2.523 . . . . 0.0 115.475 -175.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 49.5 p -140.97 137.36 32.99 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.009 1.323 . . . . 0.0 111.298 172.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.38 -23.86 64.71 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.653 -0.655 . . . . 0.0 111.949 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -61.68 -31.76 71.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.768 0.827 . . . . 0.0 112.918 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 55.8 p -64.88 -22.11 66.93 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.0 mt -107.29 -0.34 22.59 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.409 1.884 . . . . 0.0 113.063 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.5 118.5 0.46 Allowed Glycine 0 CA--C 1.539 1.543 0 C-N-CA 126.208 1.861 . . . . 0.0 113.063 -170.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.7 t -75.24 132.84 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.406 1.082 . . . . 0.0 110.767 174.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.43 -174.35 2.51 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.733 1.613 . . . . 0.0 111.494 172.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.843 ' OD1' ' HB2' ' A' ' 1' ' ' MET . 28.1 t0 -139.65 148.82 42.96 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.968 -1.082 . . . . 0.0 113.102 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.92 23.2 75.39 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 123.87 0.747 . . . . 0.0 113.965 -173.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -68.21 165.04 19.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.234 1.414 . . . . 0.0 112.152 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.7 pttm -139.62 142.15 37.07 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 171.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -116.79 121.91 42.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.718 1.207 . . . . 0.0 110.254 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.9 t -96.64 128.97 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.48 0.712 . . . . 0.0 109.875 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.0 mt -111.38 131.54 55.11 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.257 1.023 . . . . 0.0 109.717 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.0 tt -124.91 142.02 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.841 1.256 . . . . 0.0 110.609 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.1 t -132.5 136.48 46.68 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.071 1.348 . . . . 0.0 111.528 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 . . . . . 0 N--CA 1.474 0.746 0 C-N-CA 125.026 1.33 . . . . 0.0 111.463 178.251 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.34 0.114 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -108.84 151.11 26.69 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 120.318 -1.489 . . . . 0.0 113.279 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mt -137.41 134.49 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.986 1.714 . . . . 0.0 109.676 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -93.47 101.44 13.64 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.92 1.288 . . . . 0.0 111.168 174.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 tt -83.49 137.27 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.421 -0.8 . . . . 0.0 110.146 169.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.74 90.33 40.59 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 124.78 1.232 . . . . 0.0 110.464 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -87.64 142.7 5.97 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.467 2.778 . . . . 0.0 112.481 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.91 38.12 0.2 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 125.89 1.676 . . . . 0.0 114.79 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.9 m -139.94 161.49 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 125.767 1.627 . . . . 0.0 112.374 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.3 -122.96 29.85 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.88 0.752 . . . . 0.0 111.91 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.56 -13.24 74.36 Favored Glycine 0 CA--C 1.539 1.571 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 173.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.62 7.0 45.54 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 125.281 1.42 . . . . 0.0 115.831 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.4 m -89.33 154.97 49.16 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 125.399 1.479 . . . . 0.0 113.204 -173.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -64.16 150.6 88.0 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.016 2.477 . . . . 0.0 112.447 169.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mt -137.85 125.96 22.91 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.07 1.748 . . . . 0.0 110.677 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -77.2 114.6 16.18 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.197 0.999 . . . . 0.0 111.325 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.5 mp -114.69 155.82 25.92 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.777 1.631 . . . . 0.0 110.703 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -114.01 133.24 55.63 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.409 1.483 . . . . 0.0 109.701 169.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.04 156.61 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.687 1.195 . . . . 0.0 112.044 -174.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.88 149.08 98.64 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.825 0.85 . . . . 0.0 111.914 173.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.78 -26.38 60.22 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.933 2.422 . . . . 0.0 113.053 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -82.59 12.81 4.21 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.73 1.612 . . . . 0.0 114.463 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.72 113.86 2.47 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.065 -1.022 . . . . 0.0 111.128 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 p -85.24 153.66 22.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.847 0.859 . . . . 0.0 111.536 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.9 t -63.49 -42.08 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.531 -0.731 . . . . 0.0 110.907 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.92 97.06 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.762 0.696 . . . . 0.0 113.226 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.12 -46.98 84.74 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 117.974 0.887 . . . . 0.0 111.742 175.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.76 -47.04 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.589 0.756 . . . . 0.0 111.38 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -56.99 -43.19 81.46 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.895 1.278 . . . . 0.0 111.697 177.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.0 m -65.7 -44.96 84.57 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.686 0.795 . . . . 0.0 111.444 176.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -46.6 87.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.908 0.883 . . . . 0.0 111.653 176.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.09 -51.74 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.219 1.408 . . . . 0.0 111.232 177.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.43 -43.44 96.78 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.799 0.727 . . . . 0.0 112.332 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.66 -43.66 92.89 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.638 0.775 . . . . 0.0 112.823 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.8 ttt -70.18 -36.79 74.9 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.13 0.972 . . . . 0.0 112.848 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.14 -20.41 52.11 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.132 1.373 . . . . 0.0 113.689 176.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? 57.66 19.93 5.91 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.751 2.02 . . . . 0.0 113.825 -171.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 mp -128.96 145.48 56.73 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.76 2.024 . . . . 0.0 110.973 -169.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.87 160.48 45.96 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.606 2.871 . . . . 0.0 113.831 -174.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.33 -5.26 15.5 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 124.02 3.147 . . . . 0.0 114.945 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -71.32 -39.81 71.17 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.736 -1.227 . . . . 0.0 111.715 169.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.7 t -85.97 -49.31 7.94 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.16 -0.962 . . . . 0.0 112.119 173.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.7 m -90.18 127.43 36.11 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.764 0.711 . . . . 0.0 112.093 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -140.37 163.33 33.09 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.758 1.223 . . . . 0.0 113.458 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.4 tp -140.0 136.42 33.73 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.708 2.003 . . . . 0.0 110.639 -170.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.1 p -139.93 155.7 47.03 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.528 1.131 . . . . 0.0 113.084 -178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -149.64 139.68 22.04 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.598 1.959 . . . . 0.0 109.808 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 55.61 29.9 14.4 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.199 1.4 . . . . 0.0 113.969 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.95 13.25 79.15 Favored Glycine 0 CA--C 1.541 1.68 0 C-N-CA 124.785 1.183 . . . . 0.0 114.985 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.3 mmm-85 -123.35 152.73 41.19 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.757 2.023 . . . . 0.0 112.23 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.92 124.01 30.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.738 0.815 . . . . 0.0 109.686 160.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.63 137.04 32.71 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.907 1.283 . . . . 0.0 109.42 174.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -164.51 147.73 9.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.385 1.474 . . . . 0.0 112.036 173.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 56.05 27.21 11.02 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.112 1.765 . . . . 0.0 115.378 175.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -83.96 -16.93 42.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.491 1.116 . . . . 0.0 113.954 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.27 -47.13 0.07 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 129.125 2.97 . . . . 0.0 115.956 -171.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.6 t -152.0 140.38 20.51 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.07 1.348 . . . . 0.0 110.987 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.96 -26.94 67.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.5 0.72 . . . . 0.0 112.153 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -65.3 -27.86 68.91 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.561 1.144 . . . . 0.0 113.364 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.1 t -68.35 -40.51 81.5 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.581 0.753 . . . . 0.0 112.262 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.12 -38.69 22.09 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.526 1.131 . . . . 0.0 112.021 177.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.43 97.91 0.26 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.914 1.721 . . . . 0.0 111.632 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.2 148.98 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.462 1.105 . . . . 0.0 111.735 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.34 -168.6 2.85 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.998 1.719 . . . . 0.0 111.116 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -138.75 149.46 45.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.825 1.25 . . . . 0.0 112.356 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.78 23.63 77.76 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 123.787 0.708 . . . . 0.0 113.87 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -66.92 164.99 16.34 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.93 1.292 . . . . 0.0 112.752 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -136.79 142.85 42.96 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.882 0.873 . . . . 0.0 113.281 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -127.86 125.32 39.48 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.062 1.345 . . . . 0.0 110.335 -175.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.4 126.63 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.604 1.162 . . . . 0.0 109.798 -176.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 tt -124.34 125.05 43.68 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.47 1.108 . . . . 0.0 110.923 -172.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.44 145.15 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.246 1.819 . . . . 0.0 110.275 -169.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.6 t -148.06 150.76 34.51 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.499 1.52 . . . . 0.0 110.941 176.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? . . . . . 0 N--CA 1.475 0.781 0 C-N-CA 125.565 1.546 . . . . 0.0 111.538 -177.008 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.423 ' HG2' ' H ' ' A' ' 2' ' ' LYS . 26.7 ttt . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 1' ' ' MET . 58.3 mttm -75.65 140.99 42.87 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.099 -1.0 . . . . 0.0 110.613 162.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.81 159.84 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.056 1.742 . . . . 0.0 109.961 175.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -113.8 139.57 49.02 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.961 1.304 . . . . 0.0 110.36 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 tt -126.82 141.81 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.676 0.79 . . . . 0.0 111.357 174.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 t -124.65 85.36 56.7 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 125.547 1.539 . . . . 0.0 109.862 -177.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.07 121.37 5.33 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.289 2.66 . . . . 0.0 111.528 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.29 52.77 1.65 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.38 1.472 . . . . 0.0 113.406 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -150.45 147.02 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.054 1.342 . . . . 0.0 111.809 -176.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.39 29.18 74.4 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.436 1.017 . . . . 0.0 114.958 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.49 68.37 1.52 Allowed Glycine 0 CA--C 1.532 1.143 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -167.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.26 137.02 42.85 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.49 1.043 . . . . 0.0 114.372 -170.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.1 m -148.48 152.64 38.86 Favored Pre-proline 0 N--CA 1.474 0.735 0 C-N-CA 126.298 1.839 . . . . 0.0 110.813 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -65.86 143.51 73.63 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.936 2.424 . . . . 0.0 112.45 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.9 tp -139.55 129.0 24.24 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.357 1.463 . . . . 0.0 111.118 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -82.97 144.62 29.86 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.304 1.041 . . . . 0.0 112.783 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -152.38 146.97 25.75 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.297 1.439 . . . . 0.0 111.625 168.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -81.42 135.74 35.66 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.739 0.816 . . . . 0.0 111.191 171.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.6 m -134.16 156.56 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.484 1.114 . . . . 0.0 112.279 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.82 152.07 93.81 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 124.382 1.073 . . . . 0.0 112.608 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.09 -23.74 60.32 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.119 2.546 . . . . 0.0 113.279 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -85.43 10.7 12.12 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.249 1.42 . . . . 0.0 113.739 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.99 155.44 27.5 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.079 0.854 . . . . 0.0 112.515 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.6 m -144.39 135.37 25.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.265 1.426 . . . . 0.0 110.669 -171.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.7 t -61.28 -40.27 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.367 0.667 . . . . 0.0 111.953 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.34 -39.13 97.35 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.431 -0.649 . . . . 0.0 113.37 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.69 -37.59 82.52 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 118.342 1.071 . . . . 0.0 112.489 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.48 -44.56 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.543 -0.723 . . . . 0.0 110.37 172.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -60.94 -52.61 64.28 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.02 0.928 . . . . 0.0 111.925 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.2 p -64.53 -36.07 83.02 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 118.358 -0.829 . . . . 0.0 112.852 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -58.47 -45.01 89.49 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.558 1.072 . . . . 0.0 112.084 172.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 51.9 t -69.82 -42.81 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.082 0.856 . . . . 0.0 111.87 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 88.3 m -56.74 -42.32 79.05 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.908 1.231 . . . . 0.0 112.263 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.19 -41.31 81.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.922 0.889 . . . . 0.0 112.626 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.2 ttt -71.49 -36.78 71.23 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.897 0.879 . . . . 0.0 113.07 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -77.37 -13.78 59.86 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.075 1.35 . . . . 0.0 113.295 171.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 55.1 46.39 24.14 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.485 1.914 . . . . 0.0 112.109 -176.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.1 mt -133.14 146.12 59.73 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.424 1.49 . . . . 0.0 112.956 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.18 162.07 43.66 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.974 3.116 . . . . 0.0 113.473 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.48 -7.68 16.81 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.833 3.022 . . . . 0.0 114.273 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.3 -24.64 57.51 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.794 -1.191 . . . . 0.0 113.139 170.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 74.7 p -123.13 0.87 9.11 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.806 1.243 . . . . 0.0 114.204 -174.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.7 m -146.93 125.34 12.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.301 1.441 . . . . 0.0 109.998 172.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -145.36 149.55 34.97 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.734 1.214 . . . . 0.0 113.218 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.3 tp -105.13 144.59 31.72 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.129 1.772 . . . . 0.0 111.229 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.5 p -131.71 154.6 48.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.003 1.321 . . . . 0.0 111.451 170.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -143.03 125.29 15.49 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.434 1.894 . . . . 0.0 109.479 -174.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt 53.24 31.46 11.67 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.714 1.206 . . . . 0.0 113.351 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.41 -4.58 55.12 Favored Glycine 0 CA--C 1.542 1.769 0 C-N-CA 125.529 1.538 . . . . 0.0 116.094 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -94.41 153.15 18.1 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.771 1.628 . . . . 0.0 111.993 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.25 127.67 32.63 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 157.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.5 mt -142.59 151.28 41.36 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.43 1.492 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -154.51 -48.99 0.09 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.369 1.068 . . . . 0.0 113.693 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -83.52 39.13 0.65 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.734 1.614 . . . . 0.0 113.651 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.9 m -72.53 -22.72 60.98 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.844 1.258 . . . . 0.0 113.328 -172.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 63.36 -54.09 0.2 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.71 2.804 . . . . 0.0 115.558 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -160.71 140.8 11.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.868 2.467 . . . . 0.0 108.853 168.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -73.53 -34.71 65.35 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.023 0.829 . . . . 0.0 112.242 171.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -65.75 -27.94 68.67 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -173.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.4 m -67.0 -18.23 65.29 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.9 mp -107.87 -42.16 4.78 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.142 1.377 . . . . 0.0 112.155 175.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.63 93.86 0.1 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.575 1.56 . . . . 0.0 111.771 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.1 p -76.4 149.39 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.045 0.938 . . . . 0.0 110.994 173.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -141.94 178.56 7.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.477 1.111 . . . . 0.0 113.435 -172.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -97.86 137.53 36.57 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.395 1.878 . . . . 0.0 111.31 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.94 19.6 67.18 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 115.562 0.985 . . . . 0.0 115.562 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -65.09 143.57 57.81 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.581 1.191 . . . . 0.0 111.602 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -127.61 132.84 49.72 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -166.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -121.35 141.01 51.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.061 1.744 . . . . 0.0 111.296 -175.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.6 t -124.14 122.48 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.979 0.911 . . . . 0.0 109.835 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -112.42 112.02 23.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.022 1.329 . . . . 0.0 109.062 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.9 mt -101.5 140.26 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.715 1.606 . . . . 0.0 109.921 -176.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.8 p -133.51 157.37 45.83 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.894 1.277 . . . . 0.0 112.375 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -130.31 149.64 51.9 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.017 2.127 . . . . 0.0 111.475 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.2 t -154.57 155.68 35.21 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.482 1.513 . . . . 0.0 111.088 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.5 t -141.44 140.89 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.153 1.781 . . . . 0.0 110.279 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.358 0 C-N-CA 125.439 1.495 . . . . 0.0 112.587 179.448 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 121.246 0.546 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -82.92 149.71 26.9 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.201 -0.937 . . . . 0.0 110.536 166.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.2 pt -139.85 160.41 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.554 1.942 . . . . 0.0 110.009 169.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -118.88 107.81 14.04 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.872 0.869 . . . . 0.0 111.243 172.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.9 tt -90.13 140.17 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.037 0.535 . . . . 0.0 110.933 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 t -125.84 88.94 53.38 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 125.148 1.379 . . . . 0.0 109.899 -175.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -82.41 124.06 4.06 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.448 2.765 . . . . 0.0 112.509 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.19 35.86 0.18 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.87 1.668 . . . . 0.0 114.039 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.0 m -79.42 51.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 126.793 2.037 . . . . 0.0 113.315 -171.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.96 53.01 7.39 Favored Glycine 0 CA--C 1.533 1.218 0 O-C-N 121.276 -0.89 . . . . 0.0 112.877 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.97 23.89 36.83 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.405 1.002 . . . . 0.0 114.747 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.19 138.72 45.75 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 118.18 0.99 . . . . 0.0 113.554 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.5 p -84.1 155.13 64.04 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 125.427 1.491 . . . . 0.0 112.969 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -62.04 145.15 96.72 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.256 2.637 . . . . 0.0 111.825 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.91 127.05 29.91 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.814 1.246 . . . . 0.0 111.392 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -75.53 130.74 39.34 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.724 1.209 . . . . 0.0 111.291 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.94 149.49 41.91 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.611 1.564 . . . . 0.0 111.143 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -85.48 141.8 29.66 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.089 1.356 . . . . 0.0 111.2 169.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.45 142.17 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.482 1.113 . . . . 0.0 112.897 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.97 150.32 61.38 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.187 1.395 . . . . 0.0 112.674 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.15 -23.58 60.09 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.55 2.833 . . . . 0.0 113.619 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -78.82 0.92 25.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.226 1.41 . . . . 0.0 113.872 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.11 140.23 56.06 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.259 0.936 . . . . 0.0 111.972 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.2 m -119.5 131.96 55.68 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.134 1.374 . . . . 0.0 110.23 -174.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.8 m -61.55 -31.96 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -174.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.64 -37.22 92.33 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 123.776 0.703 . . . . 0.0 113.292 173.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.15 -41.9 73.25 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.214 1.007 . . . . 0.0 111.689 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.46 -45.31 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.549 0.739 . . . . 0.0 111.041 175.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -55.36 -49.07 73.23 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.644 1.177 . . . . 0.0 111.239 172.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 90.5 m -65.26 -40.2 93.66 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.226 0.61 . . . . 0.0 111.849 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -59.61 -46.95 87.45 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.252 1.021 . . . . 0.0 111.638 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 36.0 t -61.64 -46.92 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.162 0.985 . . . . 0.0 111.865 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.6 m -63.93 -38.49 91.29 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.4 0.68 . . . . 0.0 112.283 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.26 -41.81 84.95 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.823 0.849 . . . . 0.0 112.421 174.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -66.08 -41.47 90.64 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.329 1.051 . . . . 0.0 112.832 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -85.28 -9.44 57.7 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.79 12.97 1.84 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 127.646 2.379 . . . . 0.0 115.063 -174.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.9 mp -118.66 153.61 52.29 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 126.743 2.017 . . . . 0.0 111.537 -175.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.06 163.87 37.73 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 124.245 3.297 . . . . 0.0 114.235 -173.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -64.91 -14.6 46.05 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.257 2.638 . . . . 0.0 114.026 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -68.58 -26.89 65.62 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.345 1.058 . . . . 0.0 113.215 171.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 34.6 p -109.01 -21.4 12.64 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.078 1.351 . . . . 0.0 113.573 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.3 m -126.54 126.03 43.01 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.145 0.978 . . . . 0.0 110.899 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -141.97 166.25 25.22 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.844 1.258 . . . . 0.0 113.354 -169.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.0 tp -136.93 140.33 42.19 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.869 1.668 . . . . 0.0 111.278 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.8 p -137.29 156.67 47.98 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.181 1.392 . . . . 0.0 112.767 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -152.53 131.92 12.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.441 2.297 . . . . 0.0 110.144 -174.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.35 40.01 17.52 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.357 1.463 . . . . 0.0 113.444 174.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.29 8.7 87.62 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 125.132 1.348 . . . . 0.0 116.334 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -133.89 160.78 36.64 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.707 1.603 . . . . 0.0 112.619 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.41 155.52 29.93 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.274 0.629 . . . . 0.0 110.866 160.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.6 mt -116.86 133.58 55.83 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.55 1.14 . . . . 0.0 111.065 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.2 141.65 18.7 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.926 1.29 . . . . 0.0 111.403 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.5 t0 55.09 33.58 20.71 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.776 1.63 . . . . 0.0 114.789 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.0 p -83.43 -29.48 28.06 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.565 1.146 . . . . 0.0 113.595 -171.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 61.42 -23.45 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 129.107 2.963 . . . . 0.0 116.979 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.1 p -149.09 161.58 41.68 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.796 2.039 . . . . 0.0 111.25 171.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 65.8 mt -77.01 -20.95 55.37 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.738 -0.601 . . . . 0.0 112.595 164.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -63.67 -36.24 83.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.164 0.986 . . . . 0.0 112.421 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.8 m -69.95 -19.2 63.38 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 174.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.1 mt -90.11 -24.74 21.02 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.731 1.213 . . . . 0.0 113.48 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.97 41.09 72.78 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 123.643 0.64 . . . . 0.0 113.158 -174.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.0 p -55.64 149.19 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.907 1.283 . . . . 0.0 112.22 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.79 151.27 30.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.211 1.004 . . . . 0.0 112.182 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -64.22 128.62 36.58 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.67 0.788 . . . . 0.0 111.195 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.78 8.65 76.09 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.013 1.292 . . . . 0.0 115.858 -176.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -62.08 152.04 33.85 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.665 1.733 . . . . 0.0 113.6 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -103.39 154.15 19.72 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.685 1.194 . . . . 0.0 114.179 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -135.78 143.2 45.1 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.119 2.168 . . . . 0.0 109.679 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.9 t -121.7 126.22 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.745 0.818 . . . . 0.0 110.34 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 tt -111.86 122.31 47.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.733 1.613 . . . . 0.0 109.194 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -113.92 142.74 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.722 1.609 . . . . 0.0 110.061 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.7 t -136.87 150.66 48.4 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.092 1.357 . . . . 0.0 112.052 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -127.96 106.67 9.25 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.681 1.993 . . . . 0.0 110.154 -176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.9 m -78.6 76.41 5.1 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.542 1.137 . . . . 0.0 110.829 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.95 -17.9 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.252 0 C-N-CA 125.56 1.553 . . . . 0.0 113.877 179.491 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.913 0.387 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -102.71 152.23 21.46 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.739 1.215 . . . . 0.0 112.315 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -133.44 154.46 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.283 1.833 . . . . 0.0 109.608 173.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -98.12 146.26 25.74 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.235 0.614 . . . . 0.0 110.549 161.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.4 tt -123.5 136.74 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 124.473 1.109 . . . . 0.0 109.62 165.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -123.46 78.85 54.46 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.943 1.297 . . . . 0.0 109.359 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -81.56 138.02 10.57 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.882 2.388 . . . . 0.0 112.556 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.29 35.7 0.18 Allowed 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.676 1.59 . . . . 0.0 114.394 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.85 160.89 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 126.517 1.927 . . . . 0.0 111.701 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.45 -117.94 12.88 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 123.876 0.75 . . . . 0.0 112.144 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.79 -18.2 72.08 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 123.905 0.764 . . . . 0.0 114.745 174.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.89 11.82 58.74 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-N 118.747 1.273 . . . . 0.0 115.095 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.2 p -106.85 160.14 27.37 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.846 2.058 . . . . 0.0 112.765 -168.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.38 137.37 55.36 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.926 2.417 . . . . 0.0 112.076 171.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 mp -124.1 137.09 54.61 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.319 1.448 . . . . 0.0 110.427 167.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -99.82 135.08 41.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.626 1.17 . . . . 0.0 111.844 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.7 mt -142.23 147.61 36.79 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.039 1.736 . . . . 0.0 111.778 -173.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -81.05 144.06 32.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.284 1.034 . . . . 0.0 110.834 166.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.1 p -144.71 145.24 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.777 0.831 . . . . 0.0 112.514 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 148.09 91.45 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.537 1.135 . . . . 0.0 112.6 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.84 -23.1 41.81 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.202 2.601 . . . . 0.0 113.182 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -81.91 5.79 17.9 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.443 1.497 . . . . 0.0 113.858 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.77 140.47 51.5 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.211 -0.931 . . . . 0.0 112.149 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.6 p -120.05 149.6 41.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.307 1.043 . . . . 0.0 112.109 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.8 m -60.79 -36.06 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.853 0.861 . . . . 0.0 112.519 175.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.83 -44.49 91.96 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 123.893 0.759 . . . . 0.0 112.357 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.75 -47.72 79.89 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 117.767 0.783 . . . . 0.0 112.06 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.4 t -63.14 -48.11 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.466 0.575 . . . . 0.0 111.316 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -59.71 -48.11 82.98 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.71 0.804 . . . . 0.0 111.66 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.5 m -68.62 -36.48 78.7 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.761 -0.587 . . . . 0.0 111.851 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -66.98 -38.78 86.67 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.862 0.865 . . . . 0.0 112.337 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.0 t -56.29 -51.8 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.725 0.81 . . . . 0.0 110.956 167.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.2 m -62.41 -37.18 84.8 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.19 -44.38 84.14 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.024 0.929 . . . . 0.0 112.565 174.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 96.4 mtp -68.63 -39.39 80.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.807 0.843 . . . . 0.0 113.11 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -80.67 -12.56 59.47 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 175.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 58.59 17.43 5.0 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 127.165 2.186 . . . . 0.0 114.162 -173.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 mp -130.04 152.02 79.3 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 127.156 2.183 . . . . 0.0 110.702 -171.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.21 164.74 32.84 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 124.111 3.207 . . . . 0.0 114.115 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.59 -12.28 34.28 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.334 2.689 . . . . 0.0 114.014 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -66.03 -36.84 84.32 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.976 -1.078 . . . . 0.0 112.059 170.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.5 p -90.66 -19.66 23.38 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 89.5 m -136.44 124.83 23.36 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.533 1.515 . . . . 0.0 111.732 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -125.86 157.73 36.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.861 1.665 . . . . 0.0 112.221 -173.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.0 tp -125.98 136.49 53.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.445 1.898 . . . . 0.0 111.308 -173.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.0 p -134.37 153.22 52.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.405 1.082 . . . . 0.0 112.543 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -152.26 136.13 16.34 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.186 1.795 . . . . 0.0 110.059 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt 51.54 33.61 10.86 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.756 1.622 . . . . 0.0 114.362 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.32 19.36 77.47 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.125 0.869 . . . . 0.0 115.091 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -129.02 160.96 31.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.048 2.139 . . . . 0.0 111.24 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -88.58 131.97 34.73 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.696 0.798 . . . . 0.0 110.113 160.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.5 tp -96.94 112.63 24.3 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.148 0.979 . . . . 0.0 110.464 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -154.04 151.14 28.99 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.996 1.318 . . . . 0.0 112.33 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.6 t0 56.18 29.58 14.98 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.928 2.091 . . . . 0.0 115.037 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.0 p -88.36 -20.11 25.75 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 58.09 -64.79 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.87 2.068 . . . . 0.0 114.266 -163.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.7 p -144.01 150.03 37.61 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.16 1.384 . . . . 0.0 111.989 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.51 -30.8 71.61 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.686 0.794 . . . . 0.0 112.631 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.68 -22.51 65.28 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.231 -0.918 . . . . 0.0 113.26 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.7 p -69.44 -26.53 64.65 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 56.6 mt -98.02 -6.35 32.09 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.117 1.767 . . . . 0.0 113.16 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.33 115.39 1.46 Allowed Glycine 0 CA--C 1.536 1.347 0 C-N-CA 126.206 1.86 . . . . 0.0 112.385 -171.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 m -74.43 154.45 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.75 1.22 . . . . 0.0 112.684 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -147.81 160.06 43.16 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.317 1.847 . . . . 0.0 110.319 170.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -93.09 147.49 22.82 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.821 0.848 . . . . 0.0 112.485 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.82 30.78 59.07 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 115.068 0.787 . . . . 0.0 115.068 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.29 148.34 51.86 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.631 1.215 . . . . 0.0 111.891 173.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -120.74 111.75 17.99 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.367 1.067 . . . . 0.0 111.563 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -94.04 144.23 25.66 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.126 1.37 . . . . 0.0 111.222 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.08 128.34 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.484 1.114 . . . . 0.0 109.664 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.3 tp -115.16 123.21 48.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.026 0.93 . . . . 0.0 110.967 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.4 123.56 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.408 1.483 . . . . 0.0 109.708 -171.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.2 t -111.57 141.19 45.48 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.257 1.023 . . . . 0.0 111.76 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? -81.77 122.64 27.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.557 1.543 . . . . 0.0 110.475 175.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.3 m -65.23 142.85 58.16 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.638 0.775 . . . . 0.0 110.28 169.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.8 p -137.03 139.99 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.632 1.173 . . . . 0.0 111.416 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.19 0 C-N-CA 125.302 1.43 . . . . 0.0 112.496 -176.282 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 mmt . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.668 0.271 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.88 148.92 27.04 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.651 -1.28 . . . . 0.0 112.298 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.22 155.97 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.883 1.673 . . . . 0.0 110.434 172.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -111.19 119.36 38.7 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.414 1.086 . . . . 0.0 111.083 169.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 tp -86.98 137.82 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 165.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 t -128.81 77.99 76.82 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 124.718 1.207 . . . . 0.0 109.789 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.09 136.74 10.43 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.317 2.678 . . . . 0.0 112.114 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.46 36.49 0.16 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.679 1.592 . . . . 0.0 113.463 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.6 t -138.32 147.56 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.106 1.762 . . . . 0.0 110.641 -170.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.11 -117.71 10.81 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 123.969 0.795 . . . . 0.0 111.967 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.53 -19.58 71.02 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 123.85 0.738 . . . . 0.0 114.519 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.51 3.66 41.38 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 124.87 1.224 . . . . 0.0 115.667 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.0 p -91.31 157.22 42.85 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 126.583 1.953 . . . . 0.0 113.203 -171.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -64.23 145.36 88.7 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.992 2.461 . . . . 0.0 111.784 168.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 tt -137.07 122.48 19.5 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.95 1.3 . . . . 0.0 110.313 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -90.52 137.81 32.06 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.226 1.01 . . . . 0.0 113.017 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.0 mt -144.72 148.17 33.86 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.984 1.714 . . . . 0.0 111.826 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -80.65 138.2 36.39 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.641 1.176 . . . . 0.0 110.382 166.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.4 m -140.0 153.33 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.458 1.103 . . . . 0.0 112.33 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.85 150.49 96.47 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.04 0.936 . . . . 0.0 112.197 175.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.64 -21.01 52.68 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.082 2.521 . . . . 0.0 112.957 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.88 15.68 2.15 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.853 1.661 . . . . 0.0 114.015 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.18 142.49 54.29 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.163 -0.961 . . . . 0.0 112.128 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.3 m -133.56 138.58 46.11 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.241 1.416 . . . . 0.0 111.046 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.9 t -57.49 -47.76 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.339 1.055 . . . . 0.0 112.587 -173.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.6 -38.33 96.22 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.674 -0.515 . . . . 0.0 112.968 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.18 -46.07 78.64 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 117.986 0.893 . . . . 0.0 111.814 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -60.8 -49.14 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.805 0.842 . . . . 0.0 110.971 176.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -62.42 -46.37 88.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.264 0.626 . . . . 0.0 111.777 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.6 m -59.62 -43.92 93.63 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.475 0.71 . . . . 0.0 111.51 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -66.32 -37.7 85.98 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.576 0.751 . . . . 0.0 112.469 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.02 -46.59 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.502 0.592 . . . . 0.0 111.794 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.2 m -58.6 -40.44 83.26 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.501 1.046 . . . . 0.0 112.144 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.72 -41.51 87.8 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.893 0.877 . . . . 0.0 112.715 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.6 tpt -68.28 -41.25 81.27 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.515 1.126 . . . . 0.0 112.767 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -74.77 -24.62 58.71 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.511 1.524 . . . . 0.0 113.137 172.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.79 30.25 19.55 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.805 2.042 . . . . 0.0 113.221 -171.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 mp -120.32 153.83 56.06 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.948 2.099 . . . . 0.0 111.454 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.74 162.54 38.98 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.899 3.066 . . . . 0.0 113.496 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -67.58 -16.22 46.53 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.537 2.825 . . . . 0.0 114.819 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -79.79 -29.6 40.4 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.675 1.125 . . . . 0.0 113.613 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.7 p -86.64 9.55 18.31 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.702 1.201 . . . . 0.0 113.69 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 t -135.85 144.81 45.84 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.36 1.464 . . . . 0.0 110.897 176.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -133.52 148.01 51.63 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.505 1.922 . . . . 0.0 110.4 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.3 tp -139.67 121.24 15.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.34 1.456 . . . . 0.0 110.563 -169.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.7 m -132.71 141.11 48.42 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.596 1.158 . . . . 0.0 112.342 -169.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -143.75 131.94 21.89 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.779 2.032 . . . . 0.0 110.608 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt 50.14 37.64 15.07 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.008 1.323 . . . . 0.0 113.82 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.18 17.35 79.57 Favored Glycine 0 CA--C 1.541 1.683 0 C-N-CA 124.718 1.151 . . . . 0.0 115.788 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -136.7 154.13 50.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.675 1.99 . . . . 0.0 112.881 -175.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.41 129.27 34.57 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.82 0.848 . . . . 0.0 110.521 165.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.1 130.72 34.84 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.989 0.916 . . . . 0.0 110.223 169.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -162.23 141.94 9.72 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.513 1.525 . . . . 0.0 111.637 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 t0 56.55 25.34 9.71 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 172.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.1 p -82.96 -16.03 48.94 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.839 -1.163 . . . . 0.0 113.234 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 62.67 -56.1 0.15 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 128.775 2.83 . . . . 0.0 115.02 -171.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 21.5 p -148.93 148.21 29.55 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.344 1.858 . . . . 0.0 111.593 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.69 -25.46 68.22 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.689 0.796 . . . . 0.0 112.991 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -62.01 -27.36 68.82 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.065 -1.022 . . . . 0.0 113.084 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.5 m -69.11 -23.93 64.05 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.114 0.966 . . . . 0.0 113.162 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.6 mt -93.45 -22.87 18.63 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.238 1.415 . . . . 0.0 112.724 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.53 114.03 3.01 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.47 1.986 . . . . 0.0 111.344 -167.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.2 t -72.74 143.18 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.717 1.207 . . . . 0.0 111.314 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -138.55 146.14 41.52 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.549 1.54 . . . . 0.0 110.38 168.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -78.38 147.38 34.14 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.289 -0.882 . . . . 0.0 112.411 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.7 21.81 78.07 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 115.044 0.778 . . . . 0.0 115.044 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -56.98 140.0 50.26 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.728 1.264 . . . . 0.0 111.309 170.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -121.44 137.04 54.89 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.856 0.862 . . . . 0.0 112.138 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -119.0 121.87 40.88 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.463 1.505 . . . . 0.0 109.731 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.5 t -91.81 130.59 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.326 0.65 . . . . 0.0 109.428 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 tp -120.31 123.45 43.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.151 0.98 . . . . 0.0 110.892 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -113.28 129.18 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.411 1.485 . . . . 0.0 110.014 -172.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.6 t -94.37 145.88 24.45 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.497 1.119 . . . . 0.0 111.787 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.55 130.47 34.74 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.633 1.173 . . . . 0.0 110.615 171.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -129.61 -51.11 1.16 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.883 0.873 . . . . 0.0 112.737 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.2 t -73.82 129.98 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.771 0.828 . . . . 0.0 110.131 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.247 0 C-N-CA 126.033 1.778 . . . . 0.0 112.374 -177.559 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.979 0.419 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -121.52 147.45 45.77 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.737 1.215 . . . . 0.0 112.544 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.12 166.44 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.542 1.937 . . . . 0.0 110.265 172.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -128.38 100.78 5.93 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.894 0.878 . . . . 0.0 111.287 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.5 tt -86.55 141.8 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.77 0.828 . . . . 0.0 111.209 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.6 t -128.84 80.89 71.9 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 125.491 1.517 . . . . 0.0 109.483 -176.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.5 142.7 33.37 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.952 2.434 . . . . 0.0 111.94 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.62 23.29 0.23 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.399 1.48 . . . . 0.0 113.908 174.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -155.8 160.55 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 127.246 2.218 . . . . 0.0 109.889 -172.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.43 34.81 53.62 Favored Glycine 0 CA--C 1.535 1.292 0 O-C-N 121.389 -0.819 . . . . 0.0 113.998 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.33 -9.17 64.89 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.575 1.559 . . . . 0.0 114.887 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.7 -0.44 43.75 Favored Glycine 0 CA--C 1.54 1.598 0 N-CA-C 116.555 1.382 . . . . 0.0 116.555 170.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.4 m -80.38 152.34 73.1 Favored Pre-proline 0 N--CA 1.472 0.629 0 C-N-CA 124.676 1.19 . . . . 0.0 113.053 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -64.43 145.34 87.76 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.067 2.511 . . . . 0.0 111.845 170.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.7 mt -131.68 121.86 24.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.503 1.521 . . . . 0.0 110.58 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -88.89 132.77 34.54 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.553 1.141 . . . . 0.0 111.284 178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 mt -149.81 143.49 25.39 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.347 1.059 . . . . 0.0 111.624 -173.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -69.82 150.97 46.28 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.351 0.66 . . . . 0.0 111.98 168.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 p -146.37 140.15 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.349 1.06 . . . . 0.0 111.538 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.56 145.27 78.73 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.021 0.928 . . . . 0.0 111.956 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.2 -20.88 49.11 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.833 2.355 . . . . 0.0 113.198 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -75.72 -7.18 53.73 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.2 157.76 30.55 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.162 0.892 . . . . 0.0 112.847 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.85 145.9 51.82 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.95 1.3 . . . . 0.0 110.885 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.1 t -66.37 -34.05 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 121.373 -0.829 . . . . 0.0 111.295 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.25 -43.7 99.05 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.439 1.018 . . . . 0.0 113.054 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.87 -45.47 85.88 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.98 0.89 . . . . 0.0 111.717 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.3 t -60.92 -49.3 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.012 0.925 . . . . 0.0 111.99 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.9 ptt85 -64.08 -39.52 94.24 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.123 0.874 . . . . 0.0 112.07 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.7 m -62.69 -41.22 98.99 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.596 0.758 . . . . 0.0 111.376 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -42.57 97.17 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.708 0.803 . . . . 0.0 112.191 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 70.2 t -74.67 -35.74 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.541 0.736 . . . . 0.0 112.559 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 87.1 m -60.25 -45.51 93.01 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.589 -0.694 . . . . 0.0 111.465 170.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.46 -41.1 89.56 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.984 0.914 . . . . 0.0 112.829 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 57.7 ttm -61.69 -43.84 98.09 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.396 1.078 . . . . 0.0 112.849 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -85.94 -6.38 59.07 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.4 tptm 53.54 53.67 11.21 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.059 2.144 . . . . 0.0 112.451 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.7 mt -133.16 148.38 68.98 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.612 1.565 . . . . 0.0 112.164 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -69.49 160.42 49.83 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.563 2.842 . . . . 0.0 112.444 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.07 -26.01 73.43 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.741 2.294 . . . . 0.0 113.13 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -70.09 -3.19 15.41 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.492 -1.38 . . . . 0.0 114.604 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.8 p -127.7 14.67 6.99 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.368 1.467 . . . . 0.0 113.075 165.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 m -154.53 110.69 3.23 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.031 1.733 . . . . 0.0 110.868 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.2 mtt-85 -132.15 155.22 48.56 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.557 1.143 . . . . 0.0 112.886 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.0 tp -127.37 131.53 50.33 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.255 1.822 . . . . 0.0 110.596 -174.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.8 p -136.84 152.16 49.95 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.415 1.086 . . . . 0.0 113.371 -175.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -142.26 134.5 27.65 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.575 1.95 . . . . 0.0 110.382 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 tptm 51.68 33.31 10.68 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.465 1.506 . . . . 0.0 114.191 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.75 10.09 84.67 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 125.285 1.422 . . . . 0.0 115.931 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -127.34 149.94 49.82 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.792 1.637 . . . . 0.0 112.678 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.12 88.51 6.55 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.735 1.214 . . . . 0.0 110.844 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.2 mp -65.39 147.55 53.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.916 0.886 . . . . 0.0 111.68 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -158.07 -51.05 0.07 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.888 1.275 . . . . 0.0 113.437 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -84.53 40.25 0.78 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.492 1.517 . . . . 0.0 113.295 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.0 m -73.82 -27.26 61.02 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.41 1.084 . . . . 0.0 112.808 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 62.0 -61.92 0.1 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 128.035 2.534 . . . . 0.0 114.776 -174.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.4 p -147.29 150.57 35.05 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.217 1.407 . . . . 0.0 111.319 170.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.07 -20.61 62.34 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.122 0.569 . . . . 0.0 112.471 167.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.09 -54.35 39.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.575 1.55 . . . . 0.0 112.346 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.3 m -69.27 -28.47 66.34 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.9 tp -74.68 -27.84 60.58 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.989 0.916 . . . . 0.0 112.788 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.61 54.24 6.12 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.383 0.992 . . . . 0.0 113.042 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.6 p -56.62 151.88 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.633 1.173 . . . . 0.0 112.905 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.83 161.07 33.83 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.01 1.324 . . . . 0.0 112.945 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -60.95 129.81 43.28 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.099 1.36 . . . . 0.0 112.29 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.46 4.97 59.27 Favored Glycine 0 CA--C 1.535 1.281 0 N-CA-C 115.99 1.156 . . . . 0.0 115.99 171.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -64.68 138.02 58.15 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.179 1.49 . . . . 0.0 110.649 168.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -132.98 134.46 44.51 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -167.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -124.32 136.55 54.19 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.698 1.199 . . . . 0.0 111.484 -167.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t -100.73 132.29 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.725 0.81 . . . . 0.0 109.864 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 tt -120.43 103.44 9.19 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.845 0.858 . . . . 0.0 110.299 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -86.71 141.41 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 126.25 1.82 . . . . 0.0 109.867 -176.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.8 t -146.67 156.55 43.27 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.16 0.984 . . . . 0.0 111.899 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -140.25 143.88 36.2 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.024 1.33 . . . . 0.0 112.573 -171.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.2 p -141.37 163.02 34.08 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.361 1.864 . . . . 0.0 111.782 -174.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.2 m -67.07 154.86 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.314 1.046 . . . . 0.0 112.961 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.266 0 C-N-CA 125.166 1.365 . . . . 0.0 113.571 175.603 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -101.82 140.06 36.62 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.0 -1.688 . . . . 0.0 112.458 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.83 171.1 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 127.297 2.239 . . . . 0.0 110.399 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -127.2 149.95 49.75 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.809 1.244 . . . . 0.0 110.962 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.1 tt -129.38 142.47 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.119 0.968 . . . . 0.0 110.777 172.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.83 77.85 76.12 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 125.292 1.437 . . . . 0.0 109.779 -173.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.84 133.91 15.87 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.163 2.575 . . . . 0.0 111.497 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.7 41.47 0.27 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.253 1.421 . . . . 0.0 113.314 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.4 t -139.22 147.28 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.031 1.732 . . . . 0.0 110.718 -170.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.13 -119.92 16.37 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 123.898 0.761 . . . . 0.0 111.947 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.34 -18.41 71.43 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 123.684 0.659 . . . . 0.0 114.678 174.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.84 3.19 41.68 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 124.966 1.27 . . . . 0.0 115.748 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.5 p -82.33 155.72 69.14 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.996 1.718 . . . . 0.0 113.363 -174.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -67.34 152.18 79.49 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.302 2.668 . . . . 0.0 112.097 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.1 tp -141.31 125.3 17.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.797 1.239 . . . . 0.0 111.759 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -71.08 142.01 50.84 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.21 1.404 . . . . 0.0 112.327 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.75 151.78 37.73 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.382 1.473 . . . . 0.0 110.351 174.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -111.68 128.68 56.15 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.776 1.23 . . . . 0.0 110.465 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.5 m -140.53 155.1 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.206 1.402 . . . . 0.0 112.483 -165.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.98 150.29 97.64 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 123.82 0.848 . . . . 0.0 111.788 171.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.2 -25.34 57.76 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.966 2.444 . . . . 0.0 112.971 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -76.34 12.57 1.17 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.908 1.683 . . . . 0.0 114.728 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.55 105.12 0.73 Allowed 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.916 -1.115 . . . . 0.0 111.917 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.0 m -75.61 130.1 38.24 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.476 1.11 . . . . 0.0 111.15 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.9 t -60.93 -35.2 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.994 0.918 . . . . 0.0 112.925 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.59 -40.0 97.23 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 121.319 -0.863 . . . . 0.0 113.223 172.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.66 -34.76 77.57 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 117.975 0.887 . . . . 0.0 112.324 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.2 t -60.48 -44.39 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 O-C-N 121.505 -0.747 . . . . 0.0 110.814 172.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -61.42 -54.21 46.47 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.323 173.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 66.4 p -63.17 -34.44 77.63 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.41 1.005 . . . . 0.0 112.853 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -61.06 -47.5 86.09 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.739 0.816 . . . . 0.0 111.751 173.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.0 t -66.6 -41.87 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.805 176.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 92.4 m -57.84 -41.87 83.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.46 1.027 . . . . 0.0 112.087 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.51 -41.5 88.77 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.696 0.798 . . . . 0.0 112.849 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.5 mtt -67.29 -39.49 86.01 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.04 0.936 . . . . 0.0 113.106 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.453 ' HE3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -79.14 -23.22 44.13 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.879 1.272 . . . . 0.0 113.647 176.635 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt 58.78 31.3 21.07 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.419 1.888 . . . . 0.0 113.189 -167.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 mp -114.24 150.58 43.92 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 126.249 1.82 . . . . 0.0 111.035 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -69.54 161.84 44.32 Favored 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.702 2.935 . . . . 0.0 112.726 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -65.18 -20.18 62.77 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.22 2.613 . . . . 0.0 113.674 176.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -67.65 -31.56 71.64 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.149 -0.969 . . . . 0.0 113.309 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 47.8 p -94.41 20.17 8.65 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.382 1.473 . . . . 0.0 113.704 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 t -145.68 152.55 39.8 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.334 1.054 . . . . 0.0 112.373 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 88.0 mmt-85 -139.36 145.55 39.15 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.924 1.69 . . . . 0.0 111.283 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.8 tp -134.71 127.9 31.91 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.441 1.896 . . . . 0.0 109.834 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.6 p -140.67 155.48 46.48 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.418 1.087 . . . . 0.0 112.772 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -146.41 140.49 26.35 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.101 1.76 . . . . 0.0 110.013 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.1 tptt 50.95 34.8 11.17 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.644 1.578 . . . . 0.0 114.035 -177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.87 14.94 81.17 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.757 1.17 . . . . 0.0 115.292 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -130.71 145.45 51.94 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.129 1.772 . . . . 0.0 111.739 -173.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.84 119.4 23.86 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.739 0.815 . . . . 0.0 110.655 171.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.1 mp -93.37 135.42 34.62 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.25 1.02 . . . . 0.0 110.212 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -160.64 149.7 16.97 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.227 1.811 . . . . 0.0 110.127 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 56.18 27.43 11.61 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.601 1.561 . . . . 0.0 114.823 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -73.23 -26.09 60.99 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.52 1.128 . . . . 0.0 113.638 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 61.04 -43.85 0.12 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.73 2.812 . . . . 0.0 115.079 -167.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.8 t -155.05 145.43 22.05 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.121 1.768 . . . . 0.0 110.62 174.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.72 -18.85 65.39 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.671 -0.643 . . . . 0.0 111.938 172.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.66 -24.11 67.47 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.033 -1.042 . . . . 0.0 112.772 173.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.7 t -68.25 -36.89 80.15 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.808 0.843 . . . . 0.0 112.283 172.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.4 mt -85.66 -20.67 29.08 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.972 1.309 . . . . 0.0 113.323 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.64 115.77 3.75 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.757 2.123 . . . . 0.0 111.856 -172.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.6 m -77.7 151.86 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.851 1.261 . . . . 0.0 113.364 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.89 163.61 39.77 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.407 1.883 . . . . 0.0 110.755 169.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -90.89 150.23 21.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.166 0.987 . . . . 0.0 112.806 172.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.67 81.67 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.739 1.161 . . . . 0.0 114.804 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -62.19 120.95 11.91 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.531 1.165 . . . . 0.0 110.745 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -106.15 114.87 29.26 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.045 0.938 . . . . 0.0 112.075 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -93.61 125.8 38.42 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.575 1.55 . . . . 0.0 110.545 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.0 t -96.39 133.26 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.724 0.81 . . . . 0.0 109.433 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.5 tt -130.37 123.49 30.03 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.851 0.86 . . . . 0.0 111.232 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.4 mm -117.07 122.01 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.112 1.365 . . . . 0.0 110.163 -171.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -81.66 143.35 31.97 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.328 0.651 . . . . 0.0 110.949 167.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -78.12 152.23 32.93 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.753 0.821 . . . . 0.0 110.335 167.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 76.3 p -119.64 165.99 13.76 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.396 1.478 . . . . 0.0 111.501 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.4 p -137.14 142.59 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.077 1.351 . . . . 0.0 111.482 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.256 0 C-N-CA 125.565 1.555 . . . . 0.0 112.464 -178.369 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.5 mtt . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -79.76 149.28 31.17 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.16 -0.962 . . . . 0.0 111.559 166.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.97 140.26 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.918 2.087 . . . . 0.0 109.08 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -100.24 110.41 22.66 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.856 1.262 . . . . 0.0 110.951 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.3 tt -90.56 138.47 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.766 -0.584 . . . . 0.0 110.354 171.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.7 t -127.37 81.89 69.24 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 125.134 1.373 . . . . 0.0 109.65 -175.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -84.06 135.55 6.52 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.892 2.395 . . . . 0.0 113.02 -177.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.1 37.23 0.25 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.771 1.628 . . . . 0.0 114.109 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.84 157.16 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.681 1.593 . . . . 0.0 111.148 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.58 -115.48 7.38 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.207 0.908 . . . . 0.0 111.863 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.35 -21.93 70.75 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 123.736 0.684 . . . . 0.0 114.376 174.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.33 23.7 70.22 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 118.539 1.169 . . . . 0.0 114.576 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -133.14 155.88 80.54 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 125.822 1.649 . . . . 0.0 112.964 -163.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.1 138.16 55.39 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.991 2.46 . . . . 0.0 112.564 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.2 mt -131.36 122.8 26.97 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.734 1.614 . . . . 0.0 110.205 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -79.71 141.39 36.43 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.709 0.804 . . . . 0.0 111.894 173.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 tp -150.25 144.69 25.75 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.954 1.301 . . . . 0.0 111.229 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -86.05 136.54 33.19 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.98 0.912 . . . . 0.0 111.017 170.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 t -142.98 142.53 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.426 1.09 . . . . 0.0 111.019 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.49 152.14 96.5 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.689 1.196 . . . . 0.0 113.192 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.07 -20.23 50.58 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.379 2.719 . . . . 0.0 113.492 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -72.02 6.0 2.38 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.87 1.668 . . . . 0.0 114.354 172.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.3 131.05 47.04 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.572 1.078 . . . . 0.0 112.496 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.0 m -116.47 133.25 56.23 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.469 1.508 . . . . 0.0 109.798 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.0 t -59.67 -41.0 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.304 0.642 . . . . 0.0 112.155 -175.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.71 -36.54 91.91 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.522 -0.599 . . . . 0.0 113.413 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.9 -44.22 73.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.381 1.091 . . . . 0.0 111.945 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.66 -47.01 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.591 0.756 . . . . 0.0 111.169 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -61.63 -43.55 98.64 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.457 1.103 . . . . 0.0 111.944 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 88.3 m -62.52 -42.6 99.62 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.655 0.662 . . . . 0.0 111.696 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.67 -43.78 98.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.004 0.921 . . . . 0.0 111.489 176.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.79 -52.86 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.236 1.015 . . . . 0.0 111.504 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 85.1 m -61.06 -35.88 78.11 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.778 0.717 . . . . 0.0 112.599 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.82 -44.25 81.68 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.824 0.849 . . . . 0.0 112.911 173.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 71.7 mtm -68.97 -39.06 79.68 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.527 -0.733 . . . . 0.0 112.928 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -15.63 58.87 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.82 1.248 . . . . 0.0 113.426 176.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? 57.18 32.53 21.87 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.597 1.959 . . . . 0.0 112.447 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 32.0 mt -148.42 152.06 37.84 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 126.268 1.827 . . . . 0.0 112.311 -165.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.58 164.03 35.96 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 124.395 3.397 . . . . 0.0 114.44 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.95 -5.21 15.12 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.651 2.901 . . . . 0.0 114.476 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -75.05 -32.39 61.53 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.796 -1.19 . . . . 0.0 113.287 168.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.7 p -95.15 -20.35 19.33 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.1 m -135.16 130.4 35.33 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.308 1.043 . . . . 0.0 111.055 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -132.02 159.33 39.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.816 1.647 . . . . 0.0 112.598 -173.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.8 tp -127.61 137.0 52.43 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.184 1.794 . . . . 0.0 110.752 -176.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.5 p -132.64 151.45 51.95 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.028 0.931 . . . . 0.0 111.993 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -138.3 128.98 26.55 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.005 1.722 . . . . 0.0 109.984 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt 50.28 37.05 14.1 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.114 1.366 . . . . 0.0 114.076 172.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.22 11.49 80.71 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.447 1.499 . . . . 0.0 116.248 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -137.34 155.02 49.91 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.222 1.511 . . . . 0.0 113.59 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.14 99.52 11.57 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.57 1.148 . . . . 0.0 110.249 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.58 141.28 57.89 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.187 0.995 . . . . 0.0 110.994 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -166.6 154.48 9.91 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.649 1.58 . . . . 0.0 111.954 173.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.9 t0 57.41 28.72 15.82 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.973 1.709 . . . . 0.0 115.468 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.6 p -84.45 -24.73 29.38 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -174.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 59.49 -46.52 0.08 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 128.287 2.635 . . . . 0.0 115.803 -167.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 t -151.67 142.71 23.12 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.312 1.445 . . . . 0.0 111.229 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.4 tp -70.04 -22.86 63.04 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.699 0.799 . . . . 0.0 112.645 174.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.83 -33.6 75.08 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.085 -1.009 . . . . 0.0 113.168 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.4 t -64.81 -33.89 77.05 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.469 0.708 . . . . 0.0 112.32 174.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 87.0 mt -84.98 -3.98 58.97 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.548 1.539 . . . . 0.0 113.504 173.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.74 113.76 0.49 Allowed Glycine 0 CA--C 1.536 1.397 0 C-N-CA 126.026 1.774 . . . . 0.0 112.825 -170.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 m -70.79 157.56 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.206 1.002 . . . . 0.0 112.196 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -138.12 -169.07 2.49 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.084 1.754 . . . . 0.0 110.874 174.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -138.07 150.59 47.04 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.274 1.029 . . . . 0.0 112.58 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.82 21.75 75.22 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 123.32 0.486 . . . . 0.0 113.9 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -60.86 153.34 24.93 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.835 1.254 . . . . 0.0 112.858 176.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -134.41 136.69 43.47 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.094 0.958 . . . . 0.0 113.028 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -125.69 136.13 52.87 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.189 1.795 . . . . 0.0 109.411 -174.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.8 t -117.38 124.21 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.571 0.749 . . . . 0.0 110.079 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tp -104.39 125.99 51.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.692 0.797 . . . . 0.0 110.332 176.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.5 pt -116.5 146.27 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.348 1.459 . . . . 0.0 110.336 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.8 t -139.43 146.89 40.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.037 0.935 . . . . 0.0 111.548 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 55.6 ttt-85 -133.12 126.77 32.46 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.331 1.852 . . . . 0.0 110.475 -169.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 74.9 p -73.68 153.55 40.05 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.209 0.604 . . . . 0.0 111.659 173.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.7 t -88.07 99.08 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.651 0.781 . . . . 0.0 109.106 174.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.265 0 C-N-CA 126.083 1.802 . . . . 0.0 113.093 -178.003 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.503 ' HB2' ' OD1' ' A' ' 65' ' ' ASP . 15.8 mmt . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 mtmm -86.33 143.23 27.97 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.915 0.886 . . . . 0.0 110.283 162.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.3 157.54 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.009 1.723 . . . . 0.0 109.687 172.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -122.45 102.07 7.87 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.085 0.954 . . . . 0.0 110.88 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 tt -87.26 141.66 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 122.791 0.436 . . . . 0.0 110.71 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.3 t -130.73 81.78 66.47 Favored Pre-proline 0 N--CA 1.47 0.56 0 C-N-CA 125.276 1.43 . . . . 0.0 109.48 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.41 134.22 12.43 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.685 2.257 . . . . 0.0 112.046 178.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.18 40.65 0.21 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.024 1.33 . . . . 0.0 113.515 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.2 t -137.97 147.11 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.044 1.738 . . . . 0.0 110.814 -170.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.13 -121.55 21.55 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.845 0.736 . . . . 0.0 111.961 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.05 -17.31 71.67 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.671 0.653 . . . . 0.0 114.59 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.36 3.34 61.56 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.778 1.18 . . . . 0.0 115.402 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 m -72.65 152.13 91.47 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.103 1.361 . . . . 0.0 113.717 -172.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -64.97 152.64 81.67 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.706 2.271 . . . . 0.0 111.81 164.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.3 tp -142.64 124.52 15.16 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.785 1.234 . . . . 0.0 111.323 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -82.77 135.11 35.08 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.951 0.901 . . . . 0.0 111.899 175.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.3 mt -142.7 141.25 31.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.14 1.776 . . . . 0.0 110.761 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -76.78 144.61 39.07 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.626 0.77 . . . . 0.0 111.832 166.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.9 m -142.11 153.79 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.854 1.262 . . . . 0.0 111.452 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.76 150.7 88.69 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.218 0.607 . . . . 0.0 111.692 169.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -65.29 -20.92 62.14 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.781 2.321 . . . . 0.0 112.889 173.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -80.22 7.53 9.21 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.026 1.73 . . . . 0.0 114.185 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.18 117.53 4.5 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.691 1.197 . . . . 0.0 112.963 -174.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.9 m -91.34 141.27 28.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.36 1.464 . . . . 0.0 111.684 -176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.48 -44.22 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.556 -0.715 . . . . 0.0 111.986 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.2 -36.83 93.0 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.513 0.577 . . . . 0.0 113.681 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.82 -43.67 83.19 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.167 0.983 . . . . 0.0 111.797 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 82.3 t -63.7 -44.81 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.854 0.862 . . . . 0.0 111.252 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -64.02 -38.02 89.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.286 1.035 . . . . 0.0 111.966 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.0 m -66.34 -44.95 81.85 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.19 0.996 . . . . 0.0 111.423 174.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -58.17 -45.04 88.2 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.0 0.92 . . . . 0.0 112.139 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.8 t -59.67 -53.24 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.086 0.955 . . . . 0.0 111.112 173.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.3 t -61.08 -41.52 96.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.357 0.663 . . . . 0.0 112.535 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.9 73.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.065 0.946 . . . . 0.0 112.79 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.9 ttp -73.42 -22.57 60.19 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.6 mmpm? -93.23 -15.39 25.94 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.959 1.304 . . . . 0.0 113.688 170.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt 55.71 24.85 7.6 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.933 2.493 . . . . 0.0 114.613 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.86 153.97 61.65 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.857 1.663 . . . . 0.0 111.644 -173.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -71.12 156.66 59.25 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.897 3.065 . . . . 0.0 113.243 -175.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.75 -14.5 45.19 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.824 3.016 . . . . 0.0 114.491 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -64.22 -24.99 67.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.824 0.85 . . . . 0.0 113.09 170.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 38.8 p -98.17 -26.86 14.42 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.416 1.087 . . . . 0.0 113.441 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 84.9 m -138.76 116.94 11.8 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.284 1.034 . . . . 0.0 111.61 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -109.59 162.84 14.02 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.875 1.67 . . . . 0.0 112.984 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.4 tp -129.66 140.52 51.13 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.039 1.736 . . . . 0.0 111.303 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.4 p -136.26 157.71 46.16 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.597 1.159 . . . . 0.0 112.537 171.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -139.5 131.2 27.36 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.857 2.063 . . . . 0.0 109.789 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? 47.74 37.21 6.66 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.591 1.556 . . . . 0.0 114.485 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.09 14.95 81.76 Favored Glycine 0 CA--C 1.54 1.632 0 N-CA-C 115.715 1.046 . . . . 0.0 115.715 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -134.32 159.85 39.72 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.759 1.623 . . . . 0.0 111.761 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.12 133.16 34.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.407 0.683 . . . . 0.0 111.332 169.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.0 mt -86.41 127.55 34.84 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.822 0.849 . . . . 0.0 110.457 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.33 131.89 9.52 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.306 1.442 . . . . 0.0 110.541 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.0 t0 55.26 29.18 12.39 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.703 1.601 . . . . 0.0 115.094 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.2 p -84.5 -11.99 55.08 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.762 -1.211 . . . . 0.0 113.95 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 63.6 -54.15 0.22 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.893 2.477 . . . . 0.0 115.388 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.1 p -147.33 158.09 43.83 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.312 1.845 . . . . 0.0 111.516 176.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.4 -34.17 77.56 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.721 -0.612 . . . . 0.0 112.066 168.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.6 tm-20 -63.14 -33.54 75.69 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.832 0.853 . . . . 0.0 113.034 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 p -63.75 -27.65 69.34 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.4 mt -98.07 4.75 49.17 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.858 1.663 . . . . 0.0 113.17 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.16 100.11 0.76 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.367 1.46 . . . . 0.0 112.141 -172.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.5 p -73.65 150.68 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.869 1.267 . . . . 0.0 111.813 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.69 -171.86 3.33 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.041 1.736 . . . . 0.0 111.041 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.503 ' OD1' ' HB2' ' A' ' 1' ' ' MET . 14.2 t0 -121.88 145.2 48.32 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.453 1.101 . . . . 0.0 111.647 174.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.01 20.6 77.5 Favored Glycine 0 CA--C 1.539 1.533 0 CA-C-O 119.705 -0.497 . . . . 0.0 114.333 -174.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -58.47 136.48 57.51 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.432 1.116 . . . . 0.0 111.835 172.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -112.25 140.68 46.76 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -123.66 132.64 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.151 1.781 . . . . 0.0 109.295 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.7 t -123.58 121.3 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 118.719 0.69 . . . . 0.0 110.873 -173.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 tp -96.32 137.72 34.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.379 1.072 . . . . 0.0 110.178 175.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.32 125.43 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.485 1.114 . . . . 0.0 109.027 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.7 t -118.1 142.04 47.84 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.711 1.204 . . . . 0.0 112.141 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 -80.79 138.06 36.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.912 1.285 . . . . 0.0 111.478 171.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.3 p -71.66 110.35 6.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.884 0.874 . . . . 0.0 110.091 169.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.5 t -73.77 120.05 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.509 0.723 . . . . 0.0 109.918 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.163 0 C-N-CA 125.25 1.405 . . . . 0.0 112.595 -177.73 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 121.344 0.592 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -92.75 139.31 30.68 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.652 1.181 . . . . 0.0 111.197 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pp -137.0 162.84 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.773 1.629 . . . . 0.0 110.849 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -126.79 138.73 53.4 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.203 1.001 . . . . 0.0 112.153 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.9 mt -121.18 133.91 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.936 1.295 . . . . 0.0 109.096 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.23 92.87 37.71 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.692 1.197 . . . . 0.0 110.831 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -88.25 130.87 2.5 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.915 2.41 . . . . 0.0 112.493 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.23 29.95 0.12 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.514 1.526 . . . . 0.0 114.507 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.3 m -73.95 73.87 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 126.471 1.908 . . . . 0.0 112.767 -173.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.0 38.91 63.89 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.143 0.878 . . . . 0.0 113.192 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.55 29.46 29.8 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.311 0.958 . . . . 0.0 114.289 -174.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.78 141.22 48.1 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 124.622 1.106 . . . . 0.0 114.103 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 m -80.03 154.62 75.16 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 125.107 1.363 . . . . 0.0 113.418 -176.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -62.89 147.43 94.62 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.075 2.517 . . . . 0.0 111.997 166.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.86 138.03 35.39 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.64 1.576 . . . . 0.0 110.813 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -87.73 140.34 29.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.069 1.348 . . . . 0.0 112.122 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 mp -140.85 164.94 28.88 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.083 1.753 . . . . 0.0 111.459 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -116.39 137.53 52.08 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.52 1.528 . . . . 0.0 110.217 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.3 158.99 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.743 1.217 . . . . 0.0 111.879 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.2 149.13 98.62 Favored Pre-proline 0 CA--C 1.551 0.984 0 O-C-N 121.767 -0.583 . . . . 0.0 111.498 170.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.46 -24.32 56.94 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.944 2.429 . . . . 0.0 113.221 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -82.95 33.35 0.44 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.925 1.69 . . . . 0.0 113.638 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.41 117.76 5.64 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.184 -0.948 . . . . 0.0 111.199 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.2 m -97.46 129.36 44.66 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.732 1.213 . . . . 0.0 110.888 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.8 -44.0 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.917 0.887 . . . . 0.0 112.226 -175.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.46 -36.47 93.42 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.517 0.579 . . . . 0.0 113.51 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.92 -37.98 76.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.38 1.09 . . . . 0.0 112.378 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.7 t -68.65 -43.93 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.276 1.03 . . . . 0.0 111.24 174.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -63.84 -37.39 87.2 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.022 0.929 . . . . 0.0 112.241 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.9 m -64.17 -39.77 94.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.661 0.785 . . . . 0.0 111.328 170.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.24 -47.95 83.81 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.872 0.869 . . . . 0.0 111.281 174.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.4 t -56.9 -50.22 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.04 1.336 . . . . 0.0 111.342 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.5 t -59.93 -44.71 94.17 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.756 0.822 . . . . 0.0 112.109 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.84 86.17 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.994 0.918 . . . . 0.0 113.177 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.4 mtt -68.64 -42.49 77.94 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.107 0.963 . . . . 0.0 112.748 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.98 -23.28 41.71 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.01 26.24 15.53 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.962 1.705 . . . . 0.0 113.275 -174.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.79 153.91 70.39 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 126.845 2.058 . . . . 0.0 111.317 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.47 163.63 38.16 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 124.293 3.329 . . . . 0.0 114.247 -173.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.57 -15.78 51.75 Favored 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 123.421 2.747 . . . . 0.0 113.992 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -67.67 -28.86 68.05 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.138 -0.976 . . . . 0.0 113.208 173.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.1 p -102.95 -10.16 19.23 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.087 1.355 . . . . 0.0 113.872 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.4 m -148.63 123.49 9.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.836 1.254 . . . . 0.0 111.263 172.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -110.49 160.39 16.66 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.718 1.207 . . . . 0.0 113.447 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.6 tp -126.43 132.52 51.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.798 2.039 . . . . 0.0 110.391 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.5 p -137.11 158.36 44.62 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.362 1.065 . . . . 0.0 111.966 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -133.44 126.58 31.51 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.137 2.175 . . . . 0.0 109.378 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt 51.49 30.66 6.55 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.17 0.988 . . . . 0.0 113.382 -174.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.34 2.28 73.15 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 125.26 1.409 . . . . 0.0 115.958 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.44 146.3 29.68 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.948 2.099 . . . . 0.0 111.357 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.8 122.15 25.68 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.576 -0.703 . . . . 0.0 110.968 169.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.2 mt -83.35 134.17 34.92 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.201 1.0 . . . . 0.0 111.097 171.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -160.38 144.76 14.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.456 1.502 . . . . 0.0 110.578 170.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.9 t0 52.69 27.99 5.8 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.778 1.631 . . . . 0.0 115.021 174.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.9 m -83.04 -23.82 33.04 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.078 1.351 . . . . 0.0 112.926 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 61.63 -52.85 0.13 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 128.403 2.681 . . . . 0.0 115.544 -172.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.0 t -159.15 142.27 14.5 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.031 1.332 . . . . 0.0 111.641 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.16 -26.75 67.57 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.538 0.735 . . . . 0.0 112.314 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.43 -20.01 64.62 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.755 1.161 . . . . 0.0 113.361 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.7 t -74.91 -38.19 61.89 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.112 0.965 . . . . 0.0 112.374 173.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.47 -35.73 14.94 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.887 1.275 . . . . 0.0 112.929 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 140.42 87.77 0.13 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.042 1.782 . . . . 0.0 112.267 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.3 p -76.72 147.36 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.011 1.324 . . . . 0.0 112.357 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.19 156.13 37.98 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.894 1.278 . . . . 0.0 112.483 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -67.65 147.09 53.17 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.339 -0.851 . . . . 0.0 111.287 162.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.78 14.32 77.95 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 123.867 0.746 . . . . 0.0 114.493 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -55.4 132.91 49.36 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.729 1.264 . . . . 0.0 110.579 168.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.48 131.95 45.41 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.268 1.027 . . . . 0.0 112.443 -165.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -128.07 132.1 49.06 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.432 1.493 . . . . 0.0 110.637 -169.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.74 133.96 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.166 0.987 . . . . 0.0 110.752 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 tp -109.93 115.47 29.85 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.313 1.045 . . . . 0.0 110.049 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.2 mm -105.32 94.09 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.256 1.023 . . . . 0.0 108.983 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -79.22 152.02 30.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.259 1.424 . . . . 0.0 111.243 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -131.48 139.5 49.35 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.74 1.216 . . . . 0.0 112.197 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.4 m -68.3 143.03 55.36 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.071 1.348 . . . . 0.0 112.365 -172.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.2 t -128.65 -49.22 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.715 1.206 . . . . 0.0 112.015 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.194 0 CA-C-O 118.265 -1.297 . . . . 0.0 113.173 -179.366 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 110.583 -0.154 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -86.13 145.4 27.04 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.179 -1.575 . . . . 0.0 112.944 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.4 mm -136.48 140.12 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 127.873 2.469 . . . . 0.0 108.641 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -91.84 140.2 29.91 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.177 0.591 . . . . 0.0 110.596 167.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.6 pt -118.78 139.78 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.888 0.875 . . . . 0.0 110.317 168.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 t -129.95 73.71 81.18 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 124.602 1.161 . . . . 0.0 110.371 -175.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -78.62 134.34 12.22 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.508 2.805 . . . . 0.0 112.014 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.05 35.17 0.2 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.603 1.561 . . . . 0.0 114.545 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.4 m -138.94 161.59 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 126.09 1.756 . . . . 0.0 111.874 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.87 -119.97 18.31 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 123.687 0.661 . . . . 0.0 111.467 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.09 -17.85 74.18 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 123.684 0.659 . . . . 0.0 114.691 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.48 2.48 35.01 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.206 1.384 . . . . 0.0 115.229 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.6 p -85.63 156.55 58.8 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.392 1.877 . . . . 0.0 113.591 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.32 153.08 79.4 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.051 2.5 . . . . 0.0 112.4 170.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.8 tp -143.19 130.04 20.48 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.185 1.394 . . . . 0.0 111.671 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -80.35 134.97 36.1 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.41 1.084 . . . . 0.0 111.967 172.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.4 mt -142.93 149.53 38.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.118 1.767 . . . . 0.0 111.409 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -90.58 134.32 34.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.502 1.121 . . . . 0.0 110.809 169.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.59 154.64 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.612 1.165 . . . . 0.0 112.299 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.64 152.12 89.35 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.361 1.064 . . . . 0.0 112.585 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.11 -17.98 55.74 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.364 2.709 . . . . 0.0 113.544 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -80.59 4.81 17.3 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.521 1.528 . . . . 0.0 113.928 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.67 125.99 25.81 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.495 1.043 . . . . 0.0 112.565 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 m -94.21 131.27 39.96 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.045 1.338 . . . . 0.0 110.814 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.6 t -60.6 -41.54 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 O-C-N 121.348 -0.845 . . . . 0.0 111.962 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.86 -33.93 88.57 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 123.827 0.727 . . . . 0.0 113.767 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.97 -42.66 76.31 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.389 1.095 . . . . 0.0 111.463 174.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.59 -48.03 88.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.77 0.828 . . . . 0.0 110.876 174.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.4 mmm-85 -58.14 -45.99 86.43 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.792 0.837 . . . . 0.0 112.115 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.7 m -60.34 -44.53 95.43 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.332 0.653 . . . . 0.0 111.902 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -42.85 99.44 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.149 0.979 . . . . 0.0 111.568 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.0 t -67.18 -47.76 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.589 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 97.8 m -57.67 -42.32 83.31 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.025 1.284 . . . . 0.0 112.087 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.94 -41.18 91.64 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.79 0.836 . . . . 0.0 112.797 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.7 ttt -70.85 -41.68 71.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.257 1.023 . . . . 0.0 112.815 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -29.11 63.85 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.762 1.225 . . . . 0.0 112.641 173.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? 68.65 31.75 4.51 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 127.247 2.219 . . . . 0.0 113.208 -173.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mp -128.98 153.65 80.26 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.193 1.797 . . . . 0.0 111.824 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.14 159.62 53.13 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.836 3.024 . . . . 0.0 113.245 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.51 -15.25 48.91 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.923 3.082 . . . . 0.0 114.408 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -70.23 -25.14 63.24 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.475 1.034 . . . . 0.0 113.031 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.4 m -93.46 0.65 56.84 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.962 1.305 . . . . 0.0 113.22 -175.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.0 t -137.34 140.21 41.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.939 1.296 . . . . 0.0 112.056 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -134.16 140.8 46.79 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.72 1.608 . . . . 0.0 110.772 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.4 tp -131.63 129.92 41.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.508 1.523 . . . . 0.0 110.907 -171.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -139.7 153.82 47.33 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.48 1.112 . . . . 0.0 112.948 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -143.72 138.64 29.01 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.263 1.825 . . . . 0.0 110.24 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 55.03 30.89 15.04 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.863 1.265 . . . . 0.0 113.777 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.45 18.19 79.28 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 124.786 1.184 . . . . 0.0 114.952 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -134.15 142.78 47.58 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.373 1.869 . . . . 0.0 111.132 -170.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.91 135.55 40.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.762 0.825 . . . . 0.0 111.919 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.4 mt -103.91 136.81 42.88 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.486 1.114 . . . . 0.0 110.798 173.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.48 149.65 18.94 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.119 1.368 . . . . 0.0 111.164 171.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.0 t0 54.23 27.67 8.16 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.778 1.631 . . . . 0.0 114.88 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -75.24 -24.88 57.72 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.388 1.075 . . . . 0.0 113.287 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 60.53 -56.01 0.08 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 128.584 2.754 . . . . 0.0 114.898 -169.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 p -146.92 133.57 19.91 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.934 1.694 . . . . 0.0 111.205 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.79 -32.8 74.53 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.871 0.869 . . . . 0.0 112.882 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -62.09 -26.83 68.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.145 0.978 . . . . 0.0 113.383 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.6 m -71.05 -28.15 64.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.385 1.074 . . . . 0.0 113.445 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 72.3 mt -99.76 -32.21 11.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.74 1.216 . . . . 0.0 112.966 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 138.39 81.55 0.09 OUTLIER Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.516 1.532 . . . . 0.0 112.162 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.4 p -70.52 147.07 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.268 1.027 . . . . 0.0 111.633 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -146.36 167.96 22.29 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.619 1.568 . . . . 0.0 111.863 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -106.48 145.69 31.49 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.375 1.47 . . . . 0.0 113.446 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.53 13.45 82.93 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 123.798 0.714 . . . . 0.0 114.463 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -65.03 159.92 22.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.412 1.085 . . . . 0.0 111.796 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.72 130.96 28.44 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -101.43 138.5 38.36 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.242 1.417 . . . . 0.0 111.093 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.87 134.47 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.263 1.025 . . . . 0.0 109.574 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.0 tt -130.84 125.46 33.7 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.759 0.824 . . . . 0.0 111.514 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.0 mm -113.41 135.78 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.123 1.769 . . . . 0.0 110.476 -170.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.2 t -102.05 143.48 31.84 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.803 1.241 . . . . 0.0 111.346 172.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.06 114.62 27.19 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.626 1.17 . . . . 0.0 111.055 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.2 t -71.98 157.24 38.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.006 0.922 . . . . 0.0 112.338 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.6 t -124.61 -46.16 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.509 1.524 . . . . 0.0 112.154 -176.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.321 0 CA-C-O 117.862 -1.521 . . . . 0.0 113.976 -178.511 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ttt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 120.657 0.265 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -68.56 147.52 51.84 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.624 -1.297 . . . . 0.0 111.072 158.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -143.95 166.11 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 127.568 2.347 . . . . 0.0 110.165 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -125.69 134.9 51.66 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.062 0.945 . . . . 0.0 111.355 167.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 54.5 mt -121.53 131.03 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.999 1.319 . . . . 0.0 108.669 177.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 p -121.49 98.11 46.48 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 124.563 1.145 . . . . 0.0 110.77 173.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -84.58 144.11 9.98 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.298 2.666 . . . . 0.0 111.38 172.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.34 34.38 0.11 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 125.687 1.595 . . . . 0.0 113.553 173.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.3 t -134.29 144.32 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.263 1.825 . . . . 0.0 110.684 -167.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.24 -113.76 6.21 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.05 0.833 . . . . 0.0 112.234 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.73 -20.22 70.05 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 123.984 0.802 . . . . 0.0 114.548 174.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.37 12.86 64.26 Favored Glycine 0 CA--C 1.54 1.606 0 CA-C-N 118.547 1.173 . . . . 0.0 115.47 175.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.0 p -111.86 155.97 42.39 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 126.254 1.822 . . . . 0.0 113.003 -167.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.6 145.11 91.3 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.977 2.451 . . . . 0.0 112.317 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.92 129.62 34.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.6 1.56 . . . . 0.0 109.998 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.84 135.21 43.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.654 1.181 . . . . 0.0 111.543 173.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.13 168.59 19.38 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.832 1.653 . . . . 0.0 110.602 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.2 143.56 49.95 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.909 1.284 . . . . 0.0 111.086 166.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.5 m -141.45 158.12 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.033 1.333 . . . . 0.0 112.109 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.64 149.23 98.35 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.238 1.015 . . . . 0.0 112.179 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -67.69 -17.71 47.81 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.623 2.882 . . . . 0.0 113.837 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.48 -6.7 59.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.205 1.402 . . . . 0.0 114.136 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.76 141.5 52.74 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.471 1.032 . . . . 0.0 111.282 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.9 t -130.83 145.94 52.13 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.365 1.066 . . . . 0.0 111.328 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.24 -35.28 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.439 0.696 . . . . 0.0 111.807 -169.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.57 -35.98 91.93 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 121.736 -0.603 . . . . 0.0 113.84 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.89 -41.91 67.41 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.596 1.198 . . . . 0.0 112.045 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.79 -44.44 99.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.561 0.744 . . . . 0.0 110.685 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -60.35 -47.16 87.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.373 1.069 . . . . 0.0 111.523 174.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.1 m -59.85 -45.77 91.4 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.937 0.895 . . . . 0.0 111.813 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -60.2 -43.31 96.02 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.705 0.802 . . . . 0.0 112.505 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.51 -41.32 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.777 0.717 . . . . 0.0 112.105 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 87.5 m -60.53 -37.16 80.3 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.527 1.058 . . . . 0.0 112.31 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.0 77.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.252 1.021 . . . . 0.0 113.122 174.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.3 mmt -66.83 -38.32 86.21 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.325 -0.859 . . . . 0.0 112.524 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -23.1 58.56 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.991 1.316 . . . . 0.0 113.385 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.5 mtpt 51.04 45.02 28.36 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.958 2.103 . . . . 0.0 112.435 -167.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.2 mt -136.17 151.34 73.33 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.786 1.634 . . . . 0.0 112.245 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -70.77 162.44 42.58 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 124.004 3.136 . . . . 0.0 113.526 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.69 -11.58 29.72 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 123.662 2.908 . . . . 0.0 114.305 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -72.07 -32.85 67.44 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.694 1.197 . . . . 0.0 113.123 173.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.6 p -105.11 -5.23 20.99 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.156 1.382 . . . . 0.0 113.858 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.0 m -147.63 125.18 11.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.137 1.775 . . . . 0.0 110.077 176.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -140.47 147.19 39.24 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.1 tp -108.85 140.17 42.67 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.587 1.955 . . . . 0.0 111.028 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.9 t -141.88 157.33 45.12 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.263 1.425 . . . . 0.0 111.485 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -132.0 129.99 40.83 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.67 1.588 . . . . 0.0 110.359 -174.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp 51.36 29.06 4.79 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.61 14.84 82.07 Favored Glycine 0 CA--C 1.541 1.709 0 C-N-CA 125.288 1.423 . . . . 0.0 116.09 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.47 129.26 30.81 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.781 1.632 . . . . 0.0 111.267 -177.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.76 131.65 46.83 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.332 0.653 . . . . 0.0 112.501 -175.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.1 mt -131.68 153.9 49.53 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.461 1.504 . . . . 0.0 111.607 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -161.08 -48.83 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.978 1.711 . . . . 0.0 111.268 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -81.54 27.82 0.42 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.688 1.995 . . . . 0.0 114.115 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.8 m -68.09 -27.56 66.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.25 1.42 . . . . 0.0 113.277 -172.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 64.5 -63.43 0.17 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.231 2.612 . . . . 0.0 114.895 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.6 p -149.08 146.99 27.99 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.249 1.819 . . . . 0.0 110.485 168.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.4 mt -74.08 -27.4 60.88 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.538 -0.726 . . . . 0.0 112.068 171.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -58.53 -36.21 73.51 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.227 1.011 . . . . 0.0 113.079 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.8 p -63.71 -20.01 65.39 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.5 mt -105.6 -2.44 23.48 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.034 1.733 . . . . 0.0 113.294 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.26 113.84 0.35 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.629 1.585 . . . . 0.0 112.578 -171.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.67 146.04 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.976 1.31 . . . . 0.0 111.676 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -145.71 174.74 10.94 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.672 1.589 . . . . 0.0 111.797 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -78.29 162.05 26.8 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.027 0.931 . . . . 0.0 110.903 162.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.67 14.81 81.68 Favored Glycine 0 CA--C 1.536 1.406 0 N-CA-C 115.844 1.098 . . . . 0.0 115.844 174.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.59 127.25 31.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.852 1.326 . . . . 0.0 110.613 165.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -129.03 130.4 46.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.882 1.273 . . . . 0.0 111.981 -166.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -125.51 133.24 52.44 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.798 1.639 . . . . 0.0 111.195 -170.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.6 t -118.1 129.54 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.814 1.245 . . . . 0.0 109.152 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.38 120.57 34.39 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.263 1.025 . . . . 0.0 110.108 -176.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.4 mt -116.19 130.03 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.82 1.248 . . . . 0.0 109.12 -172.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.8 p -120.02 158.46 26.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.19 1.396 . . . . 0.0 111.053 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -137.1 116.46 12.71 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.433 1.093 . . . . 0.0 111.37 -175.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.9 m -101.28 50.06 0.86 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.099 1.36 . . . . 0.0 110.82 -175.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.9 p -77.39 143.91 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.677 1.191 . . . . 0.0 111.533 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.272 0 C-N-CA 125.303 1.43 . . . . 0.0 113.82 -179.249 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptm . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -86.44 149.61 24.87 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.127 -1.608 . . . . 0.0 111.812 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.4 pt -130.74 166.08 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.764 2.025 . . . . 0.0 111.117 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -131.07 112.46 12.91 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.577 1.151 . . . . 0.0 110.079 170.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.3 tt -94.81 139.69 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 122.779 0.432 . . . . 0.0 110.652 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 t -126.92 81.43 69.63 Favored Pre-proline 0 N--CA 1.471 0.609 0 C-N-CA 125.247 1.419 . . . . 0.0 109.649 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.53 136.39 12.34 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.474 2.116 . . . . 0.0 112.473 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.83 41.1 0.15 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.133 1.373 . . . . 0.0 113.194 171.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.4 t -135.86 142.66 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.348 1.859 . . . . 0.0 110.35 -169.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.43 -116.5 9.44 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.949 0.785 . . . . 0.0 112.533 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.82 -14.9 68.38 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.212 0.911 . . . . 0.0 115.081 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.69 7.37 47.66 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 118.885 1.342 . . . . 0.0 115.929 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.6 m -94.43 155.48 39.65 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.696 1.598 . . . . 0.0 113.166 -170.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -63.01 147.23 94.74 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.212 2.608 . . . . 0.0 112.18 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 tt -138.75 122.61 17.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.414 1.486 . . . . 0.0 110.391 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -82.27 143.39 31.35 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.958 0.903 . . . . 0.0 112.783 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 tp -152.2 153.81 34.55 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.535 1.134 . . . . 0.0 111.657 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -85.22 150.43 24.8 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.374 -0.829 . . . . 0.0 111.338 163.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p -148.16 149.66 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.101 0.961 . . . . 0.0 111.643 174.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.06 149.91 98.23 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.992 0.917 . . . . 0.0 112.482 176.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.56 -21.09 46.57 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.278 2.652 . . . . 0.0 113.023 175.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -78.76 16.45 0.87 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.954 1.702 . . . . 0.0 113.648 175.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.35 121.94 10.04 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.391 1.076 . . . . 0.0 112.003 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.6 m -107.83 130.23 55.01 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.283 1.433 . . . . 0.0 109.861 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.1 t -58.94 -42.93 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.383 0.673 . . . . 0.0 111.637 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.77 -37.48 92.51 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.619 1.104 . . . . 0.0 113.578 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.02 -45.12 71.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.326 1.063 . . . . 0.0 111.705 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.32 -50.68 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.814 0.846 . . . . 0.0 111.581 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.27 -37.15 86.47 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.683 -0.636 . . . . 0.0 112.468 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.1 m -67.13 -42.03 85.14 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.522 0.601 . . . . 0.0 111.451 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -40.2 93.72 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.996 0.919 . . . . 0.0 111.887 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -62.18 -52.54 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.555 1.142 . . . . 0.0 111.502 172.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 88.3 m -62.24 -35.51 79.14 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.51 0.596 . . . . 0.0 112.23 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.64 86.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.404 1.081 . . . . 0.0 112.752 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -43.95 87.16 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.726 0.81 . . . . 0.0 112.365 174.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 36' ' ' LYS . 8.0 mmpt? -73.71 -20.48 60.52 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.704 1.202 . . . . 0.0 113.99 177.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? 55.92 27.84 11.69 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.59 1.956 . . . . 0.0 113.075 -170.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.24 154.74 70.25 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.486 1.914 . . . . 0.0 111.394 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.69 165.07 33.24 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.425 3.417 . . . . 0.0 114.225 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.34 -17.5 58.14 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.312 2.675 . . . . 0.0 114.091 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -64.64 -28.91 69.93 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.829 -1.169 . . . . 0.0 112.796 173.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.0 p -98.48 -14.05 20.23 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.271 1.428 . . . . 0.0 114.328 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 100.0 m -142.66 117.03 9.61 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 119.899 1.227 . . . . 0.0 111.919 174.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.5 167.74 10.62 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.003 1.721 . . . . 0.0 113.137 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.8 tp -142.63 136.42 29.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.03 1.732 . . . . 0.0 111.372 -173.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.4 p -135.57 158.31 44.69 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.54 1.136 . . . . 0.0 113.213 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -147.62 130.39 16.08 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.3 2.24 . . . . 0.0 110.052 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? 50.67 31.36 5.75 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.323 1.449 . . . . 0.0 113.78 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.86 7.35 88.37 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.01 1.291 . . . . 0.0 115.96 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -120.54 158.97 26.16 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.581 1.552 . . . . 0.0 112.409 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.39 127.76 32.5 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.649 0.78 . . . . 0.0 110.534 165.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.7 mt -75.46 138.12 41.4 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.376 0.671 . . . . 0.0 110.762 169.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -163.28 142.5 8.46 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.427 1.491 . . . . 0.0 111.464 170.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t0 57.19 21.39 6.52 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.3 m -70.84 -26.92 63.49 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.857 1.263 . . . . 0.0 112.9 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 63.65 -56.0 0.21 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 128.619 2.767 . . . . 0.0 115.01 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.3 p -145.06 144.46 30.98 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.274 1.429 . . . . 0.0 111.48 170.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.4 -28.54 68.01 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.558 -0.714 . . . . 0.0 112.271 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -65.29 -26.87 68.26 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.362 -0.836 . . . . 0.0 113.167 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.5 t -63.07 -37.49 87.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.738 0.815 . . . . 0.0 112.614 172.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.0 mt -90.68 -10.33 43.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.936 1.294 . . . . 0.0 113.689 174.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.51 118.14 2.49 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 126.471 1.986 . . . . 0.0 112.545 -172.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.7 t -73.51 144.89 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.811 1.244 . . . . 0.0 111.219 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.06 156.55 38.04 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.635 1.574 . . . . 0.0 110.551 166.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -88.77 146.92 24.73 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.152 -0.967 . . . . 0.0 112.522 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.0 26.59 66.29 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.631 0.613 . . . . 0.0 114.631 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -61.8 140.11 58.27 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.499 1.149 . . . . 0.0 111.869 175.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -119.13 134.23 55.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.711 0.804 . . . . 0.0 112.581 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -122.28 138.25 54.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.427 1.491 . . . . 0.0 110.755 -174.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.83 123.07 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.591 0.757 . . . . 0.0 110.594 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tp -97.92 134.97 40.32 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.4 1.08 . . . . 0.0 110.637 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.08 111.7 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.719 1.208 . . . . 0.0 109.711 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.4 t -90.74 152.39 20.83 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.83 1.252 . . . . 0.0 111.292 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -122.38 121.49 36.78 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.673 1.589 . . . . 0.0 111.004 172.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.8 p -76.3 160.62 29.46 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.655 1.582 . . . . 0.0 112.417 176.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.7 t -70.7 -34.87 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.4 1.08 . . . . 0.0 112.222 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 C-N-CA 125.697 1.617 . . . . 0.0 113.401 -179.098 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 121.188 0.518 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -114.05 149.02 36.08 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.195 1.398 . . . . 0.0 111.414 170.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -128.52 155.32 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.865 1.666 . . . . 0.0 110.047 173.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -118.86 93.81 4.23 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.854 1.262 . . . . 0.0 110.22 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 tt -79.71 140.47 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.783 -0.573 . . . . 0.0 110.743 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.7 t -131.51 82.31 61.97 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 125.261 1.425 . . . . 0.0 109.842 -172.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.39 136.45 9.94 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.631 2.22 . . . . 0.0 113.098 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.96 39.22 0.18 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.592 1.557 . . . . 0.0 113.564 172.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.6 t -137.99 145.87 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.987 1.715 . . . . 0.0 110.691 -171.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.44 -119.58 17.33 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.054 0.835 . . . . 0.0 112.429 176.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.9 -14.42 67.87 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 124.088 0.851 . . . . 0.0 114.903 175.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.27 6.22 46.23 Favored Glycine 0 CA--C 1.541 1.71 0 CA-C-N 118.812 1.306 . . . . 0.0 115.87 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.2 m -90.83 153.57 45.35 Favored Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 125.369 1.468 . . . . 0.0 113.334 -171.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -66.25 152.98 79.79 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 123.403 2.735 . . . . 0.0 112.646 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 tp -140.1 118.72 12.32 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.427 1.491 . . . . 0.0 111.586 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -69.51 137.56 52.61 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.436 1.094 . . . . 0.0 111.575 169.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.3 tp -150.64 136.9 18.6 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.532 1.133 . . . . 0.0 111.51 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.02 143.33 43.6 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.612 0.765 . . . . 0.0 111.626 171.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.17 147.95 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.232 1.013 . . . . 0.0 112.1 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.79 150.89 95.28 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.143 0.977 . . . . 0.0 112.537 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.58 -27.12 53.67 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.043 2.496 . . . . 0.0 113.048 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -77.35 14.39 0.97 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.398 1.479 . . . . 0.0 114.134 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.13 100.29 0.32 Allowed 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.844 -1.16 . . . . 0.0 112.212 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.7 t -73.62 148.77 42.54 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.427 1.091 . . . . 0.0 110.858 168.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.6 m -57.75 -31.55 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.85 0.86 . . . . 0.0 112.485 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.33 -41.78 99.37 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.576 0.608 . . . . 0.0 112.732 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.2 -44.82 82.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.771 0.828 . . . . 0.0 111.75 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.2 t -62.98 -49.46 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.879 0.871 . . . . 0.0 110.924 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -35.92 78.26 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.853 1.261 . . . . 0.0 112.369 -177.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.6 m -66.79 -45.44 78.44 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.551 0.74 . . . . 0.0 111.435 172.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -63.18 -39.28 94.19 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.702 0.683 . . . . 0.0 111.928 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -56.94 -52.0 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.51 1.124 . . . . 0.0 111.385 170.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 51.8 t -60.86 -42.78 98.52 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.123 0.569 . . . . 0.0 112.207 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.23 -40.72 86.37 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.972 0.909 . . . . 0.0 113.254 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.8 tpp -67.73 -44.07 78.46 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.808 1.243 . . . . 0.0 112.094 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -76.63 -24.03 53.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.691 0.796 . . . . 0.0 113.043 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.3 ttpp 59.67 27.25 16.45 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.457 2.303 . . . . 0.0 114.144 -173.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.01 154.49 81.38 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 126.192 1.797 . . . . 0.0 112.033 -175.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.81 159.95 50.98 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.904 3.069 . . . . 0.0 113.974 -171.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.57 -10.24 28.46 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.269 3.312 . . . . 0.0 114.978 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -73.46 -21.56 60.41 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.195 -0.941 . . . . 0.0 112.601 167.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.9 m -108.48 -37.26 6.0 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.018 1.327 . . . . 0.0 112.844 -172.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.2 t -97.52 139.09 33.97 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.69 0.796 . . . . 0.0 111.728 170.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -136.54 154.11 50.81 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.592 1.557 . . . . 0.0 111.476 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.8 tp -138.23 132.9 32.5 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.472 1.509 . . . . 0.0 111.217 -171.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.2 p -140.17 155.12 47.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.26 1.024 . . . . 0.0 113.526 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -149.01 131.64 15.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.788 2.035 . . . . 0.0 110.302 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.0 tptt 54.27 29.05 10.04 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.166 1.386 . . . . 0.0 114.319 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.73 3.33 87.11 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.382 1.468 . . . . 0.0 115.562 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -112.55 161.26 16.97 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.821 2.048 . . . . 0.0 111.334 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.03 142.25 28.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.61 0.764 . . . . 0.0 110.64 161.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.16 118.82 34.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.134 0.974 . . . . 0.0 111.053 172.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.39 145.72 22.97 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.489 1.516 . . . . 0.0 111.109 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 54.63 23.52 4.77 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.589 1.956 . . . . 0.0 116.137 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 p -75.94 -24.02 55.46 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 120.818 -1.176 . . . . 0.0 113.69 -176.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 63.79 -40.15 0.21 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 128.739 2.816 . . . . 0.0 115.122 -172.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 t -152.22 154.6 36.1 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.188 1.795 . . . . 0.0 111.656 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.66 -25.14 68.08 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.211 1.005 . . . . 0.0 112.899 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.92 -27.84 69.42 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.3 m -65.0 -28.04 69.23 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.994 0.918 . . . . 0.0 112.963 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 mp -96.71 -10.06 27.71 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.468 1.507 . . . . 0.0 112.745 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.5 28.9 74.07 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.43 1.014 . . . . 0.0 114.468 177.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.8 m -65.97 151.79 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.515 1.126 . . . . 0.0 113.949 -170.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.08 179.07 7.03 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.238 1.415 . . . . 0.0 112.657 173.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -73.58 152.04 40.71 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 121.112 -0.992 . . . . 0.0 111.631 165.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.37 29.23 53.82 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 115.856 1.103 . . . . 0.0 115.856 172.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -62.11 155.33 24.54 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.772 1.286 . . . . 0.0 112.263 172.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -125.81 136.62 53.33 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.877 0.871 . . . . 0.0 112.347 173.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -122.23 133.53 54.71 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.855 1.262 . . . . 0.0 110.548 -173.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.9 t -103.24 129.42 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.209 0.603 . . . . 0.0 110.338 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 tp -105.57 131.17 53.29 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.087 0.955 . . . . 0.0 110.572 172.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -115.84 146.32 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.621 1.569 . . . . 0.0 109.53 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.6 t -127.34 164.94 20.69 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.167 1.387 . . . . 0.0 112.085 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -133.43 139.22 46.61 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.964 2.106 . . . . 0.0 110.44 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.6 p -81.65 130.11 34.94 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.417 0.687 . . . . 0.0 110.296 168.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.6 m -137.47 16.43 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 125.166 1.386 . . . . 0.0 113.169 -173.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.165 0 C-N-CA 125.821 1.677 . . . . 0.0 112.829 179.784 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 mmt . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.0 140.23 45.34 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.469 -1.395 . . . . 0.0 111.145 160.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pp -131.01 166.58 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.657 1.983 . . . . 0.0 110.311 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -120.99 102.66 8.48 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.458 1.103 . . . . 0.0 110.795 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.6 tt -77.84 143.14 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.859 -0.525 . . . . 0.0 110.067 173.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.5 79.93 72.61 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 124.824 1.249 . . . . 0.0 109.551 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.39 134.27 15.39 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.723 2.949 . . . . 0.0 112.32 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.32 28.76 0.15 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.558 1.543 . . . . 0.0 114.377 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.1 m -138.39 162.89 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 126.181 1.792 . . . . 0.0 111.699 -176.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.76 -128.78 35.32 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 123.602 0.62 . . . . 0.0 111.806 -175.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.73 -15.1 73.31 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 174.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.74 -1.09 54.85 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 124.97 1.271 . . . . 0.0 115.798 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -71.69 151.79 93.48 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 125.278 1.431 . . . . 0.0 113.195 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -64.17 150.54 88.11 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.716 2.278 . . . . 0.0 111.448 166.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.7 tp -142.8 132.86 24.39 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.252 1.021 . . . . 0.0 111.961 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -78.23 133.85 37.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.123 0.969 . . . . 0.0 112.335 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mp -139.82 143.6 36.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.479 1.512 . . . . 0.0 110.763 169.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -81.1 136.42 35.92 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.519 0.728 . . . . 0.0 110.26 166.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.8 142.67 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.733 0.813 . . . . 0.0 112.154 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.29 147.94 96.48 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.864 0.866 . . . . 0.0 112.498 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.49 -19.61 65.28 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.444 2.763 . . . . 0.0 113.67 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -78.91 4.65 13.55 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.868 1.667 . . . . 0.0 114.659 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 124.83 21.5 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.568 1.076 . . . . 0.0 112.649 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.2 m -107.89 138.58 43.89 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.557 1.543 . . . . 0.0 111.305 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.0 t -56.62 -47.29 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.023 0.929 . . . . 0.0 112.547 -175.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.5 -41.5 98.71 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.429 0.537 . . . . 0.0 112.926 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.13 -45.74 79.99 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.006 0.903 . . . . 0.0 112.139 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.48 -52.84 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.9 0.88 . . . . 0.0 110.849 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -62.33 -45.68 92.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.903 0.881 . . . . 0.0 111.606 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 84.6 m -61.17 -41.34 96.6 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.359 0.663 . . . . 0.0 111.917 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -63.43 -40.68 97.83 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.003 0.819 . . . . 0.0 112.416 176.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.6 t -67.68 -43.75 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.201 0.91 . . . . 0.0 111.53 174.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 93.9 m -56.88 -43.1 80.93 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.478 1.036 . . . . 0.0 112.081 174.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.19 89.09 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.111 0.964 . . . . 0.0 112.803 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.3 tpt -67.83 -39.59 83.87 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.869 0.868 . . . . 0.0 112.496 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -19.02 56.42 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.28 1.432 . . . . 0.0 113.916 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt 58.28 29.05 17.5 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.733 2.013 . . . . 0.0 113.328 -169.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mp -128.08 154.83 78.61 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 126.275 1.83 . . . . 0.0 111.82 -174.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.37 165.33 32.05 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 124.399 3.4 . . . . 0.0 115.102 -171.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -63.15 -15.85 50.69 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.644 2.896 . . . . 0.0 113.928 170.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -68.66 -21.16 64.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.236 1.014 . . . . 0.0 113.136 171.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.9 p -114.86 -38.73 3.86 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.051 1.34 . . . . 0.0 113.183 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 81.7 m -92.84 124.67 37.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.29 1.436 . . . . 0.0 111.001 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -149.27 146.22 27.46 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -171.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.18 148.08 34.81 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.245 1.818 . . . . 0.0 111.91 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.0 m -143.04 143.15 31.77 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.834 1.654 . . . . 0.0 111.836 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -144.49 133.54 22.75 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.357 1.863 . . . . 0.0 110.635 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? 52.78 30.49 9.05 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.805 1.242 . . . . 0.0 113.488 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.31 16.57 78.73 Favored Glycine 0 CA--C 1.54 1.627 0 C-N-CA 124.852 1.215 . . . . 0.0 115.218 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 -135.68 155.32 50.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.526 1.93 . . . . 0.0 111.757 -173.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.01 132.32 44.11 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.634 -0.666 . . . . 0.0 111.775 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.35 127.62 37.9 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.58 1.152 . . . . 0.0 109.86 167.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -164.46 147.32 8.94 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.802 1.641 . . . . 0.0 111.162 174.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 56.1 23.96 7.42 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.3 p -75.39 -17.79 60.11 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 120.859 -1.15 . . . . 0.0 113.478 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 61.64 -56.09 0.12 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 128.408 2.683 . . . . 0.0 114.144 -166.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.5 p -147.53 157.51 43.59 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.781 1.632 . . . . 0.0 111.048 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.27 -32.82 74.46 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.459 -0.776 . . . . 0.0 111.304 168.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -63.06 -31.55 72.72 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.407 -0.808 . . . . 0.0 113.074 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.2 t -64.89 -23.88 67.36 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.113 0.965 . . . . 0.0 113.325 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.4 mt -106.31 -33.31 7.81 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.091 1.357 . . . . 0.0 113.486 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.41 85.9 0.19 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.098 1.808 . . . . 0.0 111.739 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.9 p -72.87 146.93 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.556 1.142 . . . . 0.0 112.181 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -149.85 -179.45 7.15 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.347 1.459 . . . . 0.0 112.178 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -97.68 150.06 21.6 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.807 1.643 . . . . 0.0 111.741 167.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.74 5.14 90.07 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.77 1.176 . . . . 0.0 115.545 176.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -61.23 145.64 50.52 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.357 1.079 . . . . 0.0 110.755 170.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.87 134.2 46.58 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -171.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -125.1 113.8 18.21 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.417 1.087 . . . . 0.0 110.64 -169.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -83.58 128.9 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.49 0.716 . . . . 0.0 109.704 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.5 tp -113.04 118.37 34.6 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.371 1.468 . . . . 0.0 109.421 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.1 pt -110.27 154.43 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.89 1.276 . . . . 0.0 111.993 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -139.16 165.73 26.38 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.644 1.577 . . . . 0.0 111.298 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.7 ttt85 -153.29 146.17 24.44 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.551 1.541 . . . . 0.0 111.016 -168.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 77.8 p -134.07 -34.81 0.97 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.223 1.009 . . . . 0.0 113.652 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 67.6 t -141.46 139.04 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.882 1.673 . . . . 0.0 110.542 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.151 0 C-N-CA 124.627 1.108 . . . . 0.0 115.226 178.963 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -80.68 142.65 33.72 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.049 -1.657 . . . . 0.0 112.476 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.9 pt -131.3 162.29 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 127.103 2.161 . . . . 0.0 110.415 170.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -123.88 92.74 3.74 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.035 1.334 . . . . 0.0 110.627 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.5 tt -78.71 141.13 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 122.13 -0.356 . . . . 0.0 110.356 174.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.8 t -130.6 79.82 71.32 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.383 1.473 . . . . 0.0 109.426 -174.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.85 137.03 13.75 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.253 1.969 . . . . 0.0 112.509 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.0 41.53 0.16 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.718 1.607 . . . . 0.0 112.63 170.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -139.14 142.51 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.539 1.936 . . . . 0.0 109.907 -167.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.48 -115.15 7.51 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 123.754 0.692 . . . . 0.0 112.479 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.44 -18.16 71.36 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.127 0.87 . . . . 0.0 114.972 176.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.95 6.45 56.33 Favored Glycine 0 CA--C 1.541 1.68 0 CA-C-N 118.737 1.268 . . . . 0.0 115.627 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.1 p -95.34 158.91 33.89 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.485 1.914 . . . . 0.0 113.561 -169.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.49 143.25 75.03 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.163 2.575 . . . . 0.0 112.115 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.5 mt -131.28 115.83 16.81 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.017 1.727 . . . . 0.0 110.515 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -74.4 125.58 28.83 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.836 0.855 . . . . 0.0 111.238 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt -138.17 149.05 45.49 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.606 1.563 . . . . 0.0 111.119 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -97.13 130.3 44.41 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.837 1.255 . . . . 0.0 110.156 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.9 149.71 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.922 1.289 . . . . 0.0 112.903 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.11 153.56 88.9 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.8 1.24 . . . . 0.0 112.471 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.13 -25.25 50.95 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.306 2.67 . . . . 0.0 113.635 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -80.51 37.57 0.41 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.013 1.725 . . . . 0.0 112.985 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.06 67.73 3.96 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.981 1.713 . . . . 0.0 112.622 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 55.9 m -63.76 141.34 58.8 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.683 1.193 . . . . 0.0 112.275 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.1 t -60.07 -44.09 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.072 0.949 . . . . 0.0 112.161 -174.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.98 -36.4 92.18 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.498 0.57 . . . . 0.0 113.231 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.93 -50.33 64.79 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 117.992 0.896 . . . . 0.0 111.796 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.2 p -66.78 -36.86 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.867 0.758 . . . . 0.0 112.046 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -59.06 -48.1 82.84 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.475 1.11 . . . . 0.0 111.837 173.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.2 m -66.47 -39.9 89.05 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.375 0.67 . . . . 0.0 112.099 175.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -44.48 96.96 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.893 0.877 . . . . 0.0 111.755 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.9 t -61.48 -48.33 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.136 1.374 . . . . 0.0 111.362 172.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.6 -44.53 93.36 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.458 0.703 . . . . 0.0 111.967 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.49 88.51 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.204 1.002 . . . . 0.0 112.924 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.5 ttm -65.76 -43.5 88.69 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.534 1.133 . . . . 0.0 112.232 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -75.38 -29.53 59.87 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.846 1.258 . . . . 0.0 113.394 177.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.2 tptm 57.41 31.29 19.97 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.746 2.018 . . . . 0.0 113.098 -169.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.52 151.16 56.81 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 126.316 1.846 . . . . 0.0 111.082 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.88 159.18 51.19 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.943 3.095 . . . . 0.0 113.594 -173.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.17 -13.07 35.74 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.99 3.127 . . . . 0.0 114.778 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -66.29 -22.25 66.29 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.136 -0.978 . . . . 0.0 113.355 170.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.2 p -103.07 -25.84 13.27 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.71 1.204 . . . . 0.0 113.709 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.1 m -140.07 126.87 20.6 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.954 1.301 . . . . 0.0 110.928 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -134.44 166.61 22.45 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.125 1.37 . . . . 0.0 112.897 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.4 tp -137.07 135.33 37.41 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.455 1.502 . . . . 0.0 111.497 -168.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.5 p -136.49 158.54 44.19 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.491 1.116 . . . . 0.0 112.519 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -139.09 128.73 24.6 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.606 2.363 . . . . 0.0 109.701 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.62 31.97 11.01 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.643 1.177 . . . . 0.0 113.515 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.94 8.79 87.63 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 124.945 1.26 . . . . 0.0 115.943 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -122.01 151.1 41.18 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.404 1.881 . . . . 0.0 112.261 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.12 126.24 30.52 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.85 -0.531 . . . . 0.0 110.46 165.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.2 mt -74.41 137.65 42.83 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.579 0.752 . . . . 0.0 110.726 170.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.24 140.4 7.5 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.117 1.367 . . . . 0.0 111.335 170.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t0 55.72 26.45 9.43 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.957 1.703 . . . . 0.0 115.191 175.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.9 m -78.03 -15.19 59.13 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.016 1.326 . . . . 0.0 113.732 -171.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 59.4 -70.84 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.601 2.361 . . . . 0.0 114.441 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.2 p -146.38 154.23 41.4 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.158 1.383 . . . . 0.0 111.97 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.22 -20.37 60.88 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.768 -0.583 . . . . 0.0 112.391 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.66 -30.72 71.59 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.192 -0.942 . . . . 0.0 112.659 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.0 t -63.59 -24.3 67.74 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.63 0.772 . . . . 0.0 112.762 173.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.4 mt -92.68 -12.42 31.54 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.46 1.504 . . . . 0.0 113.304 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.54 17.15 64.13 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.185 1.374 . . . . 0.0 115.014 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.1 p -76.44 145.0 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.778 1.231 . . . . 0.0 113.424 -169.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.6 -177.29 5.76 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.869 1.667 . . . . 0.0 113.774 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -68.47 164.4 21.21 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.299 1.44 . . . . 0.0 113.214 172.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.83 11.62 60.16 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.587 1.089 . . . . 0.0 115.033 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -62.19 143.83 56.27 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.436 1.118 . . . . 0.0 111.552 171.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -127.18 132.64 50.44 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.101 0.96 . . . . 0.0 112.235 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -125.27 132.61 52.9 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.866 1.266 . . . . 0.0 109.944 -171.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 p -110.73 120.73 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.024 0.829 . . . . 0.0 111.123 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.99 121.11 40.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.954 1.302 . . . . 0.0 109.136 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.0 tt -119.7 131.07 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.447 1.099 . . . . 0.0 111.063 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.6 t -114.61 150.87 34.4 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.309 1.844 . . . . 0.0 111.353 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -124.97 126.16 45.03 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.179 1.792 . . . . 0.0 109.959 172.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.2 p -72.21 144.9 48.32 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.216 1.007 . . . . 0.0 111.71 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.5 t -136.36 -39.26 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.869 1.267 . . . . 0.0 112.067 -176.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.222 0 C-N-CA 125.234 1.397 . . . . 0.0 113.309 -178.633 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.28 0.562 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -108.98 141.68 40.74 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.074 1.35 . . . . 0.0 111.331 174.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.0 pt -121.56 163.05 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.07 1.748 . . . . 0.0 110.457 170.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -125.69 105.57 9.09 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.15 0.98 . . . . 0.0 110.875 174.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.4 mt -86.79 137.88 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -126.0 76.25 71.6 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 124.951 1.3 . . . . 0.0 110.086 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.97 136.59 16.68 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.92 2.413 . . . . 0.0 111.261 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.25 31.91 0.1 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.627 1.571 . . . . 0.0 114.173 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.5 t -139.52 147.67 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 126.62 1.968 . . . . 0.0 109.871 -171.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.5 30.75 70.97 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 121.642 -0.661 . . . . 0.0 114.543 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.65 -8.36 40.02 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.615 1.578 . . . . 0.0 115.11 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.32 5.36 76.91 Favored Glycine 0 CA--C 1.54 1.637 0 N-CA-C 116.355 1.302 . . . . 0.0 116.355 170.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.9 m -75.14 150.32 85.41 Favored Pre-proline 0 N--CA 1.475 0.804 0 CA-C-N 118.649 1.225 . . . . 0.0 113.432 -174.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.77 145.7 76.03 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.378 2.719 . . . . 0.0 111.898 169.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.1 mt -131.71 111.72 11.92 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.725 1.61 . . . . 0.0 110.492 178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -79.27 134.22 36.64 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.355 1.062 . . . . 0.0 111.807 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 tt -152.43 141.98 21.76 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.347 1.059 . . . . 0.0 112.349 -175.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -80.93 133.92 35.63 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.659 1.184 . . . . 0.0 112.289 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -139.1 155.51 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.878 1.271 . . . . 0.0 113.01 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.75 152.45 91.31 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.623 1.169 . . . . 0.0 112.271 172.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.02 -19.05 57.85 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.365 2.71 . . . . 0.0 113.419 174.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -78.76 5.77 10.5 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.643 1.577 . . . . 0.0 114.117 176.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.37 130.52 47.11 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.391 0.996 . . . . 0.0 112.284 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.9 m -109.7 134.73 51.65 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.47 1.508 . . . . 0.0 110.874 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.32 -40.94 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.073 0.949 . . . . 0.0 112.31 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.61 -34.93 91.0 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 123.775 0.702 . . . . 0.0 113.5 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.87 -43.23 75.79 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.339 1.07 . . . . 0.0 111.645 174.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.9 t -61.27 -46.67 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.005 0.922 . . . . 0.0 111.138 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -56.49 -51.42 68.56 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.542 1.137 . . . . 0.0 111.735 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.4 m -60.16 -42.03 94.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.505 0.722 . . . . 0.0 111.818 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.67 -50.76 72.7 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.949 0.9 . . . . 0.0 111.239 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.4 t -68.21 -41.37 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.412 0.685 . . . . 0.0 112.132 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 95.9 m -59.67 -40.41 87.7 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.335 0.971 . . . . 0.0 112.202 173.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.57 -41.99 78.95 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.55 0.74 . . . . 0.0 112.77 174.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 84.2 mtp -66.37 -39.73 89.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.353 1.061 . . . . 0.0 112.871 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -84.46 -18.27 36.44 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.718 1.207 . . . . 0.0 113.86 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp 57.75 30.03 18.31 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.457 1.903 . . . . 0.0 113.728 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.92 150.49 43.56 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 126.129 1.771 . . . . 0.0 111.141 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.64 159.85 50.75 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 123.713 2.942 . . . . 0.0 112.796 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.07 -9.89 26.67 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 124.007 3.138 . . . . 0.0 115.063 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -80.12 -36.16 35.69 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.193 1.397 . . . . 0.0 113.296 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 34.6 p -85.81 8.13 21.2 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.203 1.401 . . . . 0.0 113.827 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.0 t -144.2 142.72 30.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.679 1.591 . . . . 0.0 111.972 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 -141.02 148.51 40.39 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.465 1.506 . . . . 0.0 112.658 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.7 tp -127.48 129.41 47.38 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.008 2.123 . . . . 0.0 110.108 -177.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.8 p -140.06 155.52 47.0 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.41 1.084 . . . . 0.0 112.516 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -145.0 138.69 26.95 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.168 1.787 . . . . 0.0 110.167 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp 54.13 30.4 12.03 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.935 1.294 . . . . 0.0 114.062 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.96 16.85 80.33 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.037 1.304 . . . . 0.0 115.259 -175.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -134.13 150.86 51.16 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.085 1.754 . . . . 0.0 112.252 -171.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.1 115.95 20.79 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.945 0.898 . . . . 0.0 110.962 172.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.2 mp -86.35 131.96 34.08 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.38 1.072 . . . . 0.0 110.297 171.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.78 149.91 11.45 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.388 1.475 . . . . 0.0 110.903 171.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.7 t0 55.77 27.66 11.13 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.732 1.613 . . . . 0.0 115.073 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.6 p -78.85 -22.02 46.72 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.985 1.314 . . . . 0.0 113.523 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 62.34 -53.26 0.15 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 128.51 2.724 . . . . 0.0 115.005 -170.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 61.4 p -144.71 152.31 40.22 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.726 1.61 . . . . 0.0 111.599 172.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.7 mt -70.28 -36.27 74.27 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.344 0.658 . . . . 0.0 111.79 172.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.91 -33.67 76.23 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.6 m -68.45 -26.49 65.53 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 66.3 mt -99.29 -26.72 14.07 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.531 1.132 . . . . 0.0 113.471 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 130.76 83.93 0.3 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.839 1.685 . . . . 0.0 111.946 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.68 148.49 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.641 1.177 . . . . 0.0 111.662 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.29 158.26 43.78 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.216 1.406 . . . . 0.0 111.922 176.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -73.35 142.65 47.05 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.336 1.054 . . . . 0.0 111.69 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.91 19.55 78.7 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.414 0.926 . . . . 0.0 115.414 174.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.61 136.94 57.75 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.849 1.324 . . . . 0.0 111.384 171.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -132.9 132.11 41.68 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -172.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -119.7 97.67 5.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.251 1.421 . . . . 0.0 110.405 -161.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.65 137.47 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.889 -0.507 . . . . 0.0 110.45 174.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tt -139.47 109.0 6.18 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.623 0.769 . . . . 0.0 110.179 -170.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.3 tt -101.94 142.6 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.998 1.319 . . . . 0.0 111.348 -173.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.4 p -130.29 157.05 43.58 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.22 1.408 . . . . 0.0 110.46 173.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -129.0 137.69 51.5 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.87 0.868 . . . . 0.0 112.172 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.3 p -77.8 -20.02 53.98 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.158 1.383 . . . . 0.0 113.855 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.4 t -118.6 -40.15 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.314 1.446 . . . . 0.0 112.16 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.269 0 C-N-CA 125.314 1.435 . . . . 0.0 112.799 -176.558 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mmt . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 121.347 0.594 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -68.59 148.67 50.17 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.976 0.91 . . . . 0.0 112.28 165.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.4 mm -142.23 143.62 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 128.034 2.534 . . . . 0.0 109.176 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -100.4 144.28 29.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.194 0.997 . . . . 0.0 111.056 162.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.7 tt -133.72 134.52 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.443 1.097 . . . . 0.0 110.474 167.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 p -123.34 103.12 35.84 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.592 1.157 . . . . 0.0 110.679 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -92.89 140.69 1.89 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.721 2.28 . . . . 0.0 112.255 176.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.17 48.36 0.61 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.463 1.505 . . . . 0.0 113.522 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 p -154.34 155.3 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.437 1.495 . . . . 0.0 111.529 -172.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.93 -112.4 4.64 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.704 0.669 . . . . 0.0 112.671 174.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.13 -19.85 72.43 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 124.082 0.848 . . . . 0.0 114.799 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.24 32.85 82.18 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 118.782 1.291 . . . . 0.0 114.448 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 t -144.68 145.6 28.84 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.163 1.385 . . . . 0.0 112.103 -162.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -60.51 140.38 91.07 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.526 2.818 . . . . 0.0 113.096 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.0 tp -124.9 134.06 52.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.343 1.857 . . . . 0.0 110.44 175.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -82.79 135.05 35.08 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.676 0.791 . . . . 0.0 110.752 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.3 mt -142.21 175.09 10.02 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.873 2.069 . . . . 0.0 110.872 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -136.41 134.6 37.94 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.613 1.565 . . . . 0.0 109.962 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 m -136.03 155.19 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.136 0.974 . . . . 0.0 113.0 -173.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.24 149.87 73.33 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.853 0.861 . . . . 0.0 111.675 169.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -64.93 -21.64 63.74 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.287 2.658 . . . . 0.0 112.865 172.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -74.06 -0.94 18.03 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.925 1.69 . . . . 0.0 114.134 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.66 121.18 10.38 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.287 0.948 . . . . 0.0 111.814 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.0 p -86.16 150.73 24.2 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.773 0.829 . . . . 0.0 111.502 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.3 t -64.39 -36.6 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.812 -0.555 . . . . 0.0 110.647 173.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.35 -51.4 57.86 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.083 0.849 . . . . 0.0 112.74 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.75 93.13 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.004 0.902 . . . . 0.0 112.865 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.5 t -63.93 -47.29 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 121.833 -0.542 . . . . 0.0 111.013 175.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -63.18 -42.4 99.37 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.273 1.029 . . . . 0.0 112.074 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.8 p -69.63 -38.16 77.1 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 118.329 -0.843 . . . . 0.0 112.582 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -61.95 -43.97 97.74 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.898 1.226 . . . . 0.0 111.844 172.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.2 t -61.53 -48.27 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.832 0.742 . . . . 0.0 111.477 175.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.3 t -59.24 -44.57 92.36 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.938 0.895 . . . . 0.0 111.876 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.63 -40.93 80.12 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.255 1.022 . . . . 0.0 112.951 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 59.3 ttp -71.35 -41.04 70.26 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.14 1.376 . . . . 0.0 112.989 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -82.51 -14.59 54.71 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp 58.34 29.93 18.86 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.708 2.003 . . . . 0.0 112.995 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.2 mt -141.02 147.92 49.81 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.877 1.671 . . . . 0.0 112.378 -168.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.95 161.05 47.4 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.222 3.281 . . . . 0.0 114.582 -171.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -66.05 -16.01 50.73 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.763 2.975 . . . . 0.0 114.71 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -67.58 -45.49 75.4 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.946 -1.096 . . . . 0.0 111.756 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.2 t -88.36 -22.59 23.72 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.195 1.398 . . . . 0.0 112.955 -174.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.6 m -127.82 119.12 25.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.453 1.501 . . . . 0.0 112.204 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -133.06 160.9 35.84 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.345 1.858 . . . . 0.0 113.202 -173.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.1 tp -134.94 138.86 44.45 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.785 2.034 . . . . 0.0 110.854 -172.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.3 m -139.22 146.09 40.06 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.43 1.492 . . . . 0.0 111.388 -176.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -142.56 134.6 27.26 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.499 1.519 . . . . 0.0 110.226 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 tptm 52.91 32.69 13.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.159 1.383 . . . . 0.0 113.407 -176.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.45 14.53 74.7 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 124.495 1.045 . . . . 0.0 115.34 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.41 141.95 51.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.685 1.994 . . . . 0.0 111.4 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.45 125.84 31.54 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.874 0.87 . . . . 0.0 110.348 167.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.0 mp -82.13 138.66 34.71 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.684 0.794 . . . . 0.0 110.354 172.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 136.76 6.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.725 1.61 . . . . 0.0 110.289 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.3 t0 55.61 26.92 9.75 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.577 1.551 . . . . 0.0 114.471 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 m -78.19 -29.39 48.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.839 1.256 . . . . 0.0 113.782 -169.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 62.24 -36.59 0.12 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 128.692 2.797 . . . . 0.0 117.554 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 t -156.01 146.29 21.6 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.292 1.437 . . . . 0.0 111.123 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.27 -18.13 64.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.882 0.873 . . . . 0.0 112.86 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -68.35 -19.95 64.68 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 171.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.1 t -69.46 -41.1 76.65 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.968 0.907 . . . . 0.0 112.017 178.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.8 mp -82.47 -14.56 54.84 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.843 1.257 . . . . 0.0 112.82 170.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.99 37.25 91.98 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.475 1.036 . . . . 0.0 113.364 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.6 m -64.56 152.97 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.313 1.045 . . . . 0.0 113.802 -168.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.86 -178.38 6.83 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.197 1.399 . . . . 0.0 112.965 174.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -80.34 153.07 28.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.609 1.163 . . . . 0.0 112.231 165.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.6 26.12 61.65 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 115.351 0.9 . . . . 0.0 115.351 173.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -61.55 156.46 19.59 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.278 1.039 . . . . 0.0 112.769 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -124.7 108.66 12.23 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.175 1.39 . . . . 0.0 111.132 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -93.58 144.71 25.12 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.272 1.429 . . . . 0.0 110.998 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.0 m -124.47 133.49 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.139 0.976 . . . . 0.0 110.767 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.58 131.98 56.49 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.439 1.096 . . . . 0.0 110.781 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.64 136.59 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.948 1.699 . . . . 0.0 108.936 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.0 t -142.8 129.05 19.88 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.859 0.864 . . . . 0.0 111.408 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.1 mmt-85 -86.37 159.55 19.35 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.851 1.66 . . . . 0.0 112.325 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.0 p -70.73 155.06 41.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.386 1.075 . . . . 0.0 111.675 169.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.0 m -130.76 157.01 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.407 1.483 . . . . 0.0 111.862 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 C-N-CA 125.457 1.503 . . . . 0.0 112.991 -178.207 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ttt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -130.07 153.07 48.83 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.39 1.476 . . . . 0.0 111.917 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -133.1 158.82 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 126.8 2.04 . . . . 0.0 110.807 173.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -103.42 147.88 26.58 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.587 1.555 . . . . 0.0 110.036 164.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.2 tt -135.93 135.38 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.148 0.979 . . . . 0.0 110.396 169.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.6 p -128.26 96.75 30.27 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.82 1.248 . . . . 0.0 111.042 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -81.74 138.96 10.86 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.342 2.695 . . . . 0.0 111.683 170.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.98 40.31 0.15 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.586 1.554 . . . . 0.0 112.968 170.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.3 t -138.73 144.38 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.364 1.866 . . . . 0.0 110.037 -169.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.95 -112.4 4.79 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.965 0.793 . . . . 0.0 112.141 175.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.83 -16.8 68.62 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.223 0.916 . . . . 0.0 115.046 175.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.55 20.71 66.15 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 118.747 1.274 . . . . 0.0 115.362 171.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.4 m -129.35 153.58 80.55 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 125.6 1.56 . . . . 0.0 112.962 -164.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.92 146.19 82.14 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.293 2.662 . . . . 0.0 113.384 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.4 mt -132.5 138.4 47.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.418 1.887 . . . . 0.0 111.094 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -78.75 135.67 37.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.987 1.315 . . . . 0.0 111.87 172.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mp -142.96 150.8 40.17 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.882 1.273 . . . . 0.0 111.925 169.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -85.38 143.92 28.34 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.963 0.905 . . . . 0.0 110.471 160.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.17 148.96 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.503 1.521 . . . . 0.0 110.994 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.72 149.9 88.38 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.69 0.796 . . . . 0.0 111.658 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.42 -19.03 61.31 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.02 2.48 . . . . 0.0 112.927 171.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -77.92 -0.74 28.7 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.029 1.732 . . . . 0.0 114.441 171.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.06 142.66 56.48 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 119.415 1.007 . . . . 0.0 111.055 172.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.11 152.01 40.33 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.412 1.085 . . . . 0.0 111.411 -175.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -60.94 -32.91 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 121.566 -0.709 . . . . 0.0 112.433 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.9 -50.26 59.0 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 123.96 0.791 . . . . 0.0 111.917 173.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.4 -40.11 95.42 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.091 0.956 . . . . 0.0 112.73 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.1 t -63.02 -49.6 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.661 -0.649 . . . . 0.0 110.525 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -63.36 -45.33 91.69 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 121.566 -0.709 . . . . 0.0 112.467 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.5 p -67.75 -37.61 82.38 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.479 1.036 . . . . 0.0 112.161 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -58.1 -47.19 83.98 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.265 0.939 . . . . 0.0 111.024 172.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.9 t -63.44 -47.35 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.325 1.05 . . . . 0.0 111.414 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 93.8 m -61.63 -41.83 98.04 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.24 85.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.839 0.856 . . . . 0.0 113.113 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.5 ttt -66.64 -41.18 88.69 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.283 1.033 . . . . 0.0 112.486 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.459 ' HE3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -74.9 -24.21 58.49 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.434 1.094 . . . . 0.0 113.352 172.584 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt 59.09 28.51 17.81 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.385 2.274 . . . . 0.0 113.912 -167.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 mp -116.35 155.44 48.44 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.14 1.776 . . . . 0.0 111.634 -177.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.69 157.72 60.7 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 123.52 2.813 . . . . 0.0 112.437 178.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.48 -25.34 63.06 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.402 2.735 . . . . 0.0 114.406 -173.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -71.64 -17.59 62.25 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.696 1.134 . . . . 0.0 113.634 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.2 m -84.45 -1.04 55.02 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.684 -1.26 . . . . 0.0 112.993 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.3 t -136.13 158.01 45.45 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.49 1.516 . . . . 0.0 112.244 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -141.79 140.12 32.94 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.029 1.732 . . . . 0.0 111.2 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.5 tp -113.31 130.84 56.15 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.433 1.893 . . . . 0.0 110.143 173.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.3 p -136.8 155.63 49.57 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.956 0.902 . . . . 0.0 112.428 172.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -151.74 135.13 16.06 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.303 1.841 . . . . 0.0 110.11 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.92 35.96 20.54 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.215 1.406 . . . . 0.0 113.353 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.83 15.91 79.44 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 124.48 1.038 . . . . 0.0 115.212 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -129.58 151.9 49.69 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.643 1.977 . . . . 0.0 111.637 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.08 135.26 38.59 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.862 -0.524 . . . . 0.0 109.673 160.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.7 tp -107.98 115.89 30.96 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.899 0.88 . . . . 0.0 109.865 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -150.1 141.13 22.97 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.915 1.286 . . . . 0.0 111.613 -169.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.6 t0 54.95 26.46 7.96 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.864 1.665 . . . . 0.0 114.836 174.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.4 p -75.28 -26.52 58.83 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.133 1.373 . . . . 0.0 113.005 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 64.04 -46.7 0.28 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 129.015 2.926 . . . . 0.0 114.892 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -152.94 139.01 18.21 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.35 1.86 . . . . 0.0 111.588 175.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.91 -37.36 87.4 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.877 0.871 . . . . 0.0 111.994 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -65.58 -18.19 65.14 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.9 m -75.61 -27.14 58.35 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.134 0.974 . . . . 0.0 113.15 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.37 -39.8 8.62 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.858 1.263 . . . . 0.0 112.036 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 145.67 93.32 0.14 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.518 1.532 . . . . 0.0 111.459 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.2 p -75.04 147.49 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.338 1.055 . . . . 0.0 111.75 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -147.09 164.82 31.82 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.458 1.503 . . . . 0.0 111.837 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -94.88 146.09 24.46 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.816 1.246 . . . . 0.0 112.841 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.03 19.46 72.51 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 123.86 0.743 . . . . 0.0 114.8 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.31 144.04 54.62 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.458 1.129 . . . . 0.0 111.498 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.25 110.96 17.62 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.674 1.19 . . . . 0.0 111.534 -177.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -92.47 131.66 37.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.787 1.235 . . . . 0.0 111.353 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -109.57 127.2 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.283 1.033 . . . . 0.0 110.298 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.28 121.16 43.59 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.71 1.604 . . . . 0.0 110.357 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.0 mm -114.93 125.38 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.902 1.281 . . . . 0.0 109.903 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.8 t -98.24 155.95 16.94 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.503 1.121 . . . . 0.0 111.622 172.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -116.05 139.02 50.7 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.192 1.397 . . . . 0.0 111.187 171.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.6 m -140.49 -53.55 0.5 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.142 0.977 . . . . 0.0 111.989 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.2 p -83.07 -27.44 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.431 1.092 . . . . 0.0 112.983 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.208 0 C-N-CA 125.603 1.573 . . . . 0.0 113.886 179.581 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.843 ' HB2' ' OD1' ' A' ' 65' ' ' ASP . 26.3 mmt . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 121.668 0.747 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 141.17 32.38 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.464 1.506 . . . . 0.0 111.045 174.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.4 mt -128.22 141.98 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.786 1.634 . . . . 0.0 109.803 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -105.55 102.23 11.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.862 1.265 . . . . 0.0 110.25 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.4 pt -78.92 143.51 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.436 -0.79 . . . . 0.0 110.326 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 t -130.61 80.18 70.57 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.907 1.283 . . . . 0.0 109.847 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.55 131.46 16.17 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.021 2.481 . . . . 0.0 112.256 175.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.44 41.07 0.18 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.878 1.271 . . . . 0.0 112.749 167.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.9 t -138.91 145.49 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 126.503 1.921 . . . . 0.0 110.202 -169.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.72 -121.19 22.97 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.721 0.677 . . . . 0.0 111.858 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.21 -18.27 72.95 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 123.952 0.787 . . . . 0.0 114.935 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.09 -0.8 57.98 Favored Glycine 0 CA--C 1.542 1.763 0 C-N-CA 124.981 1.276 . . . . 0.0 115.769 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 m -73.92 153.43 88.94 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 125.523 1.529 . . . . 0.0 113.793 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -63.55 149.37 91.18 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.729 2.286 . . . . 0.0 111.467 163.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 tt -141.4 127.07 19.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.881 1.272 . . . . 0.0 111.311 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -85.38 128.89 34.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.827 1.251 . . . . 0.0 112.581 -174.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.9 mt -141.7 146.17 35.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.561 1.544 . . . . 0.0 112.439 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -84.7 146.33 27.48 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.144 0.977 . . . . 0.0 111.112 163.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.6 m -143.6 157.87 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.291 1.436 . . . . 0.0 111.201 174.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.36 151.95 96.89 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.646 0.778 . . . . 0.0 111.824 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -65.99 -20.49 57.46 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.149 2.566 . . . . 0.0 113.027 173.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -83.98 22.16 1.21 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.482 1.913 . . . . 0.0 113.083 175.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.76 108.98 2.28 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.531 -1.355 . . . . 0.0 111.578 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.2 m -77.92 129.97 36.0 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.402 1.081 . . . . 0.0 110.954 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.1 t -57.57 -44.9 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.028 0.931 . . . . 0.0 111.719 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.24 -35.64 91.86 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.48 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.75 -42.31 77.72 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.883 1.342 . . . . 0.0 112.037 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.0 -49.05 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.448 0.699 . . . . 0.0 110.527 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -62.71 -41.66 99.25 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.513 0.725 . . . . 0.0 111.583 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.1 m -62.41 -42.0 99.11 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.651 0.78 . . . . 0.0 111.591 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -58.58 -45.64 88.61 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.359 0.981 . . . . 0.0 111.733 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 83.1 t -63.34 -47.16 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.938 0.895 . . . . 0.0 111.376 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 83.2 m -63.24 -39.9 95.9 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.067 0.547 . . . . 0.0 112.4 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.44 -39.47 77.79 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.297 1.039 . . . . 0.0 112.719 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 63.9 ttp -67.1 -40.44 86.92 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.148 0.979 . . . . 0.0 112.159 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -83.02 -10.42 58.76 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 173.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.38 25.15 12.51 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 127.29 2.236 . . . . 0.0 114.418 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mp -131.98 155.0 81.89 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 126.326 1.85 . . . . 0.0 112.169 -174.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.48 162.54 41.96 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.305 3.337 . . . . 0.0 114.215 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.67 -16.75 56.6 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 124.194 3.263 . . . . 0.0 114.792 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -66.01 -26.65 67.63 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.026 -1.047 . . . . 0.0 112.434 170.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 26.2 m -91.23 -36.59 13.83 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.492 0.717 . . . . 0.0 112.407 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.3 m -130.21 126.76 38.16 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.245 1.018 . . . . 0.0 112.162 -171.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -131.46 161.8 31.69 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.844 1.658 . . . . 0.0 112.997 -168.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.7 tp -129.29 134.54 47.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.473 2.309 . . . . 0.0 110.654 -174.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.2 p -138.52 156.8 47.19 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.724 1.21 . . . . 0.0 113.033 174.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -147.68 132.76 18.25 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.269 1.828 . . . . 0.0 110.447 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm 52.05 40.58 28.75 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.226 1.41 . . . . 0.0 113.374 173.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.49 9.17 84.57 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 125.167 1.365 . . . . 0.0 115.723 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 65.3 mtp180 -127.6 152.08 48.1 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.457 1.903 . . . . 0.0 111.958 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.36 128.06 34.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.034 0.934 . . . . 0.0 110.116 166.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.2 mt -86.35 140.56 29.93 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.829 0.852 . . . . 0.0 110.988 174.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -162.69 152.76 16.25 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.853 1.661 . . . . 0.0 111.331 171.397 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 53.91 19.89 2.16 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.629 1.972 . . . . 0.0 116.239 171.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -75.91 -29.95 58.6 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.008 1.323 . . . . 0.0 112.576 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 62.46 -53.94 0.15 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 128.006 2.523 . . . . 0.0 115.475 -175.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 49.5 p -140.97 137.36 32.99 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.009 1.323 . . . . 0.0 111.298 172.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.38 -23.86 64.71 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.653 -0.655 . . . . 0.0 111.949 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -61.68 -31.76 71.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.768 0.827 . . . . 0.0 112.918 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 55.8 p -64.88 -22.11 66.93 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.0 mt -107.29 -0.34 22.59 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.409 1.884 . . . . 0.0 113.063 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.5 118.5 0.46 Allowed Glycine 0 CA--C 1.539 1.543 0 C-N-CA 126.208 1.861 . . . . 0.0 113.063 -170.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.7 t -75.24 132.84 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.406 1.082 . . . . 0.0 110.767 174.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.43 -174.35 2.51 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.733 1.613 . . . . 0.0 111.494 172.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.843 ' OD1' ' HB2' ' A' ' 1' ' ' MET . 28.1 t0 -139.65 148.82 42.96 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.968 -1.082 . . . . 0.0 113.102 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.92 23.2 75.39 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 123.87 0.747 . . . . 0.0 113.965 -173.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -68.21 165.04 19.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.234 1.414 . . . . 0.0 112.152 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.7 pttm -139.62 142.15 37.07 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 171.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -116.79 121.91 42.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.718 1.207 . . . . 0.0 110.254 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.9 t -96.64 128.97 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.48 0.712 . . . . 0.0 109.875 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.0 mt -111.38 131.54 55.11 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.257 1.023 . . . . 0.0 109.717 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.0 tt -124.91 142.02 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.841 1.256 . . . . 0.0 110.609 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.1 t -132.5 136.48 46.68 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.071 1.348 . . . . 0.0 111.528 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -78.55 143.05 36.88 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.026 1.33 . . . . 0.0 111.463 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 82.7 m -72.53 114.09 10.28 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.789 -0.569 . . . . 0.0 110.031 174.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.0 p -74.75 -27.12 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.351 1.06 . . . . 0.0 113.145 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.192 0 C-N-CA 125.893 1.711 . . . . 0.0 113.366 179.597 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.34 0.114 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -108.84 151.11 26.69 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 120.318 -1.489 . . . . 0.0 113.279 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mt -137.41 134.49 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.986 1.714 . . . . 0.0 109.676 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -93.47 101.44 13.64 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.92 1.288 . . . . 0.0 111.168 174.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 tt -83.49 137.27 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.421 -0.8 . . . . 0.0 110.146 169.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.74 90.33 40.59 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 124.78 1.232 . . . . 0.0 110.464 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -87.64 142.7 5.97 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.467 2.778 . . . . 0.0 112.481 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.91 38.12 0.2 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 125.89 1.676 . . . . 0.0 114.79 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.9 m -139.94 161.49 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 125.767 1.627 . . . . 0.0 112.374 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.3 -122.96 29.85 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.88 0.752 . . . . 0.0 111.91 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.56 -13.24 74.36 Favored Glycine 0 CA--C 1.539 1.571 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 173.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.62 7.0 45.54 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 125.281 1.42 . . . . 0.0 115.831 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.4 m -89.33 154.97 49.16 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 125.399 1.479 . . . . 0.0 113.204 -173.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -64.16 150.6 88.0 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.016 2.477 . . . . 0.0 112.447 169.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mt -137.85 125.96 22.91 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.07 1.748 . . . . 0.0 110.677 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -77.2 114.6 16.18 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.197 0.999 . . . . 0.0 111.325 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.5 mp -114.69 155.82 25.92 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.777 1.631 . . . . 0.0 110.703 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -114.01 133.24 55.63 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.409 1.483 . . . . 0.0 109.701 169.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.04 156.61 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.687 1.195 . . . . 0.0 112.044 -174.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.88 149.08 98.64 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.825 0.85 . . . . 0.0 111.914 173.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.78 -26.38 60.22 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.933 2.422 . . . . 0.0 113.053 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -82.59 12.81 4.21 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.73 1.612 . . . . 0.0 114.463 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.72 113.86 2.47 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.065 -1.022 . . . . 0.0 111.128 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 p -85.24 153.66 22.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.847 0.859 . . . . 0.0 111.536 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.9 t -63.49 -42.08 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.531 -0.731 . . . . 0.0 110.907 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.92 97.06 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.762 0.696 . . . . 0.0 113.226 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.12 -46.98 84.74 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 117.974 0.887 . . . . 0.0 111.742 175.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.76 -47.04 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.589 0.756 . . . . 0.0 111.38 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -56.99 -43.19 81.46 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.895 1.278 . . . . 0.0 111.697 177.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.0 m -65.7 -44.96 84.57 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.686 0.795 . . . . 0.0 111.444 176.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -46.6 87.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.908 0.883 . . . . 0.0 111.653 176.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.09 -51.74 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.219 1.408 . . . . 0.0 111.232 177.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.43 -43.44 96.78 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.799 0.727 . . . . 0.0 112.332 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.66 -43.66 92.89 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.638 0.775 . . . . 0.0 112.823 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.8 ttt -70.18 -36.79 74.9 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.13 0.972 . . . . 0.0 112.848 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.14 -20.41 52.11 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.132 1.373 . . . . 0.0 113.689 176.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? 57.66 19.93 5.91 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.751 2.02 . . . . 0.0 113.825 -171.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 mp -128.96 145.48 56.73 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.76 2.024 . . . . 0.0 110.973 -169.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.87 160.48 45.96 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.606 2.871 . . . . 0.0 113.831 -174.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.33 -5.26 15.5 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 124.02 3.147 . . . . 0.0 114.945 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -71.32 -39.81 71.17 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.736 -1.227 . . . . 0.0 111.715 169.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.7 t -85.97 -49.31 7.94 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.16 -0.962 . . . . 0.0 112.119 173.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.7 m -90.18 127.43 36.11 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.764 0.711 . . . . 0.0 112.093 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -140.37 163.33 33.09 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.758 1.223 . . . . 0.0 113.458 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.4 tp -140.0 136.42 33.73 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.708 2.003 . . . . 0.0 110.639 -170.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.1 p -139.93 155.7 47.03 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.528 1.131 . . . . 0.0 113.084 -178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -149.64 139.68 22.04 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.598 1.959 . . . . 0.0 109.808 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 55.61 29.9 14.4 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.199 1.4 . . . . 0.0 113.969 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.95 13.25 79.15 Favored Glycine 0 CA--C 1.541 1.68 0 C-N-CA 124.785 1.183 . . . . 0.0 114.985 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.3 mmm-85 -123.35 152.73 41.19 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.757 2.023 . . . . 0.0 112.23 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.92 124.01 30.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.738 0.815 . . . . 0.0 109.686 160.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.63 137.04 32.71 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.907 1.283 . . . . 0.0 109.42 174.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -164.51 147.73 9.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.385 1.474 . . . . 0.0 112.036 173.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 56.05 27.21 11.02 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.112 1.765 . . . . 0.0 115.378 175.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -83.96 -16.93 42.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.491 1.116 . . . . 0.0 113.954 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.27 -47.13 0.07 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 129.125 2.97 . . . . 0.0 115.956 -171.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.6 t -152.0 140.38 20.51 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.07 1.348 . . . . 0.0 110.987 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.96 -26.94 67.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.5 0.72 . . . . 0.0 112.153 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -65.3 -27.86 68.91 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.561 1.144 . . . . 0.0 113.364 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.1 t -68.35 -40.51 81.5 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.581 0.753 . . . . 0.0 112.262 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.12 -38.69 22.09 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.526 1.131 . . . . 0.0 112.021 177.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.43 97.91 0.26 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.914 1.721 . . . . 0.0 111.632 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.2 148.98 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.462 1.105 . . . . 0.0 111.735 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.34 -168.6 2.85 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.998 1.719 . . . . 0.0 111.116 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -138.75 149.46 45.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.825 1.25 . . . . 0.0 112.356 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.78 23.63 77.76 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 123.787 0.708 . . . . 0.0 113.87 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -66.92 164.99 16.34 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.93 1.292 . . . . 0.0 112.752 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -136.79 142.85 42.96 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.882 0.873 . . . . 0.0 113.281 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -127.86 125.32 39.48 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.062 1.345 . . . . 0.0 110.335 -175.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.4 126.63 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.604 1.162 . . . . 0.0 109.798 -176.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 tt -124.34 125.05 43.68 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.47 1.108 . . . . 0.0 110.923 -172.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.44 145.15 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.246 1.819 . . . . 0.0 110.275 -169.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.6 t -148.06 150.76 34.51 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.499 1.52 . . . . 0.0 110.941 176.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -122.27 134.68 54.68 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.565 1.546 . . . . 0.0 111.538 -177.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.3 p -71.92 148.08 46.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.443 1.097 . . . . 0.0 112.484 176.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.0 t -71.2 -34.35 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.283 1.033 . . . . 0.0 111.977 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.181 0 C-N-CA 125.725 1.631 . . . . 0.0 113.141 179.766 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.536 ' HG2' ' H ' ' A' ' 2' ' ' LYS . 26.7 ttt . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.536 ' H ' ' HG2' ' A' ' 1' ' ' MET . 58.3 mttm -75.65 140.99 42.87 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.099 -1.0 . . . . 0.0 110.613 162.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.81 159.84 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.056 1.742 . . . . 0.0 109.961 175.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -113.8 139.57 49.02 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.961 1.304 . . . . 0.0 110.36 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 tt -126.82 141.81 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.676 0.79 . . . . 0.0 111.357 174.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 t -124.65 85.36 56.7 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 125.547 1.539 . . . . 0.0 109.862 -177.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.07 121.37 5.33 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.289 2.66 . . . . 0.0 111.528 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.29 52.77 1.65 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.38 1.472 . . . . 0.0 113.406 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -150.45 147.02 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.054 1.342 . . . . 0.0 111.809 -176.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.39 29.18 74.4 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.436 1.017 . . . . 0.0 114.958 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.49 68.37 1.52 Allowed Glycine 0 CA--C 1.532 1.143 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -167.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.26 137.02 42.85 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.49 1.043 . . . . 0.0 114.372 -170.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.1 m -148.48 152.64 38.86 Favored Pre-proline 0 N--CA 1.474 0.735 0 C-N-CA 126.298 1.839 . . . . 0.0 110.813 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -65.86 143.51 73.63 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.936 2.424 . . . . 0.0 112.45 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.9 tp -139.55 129.0 24.24 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.357 1.463 . . . . 0.0 111.118 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -82.97 144.62 29.86 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.304 1.041 . . . . 0.0 112.783 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -152.38 146.97 25.75 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.297 1.439 . . . . 0.0 111.625 168.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -81.42 135.74 35.66 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.739 0.816 . . . . 0.0 111.191 171.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.6 m -134.16 156.56 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.484 1.114 . . . . 0.0 112.279 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.82 152.07 93.81 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 124.382 1.073 . . . . 0.0 112.608 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.09 -23.74 60.32 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.119 2.546 . . . . 0.0 113.279 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -85.43 10.7 12.12 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.249 1.42 . . . . 0.0 113.739 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.99 155.44 27.5 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.079 0.854 . . . . 0.0 112.515 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.6 m -144.39 135.37 25.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.265 1.426 . . . . 0.0 110.669 -171.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.7 t -61.28 -40.27 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.367 0.667 . . . . 0.0 111.953 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.34 -39.13 97.35 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.431 -0.649 . . . . 0.0 113.37 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.69 -37.59 82.52 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 118.342 1.071 . . . . 0.0 112.489 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.48 -44.56 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.543 -0.723 . . . . 0.0 110.37 172.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -60.94 -52.61 64.28 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.02 0.928 . . . . 0.0 111.925 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.2 p -64.53 -36.07 83.02 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 118.358 -0.829 . . . . 0.0 112.852 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -58.47 -45.01 89.49 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.558 1.072 . . . . 0.0 112.084 172.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 51.9 t -69.82 -42.81 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.082 0.856 . . . . 0.0 111.87 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 88.3 m -56.74 -42.32 79.05 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.908 1.231 . . . . 0.0 112.263 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.19 -41.31 81.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.922 0.889 . . . . 0.0 112.626 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.2 ttt -71.49 -36.78 71.23 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.897 0.879 . . . . 0.0 113.07 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -77.37 -13.78 59.86 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.075 1.35 . . . . 0.0 113.295 171.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 55.1 46.39 24.14 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.485 1.914 . . . . 0.0 112.109 -176.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.1 mt -133.14 146.12 59.73 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.424 1.49 . . . . 0.0 112.956 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.18 162.07 43.66 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.974 3.116 . . . . 0.0 113.473 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.48 -7.68 16.81 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.833 3.022 . . . . 0.0 114.273 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.3 -24.64 57.51 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.794 -1.191 . . . . 0.0 113.139 170.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 74.7 p -123.13 0.87 9.11 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.806 1.243 . . . . 0.0 114.204 -174.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.7 m -146.93 125.34 12.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.301 1.441 . . . . 0.0 109.998 172.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -145.36 149.55 34.97 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.734 1.214 . . . . 0.0 113.218 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 69' ' ' PHE . 47.3 tp -105.13 144.59 31.72 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.129 1.772 . . . . 0.0 111.229 175.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.5 p -131.71 154.6 48.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.003 1.321 . . . . 0.0 111.451 170.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -143.03 125.29 15.49 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.434 1.894 . . . . 0.0 109.479 -174.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt 53.24 31.46 11.67 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.714 1.206 . . . . 0.0 113.351 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.41 -4.58 55.12 Favored Glycine 0 CA--C 1.542 1.769 0 C-N-CA 125.529 1.538 . . . . 0.0 116.094 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -94.41 153.15 18.1 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.771 1.628 . . . . 0.0 111.993 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.25 127.67 32.63 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 157.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.5 mt -142.59 151.28 41.36 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.43 1.492 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -154.51 -48.99 0.09 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.369 1.068 . . . . 0.0 113.693 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -83.52 39.13 0.65 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.734 1.614 . . . . 0.0 113.651 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.9 m -72.53 -22.72 60.98 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.844 1.258 . . . . 0.0 113.328 -172.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 63.36 -54.09 0.2 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.71 2.804 . . . . 0.0 115.558 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -160.71 140.8 11.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.868 2.467 . . . . 0.0 108.853 168.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -73.53 -34.71 65.35 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.023 0.829 . . . . 0.0 112.242 171.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -65.75 -27.94 68.67 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -173.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.4 m -67.0 -18.23 65.29 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.9 mp -107.87 -42.16 4.78 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.142 1.377 . . . . 0.0 112.155 175.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.63 93.86 0.1 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.575 1.56 . . . . 0.0 111.771 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.1 p -76.4 149.39 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.045 0.938 . . . . 0.0 110.994 173.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -141.94 178.56 7.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.477 1.111 . . . . 0.0 113.435 -172.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -97.86 137.53 36.57 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.395 1.878 . . . . 0.0 111.31 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.94 19.6 67.18 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 115.562 0.985 . . . . 0.0 115.562 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -65.09 143.57 57.81 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.581 1.191 . . . . 0.0 111.602 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -127.61 132.84 49.72 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -166.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.571 ' HB3' HD11 ' A' ' 45' ' ' LEU . 98.2 m-85 -121.35 141.01 51.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.061 1.744 . . . . 0.0 111.296 -175.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.6 t -124.14 122.48 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.979 0.911 . . . . 0.0 109.835 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -112.42 112.02 23.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.022 1.329 . . . . 0.0 109.062 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.9 mt -101.5 140.26 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.715 1.606 . . . . 0.0 109.921 -176.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.8 p -133.51 157.37 45.83 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.894 1.277 . . . . 0.0 112.375 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 . . . . . 0 N--CA 1.476 0.874 0 C-N-CA 127.017 2.127 . . . . 0.0 111.475 178.872 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 121.246 0.546 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -82.92 149.71 26.9 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.201 -0.937 . . . . 0.0 110.536 166.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.2 pt -139.85 160.41 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.554 1.942 . . . . 0.0 110.009 169.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -118.88 107.81 14.04 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.872 0.869 . . . . 0.0 111.243 172.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.9 tt -90.13 140.17 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.037 0.535 . . . . 0.0 110.933 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 t -125.84 88.94 53.38 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 125.148 1.379 . . . . 0.0 109.899 -175.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -82.41 124.06 4.06 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.448 2.765 . . . . 0.0 112.509 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.19 35.86 0.18 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.87 1.668 . . . . 0.0 114.039 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.0 m -79.42 51.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 126.793 2.037 . . . . 0.0 113.315 -171.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.96 53.01 7.39 Favored Glycine 0 CA--C 1.533 1.218 0 O-C-N 121.276 -0.89 . . . . 0.0 112.877 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.97 23.89 36.83 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.405 1.002 . . . . 0.0 114.747 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.19 138.72 45.75 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 118.18 0.99 . . . . 0.0 113.554 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.5 p -84.1 155.13 64.04 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 125.427 1.491 . . . . 0.0 112.969 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -62.04 145.15 96.72 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.256 2.637 . . . . 0.0 111.825 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.91 127.05 29.91 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.814 1.246 . . . . 0.0 111.392 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -75.53 130.74 39.34 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.724 1.209 . . . . 0.0 111.291 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.94 149.49 41.91 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.611 1.564 . . . . 0.0 111.143 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -85.48 141.8 29.66 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.089 1.356 . . . . 0.0 111.2 169.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.45 142.17 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.482 1.113 . . . . 0.0 112.897 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.97 150.32 61.38 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.187 1.395 . . . . 0.0 112.674 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.15 -23.58 60.09 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.55 2.833 . . . . 0.0 113.619 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -78.82 0.92 25.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.226 1.41 . . . . 0.0 113.872 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.11 140.23 56.06 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.259 0.936 . . . . 0.0 111.972 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.2 m -119.5 131.96 55.68 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.134 1.374 . . . . 0.0 110.23 -174.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.8 m -61.55 -31.96 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -174.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.64 -37.22 92.33 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 123.776 0.703 . . . . 0.0 113.292 173.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.15 -41.9 73.25 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.214 1.007 . . . . 0.0 111.689 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.46 -45.31 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.549 0.739 . . . . 0.0 111.041 175.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -55.36 -49.07 73.23 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.644 1.177 . . . . 0.0 111.239 172.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 90.5 m -65.26 -40.2 93.66 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.226 0.61 . . . . 0.0 111.849 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -59.61 -46.95 87.45 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.252 1.021 . . . . 0.0 111.638 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 36.0 t -61.64 -46.92 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.162 0.985 . . . . 0.0 111.865 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.6 m -63.93 -38.49 91.29 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.4 0.68 . . . . 0.0 112.283 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.26 -41.81 84.95 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.823 0.849 . . . . 0.0 112.421 174.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -66.08 -41.47 90.64 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.329 1.051 . . . . 0.0 112.832 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -85.28 -9.44 57.7 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.79 12.97 1.84 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 127.646 2.379 . . . . 0.0 115.063 -174.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.9 mp -118.66 153.61 52.29 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 126.743 2.017 . . . . 0.0 111.537 -175.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.06 163.87 37.73 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 124.245 3.297 . . . . 0.0 114.235 -173.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -64.91 -14.6 46.05 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.257 2.638 . . . . 0.0 114.026 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -68.58 -26.89 65.62 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.345 1.058 . . . . 0.0 113.215 171.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 34.6 p -109.01 -21.4 12.64 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.078 1.351 . . . . 0.0 113.573 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.3 m -126.54 126.03 43.01 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.145 0.978 . . . . 0.0 110.899 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -141.97 166.25 25.22 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.844 1.258 . . . . 0.0 113.354 -169.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.0 tp -136.93 140.33 42.19 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.869 1.668 . . . . 0.0 111.278 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.8 p -137.29 156.67 47.98 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.181 1.392 . . . . 0.0 112.767 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -152.53 131.92 12.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.441 2.297 . . . . 0.0 110.144 -174.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.35 40.01 17.52 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.357 1.463 . . . . 0.0 113.444 174.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.29 8.7 87.62 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 125.132 1.348 . . . . 0.0 116.334 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -133.89 160.78 36.64 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.707 1.603 . . . . 0.0 112.619 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.41 155.52 29.93 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.274 0.629 . . . . 0.0 110.866 160.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.6 mt -116.86 133.58 55.83 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.55 1.14 . . . . 0.0 111.065 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.2 141.65 18.7 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.926 1.29 . . . . 0.0 111.403 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.5 t0 55.09 33.58 20.71 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.776 1.63 . . . . 0.0 114.789 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.0 p -83.43 -29.48 28.06 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.565 1.146 . . . . 0.0 113.595 -171.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 61.42 -23.45 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 129.107 2.963 . . . . 0.0 116.979 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.1 p -149.09 161.58 41.68 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.796 2.039 . . . . 0.0 111.25 171.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 65.8 mt -77.01 -20.95 55.37 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.738 -0.601 . . . . 0.0 112.595 164.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -63.67 -36.24 83.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.164 0.986 . . . . 0.0 112.421 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.8 m -69.95 -19.2 63.38 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 174.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.1 mt -90.11 -24.74 21.02 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.731 1.213 . . . . 0.0 113.48 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.97 41.09 72.78 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 123.643 0.64 . . . . 0.0 113.158 -174.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.0 p -55.64 149.19 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.907 1.283 . . . . 0.0 112.22 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.79 151.27 30.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.211 1.004 . . . . 0.0 112.182 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -64.22 128.62 36.58 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.67 0.788 . . . . 0.0 111.195 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.78 8.65 76.09 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.013 1.292 . . . . 0.0 115.858 -176.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -62.08 152.04 33.85 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.665 1.733 . . . . 0.0 113.6 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -103.39 154.15 19.72 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.685 1.194 . . . . 0.0 114.179 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -135.78 143.2 45.1 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.119 2.168 . . . . 0.0 109.679 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.9 t -121.7 126.22 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.745 0.818 . . . . 0.0 110.34 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 tt -111.86 122.31 47.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.733 1.613 . . . . 0.0 109.194 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -113.92 142.74 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.722 1.609 . . . . 0.0 110.061 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.7 t -136.87 150.66 48.4 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.092 1.357 . . . . 0.0 112.052 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 . . . . . 0 N--CA 1.475 0.811 0 C-N-CA 126.681 1.993 . . . . 0.0 110.154 -176.251 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.913 0.387 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -102.71 152.23 21.46 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.739 1.215 . . . . 0.0 112.315 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -133.44 154.46 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.283 1.833 . . . . 0.0 109.608 173.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -98.12 146.26 25.74 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.235 0.614 . . . . 0.0 110.549 161.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.4 tt -123.5 136.74 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 124.473 1.109 . . . . 0.0 109.62 165.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -123.46 78.85 54.46 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.943 1.297 . . . . 0.0 109.359 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -81.56 138.02 10.57 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.882 2.388 . . . . 0.0 112.556 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.29 35.7 0.18 Allowed 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.676 1.59 . . . . 0.0 114.394 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.85 160.89 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 126.517 1.927 . . . . 0.0 111.701 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.45 -117.94 12.88 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 123.876 0.75 . . . . 0.0 112.144 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.79 -18.2 72.08 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 123.905 0.764 . . . . 0.0 114.745 174.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.89 11.82 58.74 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-N 118.747 1.273 . . . . 0.0 115.095 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.2 p -106.85 160.14 27.37 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.846 2.058 . . . . 0.0 112.765 -168.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.38 137.37 55.36 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.926 2.417 . . . . 0.0 112.076 171.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 mp -124.1 137.09 54.61 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.319 1.448 . . . . 0.0 110.427 167.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -99.82 135.08 41.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.626 1.17 . . . . 0.0 111.844 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.7 mt -142.23 147.61 36.79 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.039 1.736 . . . . 0.0 111.778 -173.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -81.05 144.06 32.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.284 1.034 . . . . 0.0 110.834 166.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.1 p -144.71 145.24 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.777 0.831 . . . . 0.0 112.514 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 148.09 91.45 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.537 1.135 . . . . 0.0 112.6 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.84 -23.1 41.81 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.202 2.601 . . . . 0.0 113.182 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -81.91 5.79 17.9 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.443 1.497 . . . . 0.0 113.858 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.77 140.47 51.5 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.211 -0.931 . . . . 0.0 112.149 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.6 p -120.05 149.6 41.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.307 1.043 . . . . 0.0 112.109 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.8 m -60.79 -36.06 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.853 0.861 . . . . 0.0 112.519 175.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.83 -44.49 91.96 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 123.893 0.759 . . . . 0.0 112.357 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.75 -47.72 79.89 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 117.767 0.783 . . . . 0.0 112.06 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.4 t -63.14 -48.11 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.466 0.575 . . . . 0.0 111.316 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -59.71 -48.11 82.98 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.71 0.804 . . . . 0.0 111.66 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.5 m -68.62 -36.48 78.7 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.761 -0.587 . . . . 0.0 111.851 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -66.98 -38.78 86.67 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.862 0.865 . . . . 0.0 112.337 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.0 t -56.29 -51.8 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.725 0.81 . . . . 0.0 110.956 167.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.2 m -62.41 -37.18 84.8 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.19 -44.38 84.14 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.024 0.929 . . . . 0.0 112.565 174.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 96.4 mtp -68.63 -39.39 80.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.807 0.843 . . . . 0.0 113.11 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -80.67 -12.56 59.47 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 175.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 58.59 17.43 5.0 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 127.165 2.186 . . . . 0.0 114.162 -173.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 mp -130.04 152.02 79.3 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 127.156 2.183 . . . . 0.0 110.702 -171.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.21 164.74 32.84 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 124.111 3.207 . . . . 0.0 114.115 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.59 -12.28 34.28 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.334 2.689 . . . . 0.0 114.014 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -66.03 -36.84 84.32 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.976 -1.078 . . . . 0.0 112.059 170.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.5 p -90.66 -19.66 23.38 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 89.5 m -136.44 124.83 23.36 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.533 1.515 . . . . 0.0 111.732 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -125.86 157.73 36.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.861 1.665 . . . . 0.0 112.221 -173.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.0 tp -125.98 136.49 53.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.445 1.898 . . . . 0.0 111.308 -173.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.0 p -134.37 153.22 52.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.405 1.082 . . . . 0.0 112.543 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -152.26 136.13 16.34 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.186 1.795 . . . . 0.0 110.059 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt 51.54 33.61 10.86 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.756 1.622 . . . . 0.0 114.362 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.32 19.36 77.47 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.125 0.869 . . . . 0.0 115.091 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -129.02 160.96 31.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.048 2.139 . . . . 0.0 111.24 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -88.58 131.97 34.73 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.696 0.798 . . . . 0.0 110.113 160.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.5 tp -96.94 112.63 24.3 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.148 0.979 . . . . 0.0 110.464 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -154.04 151.14 28.99 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.996 1.318 . . . . 0.0 112.33 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.6 t0 56.18 29.58 14.98 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.928 2.091 . . . . 0.0 115.037 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.0 p -88.36 -20.11 25.75 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 58.09 -64.79 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.87 2.068 . . . . 0.0 114.266 -163.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.7 p -144.01 150.03 37.61 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.16 1.384 . . . . 0.0 111.989 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.51 -30.8 71.61 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.686 0.794 . . . . 0.0 112.631 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.68 -22.51 65.28 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.231 -0.918 . . . . 0.0 113.26 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.7 p -69.44 -26.53 64.65 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 56.6 mt -98.02 -6.35 32.09 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.117 1.767 . . . . 0.0 113.16 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.33 115.39 1.46 Allowed Glycine 0 CA--C 1.536 1.347 0 C-N-CA 126.206 1.86 . . . . 0.0 112.385 -171.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 m -74.43 154.45 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.75 1.22 . . . . 0.0 112.684 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -147.81 160.06 43.16 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.317 1.847 . . . . 0.0 110.319 170.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -93.09 147.49 22.82 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.821 0.848 . . . . 0.0 112.485 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.82 30.78 59.07 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 115.068 0.787 . . . . 0.0 115.068 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.29 148.34 51.86 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.631 1.215 . . . . 0.0 111.891 173.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -120.74 111.75 17.99 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.367 1.067 . . . . 0.0 111.563 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -94.04 144.23 25.66 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.126 1.37 . . . . 0.0 111.222 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.08 128.34 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.484 1.114 . . . . 0.0 109.664 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.3 tp -115.16 123.21 48.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.026 0.93 . . . . 0.0 110.967 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.4 123.56 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.408 1.483 . . . . 0.0 109.708 -171.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.2 t -111.57 141.19 45.48 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.257 1.023 . . . . 0.0 111.76 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? . . . . . 0 N--CA 1.469 0.498 0 C-N-CA 125.557 1.543 . . . . 0.0 110.475 175.737 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 mmt . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.668 0.271 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.88 148.92 27.04 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.651 -1.28 . . . . 0.0 112.298 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.22 155.97 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.883 1.673 . . . . 0.0 110.434 172.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -111.19 119.36 38.7 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.414 1.086 . . . . 0.0 111.083 169.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 tp -86.98 137.82 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 165.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 t -128.81 77.99 76.82 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 124.718 1.207 . . . . 0.0 109.789 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.09 136.74 10.43 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.317 2.678 . . . . 0.0 112.114 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.46 36.49 0.16 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.679 1.592 . . . . 0.0 113.463 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.6 t -138.32 147.56 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.106 1.762 . . . . 0.0 110.641 -170.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.11 -117.71 10.81 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 123.969 0.795 . . . . 0.0 111.967 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.53 -19.58 71.02 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 123.85 0.738 . . . . 0.0 114.519 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.51 3.66 41.38 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 124.87 1.224 . . . . 0.0 115.667 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.0 p -91.31 157.22 42.85 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 126.583 1.953 . . . . 0.0 113.203 -171.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -64.23 145.36 88.7 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.992 2.461 . . . . 0.0 111.784 168.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 tt -137.07 122.48 19.5 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.95 1.3 . . . . 0.0 110.313 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -90.52 137.81 32.06 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.226 1.01 . . . . 0.0 113.017 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.0 mt -144.72 148.17 33.86 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.984 1.714 . . . . 0.0 111.826 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -80.65 138.2 36.39 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.641 1.176 . . . . 0.0 110.382 166.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.4 m -140.0 153.33 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.458 1.103 . . . . 0.0 112.33 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.85 150.49 96.47 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.04 0.936 . . . . 0.0 112.197 175.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.64 -21.01 52.68 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.082 2.521 . . . . 0.0 112.957 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.88 15.68 2.15 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.853 1.661 . . . . 0.0 114.015 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.18 142.49 54.29 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.163 -0.961 . . . . 0.0 112.128 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.3 m -133.56 138.58 46.11 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.241 1.416 . . . . 0.0 111.046 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.9 t -57.49 -47.76 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.339 1.055 . . . . 0.0 112.587 -173.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.6 -38.33 96.22 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.674 -0.515 . . . . 0.0 112.968 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.18 -46.07 78.64 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 117.986 0.893 . . . . 0.0 111.814 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -60.8 -49.14 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.805 0.842 . . . . 0.0 110.971 176.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -62.42 -46.37 88.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.264 0.626 . . . . 0.0 111.777 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.6 m -59.62 -43.92 93.63 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.475 0.71 . . . . 0.0 111.51 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -66.32 -37.7 85.98 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.576 0.751 . . . . 0.0 112.469 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.02 -46.59 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.502 0.592 . . . . 0.0 111.794 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.2 m -58.6 -40.44 83.26 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.501 1.046 . . . . 0.0 112.144 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.72 -41.51 87.8 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.893 0.877 . . . . 0.0 112.715 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.6 tpt -68.28 -41.25 81.27 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.515 1.126 . . . . 0.0 112.767 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -74.77 -24.62 58.71 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.511 1.524 . . . . 0.0 113.137 172.672 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.79 30.25 19.55 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.805 2.042 . . . . 0.0 113.221 -171.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 mp -120.32 153.83 56.06 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.948 2.099 . . . . 0.0 111.454 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.74 162.54 38.98 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.899 3.066 . . . . 0.0 113.496 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -67.58 -16.22 46.53 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.537 2.825 . . . . 0.0 114.819 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -79.79 -29.6 40.4 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.675 1.125 . . . . 0.0 113.613 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.7 p -86.64 9.55 18.31 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.702 1.201 . . . . 0.0 113.69 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 t -135.85 144.81 45.84 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.36 1.464 . . . . 0.0 110.897 176.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -133.52 148.01 51.63 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.505 1.922 . . . . 0.0 110.4 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.3 tp -139.67 121.24 15.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.34 1.456 . . . . 0.0 110.563 -169.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.7 m -132.71 141.11 48.42 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.596 1.158 . . . . 0.0 112.342 -169.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -143.75 131.94 21.89 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.779 2.032 . . . . 0.0 110.608 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt 50.14 37.64 15.07 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.008 1.323 . . . . 0.0 113.82 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.18 17.35 79.57 Favored Glycine 0 CA--C 1.541 1.683 0 C-N-CA 124.718 1.151 . . . . 0.0 115.788 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -136.7 154.13 50.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.675 1.99 . . . . 0.0 112.881 -175.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.41 129.27 34.57 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.82 0.848 . . . . 0.0 110.521 165.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.1 130.72 34.84 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.989 0.916 . . . . 0.0 110.223 169.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -162.23 141.94 9.72 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.513 1.525 . . . . 0.0 111.637 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 t0 56.55 25.34 9.71 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 172.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.1 p -82.96 -16.03 48.94 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.839 -1.163 . . . . 0.0 113.234 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 62.67 -56.1 0.15 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 128.775 2.83 . . . . 0.0 115.02 -171.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 21.5 p -148.93 148.21 29.55 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.344 1.858 . . . . 0.0 111.593 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.69 -25.46 68.22 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.689 0.796 . . . . 0.0 112.991 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -62.01 -27.36 68.82 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.065 -1.022 . . . . 0.0 113.084 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.5 m -69.11 -23.93 64.05 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.114 0.966 . . . . 0.0 113.162 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.6 mt -93.45 -22.87 18.63 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.238 1.415 . . . . 0.0 112.724 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.53 114.03 3.01 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.47 1.986 . . . . 0.0 111.344 -167.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.2 t -72.74 143.18 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.717 1.207 . . . . 0.0 111.314 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -138.55 146.14 41.52 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.549 1.54 . . . . 0.0 110.38 168.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -78.38 147.38 34.14 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.289 -0.882 . . . . 0.0 112.411 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.7 21.81 78.07 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 115.044 0.778 . . . . 0.0 115.044 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -56.98 140.0 50.26 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.728 1.264 . . . . 0.0 111.309 170.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -121.44 137.04 54.89 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.856 0.862 . . . . 0.0 112.138 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -119.0 121.87 40.88 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.463 1.505 . . . . 0.0 109.731 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.5 t -91.81 130.59 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.326 0.65 . . . . 0.0 109.428 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 tp -120.31 123.45 43.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.151 0.98 . . . . 0.0 110.892 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -113.28 129.18 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.411 1.485 . . . . 0.0 110.014 -172.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.6 t -94.37 145.88 24.45 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.497 1.119 . . . . 0.0 111.787 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.773 0 C-N-CA 124.633 1.173 . . . . 0.0 110.615 171.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.979 0.419 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -121.52 147.45 45.77 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.737 1.215 . . . . 0.0 112.544 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.12 166.44 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.542 1.937 . . . . 0.0 110.265 172.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -128.38 100.78 5.93 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.894 0.878 . . . . 0.0 111.287 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.5 tt -86.55 141.8 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.77 0.828 . . . . 0.0 111.209 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.6 t -128.84 80.89 71.9 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 125.491 1.517 . . . . 0.0 109.483 -176.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.5 142.7 33.37 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.952 2.434 . . . . 0.0 111.94 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.62 23.29 0.23 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.399 1.48 . . . . 0.0 113.908 174.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -155.8 160.55 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 127.246 2.218 . . . . 0.0 109.889 -172.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.43 34.81 53.62 Favored Glycine 0 CA--C 1.535 1.292 0 O-C-N 121.389 -0.819 . . . . 0.0 113.998 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.33 -9.17 64.89 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.575 1.559 . . . . 0.0 114.887 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.7 -0.44 43.75 Favored Glycine 0 CA--C 1.54 1.598 0 N-CA-C 116.555 1.382 . . . . 0.0 116.555 170.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.4 m -80.38 152.34 73.1 Favored Pre-proline 0 N--CA 1.472 0.629 0 C-N-CA 124.676 1.19 . . . . 0.0 113.053 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -64.43 145.34 87.76 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.067 2.511 . . . . 0.0 111.845 170.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.7 mt -131.68 121.86 24.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.503 1.521 . . . . 0.0 110.58 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -88.89 132.77 34.54 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.553 1.141 . . . . 0.0 111.284 178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 mt -149.81 143.49 25.39 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.347 1.059 . . . . 0.0 111.624 -173.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -69.82 150.97 46.28 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.351 0.66 . . . . 0.0 111.98 168.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 p -146.37 140.15 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.349 1.06 . . . . 0.0 111.538 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.56 145.27 78.73 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.021 0.928 . . . . 0.0 111.956 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.2 -20.88 49.11 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.833 2.355 . . . . 0.0 113.198 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -75.72 -7.18 53.73 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.2 157.76 30.55 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.162 0.892 . . . . 0.0 112.847 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.85 145.9 51.82 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.95 1.3 . . . . 0.0 110.885 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.1 t -66.37 -34.05 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 121.373 -0.829 . . . . 0.0 111.295 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.25 -43.7 99.05 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.439 1.018 . . . . 0.0 113.054 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.87 -45.47 85.88 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.98 0.89 . . . . 0.0 111.717 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.3 t -60.92 -49.3 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.012 0.925 . . . . 0.0 111.99 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.9 ptt85 -64.08 -39.52 94.24 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.123 0.874 . . . . 0.0 112.07 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.7 m -62.69 -41.22 98.99 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.596 0.758 . . . . 0.0 111.376 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.408 ' HA ' ' HE3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -60.63 -42.57 97.17 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.708 0.803 . . . . 0.0 112.191 178.625 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 70.2 t -74.67 -35.74 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.541 0.736 . . . . 0.0 112.559 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 87.1 m -60.25 -45.51 93.01 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.589 -0.694 . . . . 0.0 111.465 170.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.46 -41.1 89.56 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.984 0.914 . . . . 0.0 112.829 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 57.7 ttm -61.69 -43.84 98.09 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.396 1.078 . . . . 0.0 112.849 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -85.94 -6.38 59.07 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.4 tptm 53.54 53.67 11.21 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.059 2.144 . . . . 0.0 112.451 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.7 mt -133.16 148.38 68.98 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.612 1.565 . . . . 0.0 112.164 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -69.49 160.42 49.83 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.563 2.842 . . . . 0.0 112.444 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.07 -26.01 73.43 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.741 2.294 . . . . 0.0 113.13 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -70.09 -3.19 15.41 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.492 -1.38 . . . . 0.0 114.604 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.8 p -127.7 14.67 6.99 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.368 1.467 . . . . 0.0 113.075 165.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 m -154.53 110.69 3.23 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.031 1.733 . . . . 0.0 110.868 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.2 mtt-85 -132.15 155.22 48.56 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.557 1.143 . . . . 0.0 112.886 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.0 tp -127.37 131.53 50.33 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.255 1.822 . . . . 0.0 110.596 -174.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.8 p -136.84 152.16 49.95 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.415 1.086 . . . . 0.0 113.371 -175.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -142.26 134.5 27.65 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.575 1.95 . . . . 0.0 110.382 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 tptm 51.68 33.31 10.68 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.465 1.506 . . . . 0.0 114.191 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.75 10.09 84.67 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 125.285 1.422 . . . . 0.0 115.931 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -127.34 149.94 49.82 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.792 1.637 . . . . 0.0 112.678 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.12 88.51 6.55 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.735 1.214 . . . . 0.0 110.844 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.2 mp -65.39 147.55 53.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.916 0.886 . . . . 0.0 111.68 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -158.07 -51.05 0.07 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.888 1.275 . . . . 0.0 113.437 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -84.53 40.25 0.78 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.492 1.517 . . . . 0.0 113.295 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.0 m -73.82 -27.26 61.02 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.41 1.084 . . . . 0.0 112.808 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 62.0 -61.92 0.1 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 128.035 2.534 . . . . 0.0 114.776 -174.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.4 p -147.29 150.57 35.05 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.217 1.407 . . . . 0.0 111.319 170.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.07 -20.61 62.34 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.122 0.569 . . . . 0.0 112.471 167.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.09 -54.35 39.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.575 1.55 . . . . 0.0 112.346 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.3 m -69.27 -28.47 66.34 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.9 tp -74.68 -27.84 60.58 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.989 0.916 . . . . 0.0 112.788 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.61 54.24 6.12 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.383 0.992 . . . . 0.0 113.042 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.6 p -56.62 151.88 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.633 1.173 . . . . 0.0 112.905 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.83 161.07 33.83 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.01 1.324 . . . . 0.0 112.945 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -60.95 129.81 43.28 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.099 1.36 . . . . 0.0 112.29 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.46 4.97 59.27 Favored Glycine 0 CA--C 1.535 1.281 0 N-CA-C 115.99 1.156 . . . . 0.0 115.99 171.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -64.68 138.02 58.15 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.179 1.49 . . . . 0.0 110.649 168.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -132.98 134.46 44.51 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -167.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -124.32 136.55 54.19 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.698 1.199 . . . . 0.0 111.484 -167.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t -100.73 132.29 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.725 0.81 . . . . 0.0 109.864 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 tt -120.43 103.44 9.19 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.845 0.858 . . . . 0.0 110.299 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -86.71 141.41 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 126.25 1.82 . . . . 0.0 109.867 -176.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.8 t -146.67 156.55 43.27 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.16 0.984 . . . . 0.0 111.899 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 125.024 1.33 . . . . 0.0 112.573 -171.116 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -101.82 140.06 36.62 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.0 -1.688 . . . . 0.0 112.458 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.83 171.1 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 127.297 2.239 . . . . 0.0 110.399 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -127.2 149.95 49.75 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.809 1.244 . . . . 0.0 110.962 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.1 tt -129.38 142.47 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.119 0.968 . . . . 0.0 110.777 172.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.83 77.85 76.12 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 125.292 1.437 . . . . 0.0 109.779 -173.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.84 133.91 15.87 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.163 2.575 . . . . 0.0 111.497 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.7 41.47 0.27 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.253 1.421 . . . . 0.0 113.314 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.4 t -139.22 147.28 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.031 1.732 . . . . 0.0 110.718 -170.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.13 -119.92 16.37 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 123.898 0.761 . . . . 0.0 111.947 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.34 -18.41 71.43 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 123.684 0.659 . . . . 0.0 114.678 174.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.84 3.19 41.68 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 124.966 1.27 . . . . 0.0 115.748 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.5 p -82.33 155.72 69.14 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.996 1.718 . . . . 0.0 113.363 -174.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -67.34 152.18 79.49 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.302 2.668 . . . . 0.0 112.097 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.1 tp -141.31 125.3 17.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.797 1.239 . . . . 0.0 111.759 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -71.08 142.01 50.84 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.21 1.404 . . . . 0.0 112.327 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.75 151.78 37.73 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.382 1.473 . . . . 0.0 110.351 174.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -111.68 128.68 56.15 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.776 1.23 . . . . 0.0 110.465 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.5 m -140.53 155.1 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.206 1.402 . . . . 0.0 112.483 -165.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.98 150.29 97.64 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 123.82 0.848 . . . . 0.0 111.788 171.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.2 -25.34 57.76 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.966 2.444 . . . . 0.0 112.971 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -76.34 12.57 1.17 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.908 1.683 . . . . 0.0 114.728 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.55 105.12 0.73 Allowed 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.916 -1.115 . . . . 0.0 111.917 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.0 m -75.61 130.1 38.24 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.476 1.11 . . . . 0.0 111.15 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.9 t -60.93 -35.2 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.994 0.918 . . . . 0.0 112.925 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.59 -40.0 97.23 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 121.319 -0.863 . . . . 0.0 113.223 172.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.66 -34.76 77.57 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 117.975 0.887 . . . . 0.0 112.324 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.2 t -60.48 -44.39 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 O-C-N 121.505 -0.747 . . . . 0.0 110.814 172.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -61.42 -54.21 46.47 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.323 173.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 66.4 p -63.17 -34.44 77.63 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.41 1.005 . . . . 0.0 112.853 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -61.06 -47.5 86.09 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.739 0.816 . . . . 0.0 111.751 173.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.0 t -66.6 -41.87 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.805 176.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 92.4 m -57.84 -41.87 83.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.46 1.027 . . . . 0.0 112.087 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.51 -41.5 88.77 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.696 0.798 . . . . 0.0 112.849 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.5 mtt -67.29 -39.49 86.01 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.04 0.936 . . . . 0.0 113.106 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -79.14 -23.22 44.13 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.879 1.272 . . . . 0.0 113.647 176.635 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt 58.78 31.3 21.07 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.419 1.888 . . . . 0.0 113.189 -167.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 mp -114.24 150.58 43.92 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 126.249 1.82 . . . . 0.0 111.035 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -69.54 161.84 44.32 Favored 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.702 2.935 . . . . 0.0 112.726 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -65.18 -20.18 62.77 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.22 2.613 . . . . 0.0 113.674 176.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -67.65 -31.56 71.64 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.149 -0.969 . . . . 0.0 113.309 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 47.8 p -94.41 20.17 8.65 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.382 1.473 . . . . 0.0 113.704 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 t -145.68 152.55 39.8 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.334 1.054 . . . . 0.0 112.373 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 88.0 mmt-85 -139.36 145.55 39.15 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.924 1.69 . . . . 0.0 111.283 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.8 tp -134.71 127.9 31.91 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.441 1.896 . . . . 0.0 109.834 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.6 p -140.67 155.48 46.48 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.418 1.087 . . . . 0.0 112.772 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -146.41 140.49 26.35 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.101 1.76 . . . . 0.0 110.013 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.1 tptt 50.95 34.8 11.17 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.644 1.578 . . . . 0.0 114.035 -177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.87 14.94 81.17 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.757 1.17 . . . . 0.0 115.292 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -130.71 145.45 51.94 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.129 1.772 . . . . 0.0 111.739 -173.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.84 119.4 23.86 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.739 0.815 . . . . 0.0 110.655 171.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.1 mp -93.37 135.42 34.62 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.25 1.02 . . . . 0.0 110.212 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -160.64 149.7 16.97 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.227 1.811 . . . . 0.0 110.127 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 56.18 27.43 11.61 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.601 1.561 . . . . 0.0 114.823 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -73.23 -26.09 60.99 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.52 1.128 . . . . 0.0 113.638 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 61.04 -43.85 0.12 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.73 2.812 . . . . 0.0 115.079 -167.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.8 t -155.05 145.43 22.05 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.121 1.768 . . . . 0.0 110.62 174.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.72 -18.85 65.39 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.671 -0.643 . . . . 0.0 111.938 172.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.66 -24.11 67.47 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.033 -1.042 . . . . 0.0 112.772 173.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.7 t -68.25 -36.89 80.15 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.808 0.843 . . . . 0.0 112.283 172.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.4 mt -85.66 -20.67 29.08 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.972 1.309 . . . . 0.0 113.323 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.64 115.77 3.75 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.757 2.123 . . . . 0.0 111.856 -172.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.6 m -77.7 151.86 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.851 1.261 . . . . 0.0 113.364 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.89 163.61 39.77 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.407 1.883 . . . . 0.0 110.755 169.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -90.89 150.23 21.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.166 0.987 . . . . 0.0 112.806 172.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.67 81.67 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.739 1.161 . . . . 0.0 114.804 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -62.19 120.95 11.91 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.531 1.165 . . . . 0.0 110.745 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -106.15 114.87 29.26 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.045 0.938 . . . . 0.0 112.075 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -93.61 125.8 38.42 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.575 1.55 . . . . 0.0 110.545 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.0 t -96.39 133.26 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.724 0.81 . . . . 0.0 109.433 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.5 tt -130.37 123.49 30.03 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.851 0.86 . . . . 0.0 111.232 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.4 mm -117.07 122.01 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.112 1.365 . . . . 0.0 110.163 -171.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -81.66 143.35 31.97 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.328 0.651 . . . . 0.0 110.949 167.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 . . . . . 0 N--CA 1.472 0.659 0 C-N-CA 123.753 0.821 . . . . 0.0 110.335 167.657 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.5 mtt . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -79.76 149.28 31.17 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.16 -0.962 . . . . 0.0 111.559 166.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.97 140.26 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.918 2.087 . . . . 0.0 109.08 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -100.24 110.41 22.66 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.856 1.262 . . . . 0.0 110.951 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.3 tt -90.56 138.47 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.766 -0.584 . . . . 0.0 110.354 171.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.7 t -127.37 81.89 69.24 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 125.134 1.373 . . . . 0.0 109.65 -175.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -84.06 135.55 6.52 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.892 2.395 . . . . 0.0 113.02 -177.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.1 37.23 0.25 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.771 1.628 . . . . 0.0 114.109 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.84 157.16 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.681 1.593 . . . . 0.0 111.148 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.58 -115.48 7.38 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.207 0.908 . . . . 0.0 111.863 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.35 -21.93 70.75 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 123.736 0.684 . . . . 0.0 114.376 174.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.33 23.7 70.22 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 118.539 1.169 . . . . 0.0 114.576 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -133.14 155.88 80.54 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 125.822 1.649 . . . . 0.0 112.964 -163.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.1 138.16 55.39 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.991 2.46 . . . . 0.0 112.564 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.2 mt -131.36 122.8 26.97 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.734 1.614 . . . . 0.0 110.205 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -79.71 141.39 36.43 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.709 0.804 . . . . 0.0 111.894 173.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 tp -150.25 144.69 25.75 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.954 1.301 . . . . 0.0 111.229 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -86.05 136.54 33.19 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.98 0.912 . . . . 0.0 111.017 170.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 t -142.98 142.53 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.426 1.09 . . . . 0.0 111.019 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.49 152.14 96.5 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.689 1.196 . . . . 0.0 113.192 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.07 -20.23 50.58 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.379 2.719 . . . . 0.0 113.492 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -72.02 6.0 2.38 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.87 1.668 . . . . 0.0 114.354 172.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.3 131.05 47.04 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.572 1.078 . . . . 0.0 112.496 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.0 m -116.47 133.25 56.23 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.469 1.508 . . . . 0.0 109.798 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.0 t -59.67 -41.0 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.304 0.642 . . . . 0.0 112.155 -175.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.71 -36.54 91.91 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.522 -0.599 . . . . 0.0 113.413 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.9 -44.22 73.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.381 1.091 . . . . 0.0 111.945 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.66 -47.01 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.591 0.756 . . . . 0.0 111.169 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -61.63 -43.55 98.64 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.457 1.103 . . . . 0.0 111.944 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 88.3 m -62.52 -42.6 99.62 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.655 0.662 . . . . 0.0 111.696 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.67 -43.78 98.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.004 0.921 . . . . 0.0 111.489 176.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.79 -52.86 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.236 1.015 . . . . 0.0 111.504 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 85.1 m -61.06 -35.88 78.11 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.778 0.717 . . . . 0.0 112.599 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.82 -44.25 81.68 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.824 0.849 . . . . 0.0 112.911 173.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 71.7 mtm -68.97 -39.06 79.68 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.527 -0.733 . . . . 0.0 112.928 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -15.63 58.87 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.82 1.248 . . . . 0.0 113.426 176.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? 57.18 32.53 21.87 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.597 1.959 . . . . 0.0 112.447 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 32.0 mt -148.42 152.06 37.84 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 126.268 1.827 . . . . 0.0 112.311 -165.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.58 164.03 35.96 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 124.395 3.397 . . . . 0.0 114.44 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.95 -5.21 15.12 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.651 2.901 . . . . 0.0 114.476 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -75.05 -32.39 61.53 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.796 -1.19 . . . . 0.0 113.287 168.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.7 p -95.15 -20.35 19.33 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.1 m -135.16 130.4 35.33 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.308 1.043 . . . . 0.0 111.055 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -132.02 159.33 39.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.816 1.647 . . . . 0.0 112.598 -173.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.8 tp -127.61 137.0 52.43 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.184 1.794 . . . . 0.0 110.752 -176.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.5 p -132.64 151.45 51.95 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.028 0.931 . . . . 0.0 111.993 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -138.3 128.98 26.55 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.005 1.722 . . . . 0.0 109.984 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt 50.28 37.05 14.1 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.114 1.366 . . . . 0.0 114.076 172.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.22 11.49 80.71 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.447 1.499 . . . . 0.0 116.248 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -137.34 155.02 49.91 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.222 1.511 . . . . 0.0 113.59 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.14 99.52 11.57 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.57 1.148 . . . . 0.0 110.249 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.58 141.28 57.89 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.187 0.995 . . . . 0.0 110.994 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -166.6 154.48 9.91 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.649 1.58 . . . . 0.0 111.954 173.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.9 t0 57.41 28.72 15.82 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.973 1.709 . . . . 0.0 115.468 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.6 p -84.45 -24.73 29.38 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -174.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 59.49 -46.52 0.08 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 128.287 2.635 . . . . 0.0 115.803 -167.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 t -151.67 142.71 23.12 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.312 1.445 . . . . 0.0 111.229 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.4 tp -70.04 -22.86 63.04 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.699 0.799 . . . . 0.0 112.645 174.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.83 -33.6 75.08 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.085 -1.009 . . . . 0.0 113.168 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.4 t -64.81 -33.89 77.05 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.469 0.708 . . . . 0.0 112.32 174.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 87.0 mt -84.98 -3.98 58.97 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.548 1.539 . . . . 0.0 113.504 173.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.74 113.76 0.49 Allowed Glycine 0 CA--C 1.536 1.397 0 C-N-CA 126.026 1.774 . . . . 0.0 112.825 -170.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 m -70.79 157.56 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.206 1.002 . . . . 0.0 112.196 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -138.12 -169.07 2.49 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.084 1.754 . . . . 0.0 110.874 174.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -138.07 150.59 47.04 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.274 1.029 . . . . 0.0 112.58 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.82 21.75 75.22 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 123.32 0.486 . . . . 0.0 113.9 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -60.86 153.34 24.93 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.835 1.254 . . . . 0.0 112.858 176.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -134.41 136.69 43.47 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.094 0.958 . . . . 0.0 113.028 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -125.69 136.13 52.87 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.189 1.795 . . . . 0.0 109.411 -174.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.8 t -117.38 124.21 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.571 0.749 . . . . 0.0 110.079 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tp -104.39 125.99 51.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.692 0.797 . . . . 0.0 110.332 176.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.5 pt -116.5 146.27 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.348 1.459 . . . . 0.0 110.336 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.8 t -139.43 146.89 40.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.037 0.935 . . . . 0.0 111.548 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 55.6 ttt-85 . . . . . 0 N--CA 1.469 0.498 0 C-N-CA 126.331 1.852 . . . . 0.0 110.475 -169.382 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.477 ' HB2' ' OD1' ' A' ' 65' ' ' ASP . 15.8 mmt . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 mtmm -86.33 143.23 27.97 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.915 0.886 . . . . 0.0 110.283 162.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.3 157.54 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.009 1.723 . . . . 0.0 109.687 172.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -122.45 102.07 7.87 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.085 0.954 . . . . 0.0 110.88 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 tt -87.26 141.66 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 122.791 0.436 . . . . 0.0 110.71 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.3 t -130.73 81.78 66.47 Favored Pre-proline 0 N--CA 1.47 0.56 0 C-N-CA 125.276 1.43 . . . . 0.0 109.48 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.41 134.22 12.43 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.685 2.257 . . . . 0.0 112.046 178.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.18 40.65 0.21 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.024 1.33 . . . . 0.0 113.515 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.2 t -137.97 147.11 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.044 1.738 . . . . 0.0 110.814 -170.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.13 -121.55 21.55 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.845 0.736 . . . . 0.0 111.961 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.05 -17.31 71.67 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.671 0.653 . . . . 0.0 114.59 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.36 3.34 61.56 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.778 1.18 . . . . 0.0 115.402 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 m -72.65 152.13 91.47 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.103 1.361 . . . . 0.0 113.717 -172.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -64.97 152.64 81.67 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.706 2.271 . . . . 0.0 111.81 164.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.3 tp -142.64 124.52 15.16 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.785 1.234 . . . . 0.0 111.323 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -82.77 135.11 35.08 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.951 0.901 . . . . 0.0 111.899 175.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.3 mt -142.7 141.25 31.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.14 1.776 . . . . 0.0 110.761 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -76.78 144.61 39.07 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.626 0.77 . . . . 0.0 111.832 166.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.9 m -142.11 153.79 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.854 1.262 . . . . 0.0 111.452 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.76 150.7 88.69 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.218 0.607 . . . . 0.0 111.692 169.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -65.29 -20.92 62.14 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.781 2.321 . . . . 0.0 112.889 173.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -80.22 7.53 9.21 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.026 1.73 . . . . 0.0 114.185 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.18 117.53 4.5 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.691 1.197 . . . . 0.0 112.963 -174.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.9 m -91.34 141.27 28.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.36 1.464 . . . . 0.0 111.684 -176.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.48 -44.22 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.556 -0.715 . . . . 0.0 111.986 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.2 -36.83 93.0 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.513 0.577 . . . . 0.0 113.681 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.82 -43.67 83.19 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.167 0.983 . . . . 0.0 111.797 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 82.3 t -63.7 -44.81 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.854 0.862 . . . . 0.0 111.252 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -64.02 -38.02 89.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.286 1.035 . . . . 0.0 111.966 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.0 m -66.34 -44.95 81.85 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.19 0.996 . . . . 0.0 111.423 174.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -58.17 -45.04 88.2 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.0 0.92 . . . . 0.0 112.139 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.8 t -59.67 -53.24 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.086 0.955 . . . . 0.0 111.112 173.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.3 t -61.08 -41.52 96.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.357 0.663 . . . . 0.0 112.535 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.9 73.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.065 0.946 . . . . 0.0 112.79 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.9 ttp -73.42 -22.57 60.19 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.6 mmpm? -93.23 -15.39 25.94 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.959 1.304 . . . . 0.0 113.688 170.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt 55.71 24.85 7.6 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.933 2.493 . . . . 0.0 114.613 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.86 153.97 61.65 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.857 1.663 . . . . 0.0 111.644 -173.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -71.12 156.66 59.25 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.897 3.065 . . . . 0.0 113.243 -175.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.75 -14.5 45.19 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.824 3.016 . . . . 0.0 114.491 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -64.22 -24.99 67.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.824 0.85 . . . . 0.0 113.09 170.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 38.8 p -98.17 -26.86 14.42 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.416 1.087 . . . . 0.0 113.441 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 84.9 m -138.76 116.94 11.8 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.284 1.034 . . . . 0.0 111.61 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -109.59 162.84 14.02 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.875 1.67 . . . . 0.0 112.984 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.4 tp -129.66 140.52 51.13 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.039 1.736 . . . . 0.0 111.303 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.4 p -136.26 157.71 46.16 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.597 1.159 . . . . 0.0 112.537 171.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -139.5 131.2 27.36 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.857 2.063 . . . . 0.0 109.789 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? 47.74 37.21 6.66 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.591 1.556 . . . . 0.0 114.485 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.09 14.95 81.76 Favored Glycine 0 CA--C 1.54 1.632 0 N-CA-C 115.715 1.046 . . . . 0.0 115.715 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -134.32 159.85 39.72 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.759 1.623 . . . . 0.0 111.761 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.12 133.16 34.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.407 0.683 . . . . 0.0 111.332 169.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.0 mt -86.41 127.55 34.84 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.822 0.849 . . . . 0.0 110.457 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.33 131.89 9.52 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.306 1.442 . . . . 0.0 110.541 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.0 t0 55.26 29.18 12.39 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.703 1.601 . . . . 0.0 115.094 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.2 p -84.5 -11.99 55.08 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.762 -1.211 . . . . 0.0 113.95 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 63.6 -54.15 0.22 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.893 2.477 . . . . 0.0 115.388 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.1 p -147.33 158.09 43.83 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.312 1.845 . . . . 0.0 111.516 176.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.4 -34.17 77.56 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.721 -0.612 . . . . 0.0 112.066 168.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.6 tm-20 -63.14 -33.54 75.69 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.832 0.853 . . . . 0.0 113.034 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 p -63.75 -27.65 69.34 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.4 mt -98.07 4.75 49.17 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.858 1.663 . . . . 0.0 113.17 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.16 100.11 0.76 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.367 1.46 . . . . 0.0 112.141 -172.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.5 p -73.65 150.68 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.869 1.267 . . . . 0.0 111.813 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.69 -171.86 3.33 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.041 1.736 . . . . 0.0 111.041 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.477 ' OD1' ' HB2' ' A' ' 1' ' ' MET . 14.2 t0 -121.88 145.2 48.32 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.453 1.101 . . . . 0.0 111.647 174.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.01 20.6 77.5 Favored Glycine 0 CA--C 1.539 1.533 0 CA-C-O 119.705 -0.497 . . . . 0.0 114.333 -174.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -58.47 136.48 57.51 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.432 1.116 . . . . 0.0 111.835 172.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -112.25 140.68 46.76 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -123.66 132.64 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.151 1.781 . . . . 0.0 109.295 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.7 t -123.58 121.3 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 118.719 0.69 . . . . 0.0 110.873 -173.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 tp -96.32 137.72 34.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.379 1.072 . . . . 0.0 110.178 175.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.32 125.43 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.485 1.114 . . . . 0.0 109.027 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.7 t -118.1 142.04 47.84 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.711 1.204 . . . . 0.0 112.141 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 . . . . . 0 N--CA 1.472 0.66 0 C-N-CA 124.912 1.285 . . . . 0.0 111.478 171.204 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 121.344 0.592 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -92.75 139.31 30.68 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.652 1.181 . . . . 0.0 111.197 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pp -137.0 162.84 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.773 1.629 . . . . 0.0 110.849 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -126.79 138.73 53.4 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.203 1.001 . . . . 0.0 112.153 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.9 mt -121.18 133.91 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.936 1.295 . . . . 0.0 109.096 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.23 92.87 37.71 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.692 1.197 . . . . 0.0 110.831 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -88.25 130.87 2.5 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.915 2.41 . . . . 0.0 112.493 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.23 29.95 0.12 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.514 1.526 . . . . 0.0 114.507 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.3 m -73.95 73.87 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 126.471 1.908 . . . . 0.0 112.767 -173.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.0 38.91 63.89 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.143 0.878 . . . . 0.0 113.192 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.55 29.46 29.8 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.311 0.958 . . . . 0.0 114.289 -174.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.78 141.22 48.1 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 124.622 1.106 . . . . 0.0 114.103 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 m -80.03 154.62 75.16 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 125.107 1.363 . . . . 0.0 113.418 -176.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -62.89 147.43 94.62 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.075 2.517 . . . . 0.0 111.997 166.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.86 138.03 35.39 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.64 1.576 . . . . 0.0 110.813 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -87.73 140.34 29.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.069 1.348 . . . . 0.0 112.122 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 mp -140.85 164.94 28.88 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.083 1.753 . . . . 0.0 111.459 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -116.39 137.53 52.08 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.52 1.528 . . . . 0.0 110.217 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.3 158.99 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.743 1.217 . . . . 0.0 111.879 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.2 149.13 98.62 Favored Pre-proline 0 CA--C 1.551 0.984 0 O-C-N 121.767 -0.583 . . . . 0.0 111.498 170.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.46 -24.32 56.94 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.944 2.429 . . . . 0.0 113.221 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -82.95 33.35 0.44 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.925 1.69 . . . . 0.0 113.638 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.41 117.76 5.64 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.184 -0.948 . . . . 0.0 111.199 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.2 m -97.46 129.36 44.66 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.732 1.213 . . . . 0.0 110.888 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.8 -44.0 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.917 0.887 . . . . 0.0 112.226 -175.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.46 -36.47 93.42 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.517 0.579 . . . . 0.0 113.51 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.92 -37.98 76.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.38 1.09 . . . . 0.0 112.378 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.7 t -68.65 -43.93 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.276 1.03 . . . . 0.0 111.24 174.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -63.84 -37.39 87.2 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.022 0.929 . . . . 0.0 112.241 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.9 m -64.17 -39.77 94.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.661 0.785 . . . . 0.0 111.328 170.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.24 -47.95 83.81 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.872 0.869 . . . . 0.0 111.281 174.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.4 t -56.9 -50.22 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.04 1.336 . . . . 0.0 111.342 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.5 t -59.93 -44.71 94.17 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.756 0.822 . . . . 0.0 112.109 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.84 86.17 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.994 0.918 . . . . 0.0 113.177 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.4 mtt -68.64 -42.49 77.94 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.107 0.963 . . . . 0.0 112.748 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.98 -23.28 41.71 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.01 26.24 15.53 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.962 1.705 . . . . 0.0 113.275 -174.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.79 153.91 70.39 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 126.845 2.058 . . . . 0.0 111.317 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.47 163.63 38.16 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 124.293 3.329 . . . . 0.0 114.247 -173.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.57 -15.78 51.75 Favored 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 123.421 2.747 . . . . 0.0 113.992 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -67.67 -28.86 68.05 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.138 -0.976 . . . . 0.0 113.208 173.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.1 p -102.95 -10.16 19.23 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.087 1.355 . . . . 0.0 113.872 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.4 m -148.63 123.49 9.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.836 1.254 . . . . 0.0 111.263 172.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -110.49 160.39 16.66 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.718 1.207 . . . . 0.0 113.447 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.6 tp -126.43 132.52 51.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.798 2.039 . . . . 0.0 110.391 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.5 p -137.11 158.36 44.62 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.362 1.065 . . . . 0.0 111.966 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -133.44 126.58 31.51 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.137 2.175 . . . . 0.0 109.378 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt 51.49 30.66 6.55 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.17 0.988 . . . . 0.0 113.382 -174.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.34 2.28 73.15 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 125.26 1.409 . . . . 0.0 115.958 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.44 146.3 29.68 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.948 2.099 . . . . 0.0 111.357 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.8 122.15 25.68 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.576 -0.703 . . . . 0.0 110.968 169.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.2 mt -83.35 134.17 34.92 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.201 1.0 . . . . 0.0 111.097 171.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -160.38 144.76 14.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.456 1.502 . . . . 0.0 110.578 170.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.9 t0 52.69 27.99 5.8 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.778 1.631 . . . . 0.0 115.021 174.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.9 m -83.04 -23.82 33.04 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.078 1.351 . . . . 0.0 112.926 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 61.63 -52.85 0.13 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 128.403 2.681 . . . . 0.0 115.544 -172.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.0 t -159.15 142.27 14.5 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.031 1.332 . . . . 0.0 111.641 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.16 -26.75 67.57 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.538 0.735 . . . . 0.0 112.314 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.43 -20.01 64.62 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.755 1.161 . . . . 0.0 113.361 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.7 t -74.91 -38.19 61.89 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.112 0.965 . . . . 0.0 112.374 173.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.47 -35.73 14.94 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.887 1.275 . . . . 0.0 112.929 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 140.42 87.77 0.13 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.042 1.782 . . . . 0.0 112.267 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.3 p -76.72 147.36 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.011 1.324 . . . . 0.0 112.357 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.19 156.13 37.98 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.894 1.278 . . . . 0.0 112.483 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -67.65 147.09 53.17 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.339 -0.851 . . . . 0.0 111.287 162.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.78 14.32 77.95 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 123.867 0.746 . . . . 0.0 114.493 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -55.4 132.91 49.36 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.729 1.264 . . . . 0.0 110.579 168.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.48 131.95 45.41 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.268 1.027 . . . . 0.0 112.443 -165.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -128.07 132.1 49.06 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.432 1.493 . . . . 0.0 110.637 -169.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.74 133.96 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.166 0.987 . . . . 0.0 110.752 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 tp -109.93 115.47 29.85 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.313 1.045 . . . . 0.0 110.049 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.2 mm -105.32 94.09 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.256 1.023 . . . . 0.0 108.983 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -79.22 152.02 30.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.259 1.424 . . . . 0.0 111.243 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 . . . . . 0 N--CA 1.474 0.759 0 C-N-CA 124.74 1.216 . . . . 0.0 112.197 -177.892 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 110.583 -0.154 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -86.13 145.4 27.04 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.179 -1.575 . . . . 0.0 112.944 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.4 mm -136.48 140.12 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 127.873 2.469 . . . . 0.0 108.641 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -91.84 140.2 29.91 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.177 0.591 . . . . 0.0 110.596 167.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.6 pt -118.78 139.78 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.888 0.875 . . . . 0.0 110.317 168.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 t -129.95 73.71 81.18 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 124.602 1.161 . . . . 0.0 110.371 -175.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -78.62 134.34 12.22 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.508 2.805 . . . . 0.0 112.014 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.05 35.17 0.2 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.603 1.561 . . . . 0.0 114.545 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.4 m -138.94 161.59 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 126.09 1.756 . . . . 0.0 111.874 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.87 -119.97 18.31 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 123.687 0.661 . . . . 0.0 111.467 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.09 -17.85 74.18 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 123.684 0.659 . . . . 0.0 114.691 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.48 2.48 35.01 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.206 1.384 . . . . 0.0 115.229 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.6 p -85.63 156.55 58.8 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.392 1.877 . . . . 0.0 113.591 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.32 153.08 79.4 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.051 2.5 . . . . 0.0 112.4 170.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.8 tp -143.19 130.04 20.48 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.185 1.394 . . . . 0.0 111.671 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -80.35 134.97 36.1 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.41 1.084 . . . . 0.0 111.967 172.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.4 mt -142.93 149.53 38.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.118 1.767 . . . . 0.0 111.409 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -90.58 134.32 34.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.502 1.121 . . . . 0.0 110.809 169.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.59 154.64 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.612 1.165 . . . . 0.0 112.299 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.64 152.12 89.35 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.361 1.064 . . . . 0.0 112.585 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.11 -17.98 55.74 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.364 2.709 . . . . 0.0 113.544 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -80.59 4.81 17.3 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.521 1.528 . . . . 0.0 113.928 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.67 125.99 25.81 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.495 1.043 . . . . 0.0 112.565 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 m -94.21 131.27 39.96 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.045 1.338 . . . . 0.0 110.814 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.6 t -60.6 -41.54 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 O-C-N 121.348 -0.845 . . . . 0.0 111.962 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.86 -33.93 88.57 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 123.827 0.727 . . . . 0.0 113.767 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.97 -42.66 76.31 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.389 1.095 . . . . 0.0 111.463 174.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.59 -48.03 88.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.77 0.828 . . . . 0.0 110.876 174.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.4 mmm-85 -58.14 -45.99 86.43 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.792 0.837 . . . . 0.0 112.115 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.7 m -60.34 -44.53 95.43 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.332 0.653 . . . . 0.0 111.902 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -42.85 99.44 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.149 0.979 . . . . 0.0 111.568 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.0 t -67.18 -47.76 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.589 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 97.8 m -57.67 -42.32 83.31 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.025 1.284 . . . . 0.0 112.087 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.94 -41.18 91.64 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.79 0.836 . . . . 0.0 112.797 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.7 ttt -70.85 -41.68 71.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.257 1.023 . . . . 0.0 112.815 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -29.11 63.85 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.762 1.225 . . . . 0.0 112.641 173.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? 68.65 31.75 4.51 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 127.247 2.219 . . . . 0.0 113.208 -173.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mp -128.98 153.65 80.26 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.193 1.797 . . . . 0.0 111.824 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.14 159.62 53.13 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.836 3.024 . . . . 0.0 113.245 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.51 -15.25 48.91 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.923 3.082 . . . . 0.0 114.408 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -70.23 -25.14 63.24 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.475 1.034 . . . . 0.0 113.031 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.4 m -93.46 0.65 56.84 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.962 1.305 . . . . 0.0 113.22 -175.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.0 t -137.34 140.21 41.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.939 1.296 . . . . 0.0 112.056 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -134.16 140.8 46.79 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.72 1.608 . . . . 0.0 110.772 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.4 tp -131.63 129.92 41.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.508 1.523 . . . . 0.0 110.907 -171.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -139.7 153.82 47.33 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.48 1.112 . . . . 0.0 112.948 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -143.72 138.64 29.01 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.263 1.825 . . . . 0.0 110.24 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 55.03 30.89 15.04 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.863 1.265 . . . . 0.0 113.777 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.45 18.19 79.28 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 124.786 1.184 . . . . 0.0 114.952 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -134.15 142.78 47.58 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.373 1.869 . . . . 0.0 111.132 -170.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.91 135.55 40.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.762 0.825 . . . . 0.0 111.919 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.4 mt -103.91 136.81 42.88 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.486 1.114 . . . . 0.0 110.798 173.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.48 149.65 18.94 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.119 1.368 . . . . 0.0 111.164 171.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.0 t0 54.23 27.67 8.16 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.778 1.631 . . . . 0.0 114.88 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -75.24 -24.88 57.72 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.388 1.075 . . . . 0.0 113.287 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 60.53 -56.01 0.08 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 128.584 2.754 . . . . 0.0 114.898 -169.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 p -146.92 133.57 19.91 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.934 1.694 . . . . 0.0 111.205 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.79 -32.8 74.53 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.871 0.869 . . . . 0.0 112.882 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -62.09 -26.83 68.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.145 0.978 . . . . 0.0 113.383 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.6 m -71.05 -28.15 64.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.385 1.074 . . . . 0.0 113.445 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 72.3 mt -99.76 -32.21 11.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.74 1.216 . . . . 0.0 112.966 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 138.39 81.55 0.09 OUTLIER Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.516 1.532 . . . . 0.0 112.162 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.4 p -70.52 147.07 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.268 1.027 . . . . 0.0 111.633 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -146.36 167.96 22.29 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.619 1.568 . . . . 0.0 111.863 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -106.48 145.69 31.49 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.375 1.47 . . . . 0.0 113.446 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.53 13.45 82.93 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 123.798 0.714 . . . . 0.0 114.463 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -65.03 159.92 22.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.412 1.085 . . . . 0.0 111.796 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.72 130.96 28.44 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -101.43 138.5 38.36 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.242 1.417 . . . . 0.0 111.093 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.87 134.47 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.263 1.025 . . . . 0.0 109.574 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.0 tt -130.84 125.46 33.7 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.759 0.824 . . . . 0.0 111.514 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.0 mm -113.41 135.78 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.123 1.769 . . . . 0.0 110.476 -170.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.2 t -102.05 143.48 31.84 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.803 1.241 . . . . 0.0 111.346 172.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.862 0 C-N-CA 124.626 1.17 . . . . 0.0 111.055 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ttt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 120.657 0.265 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -68.56 147.52 51.84 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.624 -1.297 . . . . 0.0 111.072 158.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -143.95 166.11 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 127.568 2.347 . . . . 0.0 110.165 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -125.69 134.9 51.66 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.062 0.945 . . . . 0.0 111.355 167.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 54.5 mt -121.53 131.03 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.999 1.319 . . . . 0.0 108.669 177.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 p -121.49 98.11 46.48 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 124.563 1.145 . . . . 0.0 110.77 173.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -84.58 144.11 9.98 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.298 2.666 . . . . 0.0 111.38 172.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.34 34.38 0.11 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 125.687 1.595 . . . . 0.0 113.553 173.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.3 t -134.29 144.32 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.263 1.825 . . . . 0.0 110.684 -167.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.24 -113.76 6.21 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.05 0.833 . . . . 0.0 112.234 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.73 -20.22 70.05 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 123.984 0.802 . . . . 0.0 114.548 174.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.37 12.86 64.26 Favored Glycine 0 CA--C 1.54 1.606 0 CA-C-N 118.547 1.173 . . . . 0.0 115.47 175.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.0 p -111.86 155.97 42.39 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 126.254 1.822 . . . . 0.0 113.003 -167.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.6 145.11 91.3 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.977 2.451 . . . . 0.0 112.317 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.92 129.62 34.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.6 1.56 . . . . 0.0 109.998 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.84 135.21 43.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.654 1.181 . . . . 0.0 111.543 173.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.13 168.59 19.38 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.832 1.653 . . . . 0.0 110.602 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.2 143.56 49.95 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.909 1.284 . . . . 0.0 111.086 166.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.5 m -141.45 158.12 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.033 1.333 . . . . 0.0 112.109 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.64 149.23 98.35 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.238 1.015 . . . . 0.0 112.179 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -67.69 -17.71 47.81 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.623 2.882 . . . . 0.0 113.837 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.48 -6.7 59.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.205 1.402 . . . . 0.0 114.136 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.76 141.5 52.74 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.471 1.032 . . . . 0.0 111.282 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.9 t -130.83 145.94 52.13 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.365 1.066 . . . . 0.0 111.328 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.24 -35.28 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.439 0.696 . . . . 0.0 111.807 -169.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.57 -35.98 91.93 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 121.736 -0.603 . . . . 0.0 113.84 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.89 -41.91 67.41 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.596 1.198 . . . . 0.0 112.045 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.79 -44.44 99.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.561 0.744 . . . . 0.0 110.685 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -60.35 -47.16 87.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.373 1.069 . . . . 0.0 111.523 174.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.1 m -59.85 -45.77 91.4 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.937 0.895 . . . . 0.0 111.813 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -60.2 -43.31 96.02 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.705 0.802 . . . . 0.0 112.505 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.51 -41.32 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.777 0.717 . . . . 0.0 112.105 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 87.5 m -60.53 -37.16 80.3 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.527 1.058 . . . . 0.0 112.31 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.0 77.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.252 1.021 . . . . 0.0 113.122 174.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.3 mmt -66.83 -38.32 86.21 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.325 -0.859 . . . . 0.0 112.524 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -23.1 58.56 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.991 1.316 . . . . 0.0 113.385 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.5 mtpt 51.04 45.02 28.36 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.958 2.103 . . . . 0.0 112.435 -167.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.2 mt -136.17 151.34 73.33 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.786 1.634 . . . . 0.0 112.245 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -70.77 162.44 42.58 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 124.004 3.136 . . . . 0.0 113.526 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.69 -11.58 29.72 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 123.662 2.908 . . . . 0.0 114.305 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -72.07 -32.85 67.44 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.694 1.197 . . . . 0.0 113.123 173.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.6 p -105.11 -5.23 20.99 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.156 1.382 . . . . 0.0 113.858 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.0 m -147.63 125.18 11.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.137 1.775 . . . . 0.0 110.077 176.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -140.47 147.19 39.24 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.1 tp -108.85 140.17 42.67 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.587 1.955 . . . . 0.0 111.028 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.9 t -141.88 157.33 45.12 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.263 1.425 . . . . 0.0 111.485 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -132.0 129.99 40.83 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.67 1.588 . . . . 0.0 110.359 -174.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp 51.36 29.06 4.79 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.61 14.84 82.07 Favored Glycine 0 CA--C 1.541 1.709 0 C-N-CA 125.288 1.423 . . . . 0.0 116.09 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.47 129.26 30.81 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.781 1.632 . . . . 0.0 111.267 -177.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.76 131.65 46.83 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.332 0.653 . . . . 0.0 112.501 -175.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.1 mt -131.68 153.9 49.53 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.461 1.504 . . . . 0.0 111.607 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -161.08 -48.83 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.978 1.711 . . . . 0.0 111.268 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -81.54 27.82 0.42 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.688 1.995 . . . . 0.0 114.115 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.8 m -68.09 -27.56 66.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.25 1.42 . . . . 0.0 113.277 -172.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 64.5 -63.43 0.17 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.231 2.612 . . . . 0.0 114.895 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.6 p -149.08 146.99 27.99 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.249 1.819 . . . . 0.0 110.485 168.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.4 mt -74.08 -27.4 60.88 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.538 -0.726 . . . . 0.0 112.068 171.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -58.53 -36.21 73.51 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.227 1.011 . . . . 0.0 113.079 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.8 p -63.71 -20.01 65.39 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.5 mt -105.6 -2.44 23.48 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.034 1.733 . . . . 0.0 113.294 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.26 113.84 0.35 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.629 1.585 . . . . 0.0 112.578 -171.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.67 146.04 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.976 1.31 . . . . 0.0 111.676 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -145.71 174.74 10.94 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.672 1.589 . . . . 0.0 111.797 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -78.29 162.05 26.8 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.027 0.931 . . . . 0.0 110.903 162.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.67 14.81 81.68 Favored Glycine 0 CA--C 1.536 1.406 0 N-CA-C 115.844 1.098 . . . . 0.0 115.844 174.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.59 127.25 31.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.852 1.326 . . . . 0.0 110.613 165.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -129.03 130.4 46.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.882 1.273 . . . . 0.0 111.981 -166.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -125.51 133.24 52.44 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.798 1.639 . . . . 0.0 111.195 -170.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.6 t -118.1 129.54 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.814 1.245 . . . . 0.0 109.152 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.38 120.57 34.39 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.263 1.025 . . . . 0.0 110.108 -176.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.4 mt -116.19 130.03 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.82 1.248 . . . . 0.0 109.12 -172.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.8 p -120.02 158.46 26.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.19 1.396 . . . . 0.0 111.053 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 . . . . . 0 N--CA 1.475 0.787 0 C-N-CA 124.433 1.093 . . . . 0.0 111.37 -175.807 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptm . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -86.44 149.61 24.87 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.127 -1.608 . . . . 0.0 111.812 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.4 pt -130.74 166.08 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.764 2.025 . . . . 0.0 111.117 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -131.07 112.46 12.91 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.577 1.151 . . . . 0.0 110.079 170.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.3 tt -94.81 139.69 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 122.779 0.432 . . . . 0.0 110.652 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 t -126.92 81.43 69.63 Favored Pre-proline 0 N--CA 1.471 0.609 0 C-N-CA 125.247 1.419 . . . . 0.0 109.649 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.53 136.39 12.34 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.474 2.116 . . . . 0.0 112.473 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.83 41.1 0.15 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.133 1.373 . . . . 0.0 113.194 171.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.4 t -135.86 142.66 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.348 1.859 . . . . 0.0 110.35 -169.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.43 -116.5 9.44 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.949 0.785 . . . . 0.0 112.533 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.82 -14.9 68.38 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.212 0.911 . . . . 0.0 115.081 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.69 7.37 47.66 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 118.885 1.342 . . . . 0.0 115.929 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.6 m -94.43 155.48 39.65 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.696 1.598 . . . . 0.0 113.166 -170.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -63.01 147.23 94.74 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.212 2.608 . . . . 0.0 112.18 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 tt -138.75 122.61 17.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.414 1.486 . . . . 0.0 110.391 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -82.27 143.39 31.35 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.958 0.903 . . . . 0.0 112.783 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 tp -152.2 153.81 34.55 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.535 1.134 . . . . 0.0 111.657 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -85.22 150.43 24.8 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.374 -0.829 . . . . 0.0 111.338 163.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p -148.16 149.66 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.101 0.961 . . . . 0.0 111.643 174.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.06 149.91 98.23 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.992 0.917 . . . . 0.0 112.482 176.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.56 -21.09 46.57 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.278 2.652 . . . . 0.0 113.023 175.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -78.76 16.45 0.87 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.954 1.702 . . . . 0.0 113.648 175.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.35 121.94 10.04 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.391 1.076 . . . . 0.0 112.003 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.6 m -107.83 130.23 55.01 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.283 1.433 . . . . 0.0 109.861 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.1 t -58.94 -42.93 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.383 0.673 . . . . 0.0 111.637 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.77 -37.48 92.51 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.619 1.104 . . . . 0.0 113.578 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.02 -45.12 71.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.326 1.063 . . . . 0.0 111.705 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.32 -50.68 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.814 0.846 . . . . 0.0 111.581 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.27 -37.15 86.47 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.683 -0.636 . . . . 0.0 112.468 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.1 m -67.13 -42.03 85.14 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.522 0.601 . . . . 0.0 111.451 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -40.2 93.72 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.996 0.919 . . . . 0.0 111.887 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -62.18 -52.54 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.555 1.142 . . . . 0.0 111.502 172.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 88.3 m -62.24 -35.51 79.14 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.51 0.596 . . . . 0.0 112.23 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.64 86.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.404 1.081 . . . . 0.0 112.752 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -43.95 87.16 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.726 0.81 . . . . 0.0 112.365 174.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 36' ' ' LYS . 8.0 mmpt? -73.71 -20.48 60.52 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.704 1.202 . . . . 0.0 113.99 177.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? 55.92 27.84 11.69 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.59 1.956 . . . . 0.0 113.075 -170.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.24 154.74 70.25 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.486 1.914 . . . . 0.0 111.394 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.69 165.07 33.24 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.425 3.417 . . . . 0.0 114.225 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.34 -17.5 58.14 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.312 2.675 . . . . 0.0 114.091 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -64.64 -28.91 69.93 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.829 -1.169 . . . . 0.0 112.796 173.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.0 p -98.48 -14.05 20.23 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.271 1.428 . . . . 0.0 114.328 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 100.0 m -142.66 117.03 9.61 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 119.899 1.227 . . . . 0.0 111.919 174.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.5 167.74 10.62 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.003 1.721 . . . . 0.0 113.137 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 69' ' ' PHE . 43.8 tp -142.63 136.42 29.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.03 1.732 . . . . 0.0 111.372 -173.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.4 p -135.57 158.31 44.69 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.54 1.136 . . . . 0.0 113.213 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -147.62 130.39 16.08 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.3 2.24 . . . . 0.0 110.052 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? 50.67 31.36 5.75 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.323 1.449 . . . . 0.0 113.78 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.86 7.35 88.37 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.01 1.291 . . . . 0.0 115.96 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -120.54 158.97 26.16 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.581 1.552 . . . . 0.0 112.409 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.39 127.76 32.5 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.649 0.78 . . . . 0.0 110.534 165.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.7 mt -75.46 138.12 41.4 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.376 0.671 . . . . 0.0 110.762 169.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -163.28 142.5 8.46 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.427 1.491 . . . . 0.0 111.464 170.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t0 57.19 21.39 6.52 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.3 m -70.84 -26.92 63.49 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.857 1.263 . . . . 0.0 112.9 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 63.65 -56.0 0.21 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 128.619 2.767 . . . . 0.0 115.01 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.3 p -145.06 144.46 30.98 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.274 1.429 . . . . 0.0 111.48 170.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.4 -28.54 68.01 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.558 -0.714 . . . . 0.0 112.271 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -65.29 -26.87 68.26 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.362 -0.836 . . . . 0.0 113.167 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.5 t -63.07 -37.49 87.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.738 0.815 . . . . 0.0 112.614 172.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.0 mt -90.68 -10.33 43.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.936 1.294 . . . . 0.0 113.689 174.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.51 118.14 2.49 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 126.471 1.986 . . . . 0.0 112.545 -172.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.7 t -73.51 144.89 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.811 1.244 . . . . 0.0 111.219 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.06 156.55 38.04 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.635 1.574 . . . . 0.0 110.551 166.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -88.77 146.92 24.73 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.152 -0.967 . . . . 0.0 112.522 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.0 26.59 66.29 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.631 0.613 . . . . 0.0 114.631 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -61.8 140.11 58.27 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.499 1.149 . . . . 0.0 111.869 175.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -119.13 134.23 55.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.711 0.804 . . . . 0.0 112.581 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.55 ' HB3' HD11 ' A' ' 45' ' ' LEU . 17.6 m-85 -122.28 138.25 54.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.427 1.491 . . . . 0.0 110.755 -174.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.83 123.07 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.591 0.757 . . . . 0.0 110.594 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tp -97.92 134.97 40.32 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.4 1.08 . . . . 0.0 110.637 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.08 111.7 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.719 1.208 . . . . 0.0 109.711 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.4 t -90.74 152.39 20.83 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.83 1.252 . . . . 0.0 111.292 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 . . . . . 0 N--CA 1.476 0.835 0 C-N-CA 125.673 1.589 . . . . 0.0 111.004 172.862 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 121.188 0.518 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -114.05 149.02 36.08 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.195 1.398 . . . . 0.0 111.414 170.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -128.52 155.32 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.865 1.666 . . . . 0.0 110.047 173.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -118.86 93.81 4.23 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.854 1.262 . . . . 0.0 110.22 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 tt -79.71 140.47 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.783 -0.573 . . . . 0.0 110.743 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.7 t -131.51 82.31 61.97 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 125.261 1.425 . . . . 0.0 109.842 -172.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.39 136.45 9.94 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.631 2.22 . . . . 0.0 113.098 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.96 39.22 0.18 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.592 1.557 . . . . 0.0 113.564 172.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.6 t -137.99 145.87 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.987 1.715 . . . . 0.0 110.691 -171.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.44 -119.58 17.33 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.054 0.835 . . . . 0.0 112.429 176.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.9 -14.42 67.87 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 124.088 0.851 . . . . 0.0 114.903 175.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.27 6.22 46.23 Favored Glycine 0 CA--C 1.541 1.71 0 CA-C-N 118.812 1.306 . . . . 0.0 115.87 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.2 m -90.83 153.57 45.35 Favored Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 125.369 1.468 . . . . 0.0 113.334 -171.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -66.25 152.98 79.79 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 123.403 2.735 . . . . 0.0 112.646 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 tp -140.1 118.72 12.32 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.427 1.491 . . . . 0.0 111.586 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -69.51 137.56 52.61 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.436 1.094 . . . . 0.0 111.575 169.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.3 tp -150.64 136.9 18.6 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.532 1.133 . . . . 0.0 111.51 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.02 143.33 43.6 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.612 0.765 . . . . 0.0 111.626 171.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.17 147.95 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.232 1.013 . . . . 0.0 112.1 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.79 150.89 95.28 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.143 0.977 . . . . 0.0 112.537 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.58 -27.12 53.67 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.043 2.496 . . . . 0.0 113.048 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -77.35 14.39 0.97 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.398 1.479 . . . . 0.0 114.134 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.13 100.29 0.32 Allowed 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.844 -1.16 . . . . 0.0 112.212 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.7 t -73.62 148.77 42.54 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.427 1.091 . . . . 0.0 110.858 168.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.6 m -57.75 -31.55 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.85 0.86 . . . . 0.0 112.485 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.33 -41.78 99.37 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.576 0.608 . . . . 0.0 112.732 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.2 -44.82 82.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.771 0.828 . . . . 0.0 111.75 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.2 t -62.98 -49.46 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.879 0.871 . . . . 0.0 110.924 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -35.92 78.26 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.853 1.261 . . . . 0.0 112.369 -177.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.6 m -66.79 -45.44 78.44 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.551 0.74 . . . . 0.0 111.435 172.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -63.18 -39.28 94.19 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.702 0.683 . . . . 0.0 111.928 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -56.94 -52.0 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.51 1.124 . . . . 0.0 111.385 170.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 51.8 t -60.86 -42.78 98.52 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.123 0.569 . . . . 0.0 112.207 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.23 -40.72 86.37 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.972 0.909 . . . . 0.0 113.254 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.8 tpp -67.73 -44.07 78.46 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.808 1.243 . . . . 0.0 112.094 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -76.63 -24.03 53.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.691 0.796 . . . . 0.0 113.043 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.3 ttpp 59.67 27.25 16.45 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.457 2.303 . . . . 0.0 114.144 -173.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.01 154.49 81.38 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 126.192 1.797 . . . . 0.0 112.033 -175.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.81 159.95 50.98 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.904 3.069 . . . . 0.0 113.974 -171.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.57 -10.24 28.46 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.269 3.312 . . . . 0.0 114.978 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -73.46 -21.56 60.41 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.195 -0.941 . . . . 0.0 112.601 167.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.9 m -108.48 -37.26 6.0 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.018 1.327 . . . . 0.0 112.844 -172.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.2 t -97.52 139.09 33.97 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.69 0.796 . . . . 0.0 111.728 170.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -136.54 154.11 50.81 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.592 1.557 . . . . 0.0 111.476 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.8 tp -138.23 132.9 32.5 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.472 1.509 . . . . 0.0 111.217 -171.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.2 p -140.17 155.12 47.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.26 1.024 . . . . 0.0 113.526 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -149.01 131.64 15.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.788 2.035 . . . . 0.0 110.302 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.0 tptt 54.27 29.05 10.04 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.166 1.386 . . . . 0.0 114.319 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.73 3.33 87.11 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.382 1.468 . . . . 0.0 115.562 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -112.55 161.26 16.97 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.821 2.048 . . . . 0.0 111.334 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.03 142.25 28.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.61 0.764 . . . . 0.0 110.64 161.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.16 118.82 34.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.134 0.974 . . . . 0.0 111.053 172.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.39 145.72 22.97 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.489 1.516 . . . . 0.0 111.109 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 54.63 23.52 4.77 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.589 1.956 . . . . 0.0 116.137 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 p -75.94 -24.02 55.46 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 120.818 -1.176 . . . . 0.0 113.69 -176.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 63.79 -40.15 0.21 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 128.739 2.816 . . . . 0.0 115.122 -172.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 t -152.22 154.6 36.1 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.188 1.795 . . . . 0.0 111.656 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.66 -25.14 68.08 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.211 1.005 . . . . 0.0 112.899 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.92 -27.84 69.42 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.3 m -65.0 -28.04 69.23 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.994 0.918 . . . . 0.0 112.963 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 mp -96.71 -10.06 27.71 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.468 1.507 . . . . 0.0 112.745 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.5 28.9 74.07 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.43 1.014 . . . . 0.0 114.468 177.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.8 m -65.97 151.79 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.515 1.126 . . . . 0.0 113.949 -170.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.08 179.07 7.03 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.238 1.415 . . . . 0.0 112.657 173.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -73.58 152.04 40.71 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 121.112 -0.992 . . . . 0.0 111.631 165.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.37 29.23 53.82 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 115.856 1.103 . . . . 0.0 115.856 172.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -62.11 155.33 24.54 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.772 1.286 . . . . 0.0 112.263 172.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -125.81 136.62 53.33 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.877 0.871 . . . . 0.0 112.347 173.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -122.23 133.53 54.71 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.855 1.262 . . . . 0.0 110.548 -173.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.9 t -103.24 129.42 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.209 0.603 . . . . 0.0 110.338 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 tp -105.57 131.17 53.29 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.087 0.955 . . . . 0.0 110.572 172.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -115.84 146.32 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.621 1.569 . . . . 0.0 109.53 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.6 t -127.34 164.94 20.69 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.167 1.387 . . . . 0.0 112.085 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 . . . . . 0 N--CA 1.475 0.777 0 C-N-CA 126.964 2.106 . . . . 0.0 110.44 -179.037 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 mmt . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.0 140.23 45.34 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.469 -1.395 . . . . 0.0 111.145 160.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pp -131.01 166.58 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.657 1.983 . . . . 0.0 110.311 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -120.99 102.66 8.48 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.458 1.103 . . . . 0.0 110.795 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.6 tt -77.84 143.14 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.859 -0.525 . . . . 0.0 110.067 173.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.5 79.93 72.61 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 124.824 1.249 . . . . 0.0 109.551 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.39 134.27 15.39 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.723 2.949 . . . . 0.0 112.32 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.32 28.76 0.15 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.558 1.543 . . . . 0.0 114.377 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.1 m -138.39 162.89 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 126.181 1.792 . . . . 0.0 111.699 -176.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.76 -128.78 35.32 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 123.602 0.62 . . . . 0.0 111.806 -175.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.73 -15.1 73.31 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 174.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.74 -1.09 54.85 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 124.97 1.271 . . . . 0.0 115.798 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -71.69 151.79 93.48 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 125.278 1.431 . . . . 0.0 113.195 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -64.17 150.54 88.11 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.716 2.278 . . . . 0.0 111.448 166.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.7 tp -142.8 132.86 24.39 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.252 1.021 . . . . 0.0 111.961 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -78.23 133.85 37.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.123 0.969 . . . . 0.0 112.335 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mp -139.82 143.6 36.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.479 1.512 . . . . 0.0 110.763 169.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -81.1 136.42 35.92 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.519 0.728 . . . . 0.0 110.26 166.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.8 142.67 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.733 0.813 . . . . 0.0 112.154 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.29 147.94 96.48 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.864 0.866 . . . . 0.0 112.498 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.49 -19.61 65.28 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.444 2.763 . . . . 0.0 113.67 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -78.91 4.65 13.55 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.868 1.667 . . . . 0.0 114.659 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 124.83 21.5 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.568 1.076 . . . . 0.0 112.649 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.2 m -107.89 138.58 43.89 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.557 1.543 . . . . 0.0 111.305 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.0 t -56.62 -47.29 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.023 0.929 . . . . 0.0 112.547 -175.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.5 -41.5 98.71 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.429 0.537 . . . . 0.0 112.926 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.13 -45.74 79.99 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.006 0.903 . . . . 0.0 112.139 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.48 -52.84 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.9 0.88 . . . . 0.0 110.849 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -62.33 -45.68 92.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.903 0.881 . . . . 0.0 111.606 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 84.6 m -61.17 -41.34 96.6 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.359 0.663 . . . . 0.0 111.917 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -63.43 -40.68 97.83 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.003 0.819 . . . . 0.0 112.416 176.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.6 t -67.68 -43.75 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.201 0.91 . . . . 0.0 111.53 174.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 93.9 m -56.88 -43.1 80.93 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.478 1.036 . . . . 0.0 112.081 174.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.19 89.09 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.111 0.964 . . . . 0.0 112.803 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.3 tpt -67.83 -39.59 83.87 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.869 0.868 . . . . 0.0 112.496 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -19.02 56.42 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.28 1.432 . . . . 0.0 113.916 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt 58.28 29.05 17.5 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.733 2.013 . . . . 0.0 113.328 -169.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mp -128.08 154.83 78.61 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 126.275 1.83 . . . . 0.0 111.82 -174.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.37 165.33 32.05 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 124.399 3.4 . . . . 0.0 115.102 -171.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -63.15 -15.85 50.69 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.644 2.896 . . . . 0.0 113.928 170.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -68.66 -21.16 64.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.236 1.014 . . . . 0.0 113.136 171.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.9 p -114.86 -38.73 3.86 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.051 1.34 . . . . 0.0 113.183 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 81.7 m -92.84 124.67 37.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.29 1.436 . . . . 0.0 111.001 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -149.27 146.22 27.46 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -171.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.18 148.08 34.81 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.245 1.818 . . . . 0.0 111.91 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.0 m -143.04 143.15 31.77 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.834 1.654 . . . . 0.0 111.836 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -144.49 133.54 22.75 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.357 1.863 . . . . 0.0 110.635 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? 52.78 30.49 9.05 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.805 1.242 . . . . 0.0 113.488 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.31 16.57 78.73 Favored Glycine 0 CA--C 1.54 1.627 0 C-N-CA 124.852 1.215 . . . . 0.0 115.218 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 -135.68 155.32 50.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.526 1.93 . . . . 0.0 111.757 -173.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.01 132.32 44.11 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.634 -0.666 . . . . 0.0 111.775 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.35 127.62 37.9 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.58 1.152 . . . . 0.0 109.86 167.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -164.46 147.32 8.94 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.802 1.641 . . . . 0.0 111.162 174.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 56.1 23.96 7.42 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.3 p -75.39 -17.79 60.11 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 120.859 -1.15 . . . . 0.0 113.478 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 61.64 -56.09 0.12 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 128.408 2.683 . . . . 0.0 114.144 -166.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.5 p -147.53 157.51 43.59 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.781 1.632 . . . . 0.0 111.048 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.27 -32.82 74.46 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.459 -0.776 . . . . 0.0 111.304 168.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -63.06 -31.55 72.72 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.407 -0.808 . . . . 0.0 113.074 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.2 t -64.89 -23.88 67.36 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.113 0.965 . . . . 0.0 113.325 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.4 mt -106.31 -33.31 7.81 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.091 1.357 . . . . 0.0 113.486 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.41 85.9 0.19 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.098 1.808 . . . . 0.0 111.739 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.9 p -72.87 146.93 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.556 1.142 . . . . 0.0 112.181 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -149.85 -179.45 7.15 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.347 1.459 . . . . 0.0 112.178 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -97.68 150.06 21.6 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.807 1.643 . . . . 0.0 111.741 167.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.74 5.14 90.07 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.77 1.176 . . . . 0.0 115.545 176.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -61.23 145.64 50.52 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.357 1.079 . . . . 0.0 110.755 170.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.87 134.2 46.58 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -171.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -125.1 113.8 18.21 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.417 1.087 . . . . 0.0 110.64 -169.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -83.58 128.9 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.49 0.716 . . . . 0.0 109.704 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.5 tp -113.04 118.37 34.6 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.371 1.468 . . . . 0.0 109.421 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.1 pt -110.27 154.43 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.89 1.276 . . . . 0.0 111.993 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -139.16 165.73 26.38 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.644 1.577 . . . . 0.0 111.298 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.7 ttt85 . . . . . 0 N--CA 1.473 0.696 0 C-N-CA 125.551 1.541 . . . . 0.0 111.016 -168.289 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -80.68 142.65 33.72 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.049 -1.657 . . . . 0.0 112.476 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.9 pt -131.3 162.29 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 127.103 2.161 . . . . 0.0 110.415 170.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -123.88 92.74 3.74 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.035 1.334 . . . . 0.0 110.627 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.5 tt -78.71 141.13 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 122.13 -0.356 . . . . 0.0 110.356 174.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.8 t -130.6 79.82 71.32 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.383 1.473 . . . . 0.0 109.426 -174.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.85 137.03 13.75 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.253 1.969 . . . . 0.0 112.509 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.0 41.53 0.16 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.718 1.607 . . . . 0.0 112.63 170.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -139.14 142.51 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.539 1.936 . . . . 0.0 109.907 -167.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.48 -115.15 7.51 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 123.754 0.692 . . . . 0.0 112.479 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.44 -18.16 71.36 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.127 0.87 . . . . 0.0 114.972 176.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.95 6.45 56.33 Favored Glycine 0 CA--C 1.541 1.68 0 CA-C-N 118.737 1.268 . . . . 0.0 115.627 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.1 p -95.34 158.91 33.89 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.485 1.914 . . . . 0.0 113.561 -169.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.49 143.25 75.03 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.163 2.575 . . . . 0.0 112.115 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.5 mt -131.28 115.83 16.81 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.017 1.727 . . . . 0.0 110.515 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -74.4 125.58 28.83 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.836 0.855 . . . . 0.0 111.238 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt -138.17 149.05 45.49 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.606 1.563 . . . . 0.0 111.119 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -97.13 130.3 44.41 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.837 1.255 . . . . 0.0 110.156 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.9 149.71 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.922 1.289 . . . . 0.0 112.903 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.11 153.56 88.9 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.8 1.24 . . . . 0.0 112.471 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.13 -25.25 50.95 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.306 2.67 . . . . 0.0 113.635 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -80.51 37.57 0.41 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.013 1.725 . . . . 0.0 112.985 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.06 67.73 3.96 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.981 1.713 . . . . 0.0 112.622 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 55.9 m -63.76 141.34 58.8 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.683 1.193 . . . . 0.0 112.275 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.1 t -60.07 -44.09 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.072 0.949 . . . . 0.0 112.161 -174.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.98 -36.4 92.18 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.498 0.57 . . . . 0.0 113.231 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.93 -50.33 64.79 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 117.992 0.896 . . . . 0.0 111.796 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.2 p -66.78 -36.86 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.867 0.758 . . . . 0.0 112.046 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -59.06 -48.1 82.84 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.475 1.11 . . . . 0.0 111.837 173.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.2 m -66.47 -39.9 89.05 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.375 0.67 . . . . 0.0 112.099 175.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -44.48 96.96 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.893 0.877 . . . . 0.0 111.755 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.9 t -61.48 -48.33 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.136 1.374 . . . . 0.0 111.362 172.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.6 -44.53 93.36 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.458 0.703 . . . . 0.0 111.967 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.49 88.51 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.204 1.002 . . . . 0.0 112.924 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.5 ttm -65.76 -43.5 88.69 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.534 1.133 . . . . 0.0 112.232 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -75.38 -29.53 59.87 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.846 1.258 . . . . 0.0 113.394 177.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.2 tptm 57.41 31.29 19.97 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.746 2.018 . . . . 0.0 113.098 -169.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.52 151.16 56.81 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 126.316 1.846 . . . . 0.0 111.082 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.88 159.18 51.19 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.943 3.095 . . . . 0.0 113.594 -173.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.17 -13.07 35.74 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.99 3.127 . . . . 0.0 114.778 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -66.29 -22.25 66.29 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.136 -0.978 . . . . 0.0 113.355 170.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.2 p -103.07 -25.84 13.27 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.71 1.204 . . . . 0.0 113.709 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.1 m -140.07 126.87 20.6 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.954 1.301 . . . . 0.0 110.928 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -134.44 166.61 22.45 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.125 1.37 . . . . 0.0 112.897 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 69' ' ' PHE . 39.4 tp -137.07 135.33 37.41 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.455 1.502 . . . . 0.0 111.497 -168.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.5 p -136.49 158.54 44.19 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.491 1.116 . . . . 0.0 112.519 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -139.09 128.73 24.6 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.606 2.363 . . . . 0.0 109.701 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.62 31.97 11.01 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.643 1.177 . . . . 0.0 113.515 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.94 8.79 87.63 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 124.945 1.26 . . . . 0.0 115.943 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -122.01 151.1 41.18 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.404 1.881 . . . . 0.0 112.261 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.12 126.24 30.52 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.85 -0.531 . . . . 0.0 110.46 165.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.2 mt -74.41 137.65 42.83 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.579 0.752 . . . . 0.0 110.726 170.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.24 140.4 7.5 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.117 1.367 . . . . 0.0 111.335 170.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t0 55.72 26.45 9.43 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.957 1.703 . . . . 0.0 115.191 175.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.9 m -78.03 -15.19 59.13 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.016 1.326 . . . . 0.0 113.732 -171.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 59.4 -70.84 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.601 2.361 . . . . 0.0 114.441 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.2 p -146.38 154.23 41.4 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.158 1.383 . . . . 0.0 111.97 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.22 -20.37 60.88 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.768 -0.583 . . . . 0.0 112.391 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.66 -30.72 71.59 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.192 -0.942 . . . . 0.0 112.659 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.0 t -63.59 -24.3 67.74 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.63 0.772 . . . . 0.0 112.762 173.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.4 mt -92.68 -12.42 31.54 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.46 1.504 . . . . 0.0 113.304 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.54 17.15 64.13 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.185 1.374 . . . . 0.0 115.014 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.1 p -76.44 145.0 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.778 1.231 . . . . 0.0 113.424 -169.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.6 -177.29 5.76 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.869 1.667 . . . . 0.0 113.774 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -68.47 164.4 21.21 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.299 1.44 . . . . 0.0 113.214 172.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.83 11.62 60.16 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.587 1.089 . . . . 0.0 115.033 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -62.19 143.83 56.27 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.436 1.118 . . . . 0.0 111.552 171.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -127.18 132.64 50.44 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.101 0.96 . . . . 0.0 112.235 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.459 ' HB3' HD11 ' A' ' 45' ' ' LEU . 6.9 m-85 -125.27 132.61 52.9 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.866 1.266 . . . . 0.0 109.944 -171.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 p -110.73 120.73 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.024 0.829 . . . . 0.0 111.123 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.99 121.11 40.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.954 1.302 . . . . 0.0 109.136 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.0 tt -119.7 131.07 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.447 1.099 . . . . 0.0 111.063 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.6 t -114.61 150.87 34.4 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.309 1.844 . . . . 0.0 111.353 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 . . . . . 0 N--CA 1.471 0.606 0 C-N-CA 126.179 1.792 . . . . 0.0 109.959 172.984 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.28 0.562 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -108.98 141.68 40.74 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.074 1.35 . . . . 0.0 111.331 174.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.0 pt -121.56 163.05 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.07 1.748 . . . . 0.0 110.457 170.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -125.69 105.57 9.09 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.15 0.98 . . . . 0.0 110.875 174.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.4 mt -86.79 137.88 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -126.0 76.25 71.6 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 124.951 1.3 . . . . 0.0 110.086 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.97 136.59 16.68 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.92 2.413 . . . . 0.0 111.261 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.25 31.91 0.1 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.627 1.571 . . . . 0.0 114.173 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.5 t -139.52 147.67 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 126.62 1.968 . . . . 0.0 109.871 -171.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.5 30.75 70.97 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 121.642 -0.661 . . . . 0.0 114.543 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.65 -8.36 40.02 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.615 1.578 . . . . 0.0 115.11 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.32 5.36 76.91 Favored Glycine 0 CA--C 1.54 1.637 0 N-CA-C 116.355 1.302 . . . . 0.0 116.355 170.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.9 m -75.14 150.32 85.41 Favored Pre-proline 0 N--CA 1.475 0.804 0 CA-C-N 118.649 1.225 . . . . 0.0 113.432 -174.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.77 145.7 76.03 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.378 2.719 . . . . 0.0 111.898 169.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.1 mt -131.71 111.72 11.92 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.725 1.61 . . . . 0.0 110.492 178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -79.27 134.22 36.64 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.355 1.062 . . . . 0.0 111.807 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 tt -152.43 141.98 21.76 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.347 1.059 . . . . 0.0 112.349 -175.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -80.93 133.92 35.63 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.659 1.184 . . . . 0.0 112.289 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -139.1 155.51 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.878 1.271 . . . . 0.0 113.01 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.75 152.45 91.31 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.623 1.169 . . . . 0.0 112.271 172.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.02 -19.05 57.85 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.365 2.71 . . . . 0.0 113.419 174.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -78.76 5.77 10.5 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.643 1.577 . . . . 0.0 114.117 176.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.37 130.52 47.11 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.391 0.996 . . . . 0.0 112.284 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.9 m -109.7 134.73 51.65 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.47 1.508 . . . . 0.0 110.874 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.32 -40.94 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.073 0.949 . . . . 0.0 112.31 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.61 -34.93 91.0 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 123.775 0.702 . . . . 0.0 113.5 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.87 -43.23 75.79 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.339 1.07 . . . . 0.0 111.645 174.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.9 t -61.27 -46.67 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.005 0.922 . . . . 0.0 111.138 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -56.49 -51.42 68.56 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.542 1.137 . . . . 0.0 111.735 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.4 m -60.16 -42.03 94.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.505 0.722 . . . . 0.0 111.818 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.67 -50.76 72.7 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.949 0.9 . . . . 0.0 111.239 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.4 t -68.21 -41.37 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.412 0.685 . . . . 0.0 112.132 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 95.9 m -59.67 -40.41 87.7 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.335 0.971 . . . . 0.0 112.202 173.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.57 -41.99 78.95 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.55 0.74 . . . . 0.0 112.77 174.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 84.2 mtp -66.37 -39.73 89.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.353 1.061 . . . . 0.0 112.871 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -84.46 -18.27 36.44 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.718 1.207 . . . . 0.0 113.86 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp 57.75 30.03 18.31 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.457 1.903 . . . . 0.0 113.728 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.92 150.49 43.56 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 126.129 1.771 . . . . 0.0 111.141 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.64 159.85 50.75 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 123.713 2.942 . . . . 0.0 112.796 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.07 -9.89 26.67 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 124.007 3.138 . . . . 0.0 115.063 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -80.12 -36.16 35.69 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.193 1.397 . . . . 0.0 113.296 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 34.6 p -85.81 8.13 21.2 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.203 1.401 . . . . 0.0 113.827 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.0 t -144.2 142.72 30.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.679 1.591 . . . . 0.0 111.972 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 -141.02 148.51 40.39 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.465 1.506 . . . . 0.0 112.658 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.7 tp -127.48 129.41 47.38 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.008 2.123 . . . . 0.0 110.108 -177.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.8 p -140.06 155.52 47.0 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.41 1.084 . . . . 0.0 112.516 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -145.0 138.69 26.95 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.168 1.787 . . . . 0.0 110.167 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp 54.13 30.4 12.03 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.935 1.294 . . . . 0.0 114.062 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.96 16.85 80.33 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.037 1.304 . . . . 0.0 115.259 -175.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -134.13 150.86 51.16 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.085 1.754 . . . . 0.0 112.252 -171.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.1 115.95 20.79 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.945 0.898 . . . . 0.0 110.962 172.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.2 mp -86.35 131.96 34.08 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.38 1.072 . . . . 0.0 110.297 171.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.78 149.91 11.45 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.388 1.475 . . . . 0.0 110.903 171.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.7 t0 55.77 27.66 11.13 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.732 1.613 . . . . 0.0 115.073 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.6 p -78.85 -22.02 46.72 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.985 1.314 . . . . 0.0 113.523 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 62.34 -53.26 0.15 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 128.51 2.724 . . . . 0.0 115.005 -170.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 61.4 p -144.71 152.31 40.22 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.726 1.61 . . . . 0.0 111.599 172.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.7 mt -70.28 -36.27 74.27 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.344 0.658 . . . . 0.0 111.79 172.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.91 -33.67 76.23 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.6 m -68.45 -26.49 65.53 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 66.3 mt -99.29 -26.72 14.07 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.531 1.132 . . . . 0.0 113.471 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 130.76 83.93 0.3 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.839 1.685 . . . . 0.0 111.946 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.68 148.49 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.641 1.177 . . . . 0.0 111.662 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.29 158.26 43.78 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.216 1.406 . . . . 0.0 111.922 176.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -73.35 142.65 47.05 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.336 1.054 . . . . 0.0 111.69 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.91 19.55 78.7 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.414 0.926 . . . . 0.0 115.414 174.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.61 136.94 57.75 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.849 1.324 . . . . 0.0 111.384 171.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -132.9 132.11 41.68 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -172.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -119.7 97.67 5.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.251 1.421 . . . . 0.0 110.405 -161.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.65 137.47 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.889 -0.507 . . . . 0.0 110.45 174.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tt -139.47 109.0 6.18 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.623 0.769 . . . . 0.0 110.179 -170.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.3 tt -101.94 142.6 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.998 1.319 . . . . 0.0 111.348 -173.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.4 p -130.29 157.05 43.58 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.22 1.408 . . . . 0.0 110.46 173.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 . . . . . 0 N--CA 1.479 0.992 0 C-N-CA 123.87 0.868 . . . . 0.0 112.172 178.879 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mmt . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 121.347 0.594 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -68.59 148.67 50.17 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.976 0.91 . . . . 0.0 112.28 165.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.4 mm -142.23 143.62 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 128.034 2.534 . . . . 0.0 109.176 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -100.4 144.28 29.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.194 0.997 . . . . 0.0 111.056 162.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.7 tt -133.72 134.52 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.443 1.097 . . . . 0.0 110.474 167.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 p -123.34 103.12 35.84 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.592 1.157 . . . . 0.0 110.679 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -92.89 140.69 1.89 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.721 2.28 . . . . 0.0 112.255 176.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.17 48.36 0.61 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.463 1.505 . . . . 0.0 113.522 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 p -154.34 155.3 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.437 1.495 . . . . 0.0 111.529 -172.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.93 -112.4 4.64 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.704 0.669 . . . . 0.0 112.671 174.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.13 -19.85 72.43 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 124.082 0.848 . . . . 0.0 114.799 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.24 32.85 82.18 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 118.782 1.291 . . . . 0.0 114.448 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 t -144.68 145.6 28.84 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.163 1.385 . . . . 0.0 112.103 -162.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -60.51 140.38 91.07 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.526 2.818 . . . . 0.0 113.096 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.0 tp -124.9 134.06 52.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.343 1.857 . . . . 0.0 110.44 175.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -82.79 135.05 35.08 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.676 0.791 . . . . 0.0 110.752 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.3 mt -142.21 175.09 10.02 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.873 2.069 . . . . 0.0 110.872 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -136.41 134.6 37.94 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.613 1.565 . . . . 0.0 109.962 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 m -136.03 155.19 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.136 0.974 . . . . 0.0 113.0 -173.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.24 149.87 73.33 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.853 0.861 . . . . 0.0 111.675 169.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -64.93 -21.64 63.74 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.287 2.658 . . . . 0.0 112.865 172.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -74.06 -0.94 18.03 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.925 1.69 . . . . 0.0 114.134 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.66 121.18 10.38 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.287 0.948 . . . . 0.0 111.814 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.0 p -86.16 150.73 24.2 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.773 0.829 . . . . 0.0 111.502 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.3 t -64.39 -36.6 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.812 -0.555 . . . . 0.0 110.647 173.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.35 -51.4 57.86 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.083 0.849 . . . . 0.0 112.74 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.75 93.13 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.004 0.902 . . . . 0.0 112.865 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.5 t -63.93 -47.29 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 121.833 -0.542 . . . . 0.0 111.013 175.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -63.18 -42.4 99.37 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.273 1.029 . . . . 0.0 112.074 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.8 p -69.63 -38.16 77.1 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 118.329 -0.843 . . . . 0.0 112.582 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -61.95 -43.97 97.74 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.898 1.226 . . . . 0.0 111.844 172.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.2 t -61.53 -48.27 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.832 0.742 . . . . 0.0 111.477 175.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.3 t -59.24 -44.57 92.36 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.938 0.895 . . . . 0.0 111.876 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.63 -40.93 80.12 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.255 1.022 . . . . 0.0 112.951 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 59.3 ttp -71.35 -41.04 70.26 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.14 1.376 . . . . 0.0 112.989 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -82.51 -14.59 54.71 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp 58.34 29.93 18.86 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.708 2.003 . . . . 0.0 112.995 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.2 mt -141.02 147.92 49.81 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.877 1.671 . . . . 0.0 112.378 -168.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.95 161.05 47.4 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.222 3.281 . . . . 0.0 114.582 -171.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -66.05 -16.01 50.73 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.763 2.975 . . . . 0.0 114.71 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -67.58 -45.49 75.4 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.946 -1.096 . . . . 0.0 111.756 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.2 t -88.36 -22.59 23.72 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.195 1.398 . . . . 0.0 112.955 -174.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.6 m -127.82 119.12 25.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.453 1.501 . . . . 0.0 112.204 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -133.06 160.9 35.84 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.345 1.858 . . . . 0.0 113.202 -173.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.1 tp -134.94 138.86 44.45 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.785 2.034 . . . . 0.0 110.854 -172.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.3 m -139.22 146.09 40.06 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.43 1.492 . . . . 0.0 111.388 -176.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -142.56 134.6 27.26 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.499 1.519 . . . . 0.0 110.226 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 tptm 52.91 32.69 13.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.159 1.383 . . . . 0.0 113.407 -176.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.45 14.53 74.7 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 124.495 1.045 . . . . 0.0 115.34 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.41 141.95 51.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.685 1.994 . . . . 0.0 111.4 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.45 125.84 31.54 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.874 0.87 . . . . 0.0 110.348 167.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.0 mp -82.13 138.66 34.71 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.684 0.794 . . . . 0.0 110.354 172.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 136.76 6.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.725 1.61 . . . . 0.0 110.289 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.3 t0 55.61 26.92 9.75 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.577 1.551 . . . . 0.0 114.471 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 m -78.19 -29.39 48.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.839 1.256 . . . . 0.0 113.782 -169.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 62.24 -36.59 0.12 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 128.692 2.797 . . . . 0.0 117.554 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 t -156.01 146.29 21.6 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.292 1.437 . . . . 0.0 111.123 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.27 -18.13 64.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.882 0.873 . . . . 0.0 112.86 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -68.35 -19.95 64.68 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 171.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.1 t -69.46 -41.1 76.65 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.968 0.907 . . . . 0.0 112.017 178.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.8 mp -82.47 -14.56 54.84 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.843 1.257 . . . . 0.0 112.82 170.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.99 37.25 91.98 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.475 1.036 . . . . 0.0 113.364 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.6 m -64.56 152.97 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.313 1.045 . . . . 0.0 113.802 -168.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.86 -178.38 6.83 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.197 1.399 . . . . 0.0 112.965 174.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -80.34 153.07 28.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.609 1.163 . . . . 0.0 112.231 165.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.6 26.12 61.65 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 115.351 0.9 . . . . 0.0 115.351 173.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -61.55 156.46 19.59 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.278 1.039 . . . . 0.0 112.769 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -124.7 108.66 12.23 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.175 1.39 . . . . 0.0 111.132 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -93.58 144.71 25.12 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.272 1.429 . . . . 0.0 110.998 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.0 m -124.47 133.49 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.139 0.976 . . . . 0.0 110.767 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.58 131.98 56.49 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.439 1.096 . . . . 0.0 110.781 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.64 136.59 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.948 1.699 . . . . 0.0 108.936 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.0 t -142.8 129.05 19.88 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.859 0.864 . . . . 0.0 111.408 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.1 mmt-85 . . . . . 0 N--CA 1.476 0.835 0 C-N-CA 125.851 1.66 . . . . 0.0 112.325 178.676 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ttt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -130.07 153.07 48.83 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.39 1.476 . . . . 0.0 111.917 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -133.1 158.82 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 126.8 2.04 . . . . 0.0 110.807 173.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -103.42 147.88 26.58 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.587 1.555 . . . . 0.0 110.036 164.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.2 tt -135.93 135.38 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.148 0.979 . . . . 0.0 110.396 169.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.6 p -128.26 96.75 30.27 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.82 1.248 . . . . 0.0 111.042 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -81.74 138.96 10.86 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.342 2.695 . . . . 0.0 111.683 170.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.98 40.31 0.15 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.586 1.554 . . . . 0.0 112.968 170.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.3 t -138.73 144.38 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.364 1.866 . . . . 0.0 110.037 -169.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.95 -112.4 4.79 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.965 0.793 . . . . 0.0 112.141 175.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.83 -16.8 68.62 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.223 0.916 . . . . 0.0 115.046 175.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.55 20.71 66.15 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 118.747 1.274 . . . . 0.0 115.362 171.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.4 m -129.35 153.58 80.55 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 125.6 1.56 . . . . 0.0 112.962 -164.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.92 146.19 82.14 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.293 2.662 . . . . 0.0 113.384 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.4 mt -132.5 138.4 47.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.418 1.887 . . . . 0.0 111.094 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -78.75 135.67 37.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.987 1.315 . . . . 0.0 111.87 172.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mp -142.96 150.8 40.17 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.882 1.273 . . . . 0.0 111.925 169.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -85.38 143.92 28.34 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.963 0.905 . . . . 0.0 110.471 160.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.17 148.96 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.503 1.521 . . . . 0.0 110.994 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.72 149.9 88.38 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.69 0.796 . . . . 0.0 111.658 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.42 -19.03 61.31 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.02 2.48 . . . . 0.0 112.927 171.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -77.92 -0.74 28.7 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.029 1.732 . . . . 0.0 114.441 171.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.06 142.66 56.48 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 119.415 1.007 . . . . 0.0 111.055 172.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.11 152.01 40.33 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.412 1.085 . . . . 0.0 111.411 -175.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -60.94 -32.91 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 121.566 -0.709 . . . . 0.0 112.433 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.9 -50.26 59.0 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 123.96 0.791 . . . . 0.0 111.917 173.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.4 -40.11 95.42 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.091 0.956 . . . . 0.0 112.73 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.1 t -63.02 -49.6 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.661 -0.649 . . . . 0.0 110.525 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -63.36 -45.33 91.69 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 121.566 -0.709 . . . . 0.0 112.467 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.5 p -67.75 -37.61 82.38 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.479 1.036 . . . . 0.0 112.161 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -58.1 -47.19 83.98 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.265 0.939 . . . . 0.0 111.024 172.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.9 t -63.44 -47.35 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.325 1.05 . . . . 0.0 111.414 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 93.8 m -61.63 -41.83 98.04 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.24 85.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.839 0.856 . . . . 0.0 113.113 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.5 ttt -66.64 -41.18 88.69 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.283 1.033 . . . . 0.0 112.486 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -74.9 -24.21 58.49 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.434 1.094 . . . . 0.0 113.352 172.584 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt 59.09 28.51 17.81 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.385 2.274 . . . . 0.0 113.912 -167.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 mp -116.35 155.44 48.44 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.14 1.776 . . . . 0.0 111.634 -177.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.69 157.72 60.7 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 123.52 2.813 . . . . 0.0 112.437 178.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.48 -25.34 63.06 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.402 2.735 . . . . 0.0 114.406 -173.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -71.64 -17.59 62.25 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.696 1.134 . . . . 0.0 113.634 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.2 m -84.45 -1.04 55.02 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.684 -1.26 . . . . 0.0 112.993 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.3 t -136.13 158.01 45.45 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.49 1.516 . . . . 0.0 112.244 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -141.79 140.12 32.94 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.029 1.732 . . . . 0.0 111.2 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.5 tp -113.31 130.84 56.15 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.433 1.893 . . . . 0.0 110.143 173.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.3 p -136.8 155.63 49.57 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.956 0.902 . . . . 0.0 112.428 172.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -151.74 135.13 16.06 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.303 1.841 . . . . 0.0 110.11 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.92 35.96 20.54 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.215 1.406 . . . . 0.0 113.353 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.83 15.91 79.44 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 124.48 1.038 . . . . 0.0 115.212 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -129.58 151.9 49.69 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.643 1.977 . . . . 0.0 111.637 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.08 135.26 38.59 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.862 -0.524 . . . . 0.0 109.673 160.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.7 tp -107.98 115.89 30.96 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.899 0.88 . . . . 0.0 109.865 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -150.1 141.13 22.97 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.915 1.286 . . . . 0.0 111.613 -169.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.6 t0 54.95 26.46 7.96 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.864 1.665 . . . . 0.0 114.836 174.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.4 p -75.28 -26.52 58.83 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.133 1.373 . . . . 0.0 113.005 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 64.04 -46.7 0.28 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 129.015 2.926 . . . . 0.0 114.892 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -152.94 139.01 18.21 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.35 1.86 . . . . 0.0 111.588 175.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.91 -37.36 87.4 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.877 0.871 . . . . 0.0 111.994 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -65.58 -18.19 65.14 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.9 m -75.61 -27.14 58.35 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.134 0.974 . . . . 0.0 113.15 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.37 -39.8 8.62 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.858 1.263 . . . . 0.0 112.036 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 145.67 93.32 0.14 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.518 1.532 . . . . 0.0 111.459 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.2 p -75.04 147.49 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.338 1.055 . . . . 0.0 111.75 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -147.09 164.82 31.82 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.458 1.503 . . . . 0.0 111.837 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -94.88 146.09 24.46 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.816 1.246 . . . . 0.0 112.841 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.03 19.46 72.51 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 123.86 0.743 . . . . 0.0 114.8 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.31 144.04 54.62 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.458 1.129 . . . . 0.0 111.498 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.25 110.96 17.62 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.674 1.19 . . . . 0.0 111.534 -177.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -92.47 131.66 37.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.787 1.235 . . . . 0.0 111.353 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -109.57 127.2 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.283 1.033 . . . . 0.0 110.298 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.28 121.16 43.59 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.71 1.604 . . . . 0.0 110.357 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.0 mm -114.93 125.38 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.902 1.281 . . . . 0.0 109.903 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.8 t -98.24 155.95 16.94 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.503 1.121 . . . . 0.0 111.622 172.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? . . . . . 0 N--CA 1.476 0.849 0 C-N-CA 125.192 1.397 . . . . 0.0 111.187 171.268 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.848 ' HB2' ' OD1' ' A' ' 65' ' ' ASP . 26.3 mmt . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 121.668 0.747 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 141.17 32.38 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.464 1.506 . . . . 0.0 111.045 174.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.4 mt -128.22 141.98 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.786 1.634 . . . . 0.0 109.803 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -105.55 102.23 11.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.862 1.265 . . . . 0.0 110.25 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.4 pt -78.92 143.51 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.436 -0.79 . . . . 0.0 110.326 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 t -130.61 80.18 70.57 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.907 1.283 . . . . 0.0 109.847 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.55 131.46 16.17 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.021 2.481 . . . . 0.0 112.256 175.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.44 41.07 0.18 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.878 1.271 . . . . 0.0 112.749 167.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.9 t -138.91 145.49 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 126.503 1.921 . . . . 0.0 110.202 -169.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.72 -121.19 22.97 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.721 0.677 . . . . 0.0 111.858 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.21 -18.27 72.95 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 123.952 0.787 . . . . 0.0 114.935 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.09 -0.8 57.98 Favored Glycine 0 CA--C 1.542 1.763 0 C-N-CA 124.981 1.276 . . . . 0.0 115.769 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 m -73.92 153.43 88.94 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 125.523 1.529 . . . . 0.0 113.793 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -63.55 149.37 91.18 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.729 2.286 . . . . 0.0 111.467 163.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 tt -141.4 127.07 19.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.881 1.272 . . . . 0.0 111.311 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -85.38 128.89 34.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.827 1.251 . . . . 0.0 112.581 -174.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.9 mt -141.7 146.17 35.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.561 1.544 . . . . 0.0 112.439 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -84.7 146.33 27.48 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.144 0.977 . . . . 0.0 111.112 163.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.6 m -143.6 157.87 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.291 1.436 . . . . 0.0 111.201 174.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.36 151.95 96.89 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.646 0.778 . . . . 0.0 111.824 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -65.99 -20.49 57.46 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.149 2.566 . . . . 0.0 113.027 173.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -83.98 22.16 1.21 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.482 1.913 . . . . 0.0 113.083 175.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.76 108.98 2.28 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.531 -1.355 . . . . 0.0 111.578 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.2 m -77.92 129.97 36.0 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.402 1.081 . . . . 0.0 110.954 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.1 t -57.57 -44.9 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.028 0.931 . . . . 0.0 111.719 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.24 -35.64 91.86 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.48 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.75 -42.31 77.72 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.883 1.342 . . . . 0.0 112.037 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.0 -49.05 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.448 0.699 . . . . 0.0 110.527 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -62.71 -41.66 99.25 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.513 0.725 . . . . 0.0 111.583 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.1 m -62.41 -42.0 99.11 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.651 0.78 . . . . 0.0 111.591 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -58.58 -45.64 88.61 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.359 0.981 . . . . 0.0 111.733 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 83.1 t -63.34 -47.16 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.938 0.895 . . . . 0.0 111.376 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 83.2 m -63.24 -39.9 95.9 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.067 0.547 . . . . 0.0 112.4 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.44 -39.47 77.79 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.297 1.039 . . . . 0.0 112.719 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 63.9 ttp -67.1 -40.44 86.92 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.148 0.979 . . . . 0.0 112.159 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -83.02 -10.42 58.76 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 173.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.38 25.15 12.51 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 127.29 2.236 . . . . 0.0 114.418 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mp -131.98 155.0 81.89 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 126.326 1.85 . . . . 0.0 112.169 -174.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.48 162.54 41.96 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.305 3.337 . . . . 0.0 114.215 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.67 -16.75 56.6 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 124.194 3.263 . . . . 0.0 114.792 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -66.01 -26.65 67.63 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.026 -1.047 . . . . 0.0 112.434 170.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 26.2 m -91.23 -36.59 13.83 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.492 0.717 . . . . 0.0 112.407 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.3 m -130.21 126.76 38.16 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.245 1.018 . . . . 0.0 112.162 -171.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -131.46 161.8 31.69 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.844 1.658 . . . . 0.0 112.997 -168.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.7 tp -129.29 134.54 47.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.473 2.309 . . . . 0.0 110.654 -174.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.2 p -138.52 156.8 47.19 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.724 1.21 . . . . 0.0 113.033 174.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -147.68 132.76 18.25 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.269 1.828 . . . . 0.0 110.447 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm 52.05 40.58 28.75 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.226 1.41 . . . . 0.0 113.374 173.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.49 9.17 84.57 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 125.167 1.365 . . . . 0.0 115.723 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 65.3 mtp180 -127.6 152.08 48.1 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.457 1.903 . . . . 0.0 111.958 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.36 128.06 34.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.034 0.934 . . . . 0.0 110.116 166.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.2 mt -86.35 140.56 29.93 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.829 0.852 . . . . 0.0 110.988 174.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -162.69 152.76 16.25 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.853 1.661 . . . . 0.0 111.331 171.397 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 53.91 19.89 2.16 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.629 1.972 . . . . 0.0 116.239 171.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -75.91 -29.95 58.6 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.008 1.323 . . . . 0.0 112.576 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 62.46 -53.94 0.15 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 128.006 2.523 . . . . 0.0 115.475 -175.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 49.5 p -140.97 137.36 32.99 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.009 1.323 . . . . 0.0 111.298 172.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.38 -23.86 64.71 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.653 -0.655 . . . . 0.0 111.949 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -61.68 -31.76 71.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.768 0.827 . . . . 0.0 112.918 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 55.8 p -64.88 -22.11 66.93 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.0 mt -107.29 -0.34 22.59 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.409 1.884 . . . . 0.0 113.063 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.5 118.5 0.46 Allowed Glycine 0 CA--C 1.539 1.543 0 C-N-CA 126.208 1.861 . . . . 0.0 113.063 -170.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.7 t -75.24 132.84 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.406 1.082 . . . . 0.0 110.767 174.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.43 -174.35 2.51 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.733 1.613 . . . . 0.0 111.494 172.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.848 ' OD1' ' HB2' ' A' ' 1' ' ' MET . 28.1 t0 -139.65 148.82 42.96 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.968 -1.082 . . . . 0.0 113.102 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.92 23.2 75.39 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 123.87 0.747 . . . . 0.0 113.965 -173.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -68.21 165.04 19.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.234 1.414 . . . . 0.0 112.152 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.7 pttm -139.62 142.15 37.07 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 171.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -116.79 121.91 42.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.718 1.207 . . . . 0.0 110.254 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.9 t -96.64 128.97 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.48 0.712 . . . . 0.0 109.875 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.0 mt -111.38 131.54 55.11 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.257 1.023 . . . . 0.0 109.717 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.0 tt -124.91 142.02 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.841 1.256 . . . . 0.0 110.609 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.1 t -132.5 136.48 46.68 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.071 1.348 . . . . 0.0 111.528 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 . . . . . 0 N--CA 1.474 0.746 0 C-N-CA 125.026 1.33 . . . . 0.0 111.463 178.251 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.34 0.114 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -108.84 151.11 26.69 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 120.318 -1.489 . . . . 0.0 113.279 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mt -137.41 134.49 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.986 1.714 . . . . 0.0 109.676 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -93.47 101.44 13.64 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.92 1.288 . . . . 0.0 111.168 174.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 tt -83.49 137.27 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.421 -0.8 . . . . 0.0 110.146 169.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.74 90.33 40.59 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 124.78 1.232 . . . . 0.0 110.464 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -87.64 142.7 5.97 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.467 2.778 . . . . 0.0 112.481 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.91 38.12 0.2 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 125.89 1.676 . . . . 0.0 114.79 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.9 m -139.94 161.49 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 125.767 1.627 . . . . 0.0 112.374 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.3 -122.96 29.85 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.88 0.752 . . . . 0.0 111.91 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.56 -13.24 74.36 Favored Glycine 0 CA--C 1.539 1.571 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 173.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.62 7.0 45.54 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 125.281 1.42 . . . . 0.0 115.831 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.4 m -89.33 154.97 49.16 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 125.399 1.479 . . . . 0.0 113.204 -173.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -64.16 150.6 88.0 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.016 2.477 . . . . 0.0 112.447 169.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mt -137.85 125.96 22.91 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.07 1.748 . . . . 0.0 110.677 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -77.2 114.6 16.18 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.197 0.999 . . . . 0.0 111.325 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.5 mp -114.69 155.82 25.92 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.777 1.631 . . . . 0.0 110.703 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -114.01 133.24 55.63 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.409 1.483 . . . . 0.0 109.701 169.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.04 156.61 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.687 1.195 . . . . 0.0 112.044 -174.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.88 149.08 98.64 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.825 0.85 . . . . 0.0 111.914 173.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.78 -26.38 60.22 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.933 2.422 . . . . 0.0 113.053 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -82.59 12.81 4.21 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.73 1.612 . . . . 0.0 114.463 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.72 113.86 2.47 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.065 -1.022 . . . . 0.0 111.128 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 p -85.24 153.66 22.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.847 0.859 . . . . 0.0 111.536 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.9 t -63.49 -42.08 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.531 -0.731 . . . . 0.0 110.907 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.92 97.06 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.762 0.696 . . . . 0.0 113.226 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.12 -46.98 84.74 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 117.974 0.887 . . . . 0.0 111.742 175.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.76 -47.04 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.589 0.756 . . . . 0.0 111.38 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -56.99 -43.19 81.46 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.895 1.278 . . . . 0.0 111.697 177.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.0 m -65.7 -44.96 84.57 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.686 0.795 . . . . 0.0 111.444 176.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -46.6 87.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.908 0.883 . . . . 0.0 111.653 176.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.09 -51.74 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.219 1.408 . . . . 0.0 111.232 177.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.43 -43.44 96.78 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.799 0.727 . . . . 0.0 112.332 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.66 -43.66 92.89 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.638 0.775 . . . . 0.0 112.823 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.8 ttt -70.18 -36.79 74.9 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.13 0.972 . . . . 0.0 112.848 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.14 -20.41 52.11 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.132 1.373 . . . . 0.0 113.689 176.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? 57.66 19.93 5.91 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.751 2.02 . . . . 0.0 113.825 -171.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 mp -128.96 145.48 56.73 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.76 2.024 . . . . 0.0 110.973 -169.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.87 160.48 45.96 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.606 2.871 . . . . 0.0 113.831 -174.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.33 -5.26 15.5 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 124.02 3.147 . . . . 0.0 114.945 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -71.32 -39.81 71.17 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.736 -1.227 . . . . 0.0 111.715 169.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.7 t -85.97 -49.31 7.94 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.16 -0.962 . . . . 0.0 112.119 173.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.7 m -90.18 127.43 36.11 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.764 0.711 . . . . 0.0 112.093 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -140.37 163.33 33.09 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.758 1.223 . . . . 0.0 113.458 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.4 tp -140.0 136.42 33.73 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.708 2.003 . . . . 0.0 110.639 -170.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.1 p -139.93 155.7 47.03 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.528 1.131 . . . . 0.0 113.084 -178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -149.64 139.68 22.04 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.598 1.959 . . . . 0.0 109.808 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 55.61 29.9 14.4 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.199 1.4 . . . . 0.0 113.969 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.95 13.25 79.15 Favored Glycine 0 CA--C 1.541 1.68 0 C-N-CA 124.785 1.183 . . . . 0.0 114.985 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.3 mmm-85 -123.35 152.73 41.19 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.757 2.023 . . . . 0.0 112.23 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.92 124.01 30.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.738 0.815 . . . . 0.0 109.686 160.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.63 137.04 32.71 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.907 1.283 . . . . 0.0 109.42 174.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -164.51 147.73 9.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.385 1.474 . . . . 0.0 112.036 173.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 56.05 27.21 11.02 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.112 1.765 . . . . 0.0 115.378 175.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -83.96 -16.93 42.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.491 1.116 . . . . 0.0 113.954 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.27 -47.13 0.07 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 129.125 2.97 . . . . 0.0 115.956 -171.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.6 t -152.0 140.38 20.51 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.07 1.348 . . . . 0.0 110.987 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.96 -26.94 67.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.5 0.72 . . . . 0.0 112.153 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -65.3 -27.86 68.91 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.561 1.144 . . . . 0.0 113.364 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.1 t -68.35 -40.51 81.5 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.581 0.753 . . . . 0.0 112.262 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.12 -38.69 22.09 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.526 1.131 . . . . 0.0 112.021 177.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.43 97.91 0.26 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.914 1.721 . . . . 0.0 111.632 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.2 148.98 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.462 1.105 . . . . 0.0 111.735 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.34 -168.6 2.85 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.998 1.719 . . . . 0.0 111.116 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -138.75 149.46 45.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.825 1.25 . . . . 0.0 112.356 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.78 23.63 77.76 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 123.787 0.708 . . . . 0.0 113.87 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -66.92 164.99 16.34 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.93 1.292 . . . . 0.0 112.752 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -136.79 142.85 42.96 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.882 0.873 . . . . 0.0 113.281 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -127.86 125.32 39.48 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.062 1.345 . . . . 0.0 110.335 -175.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.4 126.63 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.604 1.162 . . . . 0.0 109.798 -176.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 tt -124.34 125.05 43.68 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.47 1.108 . . . . 0.0 110.923 -172.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.44 145.15 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.246 1.819 . . . . 0.0 110.275 -169.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.6 t -148.06 150.76 34.51 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.499 1.52 . . . . 0.0 110.941 176.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? . . . . . 0 N--CA 1.475 0.781 0 C-N-CA 125.565 1.546 . . . . 0.0 111.538 -177.008 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.536 ' HG2' ' H ' ' A' ' 2' ' ' LYS . 26.7 ttt . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.536 ' H ' ' HG2' ' A' ' 1' ' ' MET . 58.3 mttm -75.65 140.99 42.87 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.099 -1.0 . . . . 0.0 110.613 162.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.81 159.84 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.056 1.742 . . . . 0.0 109.961 175.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -113.8 139.57 49.02 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.961 1.304 . . . . 0.0 110.36 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 tt -126.82 141.81 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.676 0.79 . . . . 0.0 111.357 174.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 t -124.65 85.36 56.7 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 125.547 1.539 . . . . 0.0 109.862 -177.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.07 121.37 5.33 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.289 2.66 . . . . 0.0 111.528 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.29 52.77 1.65 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.38 1.472 . . . . 0.0 113.406 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -150.45 147.02 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.054 1.342 . . . . 0.0 111.809 -176.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.39 29.18 74.4 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.436 1.017 . . . . 0.0 114.958 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.49 68.37 1.52 Allowed Glycine 0 CA--C 1.532 1.143 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -167.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.26 137.02 42.85 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.49 1.043 . . . . 0.0 114.372 -170.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.1 m -148.48 152.64 38.86 Favored Pre-proline 0 N--CA 1.474 0.735 0 C-N-CA 126.298 1.839 . . . . 0.0 110.813 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -65.86 143.51 73.63 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.936 2.424 . . . . 0.0 112.45 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.9 tp -139.55 129.0 24.24 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.357 1.463 . . . . 0.0 111.118 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -82.97 144.62 29.86 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.304 1.041 . . . . 0.0 112.783 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -152.38 146.97 25.75 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.297 1.439 . . . . 0.0 111.625 168.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -81.42 135.74 35.66 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.739 0.816 . . . . 0.0 111.191 171.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.6 m -134.16 156.56 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.484 1.114 . . . . 0.0 112.279 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.82 152.07 93.81 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 124.382 1.073 . . . . 0.0 112.608 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.09 -23.74 60.32 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.119 2.546 . . . . 0.0 113.279 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -85.43 10.7 12.12 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.249 1.42 . . . . 0.0 113.739 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.99 155.44 27.5 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.079 0.854 . . . . 0.0 112.515 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.6 m -144.39 135.37 25.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.265 1.426 . . . . 0.0 110.669 -171.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.7 t -61.28 -40.27 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.367 0.667 . . . . 0.0 111.953 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.34 -39.13 97.35 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.431 -0.649 . . . . 0.0 113.37 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.69 -37.59 82.52 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 118.342 1.071 . . . . 0.0 112.489 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.48 -44.56 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.543 -0.723 . . . . 0.0 110.37 172.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -60.94 -52.61 64.28 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.02 0.928 . . . . 0.0 111.925 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.2 p -64.53 -36.07 83.02 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 118.358 -0.829 . . . . 0.0 112.852 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -58.47 -45.01 89.49 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.558 1.072 . . . . 0.0 112.084 172.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 51.9 t -69.82 -42.81 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.082 0.856 . . . . 0.0 111.87 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 88.3 m -56.74 -42.32 79.05 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.908 1.231 . . . . 0.0 112.263 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.19 -41.31 81.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.922 0.889 . . . . 0.0 112.626 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.2 ttt -71.49 -36.78 71.23 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.897 0.879 . . . . 0.0 113.07 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -77.37 -13.78 59.86 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.075 1.35 . . . . 0.0 113.295 171.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 55.1 46.39 24.14 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.485 1.914 . . . . 0.0 112.109 -176.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.1 mt -133.14 146.12 59.73 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.424 1.49 . . . . 0.0 112.956 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.18 162.07 43.66 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.974 3.116 . . . . 0.0 113.473 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.48 -7.68 16.81 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.833 3.022 . . . . 0.0 114.273 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.3 -24.64 57.51 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.794 -1.191 . . . . 0.0 113.139 170.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 74.7 p -123.13 0.87 9.11 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.806 1.243 . . . . 0.0 114.204 -174.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.7 m -146.93 125.34 12.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.301 1.441 . . . . 0.0 109.998 172.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -145.36 149.55 34.97 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.734 1.214 . . . . 0.0 113.218 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 69' ' ' PHE . 47.3 tp -105.13 144.59 31.72 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.129 1.772 . . . . 0.0 111.229 175.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.5 p -131.71 154.6 48.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.003 1.321 . . . . 0.0 111.451 170.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -143.03 125.29 15.49 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.434 1.894 . . . . 0.0 109.479 -174.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt 53.24 31.46 11.67 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.714 1.206 . . . . 0.0 113.351 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.41 -4.58 55.12 Favored Glycine 0 CA--C 1.542 1.769 0 C-N-CA 125.529 1.538 . . . . 0.0 116.094 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -94.41 153.15 18.1 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.771 1.628 . . . . 0.0 111.993 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.25 127.67 32.63 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 157.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.5 mt -142.59 151.28 41.36 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.43 1.492 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -154.51 -48.99 0.09 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.369 1.068 . . . . 0.0 113.693 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -83.52 39.13 0.65 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.734 1.614 . . . . 0.0 113.651 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.9 m -72.53 -22.72 60.98 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.844 1.258 . . . . 0.0 113.328 -172.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 63.36 -54.09 0.2 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.71 2.804 . . . . 0.0 115.558 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -160.71 140.8 11.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.868 2.467 . . . . 0.0 108.853 168.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -73.53 -34.71 65.35 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.023 0.829 . . . . 0.0 112.242 171.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -65.75 -27.94 68.67 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -173.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.4 m -67.0 -18.23 65.29 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.9 mp -107.87 -42.16 4.78 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.142 1.377 . . . . 0.0 112.155 175.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.63 93.86 0.1 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.575 1.56 . . . . 0.0 111.771 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.1 p -76.4 149.39 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.045 0.938 . . . . 0.0 110.994 173.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -141.94 178.56 7.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.477 1.111 . . . . 0.0 113.435 -172.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -97.86 137.53 36.57 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.395 1.878 . . . . 0.0 111.31 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.94 19.6 67.18 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 115.562 0.985 . . . . 0.0 115.562 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -65.09 143.57 57.81 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.581 1.191 . . . . 0.0 111.602 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -127.61 132.84 49.72 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -166.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.571 ' HB3' HD11 ' A' ' 45' ' ' LEU . 98.2 m-85 -121.35 141.01 51.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.061 1.744 . . . . 0.0 111.296 -175.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.6 t -124.14 122.48 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.979 0.911 . . . . 0.0 109.835 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -112.42 112.02 23.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.022 1.329 . . . . 0.0 109.062 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.9 mt -101.5 140.26 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.715 1.606 . . . . 0.0 109.921 -176.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.8 p -133.51 157.37 45.83 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.894 1.277 . . . . 0.0 112.375 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -130.31 149.64 51.9 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.017 2.127 . . . . 0.0 111.475 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.2 t -154.57 155.68 35.21 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.482 1.513 . . . . 0.0 111.088 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.5 t -141.44 140.89 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.153 1.781 . . . . 0.0 110.279 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.358 0 C-N-CA 125.439 1.495 . . . . 0.0 112.587 179.448 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 121.246 0.546 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -82.92 149.71 26.9 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.201 -0.937 . . . . 0.0 110.536 166.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.2 pt -139.85 160.41 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.554 1.942 . . . . 0.0 110.009 169.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -118.88 107.81 14.04 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.872 0.869 . . . . 0.0 111.243 172.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.9 tt -90.13 140.17 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.037 0.535 . . . . 0.0 110.933 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 t -125.84 88.94 53.38 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 125.148 1.379 . . . . 0.0 109.899 -175.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -82.41 124.06 4.06 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.448 2.765 . . . . 0.0 112.509 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.19 35.86 0.18 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.87 1.668 . . . . 0.0 114.039 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.0 m -79.42 51.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 126.793 2.037 . . . . 0.0 113.315 -171.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.96 53.01 7.39 Favored Glycine 0 CA--C 1.533 1.218 0 O-C-N 121.276 -0.89 . . . . 0.0 112.877 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.97 23.89 36.83 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.405 1.002 . . . . 0.0 114.747 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.19 138.72 45.75 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 118.18 0.99 . . . . 0.0 113.554 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.5 p -84.1 155.13 64.04 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 125.427 1.491 . . . . 0.0 112.969 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -62.04 145.15 96.72 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.256 2.637 . . . . 0.0 111.825 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.91 127.05 29.91 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.814 1.246 . . . . 0.0 111.392 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -75.53 130.74 39.34 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.724 1.209 . . . . 0.0 111.291 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.94 149.49 41.91 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.611 1.564 . . . . 0.0 111.143 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -85.48 141.8 29.66 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.089 1.356 . . . . 0.0 111.2 169.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.45 142.17 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.482 1.113 . . . . 0.0 112.897 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.97 150.32 61.38 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.187 1.395 . . . . 0.0 112.674 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.15 -23.58 60.09 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.55 2.833 . . . . 0.0 113.619 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -78.82 0.92 25.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.226 1.41 . . . . 0.0 113.872 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.11 140.23 56.06 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.259 0.936 . . . . 0.0 111.972 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.2 m -119.5 131.96 55.68 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.134 1.374 . . . . 0.0 110.23 -174.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.8 m -61.55 -31.96 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -174.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.64 -37.22 92.33 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 123.776 0.703 . . . . 0.0 113.292 173.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.15 -41.9 73.25 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.214 1.007 . . . . 0.0 111.689 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.46 -45.31 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.549 0.739 . . . . 0.0 111.041 175.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -55.36 -49.07 73.23 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.644 1.177 . . . . 0.0 111.239 172.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 90.5 m -65.26 -40.2 93.66 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.226 0.61 . . . . 0.0 111.849 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -59.61 -46.95 87.45 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.252 1.021 . . . . 0.0 111.638 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 36.0 t -61.64 -46.92 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.162 0.985 . . . . 0.0 111.865 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.6 m -63.93 -38.49 91.29 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.4 0.68 . . . . 0.0 112.283 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.26 -41.81 84.95 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.823 0.849 . . . . 0.0 112.421 174.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -66.08 -41.47 90.64 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.329 1.051 . . . . 0.0 112.832 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -85.28 -9.44 57.7 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.79 12.97 1.84 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 127.646 2.379 . . . . 0.0 115.063 -174.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.9 mp -118.66 153.61 52.29 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 126.743 2.017 . . . . 0.0 111.537 -175.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.06 163.87 37.73 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 124.245 3.297 . . . . 0.0 114.235 -173.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -64.91 -14.6 46.05 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.257 2.638 . . . . 0.0 114.026 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -68.58 -26.89 65.62 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.345 1.058 . . . . 0.0 113.215 171.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 34.6 p -109.01 -21.4 12.64 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.078 1.351 . . . . 0.0 113.573 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.3 m -126.54 126.03 43.01 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.145 0.978 . . . . 0.0 110.899 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -141.97 166.25 25.22 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.844 1.258 . . . . 0.0 113.354 -169.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.0 tp -136.93 140.33 42.19 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.869 1.668 . . . . 0.0 111.278 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.8 p -137.29 156.67 47.98 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.181 1.392 . . . . 0.0 112.767 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -152.53 131.92 12.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.441 2.297 . . . . 0.0 110.144 -174.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.35 40.01 17.52 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.357 1.463 . . . . 0.0 113.444 174.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.29 8.7 87.62 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 125.132 1.348 . . . . 0.0 116.334 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -133.89 160.78 36.64 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.707 1.603 . . . . 0.0 112.619 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.41 155.52 29.93 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.274 0.629 . . . . 0.0 110.866 160.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.6 mt -116.86 133.58 55.83 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.55 1.14 . . . . 0.0 111.065 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.2 141.65 18.7 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.926 1.29 . . . . 0.0 111.403 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.5 t0 55.09 33.58 20.71 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.776 1.63 . . . . 0.0 114.789 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.0 p -83.43 -29.48 28.06 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.565 1.146 . . . . 0.0 113.595 -171.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 61.42 -23.45 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 129.107 2.963 . . . . 0.0 116.979 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.1 p -149.09 161.58 41.68 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.796 2.039 . . . . 0.0 111.25 171.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 65.8 mt -77.01 -20.95 55.37 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.738 -0.601 . . . . 0.0 112.595 164.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -63.67 -36.24 83.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.164 0.986 . . . . 0.0 112.421 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.8 m -69.95 -19.2 63.38 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 174.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.1 mt -90.11 -24.74 21.02 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.731 1.213 . . . . 0.0 113.48 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.97 41.09 72.78 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 123.643 0.64 . . . . 0.0 113.158 -174.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.0 p -55.64 149.19 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.907 1.283 . . . . 0.0 112.22 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.79 151.27 30.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.211 1.004 . . . . 0.0 112.182 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -64.22 128.62 36.58 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.67 0.788 . . . . 0.0 111.195 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.78 8.65 76.09 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.013 1.292 . . . . 0.0 115.858 -176.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -62.08 152.04 33.85 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.665 1.733 . . . . 0.0 113.6 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -103.39 154.15 19.72 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.685 1.194 . . . . 0.0 114.179 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -135.78 143.2 45.1 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.119 2.168 . . . . 0.0 109.679 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.9 t -121.7 126.22 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.745 0.818 . . . . 0.0 110.34 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 tt -111.86 122.31 47.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.733 1.613 . . . . 0.0 109.194 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -113.92 142.74 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.722 1.609 . . . . 0.0 110.061 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.7 t -136.87 150.66 48.4 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.092 1.357 . . . . 0.0 112.052 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -127.96 106.67 9.25 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.681 1.993 . . . . 0.0 110.154 -176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.9 m -78.6 76.41 5.1 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.542 1.137 . . . . 0.0 110.829 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.95 -17.9 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.252 0 C-N-CA 125.56 1.553 . . . . 0.0 113.877 179.491 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.913 0.387 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -102.71 152.23 21.46 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.739 1.215 . . . . 0.0 112.315 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -133.44 154.46 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.283 1.833 . . . . 0.0 109.608 173.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -98.12 146.26 25.74 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.235 0.614 . . . . 0.0 110.549 161.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.4 tt -123.5 136.74 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 124.473 1.109 . . . . 0.0 109.62 165.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -123.46 78.85 54.46 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.943 1.297 . . . . 0.0 109.359 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -81.56 138.02 10.57 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.882 2.388 . . . . 0.0 112.556 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.29 35.7 0.18 Allowed 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.676 1.59 . . . . 0.0 114.394 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.85 160.89 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 126.517 1.927 . . . . 0.0 111.701 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.45 -117.94 12.88 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 123.876 0.75 . . . . 0.0 112.144 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.79 -18.2 72.08 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 123.905 0.764 . . . . 0.0 114.745 174.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.89 11.82 58.74 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-N 118.747 1.273 . . . . 0.0 115.095 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.2 p -106.85 160.14 27.37 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.846 2.058 . . . . 0.0 112.765 -168.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.38 137.37 55.36 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.926 2.417 . . . . 0.0 112.076 171.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 mp -124.1 137.09 54.61 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.319 1.448 . . . . 0.0 110.427 167.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -99.82 135.08 41.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.626 1.17 . . . . 0.0 111.844 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.7 mt -142.23 147.61 36.79 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.039 1.736 . . . . 0.0 111.778 -173.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -81.05 144.06 32.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.284 1.034 . . . . 0.0 110.834 166.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.1 p -144.71 145.24 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.777 0.831 . . . . 0.0 112.514 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 148.09 91.45 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.537 1.135 . . . . 0.0 112.6 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.84 -23.1 41.81 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.202 2.601 . . . . 0.0 113.182 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -81.91 5.79 17.9 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.443 1.497 . . . . 0.0 113.858 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.77 140.47 51.5 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.211 -0.931 . . . . 0.0 112.149 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.6 p -120.05 149.6 41.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.307 1.043 . . . . 0.0 112.109 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.8 m -60.79 -36.06 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.853 0.861 . . . . 0.0 112.519 175.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.83 -44.49 91.96 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 123.893 0.759 . . . . 0.0 112.357 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.75 -47.72 79.89 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 117.767 0.783 . . . . 0.0 112.06 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.4 t -63.14 -48.11 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.466 0.575 . . . . 0.0 111.316 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -59.71 -48.11 82.98 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.71 0.804 . . . . 0.0 111.66 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.5 m -68.62 -36.48 78.7 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.761 -0.587 . . . . 0.0 111.851 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -66.98 -38.78 86.67 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.862 0.865 . . . . 0.0 112.337 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.0 t -56.29 -51.8 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.725 0.81 . . . . 0.0 110.956 167.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.2 m -62.41 -37.18 84.8 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.19 -44.38 84.14 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.024 0.929 . . . . 0.0 112.565 174.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 96.4 mtp -68.63 -39.39 80.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.807 0.843 . . . . 0.0 113.11 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -80.67 -12.56 59.47 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 175.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 58.59 17.43 5.0 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 127.165 2.186 . . . . 0.0 114.162 -173.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 mp -130.04 152.02 79.3 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 127.156 2.183 . . . . 0.0 110.702 -171.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.21 164.74 32.84 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 124.111 3.207 . . . . 0.0 114.115 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.59 -12.28 34.28 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.334 2.689 . . . . 0.0 114.014 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -66.03 -36.84 84.32 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.976 -1.078 . . . . 0.0 112.059 170.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.5 p -90.66 -19.66 23.38 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 89.5 m -136.44 124.83 23.36 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.533 1.515 . . . . 0.0 111.732 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -125.86 157.73 36.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.861 1.665 . . . . 0.0 112.221 -173.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.0 tp -125.98 136.49 53.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.445 1.898 . . . . 0.0 111.308 -173.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.0 p -134.37 153.22 52.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.405 1.082 . . . . 0.0 112.543 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -152.26 136.13 16.34 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.186 1.795 . . . . 0.0 110.059 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt 51.54 33.61 10.86 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.756 1.622 . . . . 0.0 114.362 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.32 19.36 77.47 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.125 0.869 . . . . 0.0 115.091 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -129.02 160.96 31.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.048 2.139 . . . . 0.0 111.24 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -88.58 131.97 34.73 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.696 0.798 . . . . 0.0 110.113 160.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.5 tp -96.94 112.63 24.3 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.148 0.979 . . . . 0.0 110.464 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -154.04 151.14 28.99 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.996 1.318 . . . . 0.0 112.33 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.6 t0 56.18 29.58 14.98 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.928 2.091 . . . . 0.0 115.037 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.0 p -88.36 -20.11 25.75 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 58.09 -64.79 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.87 2.068 . . . . 0.0 114.266 -163.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.7 p -144.01 150.03 37.61 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.16 1.384 . . . . 0.0 111.989 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.51 -30.8 71.61 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.686 0.794 . . . . 0.0 112.631 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.68 -22.51 65.28 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.231 -0.918 . . . . 0.0 113.26 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.7 p -69.44 -26.53 64.65 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 56.6 mt -98.02 -6.35 32.09 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.117 1.767 . . . . 0.0 113.16 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.33 115.39 1.46 Allowed Glycine 0 CA--C 1.536 1.347 0 C-N-CA 126.206 1.86 . . . . 0.0 112.385 -171.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 m -74.43 154.45 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.75 1.22 . . . . 0.0 112.684 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -147.81 160.06 43.16 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.317 1.847 . . . . 0.0 110.319 170.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -93.09 147.49 22.82 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.821 0.848 . . . . 0.0 112.485 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.82 30.78 59.07 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 115.068 0.787 . . . . 0.0 115.068 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.29 148.34 51.86 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.631 1.215 . . . . 0.0 111.891 173.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -120.74 111.75 17.99 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.367 1.067 . . . . 0.0 111.563 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -94.04 144.23 25.66 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.126 1.37 . . . . 0.0 111.222 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.08 128.34 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.484 1.114 . . . . 0.0 109.664 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.3 tp -115.16 123.21 48.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.026 0.93 . . . . 0.0 110.967 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.4 123.56 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.408 1.483 . . . . 0.0 109.708 -171.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.2 t -111.57 141.19 45.48 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.257 1.023 . . . . 0.0 111.76 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? -81.77 122.64 27.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.557 1.543 . . . . 0.0 110.475 175.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.3 m -65.23 142.85 58.16 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.638 0.775 . . . . 0.0 110.28 169.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.8 p -137.03 139.99 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.632 1.173 . . . . 0.0 111.416 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.19 0 C-N-CA 125.302 1.43 . . . . 0.0 112.496 -176.282 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 mmt . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.668 0.271 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.88 148.92 27.04 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.651 -1.28 . . . . 0.0 112.298 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.22 155.97 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.883 1.673 . . . . 0.0 110.434 172.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -111.19 119.36 38.7 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.414 1.086 . . . . 0.0 111.083 169.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 tp -86.98 137.82 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 165.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 t -128.81 77.99 76.82 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 124.718 1.207 . . . . 0.0 109.789 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.09 136.74 10.43 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.317 2.678 . . . . 0.0 112.114 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.46 36.49 0.16 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.679 1.592 . . . . 0.0 113.463 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.6 t -138.32 147.56 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.106 1.762 . . . . 0.0 110.641 -170.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.11 -117.71 10.81 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 123.969 0.795 . . . . 0.0 111.967 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.53 -19.58 71.02 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 123.85 0.738 . . . . 0.0 114.519 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.51 3.66 41.38 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 124.87 1.224 . . . . 0.0 115.667 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.0 p -91.31 157.22 42.85 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 126.583 1.953 . . . . 0.0 113.203 -171.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -64.23 145.36 88.7 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.992 2.461 . . . . 0.0 111.784 168.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 tt -137.07 122.48 19.5 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.95 1.3 . . . . 0.0 110.313 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -90.52 137.81 32.06 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.226 1.01 . . . . 0.0 113.017 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.0 mt -144.72 148.17 33.86 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.984 1.714 . . . . 0.0 111.826 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -80.65 138.2 36.39 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.641 1.176 . . . . 0.0 110.382 166.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.4 m -140.0 153.33 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.458 1.103 . . . . 0.0 112.33 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.85 150.49 96.47 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.04 0.936 . . . . 0.0 112.197 175.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.64 -21.01 52.68 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.082 2.521 . . . . 0.0 112.957 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.88 15.68 2.15 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.853 1.661 . . . . 0.0 114.015 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.18 142.49 54.29 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.163 -0.961 . . . . 0.0 112.128 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.3 m -133.56 138.58 46.11 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.241 1.416 . . . . 0.0 111.046 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.9 t -57.49 -47.76 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.339 1.055 . . . . 0.0 112.587 -173.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.6 -38.33 96.22 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.674 -0.515 . . . . 0.0 112.968 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.18 -46.07 78.64 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 117.986 0.893 . . . . 0.0 111.814 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -60.8 -49.14 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.805 0.842 . . . . 0.0 110.971 176.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -62.42 -46.37 88.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.264 0.626 . . . . 0.0 111.777 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.6 m -59.62 -43.92 93.63 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.475 0.71 . . . . 0.0 111.51 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -66.32 -37.7 85.98 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.576 0.751 . . . . 0.0 112.469 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.02 -46.59 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.502 0.592 . . . . 0.0 111.794 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.2 m -58.6 -40.44 83.26 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.501 1.046 . . . . 0.0 112.144 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.72 -41.51 87.8 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.893 0.877 . . . . 0.0 112.715 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.6 tpt -68.28 -41.25 81.27 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.515 1.126 . . . . 0.0 112.767 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -74.77 -24.62 58.71 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.511 1.524 . . . . 0.0 113.137 172.672 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.79 30.25 19.55 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.805 2.042 . . . . 0.0 113.221 -171.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 mp -120.32 153.83 56.06 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.948 2.099 . . . . 0.0 111.454 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.74 162.54 38.98 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.899 3.066 . . . . 0.0 113.496 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -67.58 -16.22 46.53 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.537 2.825 . . . . 0.0 114.819 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -79.79 -29.6 40.4 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.675 1.125 . . . . 0.0 113.613 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.7 p -86.64 9.55 18.31 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.702 1.201 . . . . 0.0 113.69 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 t -135.85 144.81 45.84 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.36 1.464 . . . . 0.0 110.897 176.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -133.52 148.01 51.63 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.505 1.922 . . . . 0.0 110.4 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.3 tp -139.67 121.24 15.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.34 1.456 . . . . 0.0 110.563 -169.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.7 m -132.71 141.11 48.42 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.596 1.158 . . . . 0.0 112.342 -169.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -143.75 131.94 21.89 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.779 2.032 . . . . 0.0 110.608 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt 50.14 37.64 15.07 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.008 1.323 . . . . 0.0 113.82 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.18 17.35 79.57 Favored Glycine 0 CA--C 1.541 1.683 0 C-N-CA 124.718 1.151 . . . . 0.0 115.788 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -136.7 154.13 50.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.675 1.99 . . . . 0.0 112.881 -175.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.41 129.27 34.57 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.82 0.848 . . . . 0.0 110.521 165.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.1 130.72 34.84 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.989 0.916 . . . . 0.0 110.223 169.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -162.23 141.94 9.72 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.513 1.525 . . . . 0.0 111.637 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 t0 56.55 25.34 9.71 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 172.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.1 p -82.96 -16.03 48.94 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.839 -1.163 . . . . 0.0 113.234 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 62.67 -56.1 0.15 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 128.775 2.83 . . . . 0.0 115.02 -171.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 21.5 p -148.93 148.21 29.55 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.344 1.858 . . . . 0.0 111.593 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.69 -25.46 68.22 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.689 0.796 . . . . 0.0 112.991 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -62.01 -27.36 68.82 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.065 -1.022 . . . . 0.0 113.084 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.5 m -69.11 -23.93 64.05 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.114 0.966 . . . . 0.0 113.162 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.6 mt -93.45 -22.87 18.63 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.238 1.415 . . . . 0.0 112.724 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.53 114.03 3.01 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.47 1.986 . . . . 0.0 111.344 -167.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.2 t -72.74 143.18 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.717 1.207 . . . . 0.0 111.314 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -138.55 146.14 41.52 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.549 1.54 . . . . 0.0 110.38 168.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -78.38 147.38 34.14 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.289 -0.882 . . . . 0.0 112.411 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.7 21.81 78.07 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 115.044 0.778 . . . . 0.0 115.044 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -56.98 140.0 50.26 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.728 1.264 . . . . 0.0 111.309 170.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -121.44 137.04 54.89 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.856 0.862 . . . . 0.0 112.138 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -119.0 121.87 40.88 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.463 1.505 . . . . 0.0 109.731 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.5 t -91.81 130.59 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.326 0.65 . . . . 0.0 109.428 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 tp -120.31 123.45 43.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.151 0.98 . . . . 0.0 110.892 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -113.28 129.18 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.411 1.485 . . . . 0.0 110.014 -172.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.6 t -94.37 145.88 24.45 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.497 1.119 . . . . 0.0 111.787 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.55 130.47 34.74 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.633 1.173 . . . . 0.0 110.615 171.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -129.61 -51.11 1.16 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.883 0.873 . . . . 0.0 112.737 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.2 t -73.82 129.98 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.771 0.828 . . . . 0.0 110.131 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.247 0 C-N-CA 126.033 1.778 . . . . 0.0 112.374 -177.559 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.979 0.419 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -121.52 147.45 45.77 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.737 1.215 . . . . 0.0 112.544 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.12 166.44 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.542 1.937 . . . . 0.0 110.265 172.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -128.38 100.78 5.93 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.894 0.878 . . . . 0.0 111.287 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.5 tt -86.55 141.8 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.77 0.828 . . . . 0.0 111.209 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.6 t -128.84 80.89 71.9 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 125.491 1.517 . . . . 0.0 109.483 -176.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.5 142.7 33.37 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.952 2.434 . . . . 0.0 111.94 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.62 23.29 0.23 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.399 1.48 . . . . 0.0 113.908 174.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -155.8 160.55 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 127.246 2.218 . . . . 0.0 109.889 -172.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.43 34.81 53.62 Favored Glycine 0 CA--C 1.535 1.292 0 O-C-N 121.389 -0.819 . . . . 0.0 113.998 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.33 -9.17 64.89 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.575 1.559 . . . . 0.0 114.887 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.7 -0.44 43.75 Favored Glycine 0 CA--C 1.54 1.598 0 N-CA-C 116.555 1.382 . . . . 0.0 116.555 170.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.4 m -80.38 152.34 73.1 Favored Pre-proline 0 N--CA 1.472 0.629 0 C-N-CA 124.676 1.19 . . . . 0.0 113.053 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -64.43 145.34 87.76 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.067 2.511 . . . . 0.0 111.845 170.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.7 mt -131.68 121.86 24.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.503 1.521 . . . . 0.0 110.58 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -88.89 132.77 34.54 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.553 1.141 . . . . 0.0 111.284 178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 mt -149.81 143.49 25.39 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.347 1.059 . . . . 0.0 111.624 -173.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -69.82 150.97 46.28 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.351 0.66 . . . . 0.0 111.98 168.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 p -146.37 140.15 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.349 1.06 . . . . 0.0 111.538 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.56 145.27 78.73 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.021 0.928 . . . . 0.0 111.956 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.2 -20.88 49.11 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.833 2.355 . . . . 0.0 113.198 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -75.72 -7.18 53.73 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.2 157.76 30.55 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.162 0.892 . . . . 0.0 112.847 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.85 145.9 51.82 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.95 1.3 . . . . 0.0 110.885 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.1 t -66.37 -34.05 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 121.373 -0.829 . . . . 0.0 111.295 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.25 -43.7 99.05 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.439 1.018 . . . . 0.0 113.054 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.87 -45.47 85.88 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.98 0.89 . . . . 0.0 111.717 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.3 t -60.92 -49.3 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.012 0.925 . . . . 0.0 111.99 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.9 ptt85 -64.08 -39.52 94.24 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.123 0.874 . . . . 0.0 112.07 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.7 m -62.69 -41.22 98.99 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.596 0.758 . . . . 0.0 111.376 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.408 ' HA ' ' HE3' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -60.63 -42.57 97.17 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.708 0.803 . . . . 0.0 112.191 178.625 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 70.2 t -74.67 -35.74 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.541 0.736 . . . . 0.0 112.559 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 87.1 m -60.25 -45.51 93.01 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.589 -0.694 . . . . 0.0 111.465 170.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.46 -41.1 89.56 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.984 0.914 . . . . 0.0 112.829 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 57.7 ttm -61.69 -43.84 98.09 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.396 1.078 . . . . 0.0 112.849 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -85.94 -6.38 59.07 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.4 tptm 53.54 53.67 11.21 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.059 2.144 . . . . 0.0 112.451 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.7 mt -133.16 148.38 68.98 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.612 1.565 . . . . 0.0 112.164 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -69.49 160.42 49.83 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.563 2.842 . . . . 0.0 112.444 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.07 -26.01 73.43 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.741 2.294 . . . . 0.0 113.13 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -70.09 -3.19 15.41 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.492 -1.38 . . . . 0.0 114.604 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.8 p -127.7 14.67 6.99 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.368 1.467 . . . . 0.0 113.075 165.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 m -154.53 110.69 3.23 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.031 1.733 . . . . 0.0 110.868 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.2 mtt-85 -132.15 155.22 48.56 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.557 1.143 . . . . 0.0 112.886 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.0 tp -127.37 131.53 50.33 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.255 1.822 . . . . 0.0 110.596 -174.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.8 p -136.84 152.16 49.95 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.415 1.086 . . . . 0.0 113.371 -175.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -142.26 134.5 27.65 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.575 1.95 . . . . 0.0 110.382 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 tptm 51.68 33.31 10.68 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.465 1.506 . . . . 0.0 114.191 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.75 10.09 84.67 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 125.285 1.422 . . . . 0.0 115.931 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -127.34 149.94 49.82 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.792 1.637 . . . . 0.0 112.678 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.12 88.51 6.55 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.735 1.214 . . . . 0.0 110.844 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.2 mp -65.39 147.55 53.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.916 0.886 . . . . 0.0 111.68 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -158.07 -51.05 0.07 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.888 1.275 . . . . 0.0 113.437 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -84.53 40.25 0.78 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.492 1.517 . . . . 0.0 113.295 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.0 m -73.82 -27.26 61.02 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.41 1.084 . . . . 0.0 112.808 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 62.0 -61.92 0.1 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 128.035 2.534 . . . . 0.0 114.776 -174.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.4 p -147.29 150.57 35.05 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.217 1.407 . . . . 0.0 111.319 170.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.07 -20.61 62.34 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.122 0.569 . . . . 0.0 112.471 167.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.09 -54.35 39.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.575 1.55 . . . . 0.0 112.346 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.3 m -69.27 -28.47 66.34 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.9 tp -74.68 -27.84 60.58 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.989 0.916 . . . . 0.0 112.788 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.61 54.24 6.12 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.383 0.992 . . . . 0.0 113.042 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.6 p -56.62 151.88 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.633 1.173 . . . . 0.0 112.905 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.83 161.07 33.83 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.01 1.324 . . . . 0.0 112.945 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -60.95 129.81 43.28 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.099 1.36 . . . . 0.0 112.29 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.46 4.97 59.27 Favored Glycine 0 CA--C 1.535 1.281 0 N-CA-C 115.99 1.156 . . . . 0.0 115.99 171.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -64.68 138.02 58.15 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.179 1.49 . . . . 0.0 110.649 168.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -132.98 134.46 44.51 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -167.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -124.32 136.55 54.19 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.698 1.199 . . . . 0.0 111.484 -167.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t -100.73 132.29 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.725 0.81 . . . . 0.0 109.864 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 tt -120.43 103.44 9.19 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.845 0.858 . . . . 0.0 110.299 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -86.71 141.41 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 126.25 1.82 . . . . 0.0 109.867 -176.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.8 t -146.67 156.55 43.27 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.16 0.984 . . . . 0.0 111.899 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -140.25 143.88 36.2 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.024 1.33 . . . . 0.0 112.573 -171.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.2 p -141.37 163.02 34.08 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.361 1.864 . . . . 0.0 111.782 -174.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.2 m -67.07 154.86 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.314 1.046 . . . . 0.0 112.961 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.266 0 C-N-CA 125.166 1.365 . . . . 0.0 113.571 175.603 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -101.82 140.06 36.62 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.0 -1.688 . . . . 0.0 112.458 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.83 171.1 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 127.297 2.239 . . . . 0.0 110.399 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -127.2 149.95 49.75 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.809 1.244 . . . . 0.0 110.962 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.1 tt -129.38 142.47 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.119 0.968 . . . . 0.0 110.777 172.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.83 77.85 76.12 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 125.292 1.437 . . . . 0.0 109.779 -173.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.84 133.91 15.87 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.163 2.575 . . . . 0.0 111.497 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.7 41.47 0.27 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.253 1.421 . . . . 0.0 113.314 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.4 t -139.22 147.28 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.031 1.732 . . . . 0.0 110.718 -170.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.13 -119.92 16.37 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 123.898 0.761 . . . . 0.0 111.947 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.34 -18.41 71.43 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 123.684 0.659 . . . . 0.0 114.678 174.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.84 3.19 41.68 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 124.966 1.27 . . . . 0.0 115.748 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.5 p -82.33 155.72 69.14 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.996 1.718 . . . . 0.0 113.363 -174.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -67.34 152.18 79.49 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.302 2.668 . . . . 0.0 112.097 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.1 tp -141.31 125.3 17.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.797 1.239 . . . . 0.0 111.759 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -71.08 142.01 50.84 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.21 1.404 . . . . 0.0 112.327 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.75 151.78 37.73 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.382 1.473 . . . . 0.0 110.351 174.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -111.68 128.68 56.15 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.776 1.23 . . . . 0.0 110.465 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.5 m -140.53 155.1 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.206 1.402 . . . . 0.0 112.483 -165.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.98 150.29 97.64 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 123.82 0.848 . . . . 0.0 111.788 171.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.2 -25.34 57.76 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.966 2.444 . . . . 0.0 112.971 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -76.34 12.57 1.17 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.908 1.683 . . . . 0.0 114.728 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.55 105.12 0.73 Allowed 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.916 -1.115 . . . . 0.0 111.917 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.0 m -75.61 130.1 38.24 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.476 1.11 . . . . 0.0 111.15 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.9 t -60.93 -35.2 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.994 0.918 . . . . 0.0 112.925 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.59 -40.0 97.23 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 121.319 -0.863 . . . . 0.0 113.223 172.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.66 -34.76 77.57 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 117.975 0.887 . . . . 0.0 112.324 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.2 t -60.48 -44.39 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 O-C-N 121.505 -0.747 . . . . 0.0 110.814 172.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -61.42 -54.21 46.47 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.323 173.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 66.4 p -63.17 -34.44 77.63 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.41 1.005 . . . . 0.0 112.853 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -61.06 -47.5 86.09 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.739 0.816 . . . . 0.0 111.751 173.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.0 t -66.6 -41.87 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.805 176.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 92.4 m -57.84 -41.87 83.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.46 1.027 . . . . 0.0 112.087 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.51 -41.5 88.77 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.696 0.798 . . . . 0.0 112.849 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.5 mtt -67.29 -39.49 86.01 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.04 0.936 . . . . 0.0 113.106 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -79.14 -23.22 44.13 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.879 1.272 . . . . 0.0 113.647 176.635 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt 58.78 31.3 21.07 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.419 1.888 . . . . 0.0 113.189 -167.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 mp -114.24 150.58 43.92 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 126.249 1.82 . . . . 0.0 111.035 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -69.54 161.84 44.32 Favored 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.702 2.935 . . . . 0.0 112.726 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -65.18 -20.18 62.77 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.22 2.613 . . . . 0.0 113.674 176.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -67.65 -31.56 71.64 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.149 -0.969 . . . . 0.0 113.309 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 47.8 p -94.41 20.17 8.65 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.382 1.473 . . . . 0.0 113.704 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 t -145.68 152.55 39.8 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.334 1.054 . . . . 0.0 112.373 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 88.0 mmt-85 -139.36 145.55 39.15 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.924 1.69 . . . . 0.0 111.283 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.8 tp -134.71 127.9 31.91 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.441 1.896 . . . . 0.0 109.834 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.6 p -140.67 155.48 46.48 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.418 1.087 . . . . 0.0 112.772 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -146.41 140.49 26.35 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.101 1.76 . . . . 0.0 110.013 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.1 tptt 50.95 34.8 11.17 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.644 1.578 . . . . 0.0 114.035 -177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.87 14.94 81.17 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.757 1.17 . . . . 0.0 115.292 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -130.71 145.45 51.94 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.129 1.772 . . . . 0.0 111.739 -173.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.84 119.4 23.86 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.739 0.815 . . . . 0.0 110.655 171.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.1 mp -93.37 135.42 34.62 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.25 1.02 . . . . 0.0 110.212 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -160.64 149.7 16.97 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.227 1.811 . . . . 0.0 110.127 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 56.18 27.43 11.61 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.601 1.561 . . . . 0.0 114.823 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -73.23 -26.09 60.99 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.52 1.128 . . . . 0.0 113.638 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 61.04 -43.85 0.12 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.73 2.812 . . . . 0.0 115.079 -167.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.8 t -155.05 145.43 22.05 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.121 1.768 . . . . 0.0 110.62 174.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.72 -18.85 65.39 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.671 -0.643 . . . . 0.0 111.938 172.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.66 -24.11 67.47 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.033 -1.042 . . . . 0.0 112.772 173.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.7 t -68.25 -36.89 80.15 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.808 0.843 . . . . 0.0 112.283 172.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.4 mt -85.66 -20.67 29.08 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.972 1.309 . . . . 0.0 113.323 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.64 115.77 3.75 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.757 2.123 . . . . 0.0 111.856 -172.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.6 m -77.7 151.86 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.851 1.261 . . . . 0.0 113.364 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.89 163.61 39.77 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.407 1.883 . . . . 0.0 110.755 169.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -90.89 150.23 21.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.166 0.987 . . . . 0.0 112.806 172.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.67 81.67 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.739 1.161 . . . . 0.0 114.804 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -62.19 120.95 11.91 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.531 1.165 . . . . 0.0 110.745 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -106.15 114.87 29.26 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.045 0.938 . . . . 0.0 112.075 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -93.61 125.8 38.42 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.575 1.55 . . . . 0.0 110.545 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.0 t -96.39 133.26 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.724 0.81 . . . . 0.0 109.433 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.5 tt -130.37 123.49 30.03 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.851 0.86 . . . . 0.0 111.232 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.4 mm -117.07 122.01 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.112 1.365 . . . . 0.0 110.163 -171.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -81.66 143.35 31.97 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.328 0.651 . . . . 0.0 110.949 167.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -78.12 152.23 32.93 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.753 0.821 . . . . 0.0 110.335 167.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 76.3 p -119.64 165.99 13.76 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.396 1.478 . . . . 0.0 111.501 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.4 p -137.14 142.59 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.077 1.351 . . . . 0.0 111.482 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.256 0 C-N-CA 125.565 1.555 . . . . 0.0 112.464 -178.369 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.5 mtt . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -79.76 149.28 31.17 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.16 -0.962 . . . . 0.0 111.559 166.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.97 140.26 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.918 2.087 . . . . 0.0 109.08 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -100.24 110.41 22.66 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.856 1.262 . . . . 0.0 110.951 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.3 tt -90.56 138.47 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.766 -0.584 . . . . 0.0 110.354 171.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.7 t -127.37 81.89 69.24 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 125.134 1.373 . . . . 0.0 109.65 -175.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -84.06 135.55 6.52 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.892 2.395 . . . . 0.0 113.02 -177.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.1 37.23 0.25 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.771 1.628 . . . . 0.0 114.109 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.84 157.16 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.681 1.593 . . . . 0.0 111.148 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.58 -115.48 7.38 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.207 0.908 . . . . 0.0 111.863 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.35 -21.93 70.75 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 123.736 0.684 . . . . 0.0 114.376 174.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.33 23.7 70.22 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 118.539 1.169 . . . . 0.0 114.576 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -133.14 155.88 80.54 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 125.822 1.649 . . . . 0.0 112.964 -163.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.1 138.16 55.39 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.991 2.46 . . . . 0.0 112.564 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.2 mt -131.36 122.8 26.97 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.734 1.614 . . . . 0.0 110.205 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -79.71 141.39 36.43 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.709 0.804 . . . . 0.0 111.894 173.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 tp -150.25 144.69 25.75 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.954 1.301 . . . . 0.0 111.229 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -86.05 136.54 33.19 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.98 0.912 . . . . 0.0 111.017 170.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 t -142.98 142.53 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.426 1.09 . . . . 0.0 111.019 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.49 152.14 96.5 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.689 1.196 . . . . 0.0 113.192 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.07 -20.23 50.58 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.379 2.719 . . . . 0.0 113.492 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -72.02 6.0 2.38 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.87 1.668 . . . . 0.0 114.354 172.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.3 131.05 47.04 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.572 1.078 . . . . 0.0 112.496 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.0 m -116.47 133.25 56.23 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.469 1.508 . . . . 0.0 109.798 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.0 t -59.67 -41.0 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.304 0.642 . . . . 0.0 112.155 -175.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.71 -36.54 91.91 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.522 -0.599 . . . . 0.0 113.413 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.9 -44.22 73.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.381 1.091 . . . . 0.0 111.945 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.66 -47.01 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.591 0.756 . . . . 0.0 111.169 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -61.63 -43.55 98.64 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.457 1.103 . . . . 0.0 111.944 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 88.3 m -62.52 -42.6 99.62 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.655 0.662 . . . . 0.0 111.696 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.67 -43.78 98.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.004 0.921 . . . . 0.0 111.489 176.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.79 -52.86 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.236 1.015 . . . . 0.0 111.504 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 85.1 m -61.06 -35.88 78.11 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.778 0.717 . . . . 0.0 112.599 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.82 -44.25 81.68 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.824 0.849 . . . . 0.0 112.911 173.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 71.7 mtm -68.97 -39.06 79.68 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.527 -0.733 . . . . 0.0 112.928 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -15.63 58.87 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.82 1.248 . . . . 0.0 113.426 176.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? 57.18 32.53 21.87 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.597 1.959 . . . . 0.0 112.447 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 32.0 mt -148.42 152.06 37.84 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 126.268 1.827 . . . . 0.0 112.311 -165.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.58 164.03 35.96 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 124.395 3.397 . . . . 0.0 114.44 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.95 -5.21 15.12 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.651 2.901 . . . . 0.0 114.476 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -75.05 -32.39 61.53 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.796 -1.19 . . . . 0.0 113.287 168.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.7 p -95.15 -20.35 19.33 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.1 m -135.16 130.4 35.33 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.308 1.043 . . . . 0.0 111.055 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -132.02 159.33 39.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.816 1.647 . . . . 0.0 112.598 -173.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.8 tp -127.61 137.0 52.43 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.184 1.794 . . . . 0.0 110.752 -176.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.5 p -132.64 151.45 51.95 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.028 0.931 . . . . 0.0 111.993 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -138.3 128.98 26.55 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.005 1.722 . . . . 0.0 109.984 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt 50.28 37.05 14.1 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.114 1.366 . . . . 0.0 114.076 172.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.22 11.49 80.71 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.447 1.499 . . . . 0.0 116.248 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -137.34 155.02 49.91 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.222 1.511 . . . . 0.0 113.59 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.14 99.52 11.57 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.57 1.148 . . . . 0.0 110.249 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.58 141.28 57.89 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.187 0.995 . . . . 0.0 110.994 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -166.6 154.48 9.91 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.649 1.58 . . . . 0.0 111.954 173.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.9 t0 57.41 28.72 15.82 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.973 1.709 . . . . 0.0 115.468 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.6 p -84.45 -24.73 29.38 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -174.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 59.49 -46.52 0.08 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 128.287 2.635 . . . . 0.0 115.803 -167.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 t -151.67 142.71 23.12 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.312 1.445 . . . . 0.0 111.229 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.4 tp -70.04 -22.86 63.04 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.699 0.799 . . . . 0.0 112.645 174.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.83 -33.6 75.08 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.085 -1.009 . . . . 0.0 113.168 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.4 t -64.81 -33.89 77.05 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.469 0.708 . . . . 0.0 112.32 174.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 87.0 mt -84.98 -3.98 58.97 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.548 1.539 . . . . 0.0 113.504 173.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.74 113.76 0.49 Allowed Glycine 0 CA--C 1.536 1.397 0 C-N-CA 126.026 1.774 . . . . 0.0 112.825 -170.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 m -70.79 157.56 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.206 1.002 . . . . 0.0 112.196 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -138.12 -169.07 2.49 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.084 1.754 . . . . 0.0 110.874 174.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -138.07 150.59 47.04 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.274 1.029 . . . . 0.0 112.58 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.82 21.75 75.22 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 123.32 0.486 . . . . 0.0 113.9 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -60.86 153.34 24.93 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.835 1.254 . . . . 0.0 112.858 176.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -134.41 136.69 43.47 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.094 0.958 . . . . 0.0 113.028 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -125.69 136.13 52.87 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.189 1.795 . . . . 0.0 109.411 -174.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.8 t -117.38 124.21 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.571 0.749 . . . . 0.0 110.079 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tp -104.39 125.99 51.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.692 0.797 . . . . 0.0 110.332 176.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.5 pt -116.5 146.27 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.348 1.459 . . . . 0.0 110.336 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.8 t -139.43 146.89 40.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.037 0.935 . . . . 0.0 111.548 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 55.6 ttt-85 -133.12 126.77 32.46 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.331 1.852 . . . . 0.0 110.475 -169.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 74.9 p -73.68 153.55 40.05 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.209 0.604 . . . . 0.0 111.659 173.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.7 t -88.07 99.08 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.651 0.781 . . . . 0.0 109.106 174.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.265 0 C-N-CA 126.083 1.802 . . . . 0.0 113.093 -178.003 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.477 ' HB2' ' OD1' ' A' ' 65' ' ' ASP . 15.8 mmt . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 mtmm -86.33 143.23 27.97 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.915 0.886 . . . . 0.0 110.283 162.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.3 157.54 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.009 1.723 . . . . 0.0 109.687 172.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -122.45 102.07 7.87 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.085 0.954 . . . . 0.0 110.88 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 tt -87.26 141.66 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 122.791 0.436 . . . . 0.0 110.71 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.3 t -130.73 81.78 66.47 Favored Pre-proline 0 N--CA 1.47 0.56 0 C-N-CA 125.276 1.43 . . . . 0.0 109.48 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.41 134.22 12.43 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.685 2.257 . . . . 0.0 112.046 178.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.18 40.65 0.21 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.024 1.33 . . . . 0.0 113.515 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.2 t -137.97 147.11 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.044 1.738 . . . . 0.0 110.814 -170.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.13 -121.55 21.55 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.845 0.736 . . . . 0.0 111.961 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.05 -17.31 71.67 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.671 0.653 . . . . 0.0 114.59 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.36 3.34 61.56 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.778 1.18 . . . . 0.0 115.402 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 m -72.65 152.13 91.47 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.103 1.361 . . . . 0.0 113.717 -172.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -64.97 152.64 81.67 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.706 2.271 . . . . 0.0 111.81 164.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.3 tp -142.64 124.52 15.16 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.785 1.234 . . . . 0.0 111.323 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -82.77 135.11 35.08 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.951 0.901 . . . . 0.0 111.899 175.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.3 mt -142.7 141.25 31.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.14 1.776 . . . . 0.0 110.761 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -76.78 144.61 39.07 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.626 0.77 . . . . 0.0 111.832 166.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.9 m -142.11 153.79 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.854 1.262 . . . . 0.0 111.452 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.76 150.7 88.69 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.218 0.607 . . . . 0.0 111.692 169.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -65.29 -20.92 62.14 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.781 2.321 . . . . 0.0 112.889 173.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -80.22 7.53 9.21 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.026 1.73 . . . . 0.0 114.185 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.18 117.53 4.5 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.691 1.197 . . . . 0.0 112.963 -174.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.9 m -91.34 141.27 28.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.36 1.464 . . . . 0.0 111.684 -176.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.48 -44.22 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.556 -0.715 . . . . 0.0 111.986 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.2 -36.83 93.0 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.513 0.577 . . . . 0.0 113.681 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.82 -43.67 83.19 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.167 0.983 . . . . 0.0 111.797 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 82.3 t -63.7 -44.81 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.854 0.862 . . . . 0.0 111.252 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -64.02 -38.02 89.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.286 1.035 . . . . 0.0 111.966 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.0 m -66.34 -44.95 81.85 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.19 0.996 . . . . 0.0 111.423 174.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -58.17 -45.04 88.2 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.0 0.92 . . . . 0.0 112.139 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.8 t -59.67 -53.24 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.086 0.955 . . . . 0.0 111.112 173.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.3 t -61.08 -41.52 96.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.357 0.663 . . . . 0.0 112.535 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.9 73.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.065 0.946 . . . . 0.0 112.79 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.9 ttp -73.42 -22.57 60.19 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.6 mmpm? -93.23 -15.39 25.94 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.959 1.304 . . . . 0.0 113.688 170.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt 55.71 24.85 7.6 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.933 2.493 . . . . 0.0 114.613 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.86 153.97 61.65 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.857 1.663 . . . . 0.0 111.644 -173.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -71.12 156.66 59.25 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.897 3.065 . . . . 0.0 113.243 -175.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.75 -14.5 45.19 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.824 3.016 . . . . 0.0 114.491 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -64.22 -24.99 67.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.824 0.85 . . . . 0.0 113.09 170.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 38.8 p -98.17 -26.86 14.42 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.416 1.087 . . . . 0.0 113.441 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 84.9 m -138.76 116.94 11.8 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.284 1.034 . . . . 0.0 111.61 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -109.59 162.84 14.02 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.875 1.67 . . . . 0.0 112.984 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.4 tp -129.66 140.52 51.13 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.039 1.736 . . . . 0.0 111.303 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.4 p -136.26 157.71 46.16 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.597 1.159 . . . . 0.0 112.537 171.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -139.5 131.2 27.36 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.857 2.063 . . . . 0.0 109.789 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? 47.74 37.21 6.66 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.591 1.556 . . . . 0.0 114.485 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.09 14.95 81.76 Favored Glycine 0 CA--C 1.54 1.632 0 N-CA-C 115.715 1.046 . . . . 0.0 115.715 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -134.32 159.85 39.72 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.759 1.623 . . . . 0.0 111.761 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.12 133.16 34.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.407 0.683 . . . . 0.0 111.332 169.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.0 mt -86.41 127.55 34.84 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.822 0.849 . . . . 0.0 110.457 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.33 131.89 9.52 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.306 1.442 . . . . 0.0 110.541 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.0 t0 55.26 29.18 12.39 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.703 1.601 . . . . 0.0 115.094 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.2 p -84.5 -11.99 55.08 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.762 -1.211 . . . . 0.0 113.95 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 63.6 -54.15 0.22 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.893 2.477 . . . . 0.0 115.388 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.1 p -147.33 158.09 43.83 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.312 1.845 . . . . 0.0 111.516 176.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.4 -34.17 77.56 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.721 -0.612 . . . . 0.0 112.066 168.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.6 tm-20 -63.14 -33.54 75.69 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.832 0.853 . . . . 0.0 113.034 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 p -63.75 -27.65 69.34 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.4 mt -98.07 4.75 49.17 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.858 1.663 . . . . 0.0 113.17 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.16 100.11 0.76 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.367 1.46 . . . . 0.0 112.141 -172.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.5 p -73.65 150.68 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.869 1.267 . . . . 0.0 111.813 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.69 -171.86 3.33 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.041 1.736 . . . . 0.0 111.041 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.477 ' OD1' ' HB2' ' A' ' 1' ' ' MET . 14.2 t0 -121.88 145.2 48.32 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.453 1.101 . . . . 0.0 111.647 174.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.01 20.6 77.5 Favored Glycine 0 CA--C 1.539 1.533 0 CA-C-O 119.705 -0.497 . . . . 0.0 114.333 -174.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -58.47 136.48 57.51 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.432 1.116 . . . . 0.0 111.835 172.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -112.25 140.68 46.76 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -123.66 132.64 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.151 1.781 . . . . 0.0 109.295 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.7 t -123.58 121.3 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 118.719 0.69 . . . . 0.0 110.873 -173.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 tp -96.32 137.72 34.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.379 1.072 . . . . 0.0 110.178 175.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.32 125.43 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.485 1.114 . . . . 0.0 109.027 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.7 t -118.1 142.04 47.84 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.711 1.204 . . . . 0.0 112.141 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 -80.79 138.06 36.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.912 1.285 . . . . 0.0 111.478 171.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.3 p -71.66 110.35 6.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.884 0.874 . . . . 0.0 110.091 169.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.5 t -73.77 120.05 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.509 0.723 . . . . 0.0 109.918 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.163 0 C-N-CA 125.25 1.405 . . . . 0.0 112.595 -177.73 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 121.344 0.592 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -92.75 139.31 30.68 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.652 1.181 . . . . 0.0 111.197 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pp -137.0 162.84 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.773 1.629 . . . . 0.0 110.849 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -126.79 138.73 53.4 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.203 1.001 . . . . 0.0 112.153 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.9 mt -121.18 133.91 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.936 1.295 . . . . 0.0 109.096 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.23 92.87 37.71 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.692 1.197 . . . . 0.0 110.831 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -88.25 130.87 2.5 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.915 2.41 . . . . 0.0 112.493 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.23 29.95 0.12 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.514 1.526 . . . . 0.0 114.507 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.3 m -73.95 73.87 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 126.471 1.908 . . . . 0.0 112.767 -173.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.0 38.91 63.89 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.143 0.878 . . . . 0.0 113.192 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.55 29.46 29.8 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.311 0.958 . . . . 0.0 114.289 -174.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.78 141.22 48.1 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 124.622 1.106 . . . . 0.0 114.103 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 m -80.03 154.62 75.16 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 125.107 1.363 . . . . 0.0 113.418 -176.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -62.89 147.43 94.62 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.075 2.517 . . . . 0.0 111.997 166.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.86 138.03 35.39 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.64 1.576 . . . . 0.0 110.813 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -87.73 140.34 29.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.069 1.348 . . . . 0.0 112.122 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 mp -140.85 164.94 28.88 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.083 1.753 . . . . 0.0 111.459 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -116.39 137.53 52.08 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.52 1.528 . . . . 0.0 110.217 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.3 158.99 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.743 1.217 . . . . 0.0 111.879 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.2 149.13 98.62 Favored Pre-proline 0 CA--C 1.551 0.984 0 O-C-N 121.767 -0.583 . . . . 0.0 111.498 170.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.46 -24.32 56.94 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.944 2.429 . . . . 0.0 113.221 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -82.95 33.35 0.44 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.925 1.69 . . . . 0.0 113.638 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.41 117.76 5.64 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.184 -0.948 . . . . 0.0 111.199 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.2 m -97.46 129.36 44.66 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.732 1.213 . . . . 0.0 110.888 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.8 -44.0 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.917 0.887 . . . . 0.0 112.226 -175.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.46 -36.47 93.42 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.517 0.579 . . . . 0.0 113.51 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.92 -37.98 76.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.38 1.09 . . . . 0.0 112.378 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.7 t -68.65 -43.93 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.276 1.03 . . . . 0.0 111.24 174.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -63.84 -37.39 87.2 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.022 0.929 . . . . 0.0 112.241 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.9 m -64.17 -39.77 94.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.661 0.785 . . . . 0.0 111.328 170.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.24 -47.95 83.81 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.872 0.869 . . . . 0.0 111.281 174.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.4 t -56.9 -50.22 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.04 1.336 . . . . 0.0 111.342 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.5 t -59.93 -44.71 94.17 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.756 0.822 . . . . 0.0 112.109 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.84 86.17 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.994 0.918 . . . . 0.0 113.177 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.4 mtt -68.64 -42.49 77.94 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.107 0.963 . . . . 0.0 112.748 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.98 -23.28 41.71 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.01 26.24 15.53 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.962 1.705 . . . . 0.0 113.275 -174.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.79 153.91 70.39 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 126.845 2.058 . . . . 0.0 111.317 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.47 163.63 38.16 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 124.293 3.329 . . . . 0.0 114.247 -173.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.57 -15.78 51.75 Favored 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 123.421 2.747 . . . . 0.0 113.992 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -67.67 -28.86 68.05 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.138 -0.976 . . . . 0.0 113.208 173.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.1 p -102.95 -10.16 19.23 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.087 1.355 . . . . 0.0 113.872 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.4 m -148.63 123.49 9.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.836 1.254 . . . . 0.0 111.263 172.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -110.49 160.39 16.66 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.718 1.207 . . . . 0.0 113.447 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.6 tp -126.43 132.52 51.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.798 2.039 . . . . 0.0 110.391 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.5 p -137.11 158.36 44.62 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.362 1.065 . . . . 0.0 111.966 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -133.44 126.58 31.51 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.137 2.175 . . . . 0.0 109.378 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt 51.49 30.66 6.55 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.17 0.988 . . . . 0.0 113.382 -174.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.34 2.28 73.15 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 125.26 1.409 . . . . 0.0 115.958 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.44 146.3 29.68 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.948 2.099 . . . . 0.0 111.357 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.8 122.15 25.68 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.576 -0.703 . . . . 0.0 110.968 169.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.2 mt -83.35 134.17 34.92 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.201 1.0 . . . . 0.0 111.097 171.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -160.38 144.76 14.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.456 1.502 . . . . 0.0 110.578 170.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.9 t0 52.69 27.99 5.8 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.778 1.631 . . . . 0.0 115.021 174.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.9 m -83.04 -23.82 33.04 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.078 1.351 . . . . 0.0 112.926 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 61.63 -52.85 0.13 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 128.403 2.681 . . . . 0.0 115.544 -172.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.0 t -159.15 142.27 14.5 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.031 1.332 . . . . 0.0 111.641 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.16 -26.75 67.57 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.538 0.735 . . . . 0.0 112.314 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.43 -20.01 64.62 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.755 1.161 . . . . 0.0 113.361 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.7 t -74.91 -38.19 61.89 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.112 0.965 . . . . 0.0 112.374 173.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.47 -35.73 14.94 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.887 1.275 . . . . 0.0 112.929 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 140.42 87.77 0.13 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.042 1.782 . . . . 0.0 112.267 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.3 p -76.72 147.36 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.011 1.324 . . . . 0.0 112.357 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.19 156.13 37.98 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.894 1.278 . . . . 0.0 112.483 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -67.65 147.09 53.17 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.339 -0.851 . . . . 0.0 111.287 162.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.78 14.32 77.95 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 123.867 0.746 . . . . 0.0 114.493 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -55.4 132.91 49.36 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.729 1.264 . . . . 0.0 110.579 168.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.48 131.95 45.41 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.268 1.027 . . . . 0.0 112.443 -165.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -128.07 132.1 49.06 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.432 1.493 . . . . 0.0 110.637 -169.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.74 133.96 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.166 0.987 . . . . 0.0 110.752 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 tp -109.93 115.47 29.85 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.313 1.045 . . . . 0.0 110.049 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.2 mm -105.32 94.09 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.256 1.023 . . . . 0.0 108.983 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -79.22 152.02 30.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.259 1.424 . . . . 0.0 111.243 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -131.48 139.5 49.35 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.74 1.216 . . . . 0.0 112.197 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.4 m -68.3 143.03 55.36 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.071 1.348 . . . . 0.0 112.365 -172.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.2 t -128.65 -49.22 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.715 1.206 . . . . 0.0 112.015 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.194 0 CA-C-O 118.265 -1.297 . . . . 0.0 113.173 -179.366 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 110.583 -0.154 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -86.13 145.4 27.04 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.179 -1.575 . . . . 0.0 112.944 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.4 mm -136.48 140.12 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 127.873 2.469 . . . . 0.0 108.641 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -91.84 140.2 29.91 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.177 0.591 . . . . 0.0 110.596 167.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.6 pt -118.78 139.78 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.888 0.875 . . . . 0.0 110.317 168.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 t -129.95 73.71 81.18 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 124.602 1.161 . . . . 0.0 110.371 -175.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -78.62 134.34 12.22 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.508 2.805 . . . . 0.0 112.014 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.05 35.17 0.2 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.603 1.561 . . . . 0.0 114.545 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.4 m -138.94 161.59 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 126.09 1.756 . . . . 0.0 111.874 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.87 -119.97 18.31 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 123.687 0.661 . . . . 0.0 111.467 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.09 -17.85 74.18 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 123.684 0.659 . . . . 0.0 114.691 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.48 2.48 35.01 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.206 1.384 . . . . 0.0 115.229 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.6 p -85.63 156.55 58.8 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.392 1.877 . . . . 0.0 113.591 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.32 153.08 79.4 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.051 2.5 . . . . 0.0 112.4 170.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.8 tp -143.19 130.04 20.48 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.185 1.394 . . . . 0.0 111.671 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -80.35 134.97 36.1 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.41 1.084 . . . . 0.0 111.967 172.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.4 mt -142.93 149.53 38.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.118 1.767 . . . . 0.0 111.409 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -90.58 134.32 34.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.502 1.121 . . . . 0.0 110.809 169.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.59 154.64 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.612 1.165 . . . . 0.0 112.299 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.64 152.12 89.35 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.361 1.064 . . . . 0.0 112.585 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.11 -17.98 55.74 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.364 2.709 . . . . 0.0 113.544 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -80.59 4.81 17.3 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.521 1.528 . . . . 0.0 113.928 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.67 125.99 25.81 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.495 1.043 . . . . 0.0 112.565 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 m -94.21 131.27 39.96 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.045 1.338 . . . . 0.0 110.814 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.6 t -60.6 -41.54 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 O-C-N 121.348 -0.845 . . . . 0.0 111.962 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.86 -33.93 88.57 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 123.827 0.727 . . . . 0.0 113.767 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.97 -42.66 76.31 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.389 1.095 . . . . 0.0 111.463 174.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.59 -48.03 88.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.77 0.828 . . . . 0.0 110.876 174.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.4 mmm-85 -58.14 -45.99 86.43 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.792 0.837 . . . . 0.0 112.115 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.7 m -60.34 -44.53 95.43 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.332 0.653 . . . . 0.0 111.902 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -42.85 99.44 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.149 0.979 . . . . 0.0 111.568 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.0 t -67.18 -47.76 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.589 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 97.8 m -57.67 -42.32 83.31 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.025 1.284 . . . . 0.0 112.087 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.94 -41.18 91.64 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.79 0.836 . . . . 0.0 112.797 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.7 ttt -70.85 -41.68 71.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.257 1.023 . . . . 0.0 112.815 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -29.11 63.85 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.762 1.225 . . . . 0.0 112.641 173.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? 68.65 31.75 4.51 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 127.247 2.219 . . . . 0.0 113.208 -173.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mp -128.98 153.65 80.26 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.193 1.797 . . . . 0.0 111.824 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.14 159.62 53.13 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.836 3.024 . . . . 0.0 113.245 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.51 -15.25 48.91 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.923 3.082 . . . . 0.0 114.408 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -70.23 -25.14 63.24 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.475 1.034 . . . . 0.0 113.031 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.4 m -93.46 0.65 56.84 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.962 1.305 . . . . 0.0 113.22 -175.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.0 t -137.34 140.21 41.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.939 1.296 . . . . 0.0 112.056 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -134.16 140.8 46.79 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.72 1.608 . . . . 0.0 110.772 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.4 tp -131.63 129.92 41.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.508 1.523 . . . . 0.0 110.907 -171.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -139.7 153.82 47.33 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.48 1.112 . . . . 0.0 112.948 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -143.72 138.64 29.01 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.263 1.825 . . . . 0.0 110.24 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 55.03 30.89 15.04 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.863 1.265 . . . . 0.0 113.777 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.45 18.19 79.28 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 124.786 1.184 . . . . 0.0 114.952 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -134.15 142.78 47.58 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.373 1.869 . . . . 0.0 111.132 -170.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.91 135.55 40.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.762 0.825 . . . . 0.0 111.919 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.4 mt -103.91 136.81 42.88 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.486 1.114 . . . . 0.0 110.798 173.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.48 149.65 18.94 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.119 1.368 . . . . 0.0 111.164 171.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.0 t0 54.23 27.67 8.16 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.778 1.631 . . . . 0.0 114.88 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -75.24 -24.88 57.72 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.388 1.075 . . . . 0.0 113.287 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 60.53 -56.01 0.08 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 128.584 2.754 . . . . 0.0 114.898 -169.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 p -146.92 133.57 19.91 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.934 1.694 . . . . 0.0 111.205 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.79 -32.8 74.53 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.871 0.869 . . . . 0.0 112.882 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -62.09 -26.83 68.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.145 0.978 . . . . 0.0 113.383 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.6 m -71.05 -28.15 64.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.385 1.074 . . . . 0.0 113.445 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 72.3 mt -99.76 -32.21 11.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.74 1.216 . . . . 0.0 112.966 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 138.39 81.55 0.09 OUTLIER Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.516 1.532 . . . . 0.0 112.162 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.4 p -70.52 147.07 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.268 1.027 . . . . 0.0 111.633 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -146.36 167.96 22.29 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.619 1.568 . . . . 0.0 111.863 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -106.48 145.69 31.49 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.375 1.47 . . . . 0.0 113.446 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.53 13.45 82.93 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 123.798 0.714 . . . . 0.0 114.463 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -65.03 159.92 22.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.412 1.085 . . . . 0.0 111.796 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.72 130.96 28.44 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -101.43 138.5 38.36 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.242 1.417 . . . . 0.0 111.093 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.87 134.47 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.263 1.025 . . . . 0.0 109.574 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.0 tt -130.84 125.46 33.7 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.759 0.824 . . . . 0.0 111.514 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.0 mm -113.41 135.78 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.123 1.769 . . . . 0.0 110.476 -170.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.2 t -102.05 143.48 31.84 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.803 1.241 . . . . 0.0 111.346 172.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.06 114.62 27.19 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.626 1.17 . . . . 0.0 111.055 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.2 t -71.98 157.24 38.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.006 0.922 . . . . 0.0 112.338 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.6 t -124.61 -46.16 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.509 1.524 . . . . 0.0 112.154 -176.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.321 0 CA-C-O 117.862 -1.521 . . . . 0.0 113.976 -178.511 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ttt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 120.657 0.265 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -68.56 147.52 51.84 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.624 -1.297 . . . . 0.0 111.072 158.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -143.95 166.11 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 127.568 2.347 . . . . 0.0 110.165 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -125.69 134.9 51.66 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.062 0.945 . . . . 0.0 111.355 167.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 54.5 mt -121.53 131.03 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.999 1.319 . . . . 0.0 108.669 177.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 p -121.49 98.11 46.48 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 124.563 1.145 . . . . 0.0 110.77 173.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -84.58 144.11 9.98 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.298 2.666 . . . . 0.0 111.38 172.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.34 34.38 0.11 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 125.687 1.595 . . . . 0.0 113.553 173.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.3 t -134.29 144.32 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.263 1.825 . . . . 0.0 110.684 -167.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.24 -113.76 6.21 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.05 0.833 . . . . 0.0 112.234 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.73 -20.22 70.05 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 123.984 0.802 . . . . 0.0 114.548 174.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.37 12.86 64.26 Favored Glycine 0 CA--C 1.54 1.606 0 CA-C-N 118.547 1.173 . . . . 0.0 115.47 175.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.0 p -111.86 155.97 42.39 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 126.254 1.822 . . . . 0.0 113.003 -167.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.6 145.11 91.3 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.977 2.451 . . . . 0.0 112.317 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.92 129.62 34.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.6 1.56 . . . . 0.0 109.998 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.84 135.21 43.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.654 1.181 . . . . 0.0 111.543 173.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.13 168.59 19.38 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.832 1.653 . . . . 0.0 110.602 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.2 143.56 49.95 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.909 1.284 . . . . 0.0 111.086 166.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.5 m -141.45 158.12 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.033 1.333 . . . . 0.0 112.109 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.64 149.23 98.35 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.238 1.015 . . . . 0.0 112.179 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -67.69 -17.71 47.81 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.623 2.882 . . . . 0.0 113.837 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.48 -6.7 59.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.205 1.402 . . . . 0.0 114.136 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.76 141.5 52.74 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.471 1.032 . . . . 0.0 111.282 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.9 t -130.83 145.94 52.13 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.365 1.066 . . . . 0.0 111.328 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.24 -35.28 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.439 0.696 . . . . 0.0 111.807 -169.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.57 -35.98 91.93 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 121.736 -0.603 . . . . 0.0 113.84 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.89 -41.91 67.41 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.596 1.198 . . . . 0.0 112.045 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.79 -44.44 99.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.561 0.744 . . . . 0.0 110.685 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -60.35 -47.16 87.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.373 1.069 . . . . 0.0 111.523 174.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.1 m -59.85 -45.77 91.4 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.937 0.895 . . . . 0.0 111.813 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -60.2 -43.31 96.02 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.705 0.802 . . . . 0.0 112.505 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.51 -41.32 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.777 0.717 . . . . 0.0 112.105 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 87.5 m -60.53 -37.16 80.3 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.527 1.058 . . . . 0.0 112.31 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.0 77.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.252 1.021 . . . . 0.0 113.122 174.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.3 mmt -66.83 -38.32 86.21 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.325 -0.859 . . . . 0.0 112.524 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -23.1 58.56 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.991 1.316 . . . . 0.0 113.385 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.5 mtpt 51.04 45.02 28.36 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.958 2.103 . . . . 0.0 112.435 -167.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.2 mt -136.17 151.34 73.33 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.786 1.634 . . . . 0.0 112.245 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -70.77 162.44 42.58 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 124.004 3.136 . . . . 0.0 113.526 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.69 -11.58 29.72 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 123.662 2.908 . . . . 0.0 114.305 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -72.07 -32.85 67.44 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.694 1.197 . . . . 0.0 113.123 173.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.6 p -105.11 -5.23 20.99 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.156 1.382 . . . . 0.0 113.858 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.0 m -147.63 125.18 11.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.137 1.775 . . . . 0.0 110.077 176.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -140.47 147.19 39.24 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.1 tp -108.85 140.17 42.67 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.587 1.955 . . . . 0.0 111.028 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.9 t -141.88 157.33 45.12 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.263 1.425 . . . . 0.0 111.485 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -132.0 129.99 40.83 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.67 1.588 . . . . 0.0 110.359 -174.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp 51.36 29.06 4.79 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.61 14.84 82.07 Favored Glycine 0 CA--C 1.541 1.709 0 C-N-CA 125.288 1.423 . . . . 0.0 116.09 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.47 129.26 30.81 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.781 1.632 . . . . 0.0 111.267 -177.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.76 131.65 46.83 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.332 0.653 . . . . 0.0 112.501 -175.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.1 mt -131.68 153.9 49.53 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.461 1.504 . . . . 0.0 111.607 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -161.08 -48.83 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.978 1.711 . . . . 0.0 111.268 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -81.54 27.82 0.42 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.688 1.995 . . . . 0.0 114.115 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.8 m -68.09 -27.56 66.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.25 1.42 . . . . 0.0 113.277 -172.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 64.5 -63.43 0.17 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.231 2.612 . . . . 0.0 114.895 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.6 p -149.08 146.99 27.99 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.249 1.819 . . . . 0.0 110.485 168.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.4 mt -74.08 -27.4 60.88 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.538 -0.726 . . . . 0.0 112.068 171.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -58.53 -36.21 73.51 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.227 1.011 . . . . 0.0 113.079 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.8 p -63.71 -20.01 65.39 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.5 mt -105.6 -2.44 23.48 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.034 1.733 . . . . 0.0 113.294 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.26 113.84 0.35 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.629 1.585 . . . . 0.0 112.578 -171.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.67 146.04 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.976 1.31 . . . . 0.0 111.676 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -145.71 174.74 10.94 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.672 1.589 . . . . 0.0 111.797 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -78.29 162.05 26.8 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.027 0.931 . . . . 0.0 110.903 162.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.67 14.81 81.68 Favored Glycine 0 CA--C 1.536 1.406 0 N-CA-C 115.844 1.098 . . . . 0.0 115.844 174.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.59 127.25 31.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.852 1.326 . . . . 0.0 110.613 165.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -129.03 130.4 46.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.882 1.273 . . . . 0.0 111.981 -166.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -125.51 133.24 52.44 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.798 1.639 . . . . 0.0 111.195 -170.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.6 t -118.1 129.54 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.814 1.245 . . . . 0.0 109.152 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.38 120.57 34.39 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.263 1.025 . . . . 0.0 110.108 -176.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.4 mt -116.19 130.03 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.82 1.248 . . . . 0.0 109.12 -172.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.8 p -120.02 158.46 26.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.19 1.396 . . . . 0.0 111.053 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -137.1 116.46 12.71 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.433 1.093 . . . . 0.0 111.37 -175.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.9 m -101.28 50.06 0.86 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.099 1.36 . . . . 0.0 110.82 -175.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.9 p -77.39 143.91 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.677 1.191 . . . . 0.0 111.533 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.272 0 C-N-CA 125.303 1.43 . . . . 0.0 113.82 -179.249 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptm . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -86.44 149.61 24.87 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.127 -1.608 . . . . 0.0 111.812 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.4 pt -130.74 166.08 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.764 2.025 . . . . 0.0 111.117 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -131.07 112.46 12.91 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.577 1.151 . . . . 0.0 110.079 170.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.3 tt -94.81 139.69 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 122.779 0.432 . . . . 0.0 110.652 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 t -126.92 81.43 69.63 Favored Pre-proline 0 N--CA 1.471 0.609 0 C-N-CA 125.247 1.419 . . . . 0.0 109.649 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.53 136.39 12.34 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.474 2.116 . . . . 0.0 112.473 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.83 41.1 0.15 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.133 1.373 . . . . 0.0 113.194 171.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.4 t -135.86 142.66 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.348 1.859 . . . . 0.0 110.35 -169.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.43 -116.5 9.44 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.949 0.785 . . . . 0.0 112.533 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.82 -14.9 68.38 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.212 0.911 . . . . 0.0 115.081 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.69 7.37 47.66 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 118.885 1.342 . . . . 0.0 115.929 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.6 m -94.43 155.48 39.65 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.696 1.598 . . . . 0.0 113.166 -170.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -63.01 147.23 94.74 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.212 2.608 . . . . 0.0 112.18 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 tt -138.75 122.61 17.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.414 1.486 . . . . 0.0 110.391 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -82.27 143.39 31.35 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.958 0.903 . . . . 0.0 112.783 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 tp -152.2 153.81 34.55 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.535 1.134 . . . . 0.0 111.657 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -85.22 150.43 24.8 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.374 -0.829 . . . . 0.0 111.338 163.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p -148.16 149.66 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.101 0.961 . . . . 0.0 111.643 174.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.06 149.91 98.23 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.992 0.917 . . . . 0.0 112.482 176.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.56 -21.09 46.57 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.278 2.652 . . . . 0.0 113.023 175.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -78.76 16.45 0.87 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.954 1.702 . . . . 0.0 113.648 175.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.35 121.94 10.04 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.391 1.076 . . . . 0.0 112.003 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.6 m -107.83 130.23 55.01 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.283 1.433 . . . . 0.0 109.861 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.1 t -58.94 -42.93 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.383 0.673 . . . . 0.0 111.637 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.77 -37.48 92.51 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.619 1.104 . . . . 0.0 113.578 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.02 -45.12 71.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.326 1.063 . . . . 0.0 111.705 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.32 -50.68 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.814 0.846 . . . . 0.0 111.581 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.27 -37.15 86.47 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.683 -0.636 . . . . 0.0 112.468 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.1 m -67.13 -42.03 85.14 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.522 0.601 . . . . 0.0 111.451 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -40.2 93.72 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.996 0.919 . . . . 0.0 111.887 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -62.18 -52.54 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.555 1.142 . . . . 0.0 111.502 172.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 88.3 m -62.24 -35.51 79.14 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.51 0.596 . . . . 0.0 112.23 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.64 86.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.404 1.081 . . . . 0.0 112.752 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -43.95 87.16 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.726 0.81 . . . . 0.0 112.365 174.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 36' ' ' LYS . 8.0 mmpt? -73.71 -20.48 60.52 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.704 1.202 . . . . 0.0 113.99 177.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? 55.92 27.84 11.69 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.59 1.956 . . . . 0.0 113.075 -170.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.24 154.74 70.25 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.486 1.914 . . . . 0.0 111.394 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.69 165.07 33.24 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.425 3.417 . . . . 0.0 114.225 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.34 -17.5 58.14 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.312 2.675 . . . . 0.0 114.091 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -64.64 -28.91 69.93 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.829 -1.169 . . . . 0.0 112.796 173.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.0 p -98.48 -14.05 20.23 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.271 1.428 . . . . 0.0 114.328 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 100.0 m -142.66 117.03 9.61 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 119.899 1.227 . . . . 0.0 111.919 174.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.5 167.74 10.62 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.003 1.721 . . . . 0.0 113.137 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 69' ' ' PHE . 43.8 tp -142.63 136.42 29.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.03 1.732 . . . . 0.0 111.372 -173.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.4 p -135.57 158.31 44.69 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.54 1.136 . . . . 0.0 113.213 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -147.62 130.39 16.08 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.3 2.24 . . . . 0.0 110.052 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? 50.67 31.36 5.75 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.323 1.449 . . . . 0.0 113.78 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.86 7.35 88.37 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.01 1.291 . . . . 0.0 115.96 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -120.54 158.97 26.16 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.581 1.552 . . . . 0.0 112.409 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.39 127.76 32.5 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.649 0.78 . . . . 0.0 110.534 165.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.7 mt -75.46 138.12 41.4 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.376 0.671 . . . . 0.0 110.762 169.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -163.28 142.5 8.46 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.427 1.491 . . . . 0.0 111.464 170.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t0 57.19 21.39 6.52 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.3 m -70.84 -26.92 63.49 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.857 1.263 . . . . 0.0 112.9 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 63.65 -56.0 0.21 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 128.619 2.767 . . . . 0.0 115.01 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.3 p -145.06 144.46 30.98 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.274 1.429 . . . . 0.0 111.48 170.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.4 -28.54 68.01 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.558 -0.714 . . . . 0.0 112.271 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -65.29 -26.87 68.26 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.362 -0.836 . . . . 0.0 113.167 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.5 t -63.07 -37.49 87.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.738 0.815 . . . . 0.0 112.614 172.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.0 mt -90.68 -10.33 43.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.936 1.294 . . . . 0.0 113.689 174.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.51 118.14 2.49 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 126.471 1.986 . . . . 0.0 112.545 -172.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.7 t -73.51 144.89 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.811 1.244 . . . . 0.0 111.219 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.06 156.55 38.04 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.635 1.574 . . . . 0.0 110.551 166.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -88.77 146.92 24.73 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.152 -0.967 . . . . 0.0 112.522 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.0 26.59 66.29 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.631 0.613 . . . . 0.0 114.631 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -61.8 140.11 58.27 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.499 1.149 . . . . 0.0 111.869 175.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -119.13 134.23 55.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.711 0.804 . . . . 0.0 112.581 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.55 ' HB3' HD11 ' A' ' 45' ' ' LEU . 17.6 m-85 -122.28 138.25 54.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.427 1.491 . . . . 0.0 110.755 -174.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.83 123.07 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.591 0.757 . . . . 0.0 110.594 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tp -97.92 134.97 40.32 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.4 1.08 . . . . 0.0 110.637 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.08 111.7 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.719 1.208 . . . . 0.0 109.711 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.4 t -90.74 152.39 20.83 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.83 1.252 . . . . 0.0 111.292 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -122.38 121.49 36.78 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.673 1.589 . . . . 0.0 111.004 172.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.8 p -76.3 160.62 29.46 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.655 1.582 . . . . 0.0 112.417 176.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.7 t -70.7 -34.87 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.4 1.08 . . . . 0.0 112.222 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 C-N-CA 125.697 1.617 . . . . 0.0 113.401 -179.098 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 121.188 0.518 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -114.05 149.02 36.08 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.195 1.398 . . . . 0.0 111.414 170.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -128.52 155.32 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.865 1.666 . . . . 0.0 110.047 173.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -118.86 93.81 4.23 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.854 1.262 . . . . 0.0 110.22 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 tt -79.71 140.47 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.783 -0.573 . . . . 0.0 110.743 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.7 t -131.51 82.31 61.97 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 125.261 1.425 . . . . 0.0 109.842 -172.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.39 136.45 9.94 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.631 2.22 . . . . 0.0 113.098 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.96 39.22 0.18 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.592 1.557 . . . . 0.0 113.564 172.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.6 t -137.99 145.87 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.987 1.715 . . . . 0.0 110.691 -171.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.44 -119.58 17.33 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.054 0.835 . . . . 0.0 112.429 176.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.9 -14.42 67.87 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 124.088 0.851 . . . . 0.0 114.903 175.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.27 6.22 46.23 Favored Glycine 0 CA--C 1.541 1.71 0 CA-C-N 118.812 1.306 . . . . 0.0 115.87 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.2 m -90.83 153.57 45.35 Favored Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 125.369 1.468 . . . . 0.0 113.334 -171.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -66.25 152.98 79.79 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 123.403 2.735 . . . . 0.0 112.646 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 tp -140.1 118.72 12.32 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.427 1.491 . . . . 0.0 111.586 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -69.51 137.56 52.61 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.436 1.094 . . . . 0.0 111.575 169.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.3 tp -150.64 136.9 18.6 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.532 1.133 . . . . 0.0 111.51 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.02 143.33 43.6 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.612 0.765 . . . . 0.0 111.626 171.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.17 147.95 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.232 1.013 . . . . 0.0 112.1 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.79 150.89 95.28 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.143 0.977 . . . . 0.0 112.537 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.58 -27.12 53.67 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.043 2.496 . . . . 0.0 113.048 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -77.35 14.39 0.97 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.398 1.479 . . . . 0.0 114.134 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.13 100.29 0.32 Allowed 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.844 -1.16 . . . . 0.0 112.212 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.7 t -73.62 148.77 42.54 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.427 1.091 . . . . 0.0 110.858 168.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.6 m -57.75 -31.55 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.85 0.86 . . . . 0.0 112.485 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.33 -41.78 99.37 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.576 0.608 . . . . 0.0 112.732 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.2 -44.82 82.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.771 0.828 . . . . 0.0 111.75 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.2 t -62.98 -49.46 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.879 0.871 . . . . 0.0 110.924 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -35.92 78.26 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.853 1.261 . . . . 0.0 112.369 -177.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.6 m -66.79 -45.44 78.44 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.551 0.74 . . . . 0.0 111.435 172.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -63.18 -39.28 94.19 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.702 0.683 . . . . 0.0 111.928 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -56.94 -52.0 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.51 1.124 . . . . 0.0 111.385 170.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 51.8 t -60.86 -42.78 98.52 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.123 0.569 . . . . 0.0 112.207 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.23 -40.72 86.37 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.972 0.909 . . . . 0.0 113.254 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.8 tpp -67.73 -44.07 78.46 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.808 1.243 . . . . 0.0 112.094 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -76.63 -24.03 53.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.691 0.796 . . . . 0.0 113.043 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.3 ttpp 59.67 27.25 16.45 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.457 2.303 . . . . 0.0 114.144 -173.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.01 154.49 81.38 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 126.192 1.797 . . . . 0.0 112.033 -175.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.81 159.95 50.98 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.904 3.069 . . . . 0.0 113.974 -171.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.57 -10.24 28.46 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.269 3.312 . . . . 0.0 114.978 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -73.46 -21.56 60.41 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.195 -0.941 . . . . 0.0 112.601 167.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.9 m -108.48 -37.26 6.0 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.018 1.327 . . . . 0.0 112.844 -172.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.2 t -97.52 139.09 33.97 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.69 0.796 . . . . 0.0 111.728 170.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -136.54 154.11 50.81 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.592 1.557 . . . . 0.0 111.476 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.8 tp -138.23 132.9 32.5 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.472 1.509 . . . . 0.0 111.217 -171.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.2 p -140.17 155.12 47.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.26 1.024 . . . . 0.0 113.526 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -149.01 131.64 15.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.788 2.035 . . . . 0.0 110.302 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.0 tptt 54.27 29.05 10.04 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.166 1.386 . . . . 0.0 114.319 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.73 3.33 87.11 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.382 1.468 . . . . 0.0 115.562 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -112.55 161.26 16.97 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.821 2.048 . . . . 0.0 111.334 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.03 142.25 28.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.61 0.764 . . . . 0.0 110.64 161.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.16 118.82 34.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.134 0.974 . . . . 0.0 111.053 172.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.39 145.72 22.97 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.489 1.516 . . . . 0.0 111.109 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 54.63 23.52 4.77 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.589 1.956 . . . . 0.0 116.137 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 p -75.94 -24.02 55.46 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 120.818 -1.176 . . . . 0.0 113.69 -176.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 63.79 -40.15 0.21 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 128.739 2.816 . . . . 0.0 115.122 -172.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 t -152.22 154.6 36.1 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.188 1.795 . . . . 0.0 111.656 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.66 -25.14 68.08 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.211 1.005 . . . . 0.0 112.899 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.92 -27.84 69.42 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.3 m -65.0 -28.04 69.23 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.994 0.918 . . . . 0.0 112.963 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 mp -96.71 -10.06 27.71 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.468 1.507 . . . . 0.0 112.745 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.5 28.9 74.07 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.43 1.014 . . . . 0.0 114.468 177.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.8 m -65.97 151.79 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.515 1.126 . . . . 0.0 113.949 -170.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.08 179.07 7.03 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.238 1.415 . . . . 0.0 112.657 173.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -73.58 152.04 40.71 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 121.112 -0.992 . . . . 0.0 111.631 165.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.37 29.23 53.82 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 115.856 1.103 . . . . 0.0 115.856 172.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -62.11 155.33 24.54 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.772 1.286 . . . . 0.0 112.263 172.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -125.81 136.62 53.33 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.877 0.871 . . . . 0.0 112.347 173.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -122.23 133.53 54.71 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.855 1.262 . . . . 0.0 110.548 -173.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.9 t -103.24 129.42 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.209 0.603 . . . . 0.0 110.338 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 tp -105.57 131.17 53.29 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.087 0.955 . . . . 0.0 110.572 172.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -115.84 146.32 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.621 1.569 . . . . 0.0 109.53 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.6 t -127.34 164.94 20.69 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.167 1.387 . . . . 0.0 112.085 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -133.43 139.22 46.61 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.964 2.106 . . . . 0.0 110.44 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.6 p -81.65 130.11 34.94 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.417 0.687 . . . . 0.0 110.296 168.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.6 m -137.47 16.43 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 125.166 1.386 . . . . 0.0 113.169 -173.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.165 0 C-N-CA 125.821 1.677 . . . . 0.0 112.829 179.784 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 mmt . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.0 140.23 45.34 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.469 -1.395 . . . . 0.0 111.145 160.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pp -131.01 166.58 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.657 1.983 . . . . 0.0 110.311 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -120.99 102.66 8.48 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.458 1.103 . . . . 0.0 110.795 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.6 tt -77.84 143.14 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.859 -0.525 . . . . 0.0 110.067 173.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.5 79.93 72.61 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 124.824 1.249 . . . . 0.0 109.551 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.39 134.27 15.39 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.723 2.949 . . . . 0.0 112.32 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.32 28.76 0.15 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.558 1.543 . . . . 0.0 114.377 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.1 m -138.39 162.89 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 126.181 1.792 . . . . 0.0 111.699 -176.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.76 -128.78 35.32 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 123.602 0.62 . . . . 0.0 111.806 -175.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.73 -15.1 73.31 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 174.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.74 -1.09 54.85 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 124.97 1.271 . . . . 0.0 115.798 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -71.69 151.79 93.48 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 125.278 1.431 . . . . 0.0 113.195 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -64.17 150.54 88.11 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.716 2.278 . . . . 0.0 111.448 166.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.7 tp -142.8 132.86 24.39 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.252 1.021 . . . . 0.0 111.961 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -78.23 133.85 37.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.123 0.969 . . . . 0.0 112.335 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mp -139.82 143.6 36.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.479 1.512 . . . . 0.0 110.763 169.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -81.1 136.42 35.92 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.519 0.728 . . . . 0.0 110.26 166.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.8 142.67 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.733 0.813 . . . . 0.0 112.154 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.29 147.94 96.48 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.864 0.866 . . . . 0.0 112.498 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.49 -19.61 65.28 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.444 2.763 . . . . 0.0 113.67 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -78.91 4.65 13.55 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.868 1.667 . . . . 0.0 114.659 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 124.83 21.5 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.568 1.076 . . . . 0.0 112.649 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.2 m -107.89 138.58 43.89 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.557 1.543 . . . . 0.0 111.305 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.0 t -56.62 -47.29 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.023 0.929 . . . . 0.0 112.547 -175.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.5 -41.5 98.71 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.429 0.537 . . . . 0.0 112.926 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.13 -45.74 79.99 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.006 0.903 . . . . 0.0 112.139 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.48 -52.84 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.9 0.88 . . . . 0.0 110.849 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -62.33 -45.68 92.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.903 0.881 . . . . 0.0 111.606 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 84.6 m -61.17 -41.34 96.6 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.359 0.663 . . . . 0.0 111.917 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -63.43 -40.68 97.83 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.003 0.819 . . . . 0.0 112.416 176.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.6 t -67.68 -43.75 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.201 0.91 . . . . 0.0 111.53 174.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 93.9 m -56.88 -43.1 80.93 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.478 1.036 . . . . 0.0 112.081 174.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.19 89.09 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.111 0.964 . . . . 0.0 112.803 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.3 tpt -67.83 -39.59 83.87 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.869 0.868 . . . . 0.0 112.496 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -19.02 56.42 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.28 1.432 . . . . 0.0 113.916 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt 58.28 29.05 17.5 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.733 2.013 . . . . 0.0 113.328 -169.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mp -128.08 154.83 78.61 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 126.275 1.83 . . . . 0.0 111.82 -174.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.37 165.33 32.05 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 124.399 3.4 . . . . 0.0 115.102 -171.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -63.15 -15.85 50.69 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.644 2.896 . . . . 0.0 113.928 170.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -68.66 -21.16 64.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.236 1.014 . . . . 0.0 113.136 171.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.9 p -114.86 -38.73 3.86 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.051 1.34 . . . . 0.0 113.183 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 81.7 m -92.84 124.67 37.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.29 1.436 . . . . 0.0 111.001 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -149.27 146.22 27.46 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -171.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.18 148.08 34.81 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.245 1.818 . . . . 0.0 111.91 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.0 m -143.04 143.15 31.77 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.834 1.654 . . . . 0.0 111.836 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -144.49 133.54 22.75 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.357 1.863 . . . . 0.0 110.635 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? 52.78 30.49 9.05 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.805 1.242 . . . . 0.0 113.488 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.31 16.57 78.73 Favored Glycine 0 CA--C 1.54 1.627 0 C-N-CA 124.852 1.215 . . . . 0.0 115.218 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 -135.68 155.32 50.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.526 1.93 . . . . 0.0 111.757 -173.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.01 132.32 44.11 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.634 -0.666 . . . . 0.0 111.775 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.35 127.62 37.9 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.58 1.152 . . . . 0.0 109.86 167.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -164.46 147.32 8.94 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.802 1.641 . . . . 0.0 111.162 174.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 56.1 23.96 7.42 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.3 p -75.39 -17.79 60.11 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 120.859 -1.15 . . . . 0.0 113.478 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 61.64 -56.09 0.12 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 128.408 2.683 . . . . 0.0 114.144 -166.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.5 p -147.53 157.51 43.59 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.781 1.632 . . . . 0.0 111.048 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.27 -32.82 74.46 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.459 -0.776 . . . . 0.0 111.304 168.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -63.06 -31.55 72.72 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.407 -0.808 . . . . 0.0 113.074 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.2 t -64.89 -23.88 67.36 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.113 0.965 . . . . 0.0 113.325 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.4 mt -106.31 -33.31 7.81 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.091 1.357 . . . . 0.0 113.486 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.41 85.9 0.19 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.098 1.808 . . . . 0.0 111.739 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.9 p -72.87 146.93 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.556 1.142 . . . . 0.0 112.181 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -149.85 -179.45 7.15 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.347 1.459 . . . . 0.0 112.178 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -97.68 150.06 21.6 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.807 1.643 . . . . 0.0 111.741 167.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.74 5.14 90.07 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.77 1.176 . . . . 0.0 115.545 176.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -61.23 145.64 50.52 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.357 1.079 . . . . 0.0 110.755 170.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.87 134.2 46.58 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -171.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -125.1 113.8 18.21 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.417 1.087 . . . . 0.0 110.64 -169.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -83.58 128.9 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.49 0.716 . . . . 0.0 109.704 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.5 tp -113.04 118.37 34.6 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.371 1.468 . . . . 0.0 109.421 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.1 pt -110.27 154.43 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.89 1.276 . . . . 0.0 111.993 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -139.16 165.73 26.38 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.644 1.577 . . . . 0.0 111.298 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.7 ttt85 -153.29 146.17 24.44 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.551 1.541 . . . . 0.0 111.016 -168.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 77.8 p -134.07 -34.81 0.97 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.223 1.009 . . . . 0.0 113.652 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 67.6 t -141.46 139.04 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.882 1.673 . . . . 0.0 110.542 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.151 0 C-N-CA 124.627 1.108 . . . . 0.0 115.226 178.963 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -80.68 142.65 33.72 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.049 -1.657 . . . . 0.0 112.476 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.9 pt -131.3 162.29 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 127.103 2.161 . . . . 0.0 110.415 170.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -123.88 92.74 3.74 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.035 1.334 . . . . 0.0 110.627 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.5 tt -78.71 141.13 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 122.13 -0.356 . . . . 0.0 110.356 174.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.8 t -130.6 79.82 71.32 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.383 1.473 . . . . 0.0 109.426 -174.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.85 137.03 13.75 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.253 1.969 . . . . 0.0 112.509 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.0 41.53 0.16 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.718 1.607 . . . . 0.0 112.63 170.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -139.14 142.51 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.539 1.936 . . . . 0.0 109.907 -167.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.48 -115.15 7.51 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 123.754 0.692 . . . . 0.0 112.479 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.44 -18.16 71.36 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.127 0.87 . . . . 0.0 114.972 176.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.95 6.45 56.33 Favored Glycine 0 CA--C 1.541 1.68 0 CA-C-N 118.737 1.268 . . . . 0.0 115.627 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.1 p -95.34 158.91 33.89 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.485 1.914 . . . . 0.0 113.561 -169.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.49 143.25 75.03 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.163 2.575 . . . . 0.0 112.115 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.5 mt -131.28 115.83 16.81 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.017 1.727 . . . . 0.0 110.515 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -74.4 125.58 28.83 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.836 0.855 . . . . 0.0 111.238 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt -138.17 149.05 45.49 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.606 1.563 . . . . 0.0 111.119 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -97.13 130.3 44.41 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.837 1.255 . . . . 0.0 110.156 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.9 149.71 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.922 1.289 . . . . 0.0 112.903 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.11 153.56 88.9 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.8 1.24 . . . . 0.0 112.471 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.13 -25.25 50.95 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.306 2.67 . . . . 0.0 113.635 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -80.51 37.57 0.41 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.013 1.725 . . . . 0.0 112.985 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.06 67.73 3.96 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.981 1.713 . . . . 0.0 112.622 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 55.9 m -63.76 141.34 58.8 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.683 1.193 . . . . 0.0 112.275 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.1 t -60.07 -44.09 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.072 0.949 . . . . 0.0 112.161 -174.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.98 -36.4 92.18 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.498 0.57 . . . . 0.0 113.231 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.93 -50.33 64.79 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 117.992 0.896 . . . . 0.0 111.796 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.2 p -66.78 -36.86 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.867 0.758 . . . . 0.0 112.046 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -59.06 -48.1 82.84 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.475 1.11 . . . . 0.0 111.837 173.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.2 m -66.47 -39.9 89.05 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.375 0.67 . . . . 0.0 112.099 175.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -44.48 96.96 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.893 0.877 . . . . 0.0 111.755 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.9 t -61.48 -48.33 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.136 1.374 . . . . 0.0 111.362 172.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.6 -44.53 93.36 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.458 0.703 . . . . 0.0 111.967 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.49 88.51 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.204 1.002 . . . . 0.0 112.924 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.5 ttm -65.76 -43.5 88.69 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.534 1.133 . . . . 0.0 112.232 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -75.38 -29.53 59.87 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.846 1.258 . . . . 0.0 113.394 177.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.2 tptm 57.41 31.29 19.97 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.746 2.018 . . . . 0.0 113.098 -169.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.52 151.16 56.81 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 126.316 1.846 . . . . 0.0 111.082 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.88 159.18 51.19 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.943 3.095 . . . . 0.0 113.594 -173.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.17 -13.07 35.74 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.99 3.127 . . . . 0.0 114.778 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -66.29 -22.25 66.29 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.136 -0.978 . . . . 0.0 113.355 170.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.2 p -103.07 -25.84 13.27 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.71 1.204 . . . . 0.0 113.709 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.1 m -140.07 126.87 20.6 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.954 1.301 . . . . 0.0 110.928 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -134.44 166.61 22.45 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.125 1.37 . . . . 0.0 112.897 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 69' ' ' PHE . 39.4 tp -137.07 135.33 37.41 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.455 1.502 . . . . 0.0 111.497 -168.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.5 p -136.49 158.54 44.19 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.491 1.116 . . . . 0.0 112.519 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -139.09 128.73 24.6 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.606 2.363 . . . . 0.0 109.701 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.62 31.97 11.01 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.643 1.177 . . . . 0.0 113.515 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.94 8.79 87.63 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 124.945 1.26 . . . . 0.0 115.943 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -122.01 151.1 41.18 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.404 1.881 . . . . 0.0 112.261 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.12 126.24 30.52 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.85 -0.531 . . . . 0.0 110.46 165.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.2 mt -74.41 137.65 42.83 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.579 0.752 . . . . 0.0 110.726 170.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.24 140.4 7.5 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.117 1.367 . . . . 0.0 111.335 170.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t0 55.72 26.45 9.43 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.957 1.703 . . . . 0.0 115.191 175.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.9 m -78.03 -15.19 59.13 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.016 1.326 . . . . 0.0 113.732 -171.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 59.4 -70.84 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.601 2.361 . . . . 0.0 114.441 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.2 p -146.38 154.23 41.4 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.158 1.383 . . . . 0.0 111.97 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.22 -20.37 60.88 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.768 -0.583 . . . . 0.0 112.391 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.66 -30.72 71.59 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.192 -0.942 . . . . 0.0 112.659 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.0 t -63.59 -24.3 67.74 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.63 0.772 . . . . 0.0 112.762 173.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.4 mt -92.68 -12.42 31.54 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.46 1.504 . . . . 0.0 113.304 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.54 17.15 64.13 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.185 1.374 . . . . 0.0 115.014 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.1 p -76.44 145.0 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.778 1.231 . . . . 0.0 113.424 -169.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.6 -177.29 5.76 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.869 1.667 . . . . 0.0 113.774 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -68.47 164.4 21.21 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.299 1.44 . . . . 0.0 113.214 172.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.83 11.62 60.16 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.587 1.089 . . . . 0.0 115.033 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -62.19 143.83 56.27 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.436 1.118 . . . . 0.0 111.552 171.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -127.18 132.64 50.44 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.101 0.96 . . . . 0.0 112.235 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.459 ' HB3' HD11 ' A' ' 45' ' ' LEU . 6.9 m-85 -125.27 132.61 52.9 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.866 1.266 . . . . 0.0 109.944 -171.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 p -110.73 120.73 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.024 0.829 . . . . 0.0 111.123 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.99 121.11 40.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.954 1.302 . . . . 0.0 109.136 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.0 tt -119.7 131.07 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.447 1.099 . . . . 0.0 111.063 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.6 t -114.61 150.87 34.4 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.309 1.844 . . . . 0.0 111.353 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -124.97 126.16 45.03 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.179 1.792 . . . . 0.0 109.959 172.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.2 p -72.21 144.9 48.32 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.216 1.007 . . . . 0.0 111.71 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.5 t -136.36 -39.26 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.869 1.267 . . . . 0.0 112.067 -176.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.222 0 C-N-CA 125.234 1.397 . . . . 0.0 113.309 -178.633 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.28 0.562 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -108.98 141.68 40.74 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.074 1.35 . . . . 0.0 111.331 174.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.0 pt -121.56 163.05 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.07 1.748 . . . . 0.0 110.457 170.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -125.69 105.57 9.09 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.15 0.98 . . . . 0.0 110.875 174.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.4 mt -86.79 137.88 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -126.0 76.25 71.6 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 124.951 1.3 . . . . 0.0 110.086 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.97 136.59 16.68 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.92 2.413 . . . . 0.0 111.261 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.25 31.91 0.1 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.627 1.571 . . . . 0.0 114.173 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.5 t -139.52 147.67 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 126.62 1.968 . . . . 0.0 109.871 -171.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.5 30.75 70.97 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 121.642 -0.661 . . . . 0.0 114.543 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.65 -8.36 40.02 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.615 1.578 . . . . 0.0 115.11 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.32 5.36 76.91 Favored Glycine 0 CA--C 1.54 1.637 0 N-CA-C 116.355 1.302 . . . . 0.0 116.355 170.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.9 m -75.14 150.32 85.41 Favored Pre-proline 0 N--CA 1.475 0.804 0 CA-C-N 118.649 1.225 . . . . 0.0 113.432 -174.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.77 145.7 76.03 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.378 2.719 . . . . 0.0 111.898 169.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.1 mt -131.71 111.72 11.92 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.725 1.61 . . . . 0.0 110.492 178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -79.27 134.22 36.64 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.355 1.062 . . . . 0.0 111.807 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 tt -152.43 141.98 21.76 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.347 1.059 . . . . 0.0 112.349 -175.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -80.93 133.92 35.63 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.659 1.184 . . . . 0.0 112.289 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -139.1 155.51 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.878 1.271 . . . . 0.0 113.01 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.75 152.45 91.31 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.623 1.169 . . . . 0.0 112.271 172.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.02 -19.05 57.85 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.365 2.71 . . . . 0.0 113.419 174.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -78.76 5.77 10.5 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.643 1.577 . . . . 0.0 114.117 176.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.37 130.52 47.11 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.391 0.996 . . . . 0.0 112.284 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.9 m -109.7 134.73 51.65 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.47 1.508 . . . . 0.0 110.874 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.32 -40.94 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.073 0.949 . . . . 0.0 112.31 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.61 -34.93 91.0 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 123.775 0.702 . . . . 0.0 113.5 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.87 -43.23 75.79 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.339 1.07 . . . . 0.0 111.645 174.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.9 t -61.27 -46.67 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.005 0.922 . . . . 0.0 111.138 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -56.49 -51.42 68.56 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.542 1.137 . . . . 0.0 111.735 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.4 m -60.16 -42.03 94.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.505 0.722 . . . . 0.0 111.818 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.67 -50.76 72.7 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.949 0.9 . . . . 0.0 111.239 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.4 t -68.21 -41.37 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.412 0.685 . . . . 0.0 112.132 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 95.9 m -59.67 -40.41 87.7 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.335 0.971 . . . . 0.0 112.202 173.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.57 -41.99 78.95 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.55 0.74 . . . . 0.0 112.77 174.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 84.2 mtp -66.37 -39.73 89.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.353 1.061 . . . . 0.0 112.871 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -84.46 -18.27 36.44 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.718 1.207 . . . . 0.0 113.86 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp 57.75 30.03 18.31 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.457 1.903 . . . . 0.0 113.728 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.92 150.49 43.56 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 126.129 1.771 . . . . 0.0 111.141 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.64 159.85 50.75 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 123.713 2.942 . . . . 0.0 112.796 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.07 -9.89 26.67 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 124.007 3.138 . . . . 0.0 115.063 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -80.12 -36.16 35.69 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.193 1.397 . . . . 0.0 113.296 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 34.6 p -85.81 8.13 21.2 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.203 1.401 . . . . 0.0 113.827 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.0 t -144.2 142.72 30.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.679 1.591 . . . . 0.0 111.972 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 -141.02 148.51 40.39 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.465 1.506 . . . . 0.0 112.658 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.7 tp -127.48 129.41 47.38 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.008 2.123 . . . . 0.0 110.108 -177.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.8 p -140.06 155.52 47.0 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.41 1.084 . . . . 0.0 112.516 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -145.0 138.69 26.95 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.168 1.787 . . . . 0.0 110.167 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp 54.13 30.4 12.03 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.935 1.294 . . . . 0.0 114.062 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.96 16.85 80.33 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.037 1.304 . . . . 0.0 115.259 -175.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -134.13 150.86 51.16 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.085 1.754 . . . . 0.0 112.252 -171.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.1 115.95 20.79 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.945 0.898 . . . . 0.0 110.962 172.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.2 mp -86.35 131.96 34.08 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.38 1.072 . . . . 0.0 110.297 171.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.78 149.91 11.45 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.388 1.475 . . . . 0.0 110.903 171.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.7 t0 55.77 27.66 11.13 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.732 1.613 . . . . 0.0 115.073 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.6 p -78.85 -22.02 46.72 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.985 1.314 . . . . 0.0 113.523 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 62.34 -53.26 0.15 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 128.51 2.724 . . . . 0.0 115.005 -170.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 61.4 p -144.71 152.31 40.22 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.726 1.61 . . . . 0.0 111.599 172.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.7 mt -70.28 -36.27 74.27 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.344 0.658 . . . . 0.0 111.79 172.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.91 -33.67 76.23 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.6 m -68.45 -26.49 65.53 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 66.3 mt -99.29 -26.72 14.07 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.531 1.132 . . . . 0.0 113.471 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 130.76 83.93 0.3 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.839 1.685 . . . . 0.0 111.946 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.68 148.49 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.641 1.177 . . . . 0.0 111.662 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.29 158.26 43.78 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.216 1.406 . . . . 0.0 111.922 176.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -73.35 142.65 47.05 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.336 1.054 . . . . 0.0 111.69 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.91 19.55 78.7 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.414 0.926 . . . . 0.0 115.414 174.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.61 136.94 57.75 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.849 1.324 . . . . 0.0 111.384 171.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -132.9 132.11 41.68 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -172.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -119.7 97.67 5.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.251 1.421 . . . . 0.0 110.405 -161.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.65 137.47 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.889 -0.507 . . . . 0.0 110.45 174.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tt -139.47 109.0 6.18 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.623 0.769 . . . . 0.0 110.179 -170.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.3 tt -101.94 142.6 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.998 1.319 . . . . 0.0 111.348 -173.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.4 p -130.29 157.05 43.58 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.22 1.408 . . . . 0.0 110.46 173.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -129.0 137.69 51.5 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.87 0.868 . . . . 0.0 112.172 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.3 p -77.8 -20.02 53.98 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.158 1.383 . . . . 0.0 113.855 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.4 t -118.6 -40.15 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.314 1.446 . . . . 0.0 112.16 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.269 0 C-N-CA 125.314 1.435 . . . . 0.0 112.799 -176.558 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mmt . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 121.347 0.594 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -68.59 148.67 50.17 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.976 0.91 . . . . 0.0 112.28 165.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.4 mm -142.23 143.62 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 128.034 2.534 . . . . 0.0 109.176 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -100.4 144.28 29.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.194 0.997 . . . . 0.0 111.056 162.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.7 tt -133.72 134.52 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.443 1.097 . . . . 0.0 110.474 167.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 p -123.34 103.12 35.84 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.592 1.157 . . . . 0.0 110.679 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -92.89 140.69 1.89 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.721 2.28 . . . . 0.0 112.255 176.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.17 48.36 0.61 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.463 1.505 . . . . 0.0 113.522 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 p -154.34 155.3 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.437 1.495 . . . . 0.0 111.529 -172.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.93 -112.4 4.64 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.704 0.669 . . . . 0.0 112.671 174.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.13 -19.85 72.43 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 124.082 0.848 . . . . 0.0 114.799 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.24 32.85 82.18 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 118.782 1.291 . . . . 0.0 114.448 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 t -144.68 145.6 28.84 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.163 1.385 . . . . 0.0 112.103 -162.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -60.51 140.38 91.07 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.526 2.818 . . . . 0.0 113.096 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.0 tp -124.9 134.06 52.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.343 1.857 . . . . 0.0 110.44 175.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -82.79 135.05 35.08 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.676 0.791 . . . . 0.0 110.752 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.3 mt -142.21 175.09 10.02 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.873 2.069 . . . . 0.0 110.872 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -136.41 134.6 37.94 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.613 1.565 . . . . 0.0 109.962 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 m -136.03 155.19 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.136 0.974 . . . . 0.0 113.0 -173.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.24 149.87 73.33 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.853 0.861 . . . . 0.0 111.675 169.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -64.93 -21.64 63.74 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.287 2.658 . . . . 0.0 112.865 172.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -74.06 -0.94 18.03 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.925 1.69 . . . . 0.0 114.134 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.66 121.18 10.38 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.287 0.948 . . . . 0.0 111.814 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.0 p -86.16 150.73 24.2 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.773 0.829 . . . . 0.0 111.502 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.3 t -64.39 -36.6 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.812 -0.555 . . . . 0.0 110.647 173.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.35 -51.4 57.86 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.083 0.849 . . . . 0.0 112.74 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.75 93.13 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.004 0.902 . . . . 0.0 112.865 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.5 t -63.93 -47.29 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 121.833 -0.542 . . . . 0.0 111.013 175.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -63.18 -42.4 99.37 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.273 1.029 . . . . 0.0 112.074 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.8 p -69.63 -38.16 77.1 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 118.329 -0.843 . . . . 0.0 112.582 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -61.95 -43.97 97.74 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.898 1.226 . . . . 0.0 111.844 172.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.2 t -61.53 -48.27 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.832 0.742 . . . . 0.0 111.477 175.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.3 t -59.24 -44.57 92.36 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.938 0.895 . . . . 0.0 111.876 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.63 -40.93 80.12 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.255 1.022 . . . . 0.0 112.951 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 59.3 ttp -71.35 -41.04 70.26 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.14 1.376 . . . . 0.0 112.989 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -82.51 -14.59 54.71 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp 58.34 29.93 18.86 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.708 2.003 . . . . 0.0 112.995 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.2 mt -141.02 147.92 49.81 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.877 1.671 . . . . 0.0 112.378 -168.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.95 161.05 47.4 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.222 3.281 . . . . 0.0 114.582 -171.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -66.05 -16.01 50.73 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.763 2.975 . . . . 0.0 114.71 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -67.58 -45.49 75.4 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.946 -1.096 . . . . 0.0 111.756 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.2 t -88.36 -22.59 23.72 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.195 1.398 . . . . 0.0 112.955 -174.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.6 m -127.82 119.12 25.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.453 1.501 . . . . 0.0 112.204 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -133.06 160.9 35.84 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.345 1.858 . . . . 0.0 113.202 -173.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.1 tp -134.94 138.86 44.45 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.785 2.034 . . . . 0.0 110.854 -172.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.3 m -139.22 146.09 40.06 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.43 1.492 . . . . 0.0 111.388 -176.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -142.56 134.6 27.26 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.499 1.519 . . . . 0.0 110.226 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 tptm 52.91 32.69 13.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.159 1.383 . . . . 0.0 113.407 -176.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.45 14.53 74.7 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 124.495 1.045 . . . . 0.0 115.34 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.41 141.95 51.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.685 1.994 . . . . 0.0 111.4 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.45 125.84 31.54 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.874 0.87 . . . . 0.0 110.348 167.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.0 mp -82.13 138.66 34.71 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.684 0.794 . . . . 0.0 110.354 172.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 136.76 6.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.725 1.61 . . . . 0.0 110.289 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.3 t0 55.61 26.92 9.75 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.577 1.551 . . . . 0.0 114.471 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 m -78.19 -29.39 48.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.839 1.256 . . . . 0.0 113.782 -169.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 62.24 -36.59 0.12 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 128.692 2.797 . . . . 0.0 117.554 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 t -156.01 146.29 21.6 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.292 1.437 . . . . 0.0 111.123 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.27 -18.13 64.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.882 0.873 . . . . 0.0 112.86 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -68.35 -19.95 64.68 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 171.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.1 t -69.46 -41.1 76.65 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.968 0.907 . . . . 0.0 112.017 178.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.8 mp -82.47 -14.56 54.84 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.843 1.257 . . . . 0.0 112.82 170.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.99 37.25 91.98 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.475 1.036 . . . . 0.0 113.364 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.6 m -64.56 152.97 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.313 1.045 . . . . 0.0 113.802 -168.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.86 -178.38 6.83 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.197 1.399 . . . . 0.0 112.965 174.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -80.34 153.07 28.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.609 1.163 . . . . 0.0 112.231 165.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.6 26.12 61.65 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 115.351 0.9 . . . . 0.0 115.351 173.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -61.55 156.46 19.59 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.278 1.039 . . . . 0.0 112.769 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -124.7 108.66 12.23 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.175 1.39 . . . . 0.0 111.132 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -93.58 144.71 25.12 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.272 1.429 . . . . 0.0 110.998 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.0 m -124.47 133.49 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.139 0.976 . . . . 0.0 110.767 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.58 131.98 56.49 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.439 1.096 . . . . 0.0 110.781 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.64 136.59 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.948 1.699 . . . . 0.0 108.936 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.0 t -142.8 129.05 19.88 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.859 0.864 . . . . 0.0 111.408 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.1 mmt-85 -86.37 159.55 19.35 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.851 1.66 . . . . 0.0 112.325 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.0 p -70.73 155.06 41.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.386 1.075 . . . . 0.0 111.675 169.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.0 m -130.76 157.01 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.407 1.483 . . . . 0.0 111.862 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 C-N-CA 125.457 1.503 . . . . 0.0 112.991 -178.207 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ttt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -130.07 153.07 48.83 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.39 1.476 . . . . 0.0 111.917 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -133.1 158.82 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 126.8 2.04 . . . . 0.0 110.807 173.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -103.42 147.88 26.58 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.587 1.555 . . . . 0.0 110.036 164.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.2 tt -135.93 135.38 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.148 0.979 . . . . 0.0 110.396 169.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.6 p -128.26 96.75 30.27 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.82 1.248 . . . . 0.0 111.042 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -81.74 138.96 10.86 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.342 2.695 . . . . 0.0 111.683 170.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.98 40.31 0.15 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.586 1.554 . . . . 0.0 112.968 170.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.3 t -138.73 144.38 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.364 1.866 . . . . 0.0 110.037 -169.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.95 -112.4 4.79 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.965 0.793 . . . . 0.0 112.141 175.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.83 -16.8 68.62 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.223 0.916 . . . . 0.0 115.046 175.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.55 20.71 66.15 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 118.747 1.274 . . . . 0.0 115.362 171.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.4 m -129.35 153.58 80.55 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 125.6 1.56 . . . . 0.0 112.962 -164.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.92 146.19 82.14 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.293 2.662 . . . . 0.0 113.384 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.4 mt -132.5 138.4 47.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.418 1.887 . . . . 0.0 111.094 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -78.75 135.67 37.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.987 1.315 . . . . 0.0 111.87 172.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mp -142.96 150.8 40.17 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.882 1.273 . . . . 0.0 111.925 169.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -85.38 143.92 28.34 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.963 0.905 . . . . 0.0 110.471 160.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.17 148.96 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.503 1.521 . . . . 0.0 110.994 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.72 149.9 88.38 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.69 0.796 . . . . 0.0 111.658 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.42 -19.03 61.31 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.02 2.48 . . . . 0.0 112.927 171.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -77.92 -0.74 28.7 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.029 1.732 . . . . 0.0 114.441 171.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.06 142.66 56.48 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 119.415 1.007 . . . . 0.0 111.055 172.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.11 152.01 40.33 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.412 1.085 . . . . 0.0 111.411 -175.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -60.94 -32.91 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 121.566 -0.709 . . . . 0.0 112.433 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.9 -50.26 59.0 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 123.96 0.791 . . . . 0.0 111.917 173.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.4 -40.11 95.42 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.091 0.956 . . . . 0.0 112.73 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.1 t -63.02 -49.6 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.661 -0.649 . . . . 0.0 110.525 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -63.36 -45.33 91.69 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 121.566 -0.709 . . . . 0.0 112.467 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.5 p -67.75 -37.61 82.38 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.479 1.036 . . . . 0.0 112.161 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -58.1 -47.19 83.98 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.265 0.939 . . . . 0.0 111.024 172.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.9 t -63.44 -47.35 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.325 1.05 . . . . 0.0 111.414 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 93.8 m -61.63 -41.83 98.04 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.24 85.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.839 0.856 . . . . 0.0 113.113 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.5 ttt -66.64 -41.18 88.69 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.283 1.033 . . . . 0.0 112.486 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -74.9 -24.21 58.49 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.434 1.094 . . . . 0.0 113.352 172.584 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt 59.09 28.51 17.81 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.385 2.274 . . . . 0.0 113.912 -167.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 mp -116.35 155.44 48.44 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.14 1.776 . . . . 0.0 111.634 -177.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.69 157.72 60.7 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 123.52 2.813 . . . . 0.0 112.437 178.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.48 -25.34 63.06 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.402 2.735 . . . . 0.0 114.406 -173.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -71.64 -17.59 62.25 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.696 1.134 . . . . 0.0 113.634 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.2 m -84.45 -1.04 55.02 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.684 -1.26 . . . . 0.0 112.993 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.3 t -136.13 158.01 45.45 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.49 1.516 . . . . 0.0 112.244 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -141.79 140.12 32.94 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.029 1.732 . . . . 0.0 111.2 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.5 tp -113.31 130.84 56.15 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.433 1.893 . . . . 0.0 110.143 173.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.3 p -136.8 155.63 49.57 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.956 0.902 . . . . 0.0 112.428 172.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -151.74 135.13 16.06 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.303 1.841 . . . . 0.0 110.11 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.92 35.96 20.54 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.215 1.406 . . . . 0.0 113.353 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.83 15.91 79.44 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 124.48 1.038 . . . . 0.0 115.212 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -129.58 151.9 49.69 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.643 1.977 . . . . 0.0 111.637 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.08 135.26 38.59 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.862 -0.524 . . . . 0.0 109.673 160.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.7 tp -107.98 115.89 30.96 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.899 0.88 . . . . 0.0 109.865 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -150.1 141.13 22.97 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.915 1.286 . . . . 0.0 111.613 -169.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.6 t0 54.95 26.46 7.96 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.864 1.665 . . . . 0.0 114.836 174.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.4 p -75.28 -26.52 58.83 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.133 1.373 . . . . 0.0 113.005 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 64.04 -46.7 0.28 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 129.015 2.926 . . . . 0.0 114.892 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -152.94 139.01 18.21 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.35 1.86 . . . . 0.0 111.588 175.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.91 -37.36 87.4 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.877 0.871 . . . . 0.0 111.994 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -65.58 -18.19 65.14 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.9 m -75.61 -27.14 58.35 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.134 0.974 . . . . 0.0 113.15 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.37 -39.8 8.62 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.858 1.263 . . . . 0.0 112.036 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 145.67 93.32 0.14 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.518 1.532 . . . . 0.0 111.459 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.2 p -75.04 147.49 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.338 1.055 . . . . 0.0 111.75 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -147.09 164.82 31.82 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.458 1.503 . . . . 0.0 111.837 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -94.88 146.09 24.46 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.816 1.246 . . . . 0.0 112.841 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.03 19.46 72.51 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 123.86 0.743 . . . . 0.0 114.8 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.31 144.04 54.62 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.458 1.129 . . . . 0.0 111.498 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.25 110.96 17.62 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.674 1.19 . . . . 0.0 111.534 -177.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -92.47 131.66 37.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.787 1.235 . . . . 0.0 111.353 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -109.57 127.2 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.283 1.033 . . . . 0.0 110.298 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.28 121.16 43.59 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.71 1.604 . . . . 0.0 110.357 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.0 mm -114.93 125.38 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.902 1.281 . . . . 0.0 109.903 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.8 t -98.24 155.95 16.94 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.503 1.121 . . . . 0.0 111.622 172.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -116.05 139.02 50.7 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.192 1.397 . . . . 0.0 111.187 171.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.6 m -140.49 -53.55 0.5 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.142 0.977 . . . . 0.0 111.989 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.2 p -83.07 -27.44 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.431 1.092 . . . . 0.0 112.983 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.208 0 C-N-CA 125.603 1.573 . . . . 0.0 113.886 179.581 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.848 ' HB2' ' OD1' ' A' ' 65' ' ' ASP . 26.3 mmt . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 121.668 0.747 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 141.17 32.38 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.464 1.506 . . . . 0.0 111.045 174.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.4 mt -128.22 141.98 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.786 1.634 . . . . 0.0 109.803 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -105.55 102.23 11.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.862 1.265 . . . . 0.0 110.25 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.4 pt -78.92 143.51 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.436 -0.79 . . . . 0.0 110.326 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 t -130.61 80.18 70.57 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.907 1.283 . . . . 0.0 109.847 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.55 131.46 16.17 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.021 2.481 . . . . 0.0 112.256 175.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.44 41.07 0.18 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.878 1.271 . . . . 0.0 112.749 167.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.9 t -138.91 145.49 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 126.503 1.921 . . . . 0.0 110.202 -169.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.72 -121.19 22.97 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.721 0.677 . . . . 0.0 111.858 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.21 -18.27 72.95 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 123.952 0.787 . . . . 0.0 114.935 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.09 -0.8 57.98 Favored Glycine 0 CA--C 1.542 1.763 0 C-N-CA 124.981 1.276 . . . . 0.0 115.769 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 m -73.92 153.43 88.94 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 125.523 1.529 . . . . 0.0 113.793 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -63.55 149.37 91.18 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.729 2.286 . . . . 0.0 111.467 163.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 tt -141.4 127.07 19.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.881 1.272 . . . . 0.0 111.311 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -85.38 128.89 34.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.827 1.251 . . . . 0.0 112.581 -174.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.9 mt -141.7 146.17 35.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.561 1.544 . . . . 0.0 112.439 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -84.7 146.33 27.48 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.144 0.977 . . . . 0.0 111.112 163.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.6 m -143.6 157.87 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.291 1.436 . . . . 0.0 111.201 174.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.36 151.95 96.89 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.646 0.778 . . . . 0.0 111.824 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -65.99 -20.49 57.46 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.149 2.566 . . . . 0.0 113.027 173.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -83.98 22.16 1.21 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.482 1.913 . . . . 0.0 113.083 175.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.76 108.98 2.28 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.531 -1.355 . . . . 0.0 111.578 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.2 m -77.92 129.97 36.0 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.402 1.081 . . . . 0.0 110.954 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.1 t -57.57 -44.9 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.028 0.931 . . . . 0.0 111.719 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.24 -35.64 91.86 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.48 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.75 -42.31 77.72 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.883 1.342 . . . . 0.0 112.037 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.0 -49.05 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.448 0.699 . . . . 0.0 110.527 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -62.71 -41.66 99.25 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.513 0.725 . . . . 0.0 111.583 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.1 m -62.41 -42.0 99.11 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.651 0.78 . . . . 0.0 111.591 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -58.58 -45.64 88.61 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.359 0.981 . . . . 0.0 111.733 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 83.1 t -63.34 -47.16 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.938 0.895 . . . . 0.0 111.376 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 83.2 m -63.24 -39.9 95.9 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.067 0.547 . . . . 0.0 112.4 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.44 -39.47 77.79 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.297 1.039 . . . . 0.0 112.719 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 63.9 ttp -67.1 -40.44 86.92 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.148 0.979 . . . . 0.0 112.159 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -83.02 -10.42 58.76 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 173.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.38 25.15 12.51 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 127.29 2.236 . . . . 0.0 114.418 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mp -131.98 155.0 81.89 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 126.326 1.85 . . . . 0.0 112.169 -174.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.48 162.54 41.96 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.305 3.337 . . . . 0.0 114.215 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.67 -16.75 56.6 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 124.194 3.263 . . . . 0.0 114.792 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -66.01 -26.65 67.63 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.026 -1.047 . . . . 0.0 112.434 170.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 26.2 m -91.23 -36.59 13.83 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.492 0.717 . . . . 0.0 112.407 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.3 m -130.21 126.76 38.16 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.245 1.018 . . . . 0.0 112.162 -171.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -131.46 161.8 31.69 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.844 1.658 . . . . 0.0 112.997 -168.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.7 tp -129.29 134.54 47.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.473 2.309 . . . . 0.0 110.654 -174.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.2 p -138.52 156.8 47.19 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.724 1.21 . . . . 0.0 113.033 174.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -147.68 132.76 18.25 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.269 1.828 . . . . 0.0 110.447 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm 52.05 40.58 28.75 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.226 1.41 . . . . 0.0 113.374 173.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.49 9.17 84.57 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 125.167 1.365 . . . . 0.0 115.723 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 65.3 mtp180 -127.6 152.08 48.1 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.457 1.903 . . . . 0.0 111.958 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.36 128.06 34.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.034 0.934 . . . . 0.0 110.116 166.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.2 mt -86.35 140.56 29.93 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.829 0.852 . . . . 0.0 110.988 174.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -162.69 152.76 16.25 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.853 1.661 . . . . 0.0 111.331 171.397 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 53.91 19.89 2.16 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.629 1.972 . . . . 0.0 116.239 171.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -75.91 -29.95 58.6 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.008 1.323 . . . . 0.0 112.576 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 62.46 -53.94 0.15 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 128.006 2.523 . . . . 0.0 115.475 -175.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 49.5 p -140.97 137.36 32.99 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.009 1.323 . . . . 0.0 111.298 172.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.38 -23.86 64.71 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.653 -0.655 . . . . 0.0 111.949 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -61.68 -31.76 71.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.768 0.827 . . . . 0.0 112.918 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 55.8 p -64.88 -22.11 66.93 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.0 mt -107.29 -0.34 22.59 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.409 1.884 . . . . 0.0 113.063 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.5 118.5 0.46 Allowed Glycine 0 CA--C 1.539 1.543 0 C-N-CA 126.208 1.861 . . . . 0.0 113.063 -170.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.7 t -75.24 132.84 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.406 1.082 . . . . 0.0 110.767 174.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.43 -174.35 2.51 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.733 1.613 . . . . 0.0 111.494 172.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.848 ' OD1' ' HB2' ' A' ' 1' ' ' MET . 28.1 t0 -139.65 148.82 42.96 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.968 -1.082 . . . . 0.0 113.102 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.92 23.2 75.39 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 123.87 0.747 . . . . 0.0 113.965 -173.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -68.21 165.04 19.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.234 1.414 . . . . 0.0 112.152 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.7 pttm -139.62 142.15 37.07 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 171.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -116.79 121.91 42.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.718 1.207 . . . . 0.0 110.254 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.9 t -96.64 128.97 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.48 0.712 . . . . 0.0 109.875 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.0 mt -111.38 131.54 55.11 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.257 1.023 . . . . 0.0 109.717 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.0 tt -124.91 142.02 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.841 1.256 . . . . 0.0 110.609 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.1 t -132.5 136.48 46.68 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.071 1.348 . . . . 0.0 111.528 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -78.55 143.05 36.88 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.026 1.33 . . . . 0.0 111.463 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 82.7 m -72.53 114.09 10.28 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.789 -0.569 . . . . 0.0 110.031 174.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.0 p -74.75 -27.12 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.351 1.06 . . . . 0.0 113.145 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.192 0 C-N-CA 125.893 1.711 . . . . 0.0 113.366 179.597 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.34 0.114 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -108.84 151.11 26.69 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 120.318 -1.489 . . . . 0.0 113.279 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mt -137.41 134.49 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.986 1.714 . . . . 0.0 109.676 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -93.47 101.44 13.64 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.92 1.288 . . . . 0.0 111.168 174.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 tt -83.49 137.27 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.421 -0.8 . . . . 0.0 110.146 169.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.74 90.33 40.59 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 124.78 1.232 . . . . 0.0 110.464 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -87.64 142.7 5.97 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.467 2.778 . . . . 0.0 112.481 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.91 38.12 0.2 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 125.89 1.676 . . . . 0.0 114.79 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.9 m -139.94 161.49 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 125.767 1.627 . . . . 0.0 112.374 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.3 -122.96 29.85 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.88 0.752 . . . . 0.0 111.91 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.56 -13.24 74.36 Favored Glycine 0 CA--C 1.539 1.571 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 173.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.62 7.0 45.54 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 125.281 1.42 . . . . 0.0 115.831 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.4 m -89.33 154.97 49.16 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 125.399 1.479 . . . . 0.0 113.204 -173.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -64.16 150.6 88.0 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.016 2.477 . . . . 0.0 112.447 169.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mt -137.85 125.96 22.91 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.07 1.748 . . . . 0.0 110.677 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -77.2 114.6 16.18 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.197 0.999 . . . . 0.0 111.325 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.5 mp -114.69 155.82 25.92 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.777 1.631 . . . . 0.0 110.703 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -114.01 133.24 55.63 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.409 1.483 . . . . 0.0 109.701 169.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.04 156.61 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.687 1.195 . . . . 0.0 112.044 -174.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.88 149.08 98.64 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.825 0.85 . . . . 0.0 111.914 173.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.78 -26.38 60.22 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.933 2.422 . . . . 0.0 113.053 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -82.59 12.81 4.21 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.73 1.612 . . . . 0.0 114.463 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.72 113.86 2.47 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.065 -1.022 . . . . 0.0 111.128 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 p -85.24 153.66 22.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.847 0.859 . . . . 0.0 111.536 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.9 t -63.49 -42.08 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.531 -0.731 . . . . 0.0 110.907 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.92 97.06 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.762 0.696 . . . . 0.0 113.226 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.12 -46.98 84.74 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 117.974 0.887 . . . . 0.0 111.742 175.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.76 -47.04 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.589 0.756 . . . . 0.0 111.38 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -56.99 -43.19 81.46 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.895 1.278 . . . . 0.0 111.697 177.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.0 m -65.7 -44.96 84.57 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.686 0.795 . . . . 0.0 111.444 176.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -46.6 87.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.908 0.883 . . . . 0.0 111.653 176.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.09 -51.74 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.219 1.408 . . . . 0.0 111.232 177.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.43 -43.44 96.78 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.799 0.727 . . . . 0.0 112.332 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.66 -43.66 92.89 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.638 0.775 . . . . 0.0 112.823 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.8 ttt -70.18 -36.79 74.9 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.13 0.972 . . . . 0.0 112.848 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.14 -20.41 52.11 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.132 1.373 . . . . 0.0 113.689 176.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? 57.66 19.93 5.91 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.751 2.02 . . . . 0.0 113.825 -171.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 mp -128.96 145.48 56.73 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.76 2.024 . . . . 0.0 110.973 -169.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.87 160.48 45.96 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.606 2.871 . . . . 0.0 113.831 -174.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.33 -5.26 15.5 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 124.02 3.147 . . . . 0.0 114.945 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -71.32 -39.81 71.17 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.736 -1.227 . . . . 0.0 111.715 169.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.7 t -85.97 -49.31 7.94 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.16 -0.962 . . . . 0.0 112.119 173.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.7 m -90.18 127.43 36.11 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.764 0.711 . . . . 0.0 112.093 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -140.37 163.33 33.09 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.758 1.223 . . . . 0.0 113.458 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.4 tp -140.0 136.42 33.73 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.708 2.003 . . . . 0.0 110.639 -170.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.1 p -139.93 155.7 47.03 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.528 1.131 . . . . 0.0 113.084 -178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -149.64 139.68 22.04 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.598 1.959 . . . . 0.0 109.808 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 55.61 29.9 14.4 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.199 1.4 . . . . 0.0 113.969 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.95 13.25 79.15 Favored Glycine 0 CA--C 1.541 1.68 0 C-N-CA 124.785 1.183 . . . . 0.0 114.985 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.3 mmm-85 -123.35 152.73 41.19 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.757 2.023 . . . . 0.0 112.23 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.92 124.01 30.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.738 0.815 . . . . 0.0 109.686 160.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.63 137.04 32.71 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.907 1.283 . . . . 0.0 109.42 174.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -164.51 147.73 9.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.385 1.474 . . . . 0.0 112.036 173.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 56.05 27.21 11.02 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.112 1.765 . . . . 0.0 115.378 175.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -83.96 -16.93 42.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.491 1.116 . . . . 0.0 113.954 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.27 -47.13 0.07 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 129.125 2.97 . . . . 0.0 115.956 -171.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.6 t -152.0 140.38 20.51 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.07 1.348 . . . . 0.0 110.987 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.96 -26.94 67.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.5 0.72 . . . . 0.0 112.153 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -65.3 -27.86 68.91 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.561 1.144 . . . . 0.0 113.364 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.1 t -68.35 -40.51 81.5 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.581 0.753 . . . . 0.0 112.262 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.12 -38.69 22.09 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.526 1.131 . . . . 0.0 112.021 177.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.43 97.91 0.26 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.914 1.721 . . . . 0.0 111.632 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.2 148.98 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.462 1.105 . . . . 0.0 111.735 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.34 -168.6 2.85 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.998 1.719 . . . . 0.0 111.116 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -138.75 149.46 45.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.825 1.25 . . . . 0.0 112.356 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.78 23.63 77.76 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 123.787 0.708 . . . . 0.0 113.87 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -66.92 164.99 16.34 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.93 1.292 . . . . 0.0 112.752 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -136.79 142.85 42.96 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.882 0.873 . . . . 0.0 113.281 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -127.86 125.32 39.48 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.062 1.345 . . . . 0.0 110.335 -175.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.4 126.63 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.604 1.162 . . . . 0.0 109.798 -176.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 tt -124.34 125.05 43.68 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.47 1.108 . . . . 0.0 110.923 -172.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.44 145.15 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.246 1.819 . . . . 0.0 110.275 -169.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.6 t -148.06 150.76 34.51 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.499 1.52 . . . . 0.0 110.941 176.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -122.27 134.68 54.68 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.565 1.546 . . . . 0.0 111.538 -177.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.3 p -71.92 148.08 46.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.443 1.097 . . . . 0.0 112.484 176.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.0 t -71.2 -34.35 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.283 1.033 . . . . 0.0 111.977 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.181 0 C-N-CA 125.725 1.631 . . . . 0.0 113.141 179.766 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.536 ' HG2' ' H ' ' A' ' 2' ' ' LYS . 26.7 ttt . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.536 ' H ' ' HG2' ' A' ' 1' ' ' MET . 58.3 mttm -75.65 140.99 42.87 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.099 -1.0 . . . . 0.0 110.613 162.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.81 159.84 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.056 1.742 . . . . 0.0 109.961 175.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -113.8 139.57 49.02 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.961 1.304 . . . . 0.0 110.36 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 tt -126.82 141.81 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.676 0.79 . . . . 0.0 111.357 174.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 t -124.65 85.36 56.7 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 125.547 1.539 . . . . 0.0 109.862 -177.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.07 121.37 5.33 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.289 2.66 . . . . 0.0 111.528 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.29 52.77 1.65 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.38 1.472 . . . . 0.0 113.406 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -150.45 147.02 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.054 1.342 . . . . 0.0 111.809 -176.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.39 29.18 74.4 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.436 1.017 . . . . 0.0 114.958 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.49 68.37 1.52 Allowed Glycine 0 CA--C 1.532 1.143 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -167.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.26 137.02 42.85 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.49 1.043 . . . . 0.0 114.372 -170.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.1 m -148.48 152.64 38.86 Favored Pre-proline 0 N--CA 1.474 0.735 0 C-N-CA 126.298 1.839 . . . . 0.0 110.813 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -65.86 143.51 73.63 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.936 2.424 . . . . 0.0 112.45 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.9 tp -139.55 129.0 24.24 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.357 1.463 . . . . 0.0 111.118 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -82.97 144.62 29.86 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.304 1.041 . . . . 0.0 112.783 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -152.38 146.97 25.75 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.297 1.439 . . . . 0.0 111.625 168.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -81.42 135.74 35.66 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.739 0.816 . . . . 0.0 111.191 171.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.6 m -134.16 156.56 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.484 1.114 . . . . 0.0 112.279 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.82 152.07 93.81 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 124.382 1.073 . . . . 0.0 112.608 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.09 -23.74 60.32 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.119 2.546 . . . . 0.0 113.279 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -85.43 10.7 12.12 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.249 1.42 . . . . 0.0 113.739 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.99 155.44 27.5 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.079 0.854 . . . . 0.0 112.515 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.6 m -144.39 135.37 25.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.265 1.426 . . . . 0.0 110.669 -171.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.7 t -61.28 -40.27 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.367 0.667 . . . . 0.0 111.953 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.34 -39.13 97.35 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.431 -0.649 . . . . 0.0 113.37 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.69 -37.59 82.52 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 118.342 1.071 . . . . 0.0 112.489 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.48 -44.56 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.543 -0.723 . . . . 0.0 110.37 172.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -60.94 -52.61 64.28 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.02 0.928 . . . . 0.0 111.925 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.2 p -64.53 -36.07 83.02 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 118.358 -0.829 . . . . 0.0 112.852 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -58.47 -45.01 89.49 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.558 1.072 . . . . 0.0 112.084 172.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 51.9 t -69.82 -42.81 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.082 0.856 . . . . 0.0 111.87 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 88.3 m -56.74 -42.32 79.05 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.908 1.231 . . . . 0.0 112.263 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.19 -41.31 81.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.922 0.889 . . . . 0.0 112.626 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.2 ttt -71.49 -36.78 71.23 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.897 0.879 . . . . 0.0 113.07 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -77.37 -13.78 59.86 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.075 1.35 . . . . 0.0 113.295 171.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 55.1 46.39 24.14 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.485 1.914 . . . . 0.0 112.109 -176.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.1 mt -133.14 146.12 59.73 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.424 1.49 . . . . 0.0 112.956 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.18 162.07 43.66 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.974 3.116 . . . . 0.0 113.473 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.48 -7.68 16.81 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.833 3.022 . . . . 0.0 114.273 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.3 -24.64 57.51 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.794 -1.191 . . . . 0.0 113.139 170.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 74.7 p -123.13 0.87 9.11 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.806 1.243 . . . . 0.0 114.204 -174.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.7 m -146.93 125.34 12.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.301 1.441 . . . . 0.0 109.998 172.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -145.36 149.55 34.97 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.734 1.214 . . . . 0.0 113.218 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 69' ' ' PHE . 47.3 tp -105.13 144.59 31.72 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.129 1.772 . . . . 0.0 111.229 175.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.5 p -131.71 154.6 48.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.003 1.321 . . . . 0.0 111.451 170.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -143.03 125.29 15.49 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.434 1.894 . . . . 0.0 109.479 -174.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt 53.24 31.46 11.67 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.714 1.206 . . . . 0.0 113.351 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.41 -4.58 55.12 Favored Glycine 0 CA--C 1.542 1.769 0 C-N-CA 125.529 1.538 . . . . 0.0 116.094 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -94.41 153.15 18.1 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.771 1.628 . . . . 0.0 111.993 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.25 127.67 32.63 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 157.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.5 mt -142.59 151.28 41.36 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.43 1.492 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -154.51 -48.99 0.09 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.369 1.068 . . . . 0.0 113.693 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -83.52 39.13 0.65 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.734 1.614 . . . . 0.0 113.651 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.9 m -72.53 -22.72 60.98 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.844 1.258 . . . . 0.0 113.328 -172.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 63.36 -54.09 0.2 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.71 2.804 . . . . 0.0 115.558 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -160.71 140.8 11.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.868 2.467 . . . . 0.0 108.853 168.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -73.53 -34.71 65.35 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.023 0.829 . . . . 0.0 112.242 171.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -65.75 -27.94 68.67 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -173.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.4 m -67.0 -18.23 65.29 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.9 mp -107.87 -42.16 4.78 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.142 1.377 . . . . 0.0 112.155 175.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.63 93.86 0.1 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.575 1.56 . . . . 0.0 111.771 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.1 p -76.4 149.39 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.045 0.938 . . . . 0.0 110.994 173.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -141.94 178.56 7.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.477 1.111 . . . . 0.0 113.435 -172.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -97.86 137.53 36.57 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.395 1.878 . . . . 0.0 111.31 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.94 19.6 67.18 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 115.562 0.985 . . . . 0.0 115.562 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -65.09 143.57 57.81 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.581 1.191 . . . . 0.0 111.602 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -127.61 132.84 49.72 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -166.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.571 ' HB3' HD11 ' A' ' 45' ' ' LEU . 98.2 m-85 -121.35 141.01 51.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.061 1.744 . . . . 0.0 111.296 -175.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.6 t -124.14 122.48 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.979 0.911 . . . . 0.0 109.835 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -112.42 112.02 23.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.022 1.329 . . . . 0.0 109.062 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.9 mt -101.5 140.26 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.715 1.606 . . . . 0.0 109.921 -176.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.8 p -133.51 157.37 45.83 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.894 1.277 . . . . 0.0 112.375 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 . . . . . 0 N--CA 1.476 0.874 0 C-N-CA 127.017 2.127 . . . . 0.0 111.475 178.872 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 121.246 0.546 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -82.92 149.71 26.9 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.201 -0.937 . . . . 0.0 110.536 166.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.2 pt -139.85 160.41 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.554 1.942 . . . . 0.0 110.009 169.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -118.88 107.81 14.04 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.872 0.869 . . . . 0.0 111.243 172.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.9 tt -90.13 140.17 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.037 0.535 . . . . 0.0 110.933 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 t -125.84 88.94 53.38 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 125.148 1.379 . . . . 0.0 109.899 -175.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -82.41 124.06 4.06 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.448 2.765 . . . . 0.0 112.509 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.19 35.86 0.18 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.87 1.668 . . . . 0.0 114.039 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.0 m -79.42 51.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 126.793 2.037 . . . . 0.0 113.315 -171.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.96 53.01 7.39 Favored Glycine 0 CA--C 1.533 1.218 0 O-C-N 121.276 -0.89 . . . . 0.0 112.877 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.97 23.89 36.83 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.405 1.002 . . . . 0.0 114.747 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.19 138.72 45.75 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 118.18 0.99 . . . . 0.0 113.554 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.5 p -84.1 155.13 64.04 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 125.427 1.491 . . . . 0.0 112.969 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -62.04 145.15 96.72 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.256 2.637 . . . . 0.0 111.825 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.91 127.05 29.91 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.814 1.246 . . . . 0.0 111.392 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -75.53 130.74 39.34 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.724 1.209 . . . . 0.0 111.291 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.94 149.49 41.91 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.611 1.564 . . . . 0.0 111.143 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -85.48 141.8 29.66 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.089 1.356 . . . . 0.0 111.2 169.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.45 142.17 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.482 1.113 . . . . 0.0 112.897 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.97 150.32 61.38 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.187 1.395 . . . . 0.0 112.674 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.15 -23.58 60.09 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.55 2.833 . . . . 0.0 113.619 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -78.82 0.92 25.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.226 1.41 . . . . 0.0 113.872 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.11 140.23 56.06 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.259 0.936 . . . . 0.0 111.972 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.2 m -119.5 131.96 55.68 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.134 1.374 . . . . 0.0 110.23 -174.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.8 m -61.55 -31.96 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -174.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.64 -37.22 92.33 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 123.776 0.703 . . . . 0.0 113.292 173.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.15 -41.9 73.25 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.214 1.007 . . . . 0.0 111.689 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.46 -45.31 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.549 0.739 . . . . 0.0 111.041 175.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -55.36 -49.07 73.23 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.644 1.177 . . . . 0.0 111.239 172.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 90.5 m -65.26 -40.2 93.66 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.226 0.61 . . . . 0.0 111.849 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -59.61 -46.95 87.45 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.252 1.021 . . . . 0.0 111.638 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 36.0 t -61.64 -46.92 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.162 0.985 . . . . 0.0 111.865 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.6 m -63.93 -38.49 91.29 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.4 0.68 . . . . 0.0 112.283 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.26 -41.81 84.95 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.823 0.849 . . . . 0.0 112.421 174.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -66.08 -41.47 90.64 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.329 1.051 . . . . 0.0 112.832 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -85.28 -9.44 57.7 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.79 12.97 1.84 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 127.646 2.379 . . . . 0.0 115.063 -174.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.9 mp -118.66 153.61 52.29 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 126.743 2.017 . . . . 0.0 111.537 -175.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.06 163.87 37.73 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 124.245 3.297 . . . . 0.0 114.235 -173.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -64.91 -14.6 46.05 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.257 2.638 . . . . 0.0 114.026 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -68.58 -26.89 65.62 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.345 1.058 . . . . 0.0 113.215 171.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 34.6 p -109.01 -21.4 12.64 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.078 1.351 . . . . 0.0 113.573 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.3 m -126.54 126.03 43.01 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.145 0.978 . . . . 0.0 110.899 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -141.97 166.25 25.22 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.844 1.258 . . . . 0.0 113.354 -169.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.0 tp -136.93 140.33 42.19 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.869 1.668 . . . . 0.0 111.278 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.8 p -137.29 156.67 47.98 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.181 1.392 . . . . 0.0 112.767 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -152.53 131.92 12.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.441 2.297 . . . . 0.0 110.144 -174.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.35 40.01 17.52 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.357 1.463 . . . . 0.0 113.444 174.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.29 8.7 87.62 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 125.132 1.348 . . . . 0.0 116.334 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -133.89 160.78 36.64 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.707 1.603 . . . . 0.0 112.619 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.41 155.52 29.93 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.274 0.629 . . . . 0.0 110.866 160.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.6 mt -116.86 133.58 55.83 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.55 1.14 . . . . 0.0 111.065 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.2 141.65 18.7 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.926 1.29 . . . . 0.0 111.403 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.5 t0 55.09 33.58 20.71 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.776 1.63 . . . . 0.0 114.789 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.0 p -83.43 -29.48 28.06 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.565 1.146 . . . . 0.0 113.595 -171.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 61.42 -23.45 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 129.107 2.963 . . . . 0.0 116.979 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.1 p -149.09 161.58 41.68 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.796 2.039 . . . . 0.0 111.25 171.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 65.8 mt -77.01 -20.95 55.37 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.738 -0.601 . . . . 0.0 112.595 164.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -63.67 -36.24 83.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.164 0.986 . . . . 0.0 112.421 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.8 m -69.95 -19.2 63.38 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 174.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.1 mt -90.11 -24.74 21.02 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.731 1.213 . . . . 0.0 113.48 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.97 41.09 72.78 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 123.643 0.64 . . . . 0.0 113.158 -174.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.0 p -55.64 149.19 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.907 1.283 . . . . 0.0 112.22 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.79 151.27 30.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.211 1.004 . . . . 0.0 112.182 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -64.22 128.62 36.58 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.67 0.788 . . . . 0.0 111.195 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.78 8.65 76.09 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.013 1.292 . . . . 0.0 115.858 -176.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -62.08 152.04 33.85 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.665 1.733 . . . . 0.0 113.6 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -103.39 154.15 19.72 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.685 1.194 . . . . 0.0 114.179 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -135.78 143.2 45.1 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.119 2.168 . . . . 0.0 109.679 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.9 t -121.7 126.22 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.745 0.818 . . . . 0.0 110.34 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 tt -111.86 122.31 47.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.733 1.613 . . . . 0.0 109.194 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -113.92 142.74 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.722 1.609 . . . . 0.0 110.061 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.7 t -136.87 150.66 48.4 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.092 1.357 . . . . 0.0 112.052 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 . . . . . 0 N--CA 1.475 0.811 0 C-N-CA 126.681 1.993 . . . . 0.0 110.154 -176.251 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.913 0.387 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -102.71 152.23 21.46 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.739 1.215 . . . . 0.0 112.315 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -133.44 154.46 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.283 1.833 . . . . 0.0 109.608 173.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -98.12 146.26 25.74 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.235 0.614 . . . . 0.0 110.549 161.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.4 tt -123.5 136.74 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 124.473 1.109 . . . . 0.0 109.62 165.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -123.46 78.85 54.46 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.943 1.297 . . . . 0.0 109.359 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -81.56 138.02 10.57 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.882 2.388 . . . . 0.0 112.556 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.29 35.7 0.18 Allowed 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.676 1.59 . . . . 0.0 114.394 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.85 160.89 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 126.517 1.927 . . . . 0.0 111.701 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.45 -117.94 12.88 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 123.876 0.75 . . . . 0.0 112.144 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.79 -18.2 72.08 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 123.905 0.764 . . . . 0.0 114.745 174.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.89 11.82 58.74 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-N 118.747 1.273 . . . . 0.0 115.095 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.2 p -106.85 160.14 27.37 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.846 2.058 . . . . 0.0 112.765 -168.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.38 137.37 55.36 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.926 2.417 . . . . 0.0 112.076 171.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 mp -124.1 137.09 54.61 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.319 1.448 . . . . 0.0 110.427 167.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -99.82 135.08 41.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.626 1.17 . . . . 0.0 111.844 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.7 mt -142.23 147.61 36.79 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.039 1.736 . . . . 0.0 111.778 -173.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -81.05 144.06 32.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.284 1.034 . . . . 0.0 110.834 166.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.1 p -144.71 145.24 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.777 0.831 . . . . 0.0 112.514 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 148.09 91.45 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.537 1.135 . . . . 0.0 112.6 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.84 -23.1 41.81 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.202 2.601 . . . . 0.0 113.182 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -81.91 5.79 17.9 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.443 1.497 . . . . 0.0 113.858 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.77 140.47 51.5 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.211 -0.931 . . . . 0.0 112.149 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.6 p -120.05 149.6 41.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.307 1.043 . . . . 0.0 112.109 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.8 m -60.79 -36.06 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.853 0.861 . . . . 0.0 112.519 175.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.83 -44.49 91.96 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 123.893 0.759 . . . . 0.0 112.357 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.75 -47.72 79.89 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 117.767 0.783 . . . . 0.0 112.06 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.4 t -63.14 -48.11 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.466 0.575 . . . . 0.0 111.316 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -59.71 -48.11 82.98 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.71 0.804 . . . . 0.0 111.66 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.5 m -68.62 -36.48 78.7 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.761 -0.587 . . . . 0.0 111.851 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -66.98 -38.78 86.67 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.862 0.865 . . . . 0.0 112.337 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.0 t -56.29 -51.8 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.725 0.81 . . . . 0.0 110.956 167.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.2 m -62.41 -37.18 84.8 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.19 -44.38 84.14 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.024 0.929 . . . . 0.0 112.565 174.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 96.4 mtp -68.63 -39.39 80.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.807 0.843 . . . . 0.0 113.11 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -80.67 -12.56 59.47 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 175.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 58.59 17.43 5.0 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 127.165 2.186 . . . . 0.0 114.162 -173.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 mp -130.04 152.02 79.3 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 127.156 2.183 . . . . 0.0 110.702 -171.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.21 164.74 32.84 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 124.111 3.207 . . . . 0.0 114.115 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.59 -12.28 34.28 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.334 2.689 . . . . 0.0 114.014 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -66.03 -36.84 84.32 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.976 -1.078 . . . . 0.0 112.059 170.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.5 p -90.66 -19.66 23.38 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 89.5 m -136.44 124.83 23.36 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.533 1.515 . . . . 0.0 111.732 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -125.86 157.73 36.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.861 1.665 . . . . 0.0 112.221 -173.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.0 tp -125.98 136.49 53.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.445 1.898 . . . . 0.0 111.308 -173.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.0 p -134.37 153.22 52.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.405 1.082 . . . . 0.0 112.543 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -152.26 136.13 16.34 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.186 1.795 . . . . 0.0 110.059 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt 51.54 33.61 10.86 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.756 1.622 . . . . 0.0 114.362 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.32 19.36 77.47 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.125 0.869 . . . . 0.0 115.091 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -129.02 160.96 31.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.048 2.139 . . . . 0.0 111.24 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -88.58 131.97 34.73 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.696 0.798 . . . . 0.0 110.113 160.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.5 tp -96.94 112.63 24.3 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.148 0.979 . . . . 0.0 110.464 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -154.04 151.14 28.99 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.996 1.318 . . . . 0.0 112.33 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.6 t0 56.18 29.58 14.98 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.928 2.091 . . . . 0.0 115.037 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.0 p -88.36 -20.11 25.75 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 58.09 -64.79 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.87 2.068 . . . . 0.0 114.266 -163.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.7 p -144.01 150.03 37.61 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.16 1.384 . . . . 0.0 111.989 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.51 -30.8 71.61 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.686 0.794 . . . . 0.0 112.631 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.68 -22.51 65.28 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.231 -0.918 . . . . 0.0 113.26 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.7 p -69.44 -26.53 64.65 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 56.6 mt -98.02 -6.35 32.09 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.117 1.767 . . . . 0.0 113.16 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.33 115.39 1.46 Allowed Glycine 0 CA--C 1.536 1.347 0 C-N-CA 126.206 1.86 . . . . 0.0 112.385 -171.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 m -74.43 154.45 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.75 1.22 . . . . 0.0 112.684 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -147.81 160.06 43.16 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.317 1.847 . . . . 0.0 110.319 170.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -93.09 147.49 22.82 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.821 0.848 . . . . 0.0 112.485 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.82 30.78 59.07 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 115.068 0.787 . . . . 0.0 115.068 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.29 148.34 51.86 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.631 1.215 . . . . 0.0 111.891 173.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -120.74 111.75 17.99 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.367 1.067 . . . . 0.0 111.563 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -94.04 144.23 25.66 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.126 1.37 . . . . 0.0 111.222 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.08 128.34 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.484 1.114 . . . . 0.0 109.664 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.3 tp -115.16 123.21 48.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.026 0.93 . . . . 0.0 110.967 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.4 123.56 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.408 1.483 . . . . 0.0 109.708 -171.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.2 t -111.57 141.19 45.48 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.257 1.023 . . . . 0.0 111.76 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? . . . . . 0 N--CA 1.469 0.498 0 C-N-CA 125.557 1.543 . . . . 0.0 110.475 175.737 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 mmt . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.668 0.271 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.88 148.92 27.04 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.651 -1.28 . . . . 0.0 112.298 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.22 155.97 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.883 1.673 . . . . 0.0 110.434 172.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -111.19 119.36 38.7 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.414 1.086 . . . . 0.0 111.083 169.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 tp -86.98 137.82 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 165.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 t -128.81 77.99 76.82 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 124.718 1.207 . . . . 0.0 109.789 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.09 136.74 10.43 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.317 2.678 . . . . 0.0 112.114 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.46 36.49 0.16 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.679 1.592 . . . . 0.0 113.463 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.6 t -138.32 147.56 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.106 1.762 . . . . 0.0 110.641 -170.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.11 -117.71 10.81 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 123.969 0.795 . . . . 0.0 111.967 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.53 -19.58 71.02 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 123.85 0.738 . . . . 0.0 114.519 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.51 3.66 41.38 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 124.87 1.224 . . . . 0.0 115.667 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.0 p -91.31 157.22 42.85 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 126.583 1.953 . . . . 0.0 113.203 -171.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -64.23 145.36 88.7 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.992 2.461 . . . . 0.0 111.784 168.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 tt -137.07 122.48 19.5 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.95 1.3 . . . . 0.0 110.313 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -90.52 137.81 32.06 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.226 1.01 . . . . 0.0 113.017 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.0 mt -144.72 148.17 33.86 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.984 1.714 . . . . 0.0 111.826 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -80.65 138.2 36.39 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.641 1.176 . . . . 0.0 110.382 166.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.4 m -140.0 153.33 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.458 1.103 . . . . 0.0 112.33 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.85 150.49 96.47 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.04 0.936 . . . . 0.0 112.197 175.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.64 -21.01 52.68 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.082 2.521 . . . . 0.0 112.957 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.88 15.68 2.15 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.853 1.661 . . . . 0.0 114.015 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.18 142.49 54.29 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.163 -0.961 . . . . 0.0 112.128 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.3 m -133.56 138.58 46.11 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.241 1.416 . . . . 0.0 111.046 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.9 t -57.49 -47.76 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.339 1.055 . . . . 0.0 112.587 -173.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.6 -38.33 96.22 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.674 -0.515 . . . . 0.0 112.968 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.18 -46.07 78.64 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 117.986 0.893 . . . . 0.0 111.814 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -60.8 -49.14 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.805 0.842 . . . . 0.0 110.971 176.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -62.42 -46.37 88.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.264 0.626 . . . . 0.0 111.777 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.6 m -59.62 -43.92 93.63 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.475 0.71 . . . . 0.0 111.51 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -66.32 -37.7 85.98 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.576 0.751 . . . . 0.0 112.469 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.02 -46.59 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.502 0.592 . . . . 0.0 111.794 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.2 m -58.6 -40.44 83.26 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.501 1.046 . . . . 0.0 112.144 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.72 -41.51 87.8 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.893 0.877 . . . . 0.0 112.715 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.6 tpt -68.28 -41.25 81.27 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.515 1.126 . . . . 0.0 112.767 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.444 ' HA ' ' HE3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -74.77 -24.62 58.71 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.511 1.524 . . . . 0.0 113.137 172.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.79 30.25 19.55 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.805 2.042 . . . . 0.0 113.221 -171.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 mp -120.32 153.83 56.06 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.948 2.099 . . . . 0.0 111.454 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.74 162.54 38.98 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.899 3.066 . . . . 0.0 113.496 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -67.58 -16.22 46.53 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.537 2.825 . . . . 0.0 114.819 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -79.79 -29.6 40.4 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.675 1.125 . . . . 0.0 113.613 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.7 p -86.64 9.55 18.31 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.702 1.201 . . . . 0.0 113.69 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 t -135.85 144.81 45.84 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.36 1.464 . . . . 0.0 110.897 176.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -133.52 148.01 51.63 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.505 1.922 . . . . 0.0 110.4 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.3 tp -139.67 121.24 15.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.34 1.456 . . . . 0.0 110.563 -169.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.7 m -132.71 141.11 48.42 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.596 1.158 . . . . 0.0 112.342 -169.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -143.75 131.94 21.89 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.779 2.032 . . . . 0.0 110.608 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt 50.14 37.64 15.07 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.008 1.323 . . . . 0.0 113.82 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.18 17.35 79.57 Favored Glycine 0 CA--C 1.541 1.683 0 C-N-CA 124.718 1.151 . . . . 0.0 115.788 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -136.7 154.13 50.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.675 1.99 . . . . 0.0 112.881 -175.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.41 129.27 34.57 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.82 0.848 . . . . 0.0 110.521 165.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.1 130.72 34.84 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.989 0.916 . . . . 0.0 110.223 169.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -162.23 141.94 9.72 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.513 1.525 . . . . 0.0 111.637 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 t0 56.55 25.34 9.71 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 172.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.1 p -82.96 -16.03 48.94 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.839 -1.163 . . . . 0.0 113.234 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 62.67 -56.1 0.15 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 128.775 2.83 . . . . 0.0 115.02 -171.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 21.5 p -148.93 148.21 29.55 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.344 1.858 . . . . 0.0 111.593 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.69 -25.46 68.22 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.689 0.796 . . . . 0.0 112.991 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -62.01 -27.36 68.82 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.065 -1.022 . . . . 0.0 113.084 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.5 m -69.11 -23.93 64.05 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.114 0.966 . . . . 0.0 113.162 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.6 mt -93.45 -22.87 18.63 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.238 1.415 . . . . 0.0 112.724 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.53 114.03 3.01 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.47 1.986 . . . . 0.0 111.344 -167.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.2 t -72.74 143.18 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.717 1.207 . . . . 0.0 111.314 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -138.55 146.14 41.52 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.549 1.54 . . . . 0.0 110.38 168.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -78.38 147.38 34.14 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.289 -0.882 . . . . 0.0 112.411 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.7 21.81 78.07 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 115.044 0.778 . . . . 0.0 115.044 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -56.98 140.0 50.26 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.728 1.264 . . . . 0.0 111.309 170.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -121.44 137.04 54.89 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.856 0.862 . . . . 0.0 112.138 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -119.0 121.87 40.88 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.463 1.505 . . . . 0.0 109.731 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.5 t -91.81 130.59 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.326 0.65 . . . . 0.0 109.428 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 tp -120.31 123.45 43.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.151 0.98 . . . . 0.0 110.892 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -113.28 129.18 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.411 1.485 . . . . 0.0 110.014 -172.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.6 t -94.37 145.88 24.45 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.497 1.119 . . . . 0.0 111.787 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.773 0 C-N-CA 124.633 1.173 . . . . 0.0 110.615 171.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.979 0.419 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -121.52 147.45 45.77 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.737 1.215 . . . . 0.0 112.544 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.12 166.44 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.542 1.937 . . . . 0.0 110.265 172.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -128.38 100.78 5.93 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.894 0.878 . . . . 0.0 111.287 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.5 tt -86.55 141.8 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.77 0.828 . . . . 0.0 111.209 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.6 t -128.84 80.89 71.9 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 125.491 1.517 . . . . 0.0 109.483 -176.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.5 142.7 33.37 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.952 2.434 . . . . 0.0 111.94 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.62 23.29 0.23 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.399 1.48 . . . . 0.0 113.908 174.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -155.8 160.55 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 127.246 2.218 . . . . 0.0 109.889 -172.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.43 34.81 53.62 Favored Glycine 0 CA--C 1.535 1.292 0 O-C-N 121.389 -0.819 . . . . 0.0 113.998 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.33 -9.17 64.89 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.575 1.559 . . . . 0.0 114.887 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.7 -0.44 43.75 Favored Glycine 0 CA--C 1.54 1.598 0 N-CA-C 116.555 1.382 . . . . 0.0 116.555 170.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.4 m -80.38 152.34 73.1 Favored Pre-proline 0 N--CA 1.472 0.629 0 C-N-CA 124.676 1.19 . . . . 0.0 113.053 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -64.43 145.34 87.76 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.067 2.511 . . . . 0.0 111.845 170.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.7 mt -131.68 121.86 24.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.503 1.521 . . . . 0.0 110.58 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -88.89 132.77 34.54 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.553 1.141 . . . . 0.0 111.284 178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 mt -149.81 143.49 25.39 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.347 1.059 . . . . 0.0 111.624 -173.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -69.82 150.97 46.28 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.351 0.66 . . . . 0.0 111.98 168.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 p -146.37 140.15 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.349 1.06 . . . . 0.0 111.538 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.56 145.27 78.73 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.021 0.928 . . . . 0.0 111.956 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.2 -20.88 49.11 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.833 2.355 . . . . 0.0 113.198 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -75.72 -7.18 53.73 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.2 157.76 30.55 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.162 0.892 . . . . 0.0 112.847 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.85 145.9 51.82 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.95 1.3 . . . . 0.0 110.885 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.1 t -66.37 -34.05 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 121.373 -0.829 . . . . 0.0 111.295 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.25 -43.7 99.05 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.439 1.018 . . . . 0.0 113.054 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.87 -45.47 85.88 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.98 0.89 . . . . 0.0 111.717 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.3 t -60.92 -49.3 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.012 0.925 . . . . 0.0 111.99 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.9 ptt85 -64.08 -39.52 94.24 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.123 0.874 . . . . 0.0 112.07 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.7 m -62.69 -41.22 98.99 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.596 0.758 . . . . 0.0 111.376 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -60.63 -42.57 97.17 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.708 0.803 . . . . 0.0 112.191 178.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 70.2 t -74.67 -35.74 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.541 0.736 . . . . 0.0 112.559 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 87.1 m -60.25 -45.51 93.01 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.589 -0.694 . . . . 0.0 111.465 170.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.46 -41.1 89.56 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.984 0.914 . . . . 0.0 112.829 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 57.7 ttm -61.69 -43.84 98.09 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.396 1.078 . . . . 0.0 112.849 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -85.94 -6.38 59.07 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.4 tptm 53.54 53.67 11.21 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.059 2.144 . . . . 0.0 112.451 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.7 mt -133.16 148.38 68.98 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.612 1.565 . . . . 0.0 112.164 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -69.49 160.42 49.83 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.563 2.842 . . . . 0.0 112.444 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.07 -26.01 73.43 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.741 2.294 . . . . 0.0 113.13 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -70.09 -3.19 15.41 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.492 -1.38 . . . . 0.0 114.604 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.8 p -127.7 14.67 6.99 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.368 1.467 . . . . 0.0 113.075 165.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 m -154.53 110.69 3.23 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.031 1.733 . . . . 0.0 110.868 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.2 mtt-85 -132.15 155.22 48.56 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.557 1.143 . . . . 0.0 112.886 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.0 tp -127.37 131.53 50.33 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.255 1.822 . . . . 0.0 110.596 -174.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.8 p -136.84 152.16 49.95 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.415 1.086 . . . . 0.0 113.371 -175.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -142.26 134.5 27.65 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.575 1.95 . . . . 0.0 110.382 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 tptm 51.68 33.31 10.68 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.465 1.506 . . . . 0.0 114.191 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.75 10.09 84.67 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 125.285 1.422 . . . . 0.0 115.931 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -127.34 149.94 49.82 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.792 1.637 . . . . 0.0 112.678 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.12 88.51 6.55 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.735 1.214 . . . . 0.0 110.844 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.2 mp -65.39 147.55 53.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.916 0.886 . . . . 0.0 111.68 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -158.07 -51.05 0.07 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.888 1.275 . . . . 0.0 113.437 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -84.53 40.25 0.78 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.492 1.517 . . . . 0.0 113.295 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.0 m -73.82 -27.26 61.02 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.41 1.084 . . . . 0.0 112.808 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 62.0 -61.92 0.1 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 128.035 2.534 . . . . 0.0 114.776 -174.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.4 p -147.29 150.57 35.05 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.217 1.407 . . . . 0.0 111.319 170.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.07 -20.61 62.34 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.122 0.569 . . . . 0.0 112.471 167.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.09 -54.35 39.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.575 1.55 . . . . 0.0 112.346 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.3 m -69.27 -28.47 66.34 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.9 tp -74.68 -27.84 60.58 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.989 0.916 . . . . 0.0 112.788 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.61 54.24 6.12 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.383 0.992 . . . . 0.0 113.042 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.6 p -56.62 151.88 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.633 1.173 . . . . 0.0 112.905 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.83 161.07 33.83 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.01 1.324 . . . . 0.0 112.945 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -60.95 129.81 43.28 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.099 1.36 . . . . 0.0 112.29 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.46 4.97 59.27 Favored Glycine 0 CA--C 1.535 1.281 0 N-CA-C 115.99 1.156 . . . . 0.0 115.99 171.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -64.68 138.02 58.15 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.179 1.49 . . . . 0.0 110.649 168.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -132.98 134.46 44.51 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -167.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -124.32 136.55 54.19 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.698 1.199 . . . . 0.0 111.484 -167.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t -100.73 132.29 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.725 0.81 . . . . 0.0 109.864 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 tt -120.43 103.44 9.19 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.845 0.858 . . . . 0.0 110.299 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -86.71 141.41 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 126.25 1.82 . . . . 0.0 109.867 -176.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.8 t -146.67 156.55 43.27 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.16 0.984 . . . . 0.0 111.899 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 125.024 1.33 . . . . 0.0 112.573 -171.116 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -101.82 140.06 36.62 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.0 -1.688 . . . . 0.0 112.458 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.83 171.1 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 127.297 2.239 . . . . 0.0 110.399 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -127.2 149.95 49.75 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.809 1.244 . . . . 0.0 110.962 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.1 tt -129.38 142.47 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.119 0.968 . . . . 0.0 110.777 172.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.83 77.85 76.12 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 125.292 1.437 . . . . 0.0 109.779 -173.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.84 133.91 15.87 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.163 2.575 . . . . 0.0 111.497 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.7 41.47 0.27 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.253 1.421 . . . . 0.0 113.314 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.4 t -139.22 147.28 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.031 1.732 . . . . 0.0 110.718 -170.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.13 -119.92 16.37 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 123.898 0.761 . . . . 0.0 111.947 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.34 -18.41 71.43 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 123.684 0.659 . . . . 0.0 114.678 174.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.84 3.19 41.68 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 124.966 1.27 . . . . 0.0 115.748 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.5 p -82.33 155.72 69.14 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.996 1.718 . . . . 0.0 113.363 -174.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -67.34 152.18 79.49 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.302 2.668 . . . . 0.0 112.097 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.1 tp -141.31 125.3 17.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.797 1.239 . . . . 0.0 111.759 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -71.08 142.01 50.84 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.21 1.404 . . . . 0.0 112.327 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.75 151.78 37.73 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.382 1.473 . . . . 0.0 110.351 174.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -111.68 128.68 56.15 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.776 1.23 . . . . 0.0 110.465 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.5 m -140.53 155.1 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.206 1.402 . . . . 0.0 112.483 -165.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.98 150.29 97.64 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 123.82 0.848 . . . . 0.0 111.788 171.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.2 -25.34 57.76 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.966 2.444 . . . . 0.0 112.971 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -76.34 12.57 1.17 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.908 1.683 . . . . 0.0 114.728 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.55 105.12 0.73 Allowed 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.916 -1.115 . . . . 0.0 111.917 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.0 m -75.61 130.1 38.24 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.476 1.11 . . . . 0.0 111.15 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.9 t -60.93 -35.2 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.994 0.918 . . . . 0.0 112.925 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.59 -40.0 97.23 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 121.319 -0.863 . . . . 0.0 113.223 172.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.66 -34.76 77.57 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 117.975 0.887 . . . . 0.0 112.324 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.2 t -60.48 -44.39 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 O-C-N 121.505 -0.747 . . . . 0.0 110.814 172.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -61.42 -54.21 46.47 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.323 173.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 66.4 p -63.17 -34.44 77.63 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.41 1.005 . . . . 0.0 112.853 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -61.06 -47.5 86.09 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.739 0.816 . . . . 0.0 111.751 173.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.0 t -66.6 -41.87 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.805 176.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 92.4 m -57.84 -41.87 83.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.46 1.027 . . . . 0.0 112.087 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.51 -41.5 88.77 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.696 0.798 . . . . 0.0 112.849 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.5 mtt -67.29 -39.49 86.01 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.04 0.936 . . . . 0.0 113.106 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.464 ' HA ' ' HE3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -79.14 -23.22 44.13 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.879 1.272 . . . . 0.0 113.647 176.635 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt 58.78 31.3 21.07 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.419 1.888 . . . . 0.0 113.189 -167.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 mp -114.24 150.58 43.92 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 126.249 1.82 . . . . 0.0 111.035 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -69.54 161.84 44.32 Favored 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.702 2.935 . . . . 0.0 112.726 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -65.18 -20.18 62.77 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.22 2.613 . . . . 0.0 113.674 176.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -67.65 -31.56 71.64 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.149 -0.969 . . . . 0.0 113.309 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 47.8 p -94.41 20.17 8.65 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.382 1.473 . . . . 0.0 113.704 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 t -145.68 152.55 39.8 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.334 1.054 . . . . 0.0 112.373 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 88.0 mmt-85 -139.36 145.55 39.15 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.924 1.69 . . . . 0.0 111.283 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.8 tp -134.71 127.9 31.91 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.441 1.896 . . . . 0.0 109.834 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.6 p -140.67 155.48 46.48 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.418 1.087 . . . . 0.0 112.772 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -146.41 140.49 26.35 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.101 1.76 . . . . 0.0 110.013 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.1 tptt 50.95 34.8 11.17 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.644 1.578 . . . . 0.0 114.035 -177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.87 14.94 81.17 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.757 1.17 . . . . 0.0 115.292 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -130.71 145.45 51.94 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.129 1.772 . . . . 0.0 111.739 -173.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.84 119.4 23.86 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.739 0.815 . . . . 0.0 110.655 171.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.1 mp -93.37 135.42 34.62 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.25 1.02 . . . . 0.0 110.212 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -160.64 149.7 16.97 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.227 1.811 . . . . 0.0 110.127 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 56.18 27.43 11.61 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.601 1.561 . . . . 0.0 114.823 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -73.23 -26.09 60.99 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.52 1.128 . . . . 0.0 113.638 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 61.04 -43.85 0.12 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.73 2.812 . . . . 0.0 115.079 -167.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.8 t -155.05 145.43 22.05 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.121 1.768 . . . . 0.0 110.62 174.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.72 -18.85 65.39 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.671 -0.643 . . . . 0.0 111.938 172.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.66 -24.11 67.47 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.033 -1.042 . . . . 0.0 112.772 173.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.7 t -68.25 -36.89 80.15 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.808 0.843 . . . . 0.0 112.283 172.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.4 mt -85.66 -20.67 29.08 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.972 1.309 . . . . 0.0 113.323 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.64 115.77 3.75 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.757 2.123 . . . . 0.0 111.856 -172.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.6 m -77.7 151.86 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.851 1.261 . . . . 0.0 113.364 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.89 163.61 39.77 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.407 1.883 . . . . 0.0 110.755 169.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -90.89 150.23 21.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.166 0.987 . . . . 0.0 112.806 172.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.67 81.67 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.739 1.161 . . . . 0.0 114.804 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -62.19 120.95 11.91 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.531 1.165 . . . . 0.0 110.745 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -106.15 114.87 29.26 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.045 0.938 . . . . 0.0 112.075 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -93.61 125.8 38.42 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.575 1.55 . . . . 0.0 110.545 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.0 t -96.39 133.26 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.724 0.81 . . . . 0.0 109.433 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.5 tt -130.37 123.49 30.03 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.851 0.86 . . . . 0.0 111.232 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.4 mm -117.07 122.01 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.112 1.365 . . . . 0.0 110.163 -171.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -81.66 143.35 31.97 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.328 0.651 . . . . 0.0 110.949 167.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 . . . . . 0 N--CA 1.472 0.659 0 C-N-CA 123.753 0.821 . . . . 0.0 110.335 167.657 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.5 mtt . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -79.76 149.28 31.17 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.16 -0.962 . . . . 0.0 111.559 166.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.97 140.26 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.918 2.087 . . . . 0.0 109.08 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -100.24 110.41 22.66 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.856 1.262 . . . . 0.0 110.951 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.3 tt -90.56 138.47 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.766 -0.584 . . . . 0.0 110.354 171.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.7 t -127.37 81.89 69.24 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 125.134 1.373 . . . . 0.0 109.65 -175.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -84.06 135.55 6.52 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.892 2.395 . . . . 0.0 113.02 -177.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.1 37.23 0.25 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.771 1.628 . . . . 0.0 114.109 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.84 157.16 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.681 1.593 . . . . 0.0 111.148 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.58 -115.48 7.38 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.207 0.908 . . . . 0.0 111.863 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.35 -21.93 70.75 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 123.736 0.684 . . . . 0.0 114.376 174.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.33 23.7 70.22 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 118.539 1.169 . . . . 0.0 114.576 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -133.14 155.88 80.54 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 125.822 1.649 . . . . 0.0 112.964 -163.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.1 138.16 55.39 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.991 2.46 . . . . 0.0 112.564 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.2 mt -131.36 122.8 26.97 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.734 1.614 . . . . 0.0 110.205 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -79.71 141.39 36.43 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.709 0.804 . . . . 0.0 111.894 173.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 tp -150.25 144.69 25.75 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.954 1.301 . . . . 0.0 111.229 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -86.05 136.54 33.19 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.98 0.912 . . . . 0.0 111.017 170.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 t -142.98 142.53 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.426 1.09 . . . . 0.0 111.019 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.49 152.14 96.5 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.689 1.196 . . . . 0.0 113.192 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.07 -20.23 50.58 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.379 2.719 . . . . 0.0 113.492 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -72.02 6.0 2.38 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.87 1.668 . . . . 0.0 114.354 172.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.3 131.05 47.04 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.572 1.078 . . . . 0.0 112.496 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.0 m -116.47 133.25 56.23 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.469 1.508 . . . . 0.0 109.798 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.0 t -59.67 -41.0 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.304 0.642 . . . . 0.0 112.155 -175.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.71 -36.54 91.91 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.522 -0.599 . . . . 0.0 113.413 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.9 -44.22 73.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.381 1.091 . . . . 0.0 111.945 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.66 -47.01 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.591 0.756 . . . . 0.0 111.169 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -61.63 -43.55 98.64 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.457 1.103 . . . . 0.0 111.944 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 88.3 m -62.52 -42.6 99.62 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.655 0.662 . . . . 0.0 111.696 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.67 -43.78 98.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.004 0.921 . . . . 0.0 111.489 176.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.79 -52.86 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.236 1.015 . . . . 0.0 111.504 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 85.1 m -61.06 -35.88 78.11 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.778 0.717 . . . . 0.0 112.599 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.82 -44.25 81.68 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.824 0.849 . . . . 0.0 112.911 173.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 71.7 mtm -68.97 -39.06 79.68 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.527 -0.733 . . . . 0.0 112.928 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -15.63 58.87 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.82 1.248 . . . . 0.0 113.426 176.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? 57.18 32.53 21.87 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.597 1.959 . . . . 0.0 112.447 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 32.0 mt -148.42 152.06 37.84 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 126.268 1.827 . . . . 0.0 112.311 -165.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.58 164.03 35.96 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 124.395 3.397 . . . . 0.0 114.44 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.95 -5.21 15.12 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.651 2.901 . . . . 0.0 114.476 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -75.05 -32.39 61.53 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.796 -1.19 . . . . 0.0 113.287 168.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.7 p -95.15 -20.35 19.33 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.1 m -135.16 130.4 35.33 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.308 1.043 . . . . 0.0 111.055 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -132.02 159.33 39.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.816 1.647 . . . . 0.0 112.598 -173.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.8 tp -127.61 137.0 52.43 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.184 1.794 . . . . 0.0 110.752 -176.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.5 p -132.64 151.45 51.95 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.028 0.931 . . . . 0.0 111.993 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -138.3 128.98 26.55 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.005 1.722 . . . . 0.0 109.984 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt 50.28 37.05 14.1 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.114 1.366 . . . . 0.0 114.076 172.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.22 11.49 80.71 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.447 1.499 . . . . 0.0 116.248 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -137.34 155.02 49.91 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.222 1.511 . . . . 0.0 113.59 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.14 99.52 11.57 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.57 1.148 . . . . 0.0 110.249 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.58 141.28 57.89 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.187 0.995 . . . . 0.0 110.994 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -166.6 154.48 9.91 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.649 1.58 . . . . 0.0 111.954 173.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.9 t0 57.41 28.72 15.82 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.973 1.709 . . . . 0.0 115.468 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.6 p -84.45 -24.73 29.38 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -174.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 59.49 -46.52 0.08 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 128.287 2.635 . . . . 0.0 115.803 -167.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 t -151.67 142.71 23.12 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.312 1.445 . . . . 0.0 111.229 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.4 tp -70.04 -22.86 63.04 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.699 0.799 . . . . 0.0 112.645 174.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.83 -33.6 75.08 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.085 -1.009 . . . . 0.0 113.168 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.4 t -64.81 -33.89 77.05 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.469 0.708 . . . . 0.0 112.32 174.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 87.0 mt -84.98 -3.98 58.97 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.548 1.539 . . . . 0.0 113.504 173.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.74 113.76 0.49 Allowed Glycine 0 CA--C 1.536 1.397 0 C-N-CA 126.026 1.774 . . . . 0.0 112.825 -170.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 m -70.79 157.56 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.206 1.002 . . . . 0.0 112.196 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -138.12 -169.07 2.49 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.084 1.754 . . . . 0.0 110.874 174.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -138.07 150.59 47.04 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.274 1.029 . . . . 0.0 112.58 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.82 21.75 75.22 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 123.32 0.486 . . . . 0.0 113.9 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -60.86 153.34 24.93 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.835 1.254 . . . . 0.0 112.858 176.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -134.41 136.69 43.47 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.094 0.958 . . . . 0.0 113.028 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -125.69 136.13 52.87 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.189 1.795 . . . . 0.0 109.411 -174.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.8 t -117.38 124.21 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.571 0.749 . . . . 0.0 110.079 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tp -104.39 125.99 51.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.692 0.797 . . . . 0.0 110.332 176.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.5 pt -116.5 146.27 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.348 1.459 . . . . 0.0 110.336 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.8 t -139.43 146.89 40.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.037 0.935 . . . . 0.0 111.548 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 55.6 ttt-85 . . . . . 0 N--CA 1.469 0.498 0 C-N-CA 126.331 1.852 . . . . 0.0 110.475 -169.382 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.477 ' HB2' ' OD1' ' A' ' 65' ' ' ASP . 15.8 mmt . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 mtmm -86.33 143.23 27.97 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.915 0.886 . . . . 0.0 110.283 162.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.3 157.54 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.009 1.723 . . . . 0.0 109.687 172.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -122.45 102.07 7.87 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.085 0.954 . . . . 0.0 110.88 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 tt -87.26 141.66 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 122.791 0.436 . . . . 0.0 110.71 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.3 t -130.73 81.78 66.47 Favored Pre-proline 0 N--CA 1.47 0.56 0 C-N-CA 125.276 1.43 . . . . 0.0 109.48 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.41 134.22 12.43 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.685 2.257 . . . . 0.0 112.046 178.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.18 40.65 0.21 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.024 1.33 . . . . 0.0 113.515 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.2 t -137.97 147.11 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.044 1.738 . . . . 0.0 110.814 -170.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.13 -121.55 21.55 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.845 0.736 . . . . 0.0 111.961 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.05 -17.31 71.67 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.671 0.653 . . . . 0.0 114.59 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.36 3.34 61.56 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.778 1.18 . . . . 0.0 115.402 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 m -72.65 152.13 91.47 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.103 1.361 . . . . 0.0 113.717 -172.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -64.97 152.64 81.67 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.706 2.271 . . . . 0.0 111.81 164.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.3 tp -142.64 124.52 15.16 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.785 1.234 . . . . 0.0 111.323 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -82.77 135.11 35.08 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.951 0.901 . . . . 0.0 111.899 175.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.3 mt -142.7 141.25 31.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.14 1.776 . . . . 0.0 110.761 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -76.78 144.61 39.07 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.626 0.77 . . . . 0.0 111.832 166.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.9 m -142.11 153.79 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.854 1.262 . . . . 0.0 111.452 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.76 150.7 88.69 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.218 0.607 . . . . 0.0 111.692 169.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -65.29 -20.92 62.14 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.781 2.321 . . . . 0.0 112.889 173.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -80.22 7.53 9.21 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.026 1.73 . . . . 0.0 114.185 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.18 117.53 4.5 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.691 1.197 . . . . 0.0 112.963 -174.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.9 m -91.34 141.27 28.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.36 1.464 . . . . 0.0 111.684 -176.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.48 -44.22 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.556 -0.715 . . . . 0.0 111.986 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.2 -36.83 93.0 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.513 0.577 . . . . 0.0 113.681 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.82 -43.67 83.19 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.167 0.983 . . . . 0.0 111.797 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 82.3 t -63.7 -44.81 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.854 0.862 . . . . 0.0 111.252 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -64.02 -38.02 89.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.286 1.035 . . . . 0.0 111.966 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.0 m -66.34 -44.95 81.85 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.19 0.996 . . . . 0.0 111.423 174.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -58.17 -45.04 88.2 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.0 0.92 . . . . 0.0 112.139 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.8 t -59.67 -53.24 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.086 0.955 . . . . 0.0 111.112 173.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.3 t -61.08 -41.52 96.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.357 0.663 . . . . 0.0 112.535 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.9 73.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.065 0.946 . . . . 0.0 112.79 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.9 ttp -73.42 -22.57 60.19 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.6 mmpm? -93.23 -15.39 25.94 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.959 1.304 . . . . 0.0 113.688 170.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt 55.71 24.85 7.6 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.933 2.493 . . . . 0.0 114.613 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.86 153.97 61.65 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.857 1.663 . . . . 0.0 111.644 -173.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -71.12 156.66 59.25 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.897 3.065 . . . . 0.0 113.243 -175.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.75 -14.5 45.19 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.824 3.016 . . . . 0.0 114.491 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -64.22 -24.99 67.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.824 0.85 . . . . 0.0 113.09 170.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 38.8 p -98.17 -26.86 14.42 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.416 1.087 . . . . 0.0 113.441 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 84.9 m -138.76 116.94 11.8 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.284 1.034 . . . . 0.0 111.61 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -109.59 162.84 14.02 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.875 1.67 . . . . 0.0 112.984 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.4 tp -129.66 140.52 51.13 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.039 1.736 . . . . 0.0 111.303 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.4 p -136.26 157.71 46.16 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.597 1.159 . . . . 0.0 112.537 171.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -139.5 131.2 27.36 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.857 2.063 . . . . 0.0 109.789 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? 47.74 37.21 6.66 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.591 1.556 . . . . 0.0 114.485 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.09 14.95 81.76 Favored Glycine 0 CA--C 1.54 1.632 0 N-CA-C 115.715 1.046 . . . . 0.0 115.715 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -134.32 159.85 39.72 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.759 1.623 . . . . 0.0 111.761 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.12 133.16 34.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.407 0.683 . . . . 0.0 111.332 169.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.0 mt -86.41 127.55 34.84 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.822 0.849 . . . . 0.0 110.457 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.33 131.89 9.52 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.306 1.442 . . . . 0.0 110.541 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.0 t0 55.26 29.18 12.39 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.703 1.601 . . . . 0.0 115.094 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.2 p -84.5 -11.99 55.08 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.762 -1.211 . . . . 0.0 113.95 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 63.6 -54.15 0.22 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.893 2.477 . . . . 0.0 115.388 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.1 p -147.33 158.09 43.83 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.312 1.845 . . . . 0.0 111.516 176.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.4 -34.17 77.56 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.721 -0.612 . . . . 0.0 112.066 168.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.6 tm-20 -63.14 -33.54 75.69 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.832 0.853 . . . . 0.0 113.034 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 p -63.75 -27.65 69.34 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.4 mt -98.07 4.75 49.17 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.858 1.663 . . . . 0.0 113.17 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.16 100.11 0.76 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.367 1.46 . . . . 0.0 112.141 -172.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.5 p -73.65 150.68 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.869 1.267 . . . . 0.0 111.813 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.69 -171.86 3.33 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.041 1.736 . . . . 0.0 111.041 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.477 ' OD1' ' HB2' ' A' ' 1' ' ' MET . 14.2 t0 -121.88 145.2 48.32 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.453 1.101 . . . . 0.0 111.647 174.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.01 20.6 77.5 Favored Glycine 0 CA--C 1.539 1.533 0 CA-C-O 119.705 -0.497 . . . . 0.0 114.333 -174.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -58.47 136.48 57.51 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.432 1.116 . . . . 0.0 111.835 172.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -112.25 140.68 46.76 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -123.66 132.64 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.151 1.781 . . . . 0.0 109.295 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.7 t -123.58 121.3 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 118.719 0.69 . . . . 0.0 110.873 -173.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 tp -96.32 137.72 34.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.379 1.072 . . . . 0.0 110.178 175.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.32 125.43 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.485 1.114 . . . . 0.0 109.027 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.7 t -118.1 142.04 47.84 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.711 1.204 . . . . 0.0 112.141 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 . . . . . 0 N--CA 1.472 0.66 0 C-N-CA 124.912 1.285 . . . . 0.0 111.478 171.204 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 121.344 0.592 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -92.75 139.31 30.68 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.652 1.181 . . . . 0.0 111.197 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pp -137.0 162.84 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.773 1.629 . . . . 0.0 110.849 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -126.79 138.73 53.4 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.203 1.001 . . . . 0.0 112.153 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.9 mt -121.18 133.91 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.936 1.295 . . . . 0.0 109.096 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.23 92.87 37.71 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.692 1.197 . . . . 0.0 110.831 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -88.25 130.87 2.5 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.915 2.41 . . . . 0.0 112.493 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.23 29.95 0.12 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.514 1.526 . . . . 0.0 114.507 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.3 m -73.95 73.87 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 126.471 1.908 . . . . 0.0 112.767 -173.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.0 38.91 63.89 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.143 0.878 . . . . 0.0 113.192 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.55 29.46 29.8 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.311 0.958 . . . . 0.0 114.289 -174.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.78 141.22 48.1 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 124.622 1.106 . . . . 0.0 114.103 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 m -80.03 154.62 75.16 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 125.107 1.363 . . . . 0.0 113.418 -176.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -62.89 147.43 94.62 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.075 2.517 . . . . 0.0 111.997 166.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.86 138.03 35.39 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.64 1.576 . . . . 0.0 110.813 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -87.73 140.34 29.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.069 1.348 . . . . 0.0 112.122 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 mp -140.85 164.94 28.88 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.083 1.753 . . . . 0.0 111.459 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -116.39 137.53 52.08 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.52 1.528 . . . . 0.0 110.217 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.3 158.99 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.743 1.217 . . . . 0.0 111.879 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.2 149.13 98.62 Favored Pre-proline 0 CA--C 1.551 0.984 0 O-C-N 121.767 -0.583 . . . . 0.0 111.498 170.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.46 -24.32 56.94 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.944 2.429 . . . . 0.0 113.221 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -82.95 33.35 0.44 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.925 1.69 . . . . 0.0 113.638 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.41 117.76 5.64 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.184 -0.948 . . . . 0.0 111.199 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.2 m -97.46 129.36 44.66 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.732 1.213 . . . . 0.0 110.888 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.8 -44.0 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.917 0.887 . . . . 0.0 112.226 -175.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.46 -36.47 93.42 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.517 0.579 . . . . 0.0 113.51 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.92 -37.98 76.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.38 1.09 . . . . 0.0 112.378 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.7 t -68.65 -43.93 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.276 1.03 . . . . 0.0 111.24 174.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -63.84 -37.39 87.2 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.022 0.929 . . . . 0.0 112.241 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.9 m -64.17 -39.77 94.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.661 0.785 . . . . 0.0 111.328 170.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.24 -47.95 83.81 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.872 0.869 . . . . 0.0 111.281 174.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.4 t -56.9 -50.22 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.04 1.336 . . . . 0.0 111.342 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.5 t -59.93 -44.71 94.17 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.756 0.822 . . . . 0.0 112.109 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.84 86.17 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.994 0.918 . . . . 0.0 113.177 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.4 mtt -68.64 -42.49 77.94 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.107 0.963 . . . . 0.0 112.748 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.98 -23.28 41.71 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.01 26.24 15.53 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.962 1.705 . . . . 0.0 113.275 -174.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.79 153.91 70.39 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 126.845 2.058 . . . . 0.0 111.317 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.47 163.63 38.16 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 124.293 3.329 . . . . 0.0 114.247 -173.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.57 -15.78 51.75 Favored 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 123.421 2.747 . . . . 0.0 113.992 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -67.67 -28.86 68.05 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.138 -0.976 . . . . 0.0 113.208 173.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.1 p -102.95 -10.16 19.23 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.087 1.355 . . . . 0.0 113.872 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.4 m -148.63 123.49 9.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.836 1.254 . . . . 0.0 111.263 172.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -110.49 160.39 16.66 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.718 1.207 . . . . 0.0 113.447 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.6 tp -126.43 132.52 51.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.798 2.039 . . . . 0.0 110.391 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.5 p -137.11 158.36 44.62 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.362 1.065 . . . . 0.0 111.966 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -133.44 126.58 31.51 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.137 2.175 . . . . 0.0 109.378 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt 51.49 30.66 6.55 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.17 0.988 . . . . 0.0 113.382 -174.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.34 2.28 73.15 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 125.26 1.409 . . . . 0.0 115.958 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.44 146.3 29.68 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.948 2.099 . . . . 0.0 111.357 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.8 122.15 25.68 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.576 -0.703 . . . . 0.0 110.968 169.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.2 mt -83.35 134.17 34.92 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.201 1.0 . . . . 0.0 111.097 171.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -160.38 144.76 14.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.456 1.502 . . . . 0.0 110.578 170.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.9 t0 52.69 27.99 5.8 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.778 1.631 . . . . 0.0 115.021 174.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.9 m -83.04 -23.82 33.04 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.078 1.351 . . . . 0.0 112.926 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 61.63 -52.85 0.13 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 128.403 2.681 . . . . 0.0 115.544 -172.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.0 t -159.15 142.27 14.5 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.031 1.332 . . . . 0.0 111.641 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.16 -26.75 67.57 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.538 0.735 . . . . 0.0 112.314 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.43 -20.01 64.62 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.755 1.161 . . . . 0.0 113.361 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.7 t -74.91 -38.19 61.89 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.112 0.965 . . . . 0.0 112.374 173.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.47 -35.73 14.94 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.887 1.275 . . . . 0.0 112.929 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 140.42 87.77 0.13 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.042 1.782 . . . . 0.0 112.267 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.3 p -76.72 147.36 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.011 1.324 . . . . 0.0 112.357 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.19 156.13 37.98 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.894 1.278 . . . . 0.0 112.483 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -67.65 147.09 53.17 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.339 -0.851 . . . . 0.0 111.287 162.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.78 14.32 77.95 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 123.867 0.746 . . . . 0.0 114.493 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -55.4 132.91 49.36 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.729 1.264 . . . . 0.0 110.579 168.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.48 131.95 45.41 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.268 1.027 . . . . 0.0 112.443 -165.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -128.07 132.1 49.06 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.432 1.493 . . . . 0.0 110.637 -169.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.74 133.96 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.166 0.987 . . . . 0.0 110.752 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 tp -109.93 115.47 29.85 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.313 1.045 . . . . 0.0 110.049 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.2 mm -105.32 94.09 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.256 1.023 . . . . 0.0 108.983 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -79.22 152.02 30.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.259 1.424 . . . . 0.0 111.243 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 . . . . . 0 N--CA 1.474 0.759 0 C-N-CA 124.74 1.216 . . . . 0.0 112.197 -177.892 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 110.583 -0.154 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -86.13 145.4 27.04 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.179 -1.575 . . . . 0.0 112.944 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.4 mm -136.48 140.12 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 127.873 2.469 . . . . 0.0 108.641 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -91.84 140.2 29.91 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.177 0.591 . . . . 0.0 110.596 167.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.6 pt -118.78 139.78 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.888 0.875 . . . . 0.0 110.317 168.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 t -129.95 73.71 81.18 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 124.602 1.161 . . . . 0.0 110.371 -175.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -78.62 134.34 12.22 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.508 2.805 . . . . 0.0 112.014 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.05 35.17 0.2 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.603 1.561 . . . . 0.0 114.545 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.4 m -138.94 161.59 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 126.09 1.756 . . . . 0.0 111.874 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.87 -119.97 18.31 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 123.687 0.661 . . . . 0.0 111.467 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.09 -17.85 74.18 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 123.684 0.659 . . . . 0.0 114.691 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.48 2.48 35.01 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.206 1.384 . . . . 0.0 115.229 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.6 p -85.63 156.55 58.8 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.392 1.877 . . . . 0.0 113.591 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.32 153.08 79.4 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.051 2.5 . . . . 0.0 112.4 170.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.8 tp -143.19 130.04 20.48 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.185 1.394 . . . . 0.0 111.671 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -80.35 134.97 36.1 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.41 1.084 . . . . 0.0 111.967 172.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.4 mt -142.93 149.53 38.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.118 1.767 . . . . 0.0 111.409 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -90.58 134.32 34.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.502 1.121 . . . . 0.0 110.809 169.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.59 154.64 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.612 1.165 . . . . 0.0 112.299 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.64 152.12 89.35 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.361 1.064 . . . . 0.0 112.585 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.11 -17.98 55.74 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.364 2.709 . . . . 0.0 113.544 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -80.59 4.81 17.3 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.521 1.528 . . . . 0.0 113.928 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.67 125.99 25.81 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.495 1.043 . . . . 0.0 112.565 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 m -94.21 131.27 39.96 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.045 1.338 . . . . 0.0 110.814 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.6 t -60.6 -41.54 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 O-C-N 121.348 -0.845 . . . . 0.0 111.962 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.86 -33.93 88.57 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 123.827 0.727 . . . . 0.0 113.767 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.97 -42.66 76.31 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.389 1.095 . . . . 0.0 111.463 174.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.59 -48.03 88.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.77 0.828 . . . . 0.0 110.876 174.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.4 mmm-85 -58.14 -45.99 86.43 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.792 0.837 . . . . 0.0 112.115 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.7 m -60.34 -44.53 95.43 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.332 0.653 . . . . 0.0 111.902 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -42.85 99.44 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.149 0.979 . . . . 0.0 111.568 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.0 t -67.18 -47.76 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.589 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 97.8 m -57.67 -42.32 83.31 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.025 1.284 . . . . 0.0 112.087 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.94 -41.18 91.64 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.79 0.836 . . . . 0.0 112.797 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.7 ttt -70.85 -41.68 71.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.257 1.023 . . . . 0.0 112.815 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -29.11 63.85 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.762 1.225 . . . . 0.0 112.641 173.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? 68.65 31.75 4.51 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 127.247 2.219 . . . . 0.0 113.208 -173.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mp -128.98 153.65 80.26 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.193 1.797 . . . . 0.0 111.824 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.14 159.62 53.13 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.836 3.024 . . . . 0.0 113.245 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.51 -15.25 48.91 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.923 3.082 . . . . 0.0 114.408 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -70.23 -25.14 63.24 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.475 1.034 . . . . 0.0 113.031 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.4 m -93.46 0.65 56.84 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.962 1.305 . . . . 0.0 113.22 -175.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.0 t -137.34 140.21 41.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.939 1.296 . . . . 0.0 112.056 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -134.16 140.8 46.79 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.72 1.608 . . . . 0.0 110.772 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.4 tp -131.63 129.92 41.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.508 1.523 . . . . 0.0 110.907 -171.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -139.7 153.82 47.33 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.48 1.112 . . . . 0.0 112.948 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -143.72 138.64 29.01 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.263 1.825 . . . . 0.0 110.24 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 55.03 30.89 15.04 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.863 1.265 . . . . 0.0 113.777 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.45 18.19 79.28 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 124.786 1.184 . . . . 0.0 114.952 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -134.15 142.78 47.58 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.373 1.869 . . . . 0.0 111.132 -170.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.91 135.55 40.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.762 0.825 . . . . 0.0 111.919 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.4 mt -103.91 136.81 42.88 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.486 1.114 . . . . 0.0 110.798 173.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.48 149.65 18.94 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.119 1.368 . . . . 0.0 111.164 171.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.0 t0 54.23 27.67 8.16 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.778 1.631 . . . . 0.0 114.88 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -75.24 -24.88 57.72 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.388 1.075 . . . . 0.0 113.287 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 60.53 -56.01 0.08 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 128.584 2.754 . . . . 0.0 114.898 -169.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 p -146.92 133.57 19.91 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.934 1.694 . . . . 0.0 111.205 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.79 -32.8 74.53 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.871 0.869 . . . . 0.0 112.882 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -62.09 -26.83 68.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.145 0.978 . . . . 0.0 113.383 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.6 m -71.05 -28.15 64.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.385 1.074 . . . . 0.0 113.445 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 72.3 mt -99.76 -32.21 11.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.74 1.216 . . . . 0.0 112.966 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 138.39 81.55 0.09 OUTLIER Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.516 1.532 . . . . 0.0 112.162 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.4 p -70.52 147.07 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.268 1.027 . . . . 0.0 111.633 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -146.36 167.96 22.29 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.619 1.568 . . . . 0.0 111.863 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -106.48 145.69 31.49 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.375 1.47 . . . . 0.0 113.446 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.53 13.45 82.93 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 123.798 0.714 . . . . 0.0 114.463 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -65.03 159.92 22.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.412 1.085 . . . . 0.0 111.796 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.72 130.96 28.44 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -101.43 138.5 38.36 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.242 1.417 . . . . 0.0 111.093 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.87 134.47 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.263 1.025 . . . . 0.0 109.574 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.0 tt -130.84 125.46 33.7 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.759 0.824 . . . . 0.0 111.514 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.0 mm -113.41 135.78 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.123 1.769 . . . . 0.0 110.476 -170.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.2 t -102.05 143.48 31.84 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.803 1.241 . . . . 0.0 111.346 172.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.862 0 C-N-CA 124.626 1.17 . . . . 0.0 111.055 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ttt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 120.657 0.265 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -68.56 147.52 51.84 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.624 -1.297 . . . . 0.0 111.072 158.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -143.95 166.11 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 127.568 2.347 . . . . 0.0 110.165 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -125.69 134.9 51.66 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.062 0.945 . . . . 0.0 111.355 167.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 54.5 mt -121.53 131.03 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.999 1.319 . . . . 0.0 108.669 177.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 p -121.49 98.11 46.48 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 124.563 1.145 . . . . 0.0 110.77 173.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -84.58 144.11 9.98 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.298 2.666 . . . . 0.0 111.38 172.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.34 34.38 0.11 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 125.687 1.595 . . . . 0.0 113.553 173.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.3 t -134.29 144.32 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.263 1.825 . . . . 0.0 110.684 -167.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.24 -113.76 6.21 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.05 0.833 . . . . 0.0 112.234 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.73 -20.22 70.05 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 123.984 0.802 . . . . 0.0 114.548 174.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.37 12.86 64.26 Favored Glycine 0 CA--C 1.54 1.606 0 CA-C-N 118.547 1.173 . . . . 0.0 115.47 175.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.0 p -111.86 155.97 42.39 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 126.254 1.822 . . . . 0.0 113.003 -167.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.6 145.11 91.3 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.977 2.451 . . . . 0.0 112.317 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.92 129.62 34.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.6 1.56 . . . . 0.0 109.998 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.84 135.21 43.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.654 1.181 . . . . 0.0 111.543 173.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.13 168.59 19.38 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.832 1.653 . . . . 0.0 110.602 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.2 143.56 49.95 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.909 1.284 . . . . 0.0 111.086 166.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.5 m -141.45 158.12 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.033 1.333 . . . . 0.0 112.109 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.64 149.23 98.35 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.238 1.015 . . . . 0.0 112.179 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -67.69 -17.71 47.81 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.623 2.882 . . . . 0.0 113.837 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.48 -6.7 59.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.205 1.402 . . . . 0.0 114.136 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.76 141.5 52.74 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.471 1.032 . . . . 0.0 111.282 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.9 t -130.83 145.94 52.13 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.365 1.066 . . . . 0.0 111.328 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.24 -35.28 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.439 0.696 . . . . 0.0 111.807 -169.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.57 -35.98 91.93 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 121.736 -0.603 . . . . 0.0 113.84 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.89 -41.91 67.41 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.596 1.198 . . . . 0.0 112.045 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.79 -44.44 99.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.561 0.744 . . . . 0.0 110.685 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -60.35 -47.16 87.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.373 1.069 . . . . 0.0 111.523 174.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.1 m -59.85 -45.77 91.4 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.937 0.895 . . . . 0.0 111.813 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -60.2 -43.31 96.02 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.705 0.802 . . . . 0.0 112.505 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.51 -41.32 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.777 0.717 . . . . 0.0 112.105 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 87.5 m -60.53 -37.16 80.3 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.527 1.058 . . . . 0.0 112.31 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.0 77.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.252 1.021 . . . . 0.0 113.122 174.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.3 mmt -66.83 -38.32 86.21 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.325 -0.859 . . . . 0.0 112.524 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -23.1 58.56 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.991 1.316 . . . . 0.0 113.385 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.5 mtpt 51.04 45.02 28.36 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.958 2.103 . . . . 0.0 112.435 -167.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.2 mt -136.17 151.34 73.33 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.786 1.634 . . . . 0.0 112.245 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -70.77 162.44 42.58 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 124.004 3.136 . . . . 0.0 113.526 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.69 -11.58 29.72 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 123.662 2.908 . . . . 0.0 114.305 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -72.07 -32.85 67.44 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.694 1.197 . . . . 0.0 113.123 173.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.6 p -105.11 -5.23 20.99 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.156 1.382 . . . . 0.0 113.858 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.0 m -147.63 125.18 11.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.137 1.775 . . . . 0.0 110.077 176.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -140.47 147.19 39.24 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.1 tp -108.85 140.17 42.67 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.587 1.955 . . . . 0.0 111.028 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.9 t -141.88 157.33 45.12 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.263 1.425 . . . . 0.0 111.485 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -132.0 129.99 40.83 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.67 1.588 . . . . 0.0 110.359 -174.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp 51.36 29.06 4.79 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.61 14.84 82.07 Favored Glycine 0 CA--C 1.541 1.709 0 C-N-CA 125.288 1.423 . . . . 0.0 116.09 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.47 129.26 30.81 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.781 1.632 . . . . 0.0 111.267 -177.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.76 131.65 46.83 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.332 0.653 . . . . 0.0 112.501 -175.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.1 mt -131.68 153.9 49.53 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.461 1.504 . . . . 0.0 111.607 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -161.08 -48.83 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.978 1.711 . . . . 0.0 111.268 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -81.54 27.82 0.42 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.688 1.995 . . . . 0.0 114.115 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.8 m -68.09 -27.56 66.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.25 1.42 . . . . 0.0 113.277 -172.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 64.5 -63.43 0.17 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.231 2.612 . . . . 0.0 114.895 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.6 p -149.08 146.99 27.99 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.249 1.819 . . . . 0.0 110.485 168.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.4 mt -74.08 -27.4 60.88 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.538 -0.726 . . . . 0.0 112.068 171.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -58.53 -36.21 73.51 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.227 1.011 . . . . 0.0 113.079 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.8 p -63.71 -20.01 65.39 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.5 mt -105.6 -2.44 23.48 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.034 1.733 . . . . 0.0 113.294 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.26 113.84 0.35 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.629 1.585 . . . . 0.0 112.578 -171.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.67 146.04 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.976 1.31 . . . . 0.0 111.676 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -145.71 174.74 10.94 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.672 1.589 . . . . 0.0 111.797 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -78.29 162.05 26.8 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.027 0.931 . . . . 0.0 110.903 162.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.67 14.81 81.68 Favored Glycine 0 CA--C 1.536 1.406 0 N-CA-C 115.844 1.098 . . . . 0.0 115.844 174.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.59 127.25 31.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.852 1.326 . . . . 0.0 110.613 165.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -129.03 130.4 46.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.882 1.273 . . . . 0.0 111.981 -166.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -125.51 133.24 52.44 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.798 1.639 . . . . 0.0 111.195 -170.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.6 t -118.1 129.54 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.814 1.245 . . . . 0.0 109.152 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.38 120.57 34.39 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.263 1.025 . . . . 0.0 110.108 -176.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.4 mt -116.19 130.03 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.82 1.248 . . . . 0.0 109.12 -172.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.8 p -120.02 158.46 26.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.19 1.396 . . . . 0.0 111.053 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 . . . . . 0 N--CA 1.475 0.787 0 C-N-CA 124.433 1.093 . . . . 0.0 111.37 -175.807 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptm . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -86.44 149.61 24.87 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.127 -1.608 . . . . 0.0 111.812 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.4 pt -130.74 166.08 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.764 2.025 . . . . 0.0 111.117 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -131.07 112.46 12.91 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.577 1.151 . . . . 0.0 110.079 170.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.3 tt -94.81 139.69 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 122.779 0.432 . . . . 0.0 110.652 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 t -126.92 81.43 69.63 Favored Pre-proline 0 N--CA 1.471 0.609 0 C-N-CA 125.247 1.419 . . . . 0.0 109.649 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.53 136.39 12.34 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.474 2.116 . . . . 0.0 112.473 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.83 41.1 0.15 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.133 1.373 . . . . 0.0 113.194 171.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.4 t -135.86 142.66 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.348 1.859 . . . . 0.0 110.35 -169.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.43 -116.5 9.44 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.949 0.785 . . . . 0.0 112.533 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.82 -14.9 68.38 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.212 0.911 . . . . 0.0 115.081 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.69 7.37 47.66 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 118.885 1.342 . . . . 0.0 115.929 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.6 m -94.43 155.48 39.65 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.696 1.598 . . . . 0.0 113.166 -170.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -63.01 147.23 94.74 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.212 2.608 . . . . 0.0 112.18 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 tt -138.75 122.61 17.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.414 1.486 . . . . 0.0 110.391 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -82.27 143.39 31.35 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.958 0.903 . . . . 0.0 112.783 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 tp -152.2 153.81 34.55 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.535 1.134 . . . . 0.0 111.657 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -85.22 150.43 24.8 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.374 -0.829 . . . . 0.0 111.338 163.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p -148.16 149.66 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.101 0.961 . . . . 0.0 111.643 174.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.06 149.91 98.23 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.992 0.917 . . . . 0.0 112.482 176.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.56 -21.09 46.57 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.278 2.652 . . . . 0.0 113.023 175.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -78.76 16.45 0.87 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.954 1.702 . . . . 0.0 113.648 175.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.35 121.94 10.04 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.391 1.076 . . . . 0.0 112.003 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.6 m -107.83 130.23 55.01 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.283 1.433 . . . . 0.0 109.861 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.1 t -58.94 -42.93 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.383 0.673 . . . . 0.0 111.637 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.77 -37.48 92.51 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.619 1.104 . . . . 0.0 113.578 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.02 -45.12 71.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.326 1.063 . . . . 0.0 111.705 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.32 -50.68 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.814 0.846 . . . . 0.0 111.581 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.27 -37.15 86.47 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.683 -0.636 . . . . 0.0 112.468 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.1 m -67.13 -42.03 85.14 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.522 0.601 . . . . 0.0 111.451 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -40.2 93.72 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.996 0.919 . . . . 0.0 111.887 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -62.18 -52.54 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.555 1.142 . . . . 0.0 111.502 172.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 88.3 m -62.24 -35.51 79.14 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.51 0.596 . . . . 0.0 112.23 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.64 86.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.404 1.081 . . . . 0.0 112.752 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -43.95 87.16 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.726 0.81 . . . . 0.0 112.365 174.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 36' ' ' LYS . 8.0 mmpt? -73.71 -20.48 60.52 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.704 1.202 . . . . 0.0 113.99 177.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? 55.92 27.84 11.69 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.59 1.956 . . . . 0.0 113.075 -170.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.24 154.74 70.25 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.486 1.914 . . . . 0.0 111.394 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.69 165.07 33.24 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.425 3.417 . . . . 0.0 114.225 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.34 -17.5 58.14 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.312 2.675 . . . . 0.0 114.091 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -64.64 -28.91 69.93 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.829 -1.169 . . . . 0.0 112.796 173.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.0 p -98.48 -14.05 20.23 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.271 1.428 . . . . 0.0 114.328 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 100.0 m -142.66 117.03 9.61 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 119.899 1.227 . . . . 0.0 111.919 174.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.5 167.74 10.62 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.003 1.721 . . . . 0.0 113.137 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 69' ' ' PHE . 43.8 tp -142.63 136.42 29.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.03 1.732 . . . . 0.0 111.372 -173.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.4 p -135.57 158.31 44.69 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.54 1.136 . . . . 0.0 113.213 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -147.62 130.39 16.08 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.3 2.24 . . . . 0.0 110.052 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? 50.67 31.36 5.75 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.323 1.449 . . . . 0.0 113.78 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.86 7.35 88.37 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.01 1.291 . . . . 0.0 115.96 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -120.54 158.97 26.16 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.581 1.552 . . . . 0.0 112.409 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.39 127.76 32.5 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.649 0.78 . . . . 0.0 110.534 165.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.7 mt -75.46 138.12 41.4 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.376 0.671 . . . . 0.0 110.762 169.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -163.28 142.5 8.46 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.427 1.491 . . . . 0.0 111.464 170.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t0 57.19 21.39 6.52 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.3 m -70.84 -26.92 63.49 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.857 1.263 . . . . 0.0 112.9 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 63.65 -56.0 0.21 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 128.619 2.767 . . . . 0.0 115.01 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.3 p -145.06 144.46 30.98 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.274 1.429 . . . . 0.0 111.48 170.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.4 -28.54 68.01 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.558 -0.714 . . . . 0.0 112.271 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -65.29 -26.87 68.26 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.362 -0.836 . . . . 0.0 113.167 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.5 t -63.07 -37.49 87.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.738 0.815 . . . . 0.0 112.614 172.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.0 mt -90.68 -10.33 43.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.936 1.294 . . . . 0.0 113.689 174.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.51 118.14 2.49 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 126.471 1.986 . . . . 0.0 112.545 -172.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.7 t -73.51 144.89 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.811 1.244 . . . . 0.0 111.219 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.06 156.55 38.04 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.635 1.574 . . . . 0.0 110.551 166.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -88.77 146.92 24.73 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.152 -0.967 . . . . 0.0 112.522 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.0 26.59 66.29 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.631 0.613 . . . . 0.0 114.631 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -61.8 140.11 58.27 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.499 1.149 . . . . 0.0 111.869 175.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -119.13 134.23 55.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.711 0.804 . . . . 0.0 112.581 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.55 ' HB3' HD11 ' A' ' 45' ' ' LEU . 17.6 m-85 -122.28 138.25 54.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.427 1.491 . . . . 0.0 110.755 -174.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.83 123.07 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.591 0.757 . . . . 0.0 110.594 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tp -97.92 134.97 40.32 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.4 1.08 . . . . 0.0 110.637 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.08 111.7 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.719 1.208 . . . . 0.0 109.711 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.4 t -90.74 152.39 20.83 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.83 1.252 . . . . 0.0 111.292 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 . . . . . 0 N--CA 1.476 0.835 0 C-N-CA 125.673 1.589 . . . . 0.0 111.004 172.862 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 121.188 0.518 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -114.05 149.02 36.08 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.195 1.398 . . . . 0.0 111.414 170.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -128.52 155.32 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.865 1.666 . . . . 0.0 110.047 173.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -118.86 93.81 4.23 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.854 1.262 . . . . 0.0 110.22 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 tt -79.71 140.47 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.783 -0.573 . . . . 0.0 110.743 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.7 t -131.51 82.31 61.97 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 125.261 1.425 . . . . 0.0 109.842 -172.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.39 136.45 9.94 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.631 2.22 . . . . 0.0 113.098 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.96 39.22 0.18 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.592 1.557 . . . . 0.0 113.564 172.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.6 t -137.99 145.87 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.987 1.715 . . . . 0.0 110.691 -171.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.44 -119.58 17.33 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.054 0.835 . . . . 0.0 112.429 176.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.9 -14.42 67.87 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 124.088 0.851 . . . . 0.0 114.903 175.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.27 6.22 46.23 Favored Glycine 0 CA--C 1.541 1.71 0 CA-C-N 118.812 1.306 . . . . 0.0 115.87 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.2 m -90.83 153.57 45.35 Favored Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 125.369 1.468 . . . . 0.0 113.334 -171.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -66.25 152.98 79.79 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 123.403 2.735 . . . . 0.0 112.646 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 tp -140.1 118.72 12.32 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.427 1.491 . . . . 0.0 111.586 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -69.51 137.56 52.61 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.436 1.094 . . . . 0.0 111.575 169.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.3 tp -150.64 136.9 18.6 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.532 1.133 . . . . 0.0 111.51 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.02 143.33 43.6 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.612 0.765 . . . . 0.0 111.626 171.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.17 147.95 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.232 1.013 . . . . 0.0 112.1 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.79 150.89 95.28 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.143 0.977 . . . . 0.0 112.537 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.58 -27.12 53.67 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.043 2.496 . . . . 0.0 113.048 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -77.35 14.39 0.97 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.398 1.479 . . . . 0.0 114.134 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.13 100.29 0.32 Allowed 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.844 -1.16 . . . . 0.0 112.212 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.7 t -73.62 148.77 42.54 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.427 1.091 . . . . 0.0 110.858 168.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.6 m -57.75 -31.55 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.85 0.86 . . . . 0.0 112.485 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.33 -41.78 99.37 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.576 0.608 . . . . 0.0 112.732 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.2 -44.82 82.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.771 0.828 . . . . 0.0 111.75 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.2 t -62.98 -49.46 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.879 0.871 . . . . 0.0 110.924 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -35.92 78.26 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.853 1.261 . . . . 0.0 112.369 -177.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.6 m -66.79 -45.44 78.44 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.551 0.74 . . . . 0.0 111.435 172.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -63.18 -39.28 94.19 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.702 0.683 . . . . 0.0 111.928 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -56.94 -52.0 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.51 1.124 . . . . 0.0 111.385 170.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 51.8 t -60.86 -42.78 98.52 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.123 0.569 . . . . 0.0 112.207 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.23 -40.72 86.37 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.972 0.909 . . . . 0.0 113.254 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.8 tpp -67.73 -44.07 78.46 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.808 1.243 . . . . 0.0 112.094 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -76.63 -24.03 53.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.691 0.796 . . . . 0.0 113.043 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.3 ttpp 59.67 27.25 16.45 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.457 2.303 . . . . 0.0 114.144 -173.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.01 154.49 81.38 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 126.192 1.797 . . . . 0.0 112.033 -175.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.81 159.95 50.98 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.904 3.069 . . . . 0.0 113.974 -171.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.57 -10.24 28.46 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.269 3.312 . . . . 0.0 114.978 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -73.46 -21.56 60.41 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.195 -0.941 . . . . 0.0 112.601 167.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.9 m -108.48 -37.26 6.0 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.018 1.327 . . . . 0.0 112.844 -172.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.2 t -97.52 139.09 33.97 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.69 0.796 . . . . 0.0 111.728 170.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -136.54 154.11 50.81 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.592 1.557 . . . . 0.0 111.476 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.8 tp -138.23 132.9 32.5 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.472 1.509 . . . . 0.0 111.217 -171.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.2 p -140.17 155.12 47.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.26 1.024 . . . . 0.0 113.526 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -149.01 131.64 15.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.788 2.035 . . . . 0.0 110.302 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.0 tptt 54.27 29.05 10.04 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.166 1.386 . . . . 0.0 114.319 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.73 3.33 87.11 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.382 1.468 . . . . 0.0 115.562 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -112.55 161.26 16.97 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.821 2.048 . . . . 0.0 111.334 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.03 142.25 28.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.61 0.764 . . . . 0.0 110.64 161.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.16 118.82 34.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.134 0.974 . . . . 0.0 111.053 172.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.39 145.72 22.97 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.489 1.516 . . . . 0.0 111.109 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 54.63 23.52 4.77 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.589 1.956 . . . . 0.0 116.137 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 p -75.94 -24.02 55.46 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 120.818 -1.176 . . . . 0.0 113.69 -176.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 63.79 -40.15 0.21 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 128.739 2.816 . . . . 0.0 115.122 -172.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 t -152.22 154.6 36.1 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.188 1.795 . . . . 0.0 111.656 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.66 -25.14 68.08 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.211 1.005 . . . . 0.0 112.899 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.92 -27.84 69.42 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.3 m -65.0 -28.04 69.23 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.994 0.918 . . . . 0.0 112.963 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 mp -96.71 -10.06 27.71 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.468 1.507 . . . . 0.0 112.745 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.5 28.9 74.07 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.43 1.014 . . . . 0.0 114.468 177.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.8 m -65.97 151.79 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.515 1.126 . . . . 0.0 113.949 -170.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.08 179.07 7.03 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.238 1.415 . . . . 0.0 112.657 173.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -73.58 152.04 40.71 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 121.112 -0.992 . . . . 0.0 111.631 165.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.37 29.23 53.82 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 115.856 1.103 . . . . 0.0 115.856 172.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -62.11 155.33 24.54 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.772 1.286 . . . . 0.0 112.263 172.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -125.81 136.62 53.33 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.877 0.871 . . . . 0.0 112.347 173.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -122.23 133.53 54.71 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.855 1.262 . . . . 0.0 110.548 -173.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.9 t -103.24 129.42 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.209 0.603 . . . . 0.0 110.338 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 tp -105.57 131.17 53.29 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.087 0.955 . . . . 0.0 110.572 172.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -115.84 146.32 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.621 1.569 . . . . 0.0 109.53 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.6 t -127.34 164.94 20.69 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.167 1.387 . . . . 0.0 112.085 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 . . . . . 0 N--CA 1.475 0.777 0 C-N-CA 126.964 2.106 . . . . 0.0 110.44 -179.037 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 mmt . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.0 140.23 45.34 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.469 -1.395 . . . . 0.0 111.145 160.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pp -131.01 166.58 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.657 1.983 . . . . 0.0 110.311 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -120.99 102.66 8.48 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.458 1.103 . . . . 0.0 110.795 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.6 tt -77.84 143.14 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.859 -0.525 . . . . 0.0 110.067 173.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.5 79.93 72.61 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 124.824 1.249 . . . . 0.0 109.551 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.39 134.27 15.39 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.723 2.949 . . . . 0.0 112.32 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.32 28.76 0.15 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.558 1.543 . . . . 0.0 114.377 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.1 m -138.39 162.89 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 126.181 1.792 . . . . 0.0 111.699 -176.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.76 -128.78 35.32 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 123.602 0.62 . . . . 0.0 111.806 -175.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.73 -15.1 73.31 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 174.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.74 -1.09 54.85 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 124.97 1.271 . . . . 0.0 115.798 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -71.69 151.79 93.48 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 125.278 1.431 . . . . 0.0 113.195 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -64.17 150.54 88.11 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.716 2.278 . . . . 0.0 111.448 166.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.7 tp -142.8 132.86 24.39 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.252 1.021 . . . . 0.0 111.961 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -78.23 133.85 37.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.123 0.969 . . . . 0.0 112.335 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mp -139.82 143.6 36.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.479 1.512 . . . . 0.0 110.763 169.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -81.1 136.42 35.92 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.519 0.728 . . . . 0.0 110.26 166.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.8 142.67 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.733 0.813 . . . . 0.0 112.154 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.29 147.94 96.48 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.864 0.866 . . . . 0.0 112.498 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.49 -19.61 65.28 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.444 2.763 . . . . 0.0 113.67 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -78.91 4.65 13.55 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.868 1.667 . . . . 0.0 114.659 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 124.83 21.5 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.568 1.076 . . . . 0.0 112.649 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.2 m -107.89 138.58 43.89 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.557 1.543 . . . . 0.0 111.305 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.0 t -56.62 -47.29 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.023 0.929 . . . . 0.0 112.547 -175.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.5 -41.5 98.71 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.429 0.537 . . . . 0.0 112.926 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.13 -45.74 79.99 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.006 0.903 . . . . 0.0 112.139 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.48 -52.84 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.9 0.88 . . . . 0.0 110.849 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -62.33 -45.68 92.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.903 0.881 . . . . 0.0 111.606 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 84.6 m -61.17 -41.34 96.6 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.359 0.663 . . . . 0.0 111.917 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -63.43 -40.68 97.83 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.003 0.819 . . . . 0.0 112.416 176.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.6 t -67.68 -43.75 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.201 0.91 . . . . 0.0 111.53 174.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 93.9 m -56.88 -43.1 80.93 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.478 1.036 . . . . 0.0 112.081 174.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.19 89.09 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.111 0.964 . . . . 0.0 112.803 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.3 tpt -67.83 -39.59 83.87 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.869 0.868 . . . . 0.0 112.496 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -19.02 56.42 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.28 1.432 . . . . 0.0 113.916 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt 58.28 29.05 17.5 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.733 2.013 . . . . 0.0 113.328 -169.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mp -128.08 154.83 78.61 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 126.275 1.83 . . . . 0.0 111.82 -174.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.37 165.33 32.05 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 124.399 3.4 . . . . 0.0 115.102 -171.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -63.15 -15.85 50.69 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.644 2.896 . . . . 0.0 113.928 170.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -68.66 -21.16 64.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.236 1.014 . . . . 0.0 113.136 171.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.9 p -114.86 -38.73 3.86 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.051 1.34 . . . . 0.0 113.183 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 81.7 m -92.84 124.67 37.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.29 1.436 . . . . 0.0 111.001 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -149.27 146.22 27.46 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -171.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.18 148.08 34.81 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.245 1.818 . . . . 0.0 111.91 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.0 m -143.04 143.15 31.77 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.834 1.654 . . . . 0.0 111.836 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -144.49 133.54 22.75 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.357 1.863 . . . . 0.0 110.635 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? 52.78 30.49 9.05 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.805 1.242 . . . . 0.0 113.488 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.31 16.57 78.73 Favored Glycine 0 CA--C 1.54 1.627 0 C-N-CA 124.852 1.215 . . . . 0.0 115.218 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 -135.68 155.32 50.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.526 1.93 . . . . 0.0 111.757 -173.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.01 132.32 44.11 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.634 -0.666 . . . . 0.0 111.775 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.35 127.62 37.9 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.58 1.152 . . . . 0.0 109.86 167.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -164.46 147.32 8.94 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.802 1.641 . . . . 0.0 111.162 174.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 56.1 23.96 7.42 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.3 p -75.39 -17.79 60.11 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 120.859 -1.15 . . . . 0.0 113.478 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 61.64 -56.09 0.12 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 128.408 2.683 . . . . 0.0 114.144 -166.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.5 p -147.53 157.51 43.59 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.781 1.632 . . . . 0.0 111.048 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.27 -32.82 74.46 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.459 -0.776 . . . . 0.0 111.304 168.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -63.06 -31.55 72.72 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.407 -0.808 . . . . 0.0 113.074 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.2 t -64.89 -23.88 67.36 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.113 0.965 . . . . 0.0 113.325 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.4 mt -106.31 -33.31 7.81 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.091 1.357 . . . . 0.0 113.486 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.41 85.9 0.19 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.098 1.808 . . . . 0.0 111.739 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.9 p -72.87 146.93 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.556 1.142 . . . . 0.0 112.181 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -149.85 -179.45 7.15 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.347 1.459 . . . . 0.0 112.178 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -97.68 150.06 21.6 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.807 1.643 . . . . 0.0 111.741 167.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.74 5.14 90.07 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.77 1.176 . . . . 0.0 115.545 176.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -61.23 145.64 50.52 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.357 1.079 . . . . 0.0 110.755 170.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.87 134.2 46.58 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -171.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -125.1 113.8 18.21 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.417 1.087 . . . . 0.0 110.64 -169.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -83.58 128.9 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.49 0.716 . . . . 0.0 109.704 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.5 tp -113.04 118.37 34.6 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.371 1.468 . . . . 0.0 109.421 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.1 pt -110.27 154.43 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.89 1.276 . . . . 0.0 111.993 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -139.16 165.73 26.38 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.644 1.577 . . . . 0.0 111.298 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.7 ttt85 . . . . . 0 N--CA 1.473 0.696 0 C-N-CA 125.551 1.541 . . . . 0.0 111.016 -168.289 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -80.68 142.65 33.72 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.049 -1.657 . . . . 0.0 112.476 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.9 pt -131.3 162.29 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 127.103 2.161 . . . . 0.0 110.415 170.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -123.88 92.74 3.74 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.035 1.334 . . . . 0.0 110.627 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.5 tt -78.71 141.13 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 122.13 -0.356 . . . . 0.0 110.356 174.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.8 t -130.6 79.82 71.32 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.383 1.473 . . . . 0.0 109.426 -174.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.85 137.03 13.75 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.253 1.969 . . . . 0.0 112.509 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.0 41.53 0.16 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.718 1.607 . . . . 0.0 112.63 170.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -139.14 142.51 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.539 1.936 . . . . 0.0 109.907 -167.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.48 -115.15 7.51 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 123.754 0.692 . . . . 0.0 112.479 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.44 -18.16 71.36 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.127 0.87 . . . . 0.0 114.972 176.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.95 6.45 56.33 Favored Glycine 0 CA--C 1.541 1.68 0 CA-C-N 118.737 1.268 . . . . 0.0 115.627 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.1 p -95.34 158.91 33.89 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.485 1.914 . . . . 0.0 113.561 -169.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.49 143.25 75.03 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.163 2.575 . . . . 0.0 112.115 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.5 mt -131.28 115.83 16.81 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.017 1.727 . . . . 0.0 110.515 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -74.4 125.58 28.83 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.836 0.855 . . . . 0.0 111.238 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt -138.17 149.05 45.49 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.606 1.563 . . . . 0.0 111.119 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -97.13 130.3 44.41 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.837 1.255 . . . . 0.0 110.156 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.9 149.71 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.922 1.289 . . . . 0.0 112.903 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.11 153.56 88.9 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.8 1.24 . . . . 0.0 112.471 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.13 -25.25 50.95 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.306 2.67 . . . . 0.0 113.635 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -80.51 37.57 0.41 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.013 1.725 . . . . 0.0 112.985 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.06 67.73 3.96 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.981 1.713 . . . . 0.0 112.622 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 55.9 m -63.76 141.34 58.8 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.683 1.193 . . . . 0.0 112.275 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.1 t -60.07 -44.09 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.072 0.949 . . . . 0.0 112.161 -174.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.98 -36.4 92.18 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.498 0.57 . . . . 0.0 113.231 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.93 -50.33 64.79 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 117.992 0.896 . . . . 0.0 111.796 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.2 p -66.78 -36.86 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.867 0.758 . . . . 0.0 112.046 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -59.06 -48.1 82.84 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.475 1.11 . . . . 0.0 111.837 173.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.2 m -66.47 -39.9 89.05 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.375 0.67 . . . . 0.0 112.099 175.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -44.48 96.96 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.893 0.877 . . . . 0.0 111.755 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.9 t -61.48 -48.33 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.136 1.374 . . . . 0.0 111.362 172.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.6 -44.53 93.36 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.458 0.703 . . . . 0.0 111.967 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.49 88.51 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.204 1.002 . . . . 0.0 112.924 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.5 ttm -65.76 -43.5 88.69 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.534 1.133 . . . . 0.0 112.232 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -75.38 -29.53 59.87 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.846 1.258 . . . . 0.0 113.394 177.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.2 tptm 57.41 31.29 19.97 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.746 2.018 . . . . 0.0 113.098 -169.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.52 151.16 56.81 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 126.316 1.846 . . . . 0.0 111.082 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.88 159.18 51.19 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.943 3.095 . . . . 0.0 113.594 -173.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.17 -13.07 35.74 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.99 3.127 . . . . 0.0 114.778 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -66.29 -22.25 66.29 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.136 -0.978 . . . . 0.0 113.355 170.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.2 p -103.07 -25.84 13.27 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.71 1.204 . . . . 0.0 113.709 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.1 m -140.07 126.87 20.6 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.954 1.301 . . . . 0.0 110.928 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -134.44 166.61 22.45 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.125 1.37 . . . . 0.0 112.897 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 69' ' ' PHE . 39.4 tp -137.07 135.33 37.41 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.455 1.502 . . . . 0.0 111.497 -168.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.5 p -136.49 158.54 44.19 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.491 1.116 . . . . 0.0 112.519 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -139.09 128.73 24.6 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.606 2.363 . . . . 0.0 109.701 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.62 31.97 11.01 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.643 1.177 . . . . 0.0 113.515 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.94 8.79 87.63 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 124.945 1.26 . . . . 0.0 115.943 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -122.01 151.1 41.18 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.404 1.881 . . . . 0.0 112.261 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.12 126.24 30.52 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.85 -0.531 . . . . 0.0 110.46 165.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.2 mt -74.41 137.65 42.83 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.579 0.752 . . . . 0.0 110.726 170.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.24 140.4 7.5 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.117 1.367 . . . . 0.0 111.335 170.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t0 55.72 26.45 9.43 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.957 1.703 . . . . 0.0 115.191 175.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.9 m -78.03 -15.19 59.13 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.016 1.326 . . . . 0.0 113.732 -171.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 59.4 -70.84 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.601 2.361 . . . . 0.0 114.441 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.2 p -146.38 154.23 41.4 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.158 1.383 . . . . 0.0 111.97 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.22 -20.37 60.88 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.768 -0.583 . . . . 0.0 112.391 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.66 -30.72 71.59 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.192 -0.942 . . . . 0.0 112.659 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.0 t -63.59 -24.3 67.74 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.63 0.772 . . . . 0.0 112.762 173.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.4 mt -92.68 -12.42 31.54 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.46 1.504 . . . . 0.0 113.304 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.54 17.15 64.13 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.185 1.374 . . . . 0.0 115.014 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.1 p -76.44 145.0 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.778 1.231 . . . . 0.0 113.424 -169.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.6 -177.29 5.76 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.869 1.667 . . . . 0.0 113.774 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -68.47 164.4 21.21 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.299 1.44 . . . . 0.0 113.214 172.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.83 11.62 60.16 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.587 1.089 . . . . 0.0 115.033 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -62.19 143.83 56.27 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.436 1.118 . . . . 0.0 111.552 171.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -127.18 132.64 50.44 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.101 0.96 . . . . 0.0 112.235 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.459 ' HB3' HD11 ' A' ' 45' ' ' LEU . 6.9 m-85 -125.27 132.61 52.9 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.866 1.266 . . . . 0.0 109.944 -171.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 p -110.73 120.73 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.024 0.829 . . . . 0.0 111.123 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.99 121.11 40.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.954 1.302 . . . . 0.0 109.136 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.0 tt -119.7 131.07 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.447 1.099 . . . . 0.0 111.063 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.6 t -114.61 150.87 34.4 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.309 1.844 . . . . 0.0 111.353 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 . . . . . 0 N--CA 1.471 0.606 0 C-N-CA 126.179 1.792 . . . . 0.0 109.959 172.984 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.28 0.562 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -108.98 141.68 40.74 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.074 1.35 . . . . 0.0 111.331 174.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.0 pt -121.56 163.05 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.07 1.748 . . . . 0.0 110.457 170.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -125.69 105.57 9.09 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.15 0.98 . . . . 0.0 110.875 174.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.4 mt -86.79 137.88 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -126.0 76.25 71.6 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 124.951 1.3 . . . . 0.0 110.086 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.97 136.59 16.68 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.92 2.413 . . . . 0.0 111.261 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.25 31.91 0.1 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.627 1.571 . . . . 0.0 114.173 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.5 t -139.52 147.67 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 126.62 1.968 . . . . 0.0 109.871 -171.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.5 30.75 70.97 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 121.642 -0.661 . . . . 0.0 114.543 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.65 -8.36 40.02 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.615 1.578 . . . . 0.0 115.11 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.32 5.36 76.91 Favored Glycine 0 CA--C 1.54 1.637 0 N-CA-C 116.355 1.302 . . . . 0.0 116.355 170.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.9 m -75.14 150.32 85.41 Favored Pre-proline 0 N--CA 1.475 0.804 0 CA-C-N 118.649 1.225 . . . . 0.0 113.432 -174.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.77 145.7 76.03 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.378 2.719 . . . . 0.0 111.898 169.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.1 mt -131.71 111.72 11.92 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.725 1.61 . . . . 0.0 110.492 178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -79.27 134.22 36.64 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.355 1.062 . . . . 0.0 111.807 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 tt -152.43 141.98 21.76 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.347 1.059 . . . . 0.0 112.349 -175.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -80.93 133.92 35.63 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.659 1.184 . . . . 0.0 112.289 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -139.1 155.51 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.878 1.271 . . . . 0.0 113.01 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.75 152.45 91.31 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.623 1.169 . . . . 0.0 112.271 172.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.02 -19.05 57.85 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.365 2.71 . . . . 0.0 113.419 174.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -78.76 5.77 10.5 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.643 1.577 . . . . 0.0 114.117 176.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.37 130.52 47.11 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.391 0.996 . . . . 0.0 112.284 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.9 m -109.7 134.73 51.65 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.47 1.508 . . . . 0.0 110.874 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.32 -40.94 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.073 0.949 . . . . 0.0 112.31 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.61 -34.93 91.0 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 123.775 0.702 . . . . 0.0 113.5 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.87 -43.23 75.79 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.339 1.07 . . . . 0.0 111.645 174.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.9 t -61.27 -46.67 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.005 0.922 . . . . 0.0 111.138 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -56.49 -51.42 68.56 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.542 1.137 . . . . 0.0 111.735 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.4 m -60.16 -42.03 94.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.505 0.722 . . . . 0.0 111.818 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.67 -50.76 72.7 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.949 0.9 . . . . 0.0 111.239 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.4 t -68.21 -41.37 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.412 0.685 . . . . 0.0 112.132 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 95.9 m -59.67 -40.41 87.7 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.335 0.971 . . . . 0.0 112.202 173.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.57 -41.99 78.95 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.55 0.74 . . . . 0.0 112.77 174.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 84.2 mtp -66.37 -39.73 89.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.353 1.061 . . . . 0.0 112.871 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -84.46 -18.27 36.44 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.718 1.207 . . . . 0.0 113.86 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp 57.75 30.03 18.31 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.457 1.903 . . . . 0.0 113.728 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.92 150.49 43.56 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 126.129 1.771 . . . . 0.0 111.141 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.64 159.85 50.75 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 123.713 2.942 . . . . 0.0 112.796 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.07 -9.89 26.67 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 124.007 3.138 . . . . 0.0 115.063 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -80.12 -36.16 35.69 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.193 1.397 . . . . 0.0 113.296 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 34.6 p -85.81 8.13 21.2 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.203 1.401 . . . . 0.0 113.827 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.0 t -144.2 142.72 30.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.679 1.591 . . . . 0.0 111.972 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 -141.02 148.51 40.39 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.465 1.506 . . . . 0.0 112.658 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.7 tp -127.48 129.41 47.38 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.008 2.123 . . . . 0.0 110.108 -177.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.8 p -140.06 155.52 47.0 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.41 1.084 . . . . 0.0 112.516 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -145.0 138.69 26.95 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.168 1.787 . . . . 0.0 110.167 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp 54.13 30.4 12.03 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.935 1.294 . . . . 0.0 114.062 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.96 16.85 80.33 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.037 1.304 . . . . 0.0 115.259 -175.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -134.13 150.86 51.16 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.085 1.754 . . . . 0.0 112.252 -171.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.1 115.95 20.79 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.945 0.898 . . . . 0.0 110.962 172.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.2 mp -86.35 131.96 34.08 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.38 1.072 . . . . 0.0 110.297 171.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.78 149.91 11.45 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.388 1.475 . . . . 0.0 110.903 171.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.7 t0 55.77 27.66 11.13 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.732 1.613 . . . . 0.0 115.073 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.6 p -78.85 -22.02 46.72 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.985 1.314 . . . . 0.0 113.523 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 62.34 -53.26 0.15 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 128.51 2.724 . . . . 0.0 115.005 -170.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 61.4 p -144.71 152.31 40.22 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.726 1.61 . . . . 0.0 111.599 172.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.7 mt -70.28 -36.27 74.27 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.344 0.658 . . . . 0.0 111.79 172.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.91 -33.67 76.23 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.6 m -68.45 -26.49 65.53 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 66.3 mt -99.29 -26.72 14.07 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.531 1.132 . . . . 0.0 113.471 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 130.76 83.93 0.3 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.839 1.685 . . . . 0.0 111.946 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.68 148.49 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.641 1.177 . . . . 0.0 111.662 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.29 158.26 43.78 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.216 1.406 . . . . 0.0 111.922 176.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -73.35 142.65 47.05 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.336 1.054 . . . . 0.0 111.69 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.91 19.55 78.7 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.414 0.926 . . . . 0.0 115.414 174.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.61 136.94 57.75 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.849 1.324 . . . . 0.0 111.384 171.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -132.9 132.11 41.68 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -172.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -119.7 97.67 5.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.251 1.421 . . . . 0.0 110.405 -161.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.65 137.47 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.889 -0.507 . . . . 0.0 110.45 174.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tt -139.47 109.0 6.18 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.623 0.769 . . . . 0.0 110.179 -170.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.3 tt -101.94 142.6 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.998 1.319 . . . . 0.0 111.348 -173.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.4 p -130.29 157.05 43.58 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.22 1.408 . . . . 0.0 110.46 173.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 . . . . . 0 N--CA 1.479 0.992 0 C-N-CA 123.87 0.868 . . . . 0.0 112.172 178.879 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mmt . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 121.347 0.594 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -68.59 148.67 50.17 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.976 0.91 . . . . 0.0 112.28 165.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.4 mm -142.23 143.62 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 128.034 2.534 . . . . 0.0 109.176 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -100.4 144.28 29.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.194 0.997 . . . . 0.0 111.056 162.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.7 tt -133.72 134.52 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.443 1.097 . . . . 0.0 110.474 167.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 p -123.34 103.12 35.84 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.592 1.157 . . . . 0.0 110.679 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -92.89 140.69 1.89 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.721 2.28 . . . . 0.0 112.255 176.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.17 48.36 0.61 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.463 1.505 . . . . 0.0 113.522 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 p -154.34 155.3 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.437 1.495 . . . . 0.0 111.529 -172.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.93 -112.4 4.64 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.704 0.669 . . . . 0.0 112.671 174.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.13 -19.85 72.43 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 124.082 0.848 . . . . 0.0 114.799 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.24 32.85 82.18 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 118.782 1.291 . . . . 0.0 114.448 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 t -144.68 145.6 28.84 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.163 1.385 . . . . 0.0 112.103 -162.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -60.51 140.38 91.07 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.526 2.818 . . . . 0.0 113.096 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.0 tp -124.9 134.06 52.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.343 1.857 . . . . 0.0 110.44 175.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -82.79 135.05 35.08 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.676 0.791 . . . . 0.0 110.752 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.3 mt -142.21 175.09 10.02 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.873 2.069 . . . . 0.0 110.872 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -136.41 134.6 37.94 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.613 1.565 . . . . 0.0 109.962 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 m -136.03 155.19 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.136 0.974 . . . . 0.0 113.0 -173.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.24 149.87 73.33 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.853 0.861 . . . . 0.0 111.675 169.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -64.93 -21.64 63.74 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.287 2.658 . . . . 0.0 112.865 172.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -74.06 -0.94 18.03 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.925 1.69 . . . . 0.0 114.134 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.66 121.18 10.38 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.287 0.948 . . . . 0.0 111.814 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.0 p -86.16 150.73 24.2 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.773 0.829 . . . . 0.0 111.502 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.3 t -64.39 -36.6 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.812 -0.555 . . . . 0.0 110.647 173.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.35 -51.4 57.86 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.083 0.849 . . . . 0.0 112.74 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.75 93.13 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.004 0.902 . . . . 0.0 112.865 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.5 t -63.93 -47.29 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 121.833 -0.542 . . . . 0.0 111.013 175.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -63.18 -42.4 99.37 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.273 1.029 . . . . 0.0 112.074 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.8 p -69.63 -38.16 77.1 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 118.329 -0.843 . . . . 0.0 112.582 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -61.95 -43.97 97.74 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.898 1.226 . . . . 0.0 111.844 172.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.2 t -61.53 -48.27 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.832 0.742 . . . . 0.0 111.477 175.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.3 t -59.24 -44.57 92.36 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.938 0.895 . . . . 0.0 111.876 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.63 -40.93 80.12 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.255 1.022 . . . . 0.0 112.951 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 59.3 ttp -71.35 -41.04 70.26 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.14 1.376 . . . . 0.0 112.989 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -82.51 -14.59 54.71 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp 58.34 29.93 18.86 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.708 2.003 . . . . 0.0 112.995 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.2 mt -141.02 147.92 49.81 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.877 1.671 . . . . 0.0 112.378 -168.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.95 161.05 47.4 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.222 3.281 . . . . 0.0 114.582 -171.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -66.05 -16.01 50.73 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.763 2.975 . . . . 0.0 114.71 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -67.58 -45.49 75.4 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.946 -1.096 . . . . 0.0 111.756 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.2 t -88.36 -22.59 23.72 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.195 1.398 . . . . 0.0 112.955 -174.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.6 m -127.82 119.12 25.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.453 1.501 . . . . 0.0 112.204 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -133.06 160.9 35.84 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.345 1.858 . . . . 0.0 113.202 -173.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.1 tp -134.94 138.86 44.45 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.785 2.034 . . . . 0.0 110.854 -172.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.3 m -139.22 146.09 40.06 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.43 1.492 . . . . 0.0 111.388 -176.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -142.56 134.6 27.26 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.499 1.519 . . . . 0.0 110.226 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 tptm 52.91 32.69 13.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.159 1.383 . . . . 0.0 113.407 -176.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.45 14.53 74.7 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 124.495 1.045 . . . . 0.0 115.34 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.41 141.95 51.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.685 1.994 . . . . 0.0 111.4 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.45 125.84 31.54 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.874 0.87 . . . . 0.0 110.348 167.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.0 mp -82.13 138.66 34.71 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.684 0.794 . . . . 0.0 110.354 172.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 136.76 6.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.725 1.61 . . . . 0.0 110.289 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.3 t0 55.61 26.92 9.75 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.577 1.551 . . . . 0.0 114.471 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 m -78.19 -29.39 48.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.839 1.256 . . . . 0.0 113.782 -169.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 62.24 -36.59 0.12 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 128.692 2.797 . . . . 0.0 117.554 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 t -156.01 146.29 21.6 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.292 1.437 . . . . 0.0 111.123 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.27 -18.13 64.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.882 0.873 . . . . 0.0 112.86 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -68.35 -19.95 64.68 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 171.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.1 t -69.46 -41.1 76.65 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.968 0.907 . . . . 0.0 112.017 178.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.8 mp -82.47 -14.56 54.84 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.843 1.257 . . . . 0.0 112.82 170.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.99 37.25 91.98 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.475 1.036 . . . . 0.0 113.364 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.6 m -64.56 152.97 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.313 1.045 . . . . 0.0 113.802 -168.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.86 -178.38 6.83 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.197 1.399 . . . . 0.0 112.965 174.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -80.34 153.07 28.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.609 1.163 . . . . 0.0 112.231 165.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.6 26.12 61.65 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 115.351 0.9 . . . . 0.0 115.351 173.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -61.55 156.46 19.59 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.278 1.039 . . . . 0.0 112.769 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -124.7 108.66 12.23 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.175 1.39 . . . . 0.0 111.132 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -93.58 144.71 25.12 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.272 1.429 . . . . 0.0 110.998 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.0 m -124.47 133.49 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.139 0.976 . . . . 0.0 110.767 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.58 131.98 56.49 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.439 1.096 . . . . 0.0 110.781 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.64 136.59 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.948 1.699 . . . . 0.0 108.936 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.0 t -142.8 129.05 19.88 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.859 0.864 . . . . 0.0 111.408 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.1 mmt-85 . . . . . 0 N--CA 1.476 0.835 0 C-N-CA 125.851 1.66 . . . . 0.0 112.325 178.676 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ttt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -130.07 153.07 48.83 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.39 1.476 . . . . 0.0 111.917 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -133.1 158.82 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 126.8 2.04 . . . . 0.0 110.807 173.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -103.42 147.88 26.58 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.587 1.555 . . . . 0.0 110.036 164.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.2 tt -135.93 135.38 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.148 0.979 . . . . 0.0 110.396 169.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.6 p -128.26 96.75 30.27 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.82 1.248 . . . . 0.0 111.042 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -81.74 138.96 10.86 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.342 2.695 . . . . 0.0 111.683 170.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.98 40.31 0.15 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.586 1.554 . . . . 0.0 112.968 170.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.3 t -138.73 144.38 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.364 1.866 . . . . 0.0 110.037 -169.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.95 -112.4 4.79 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.965 0.793 . . . . 0.0 112.141 175.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.83 -16.8 68.62 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.223 0.916 . . . . 0.0 115.046 175.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.55 20.71 66.15 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 118.747 1.274 . . . . 0.0 115.362 171.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.4 m -129.35 153.58 80.55 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 125.6 1.56 . . . . 0.0 112.962 -164.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.92 146.19 82.14 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.293 2.662 . . . . 0.0 113.384 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.4 mt -132.5 138.4 47.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.418 1.887 . . . . 0.0 111.094 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -78.75 135.67 37.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.987 1.315 . . . . 0.0 111.87 172.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mp -142.96 150.8 40.17 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.882 1.273 . . . . 0.0 111.925 169.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -85.38 143.92 28.34 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.963 0.905 . . . . 0.0 110.471 160.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.17 148.96 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.503 1.521 . . . . 0.0 110.994 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.72 149.9 88.38 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.69 0.796 . . . . 0.0 111.658 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.42 -19.03 61.31 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.02 2.48 . . . . 0.0 112.927 171.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -77.92 -0.74 28.7 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.029 1.732 . . . . 0.0 114.441 171.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.06 142.66 56.48 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 119.415 1.007 . . . . 0.0 111.055 172.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.11 152.01 40.33 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.412 1.085 . . . . 0.0 111.411 -175.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -60.94 -32.91 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 121.566 -0.709 . . . . 0.0 112.433 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.9 -50.26 59.0 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 123.96 0.791 . . . . 0.0 111.917 173.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.4 -40.11 95.42 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.091 0.956 . . . . 0.0 112.73 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.1 t -63.02 -49.6 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.661 -0.649 . . . . 0.0 110.525 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -63.36 -45.33 91.69 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 121.566 -0.709 . . . . 0.0 112.467 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.5 p -67.75 -37.61 82.38 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.479 1.036 . . . . 0.0 112.161 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -58.1 -47.19 83.98 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.265 0.939 . . . . 0.0 111.024 172.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.9 t -63.44 -47.35 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.325 1.05 . . . . 0.0 111.414 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 93.8 m -61.63 -41.83 98.04 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.24 85.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.839 0.856 . . . . 0.0 113.113 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.5 ttt -66.64 -41.18 88.69 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.283 1.033 . . . . 0.0 112.486 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.471 ' HA ' ' HE3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -74.9 -24.21 58.49 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.434 1.094 . . . . 0.0 113.352 172.584 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt 59.09 28.51 17.81 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.385 2.274 . . . . 0.0 113.912 -167.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 mp -116.35 155.44 48.44 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.14 1.776 . . . . 0.0 111.634 -177.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.69 157.72 60.7 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 123.52 2.813 . . . . 0.0 112.437 178.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.48 -25.34 63.06 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.402 2.735 . . . . 0.0 114.406 -173.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -71.64 -17.59 62.25 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.696 1.134 . . . . 0.0 113.634 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.2 m -84.45 -1.04 55.02 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.684 -1.26 . . . . 0.0 112.993 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.3 t -136.13 158.01 45.45 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.49 1.516 . . . . 0.0 112.244 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -141.79 140.12 32.94 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.029 1.732 . . . . 0.0 111.2 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.5 tp -113.31 130.84 56.15 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.433 1.893 . . . . 0.0 110.143 173.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.3 p -136.8 155.63 49.57 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.956 0.902 . . . . 0.0 112.428 172.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -151.74 135.13 16.06 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.303 1.841 . . . . 0.0 110.11 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.92 35.96 20.54 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.215 1.406 . . . . 0.0 113.353 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.83 15.91 79.44 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 124.48 1.038 . . . . 0.0 115.212 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -129.58 151.9 49.69 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.643 1.977 . . . . 0.0 111.637 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.08 135.26 38.59 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.862 -0.524 . . . . 0.0 109.673 160.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.7 tp -107.98 115.89 30.96 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.899 0.88 . . . . 0.0 109.865 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -150.1 141.13 22.97 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.915 1.286 . . . . 0.0 111.613 -169.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.6 t0 54.95 26.46 7.96 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.864 1.665 . . . . 0.0 114.836 174.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.4 p -75.28 -26.52 58.83 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.133 1.373 . . . . 0.0 113.005 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 64.04 -46.7 0.28 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 129.015 2.926 . . . . 0.0 114.892 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -152.94 139.01 18.21 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.35 1.86 . . . . 0.0 111.588 175.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.91 -37.36 87.4 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.877 0.871 . . . . 0.0 111.994 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -65.58 -18.19 65.14 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.9 m -75.61 -27.14 58.35 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.134 0.974 . . . . 0.0 113.15 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.37 -39.8 8.62 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.858 1.263 . . . . 0.0 112.036 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 145.67 93.32 0.14 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.518 1.532 . . . . 0.0 111.459 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.2 p -75.04 147.49 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.338 1.055 . . . . 0.0 111.75 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -147.09 164.82 31.82 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.458 1.503 . . . . 0.0 111.837 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -94.88 146.09 24.46 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.816 1.246 . . . . 0.0 112.841 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.03 19.46 72.51 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 123.86 0.743 . . . . 0.0 114.8 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.31 144.04 54.62 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.458 1.129 . . . . 0.0 111.498 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.25 110.96 17.62 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.674 1.19 . . . . 0.0 111.534 -177.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -92.47 131.66 37.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.787 1.235 . . . . 0.0 111.353 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -109.57 127.2 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.283 1.033 . . . . 0.0 110.298 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.28 121.16 43.59 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.71 1.604 . . . . 0.0 110.357 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.0 mm -114.93 125.38 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.902 1.281 . . . . 0.0 109.903 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.8 t -98.24 155.95 16.94 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.503 1.121 . . . . 0.0 111.622 172.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? . . . . . 0 N--CA 1.476 0.849 0 C-N-CA 125.192 1.397 . . . . 0.0 111.187 171.268 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.848 ' HB2' ' OD1' ' A' ' 65' ' ' ASP . 26.3 mmt . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 121.668 0.747 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 141.17 32.38 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.464 1.506 . . . . 0.0 111.045 174.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.4 mt -128.22 141.98 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.786 1.634 . . . . 0.0 109.803 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -105.55 102.23 11.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.862 1.265 . . . . 0.0 110.25 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.4 pt -78.92 143.51 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.436 -0.79 . . . . 0.0 110.326 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 t -130.61 80.18 70.57 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.907 1.283 . . . . 0.0 109.847 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.55 131.46 16.17 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.021 2.481 . . . . 0.0 112.256 175.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.44 41.07 0.18 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.878 1.271 . . . . 0.0 112.749 167.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.9 t -138.91 145.49 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 126.503 1.921 . . . . 0.0 110.202 -169.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.72 -121.19 22.97 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.721 0.677 . . . . 0.0 111.858 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.21 -18.27 72.95 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 123.952 0.787 . . . . 0.0 114.935 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.09 -0.8 57.98 Favored Glycine 0 CA--C 1.542 1.763 0 C-N-CA 124.981 1.276 . . . . 0.0 115.769 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 m -73.92 153.43 88.94 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 125.523 1.529 . . . . 0.0 113.793 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -63.55 149.37 91.18 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.729 2.286 . . . . 0.0 111.467 163.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 tt -141.4 127.07 19.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.881 1.272 . . . . 0.0 111.311 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -85.38 128.89 34.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.827 1.251 . . . . 0.0 112.581 -174.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.9 mt -141.7 146.17 35.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.561 1.544 . . . . 0.0 112.439 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -84.7 146.33 27.48 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.144 0.977 . . . . 0.0 111.112 163.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.6 m -143.6 157.87 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.291 1.436 . . . . 0.0 111.201 174.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.36 151.95 96.89 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.646 0.778 . . . . 0.0 111.824 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -65.99 -20.49 57.46 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.149 2.566 . . . . 0.0 113.027 173.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -83.98 22.16 1.21 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.482 1.913 . . . . 0.0 113.083 175.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.76 108.98 2.28 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.531 -1.355 . . . . 0.0 111.578 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.2 m -77.92 129.97 36.0 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.402 1.081 . . . . 0.0 110.954 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.1 t -57.57 -44.9 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.028 0.931 . . . . 0.0 111.719 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.24 -35.64 91.86 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.48 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.75 -42.31 77.72 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.883 1.342 . . . . 0.0 112.037 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.0 -49.05 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.448 0.699 . . . . 0.0 110.527 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -62.71 -41.66 99.25 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.513 0.725 . . . . 0.0 111.583 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.1 m -62.41 -42.0 99.11 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.651 0.78 . . . . 0.0 111.591 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -58.58 -45.64 88.61 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.359 0.981 . . . . 0.0 111.733 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 83.1 t -63.34 -47.16 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.938 0.895 . . . . 0.0 111.376 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 83.2 m -63.24 -39.9 95.9 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.067 0.547 . . . . 0.0 112.4 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.44 -39.47 77.79 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.297 1.039 . . . . 0.0 112.719 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 63.9 ttp -67.1 -40.44 86.92 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.148 0.979 . . . . 0.0 112.159 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -83.02 -10.42 58.76 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 173.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.38 25.15 12.51 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 127.29 2.236 . . . . 0.0 114.418 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mp -131.98 155.0 81.89 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 126.326 1.85 . . . . 0.0 112.169 -174.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.48 162.54 41.96 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.305 3.337 . . . . 0.0 114.215 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.67 -16.75 56.6 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 124.194 3.263 . . . . 0.0 114.792 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -66.01 -26.65 67.63 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.026 -1.047 . . . . 0.0 112.434 170.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 26.2 m -91.23 -36.59 13.83 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.492 0.717 . . . . 0.0 112.407 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.3 m -130.21 126.76 38.16 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.245 1.018 . . . . 0.0 112.162 -171.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -131.46 161.8 31.69 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.844 1.658 . . . . 0.0 112.997 -168.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.7 tp -129.29 134.54 47.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.473 2.309 . . . . 0.0 110.654 -174.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.2 p -138.52 156.8 47.19 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.724 1.21 . . . . 0.0 113.033 174.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -147.68 132.76 18.25 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.269 1.828 . . . . 0.0 110.447 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm 52.05 40.58 28.75 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.226 1.41 . . . . 0.0 113.374 173.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.49 9.17 84.57 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 125.167 1.365 . . . . 0.0 115.723 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 65.3 mtp180 -127.6 152.08 48.1 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.457 1.903 . . . . 0.0 111.958 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.36 128.06 34.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.034 0.934 . . . . 0.0 110.116 166.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.2 mt -86.35 140.56 29.93 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.829 0.852 . . . . 0.0 110.988 174.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -162.69 152.76 16.25 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.853 1.661 . . . . 0.0 111.331 171.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 53.91 19.89 2.16 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.629 1.972 . . . . 0.0 116.239 171.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -75.91 -29.95 58.6 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.008 1.323 . . . . 0.0 112.576 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 62.46 -53.94 0.15 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 128.006 2.523 . . . . 0.0 115.475 -175.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 49.5 p -140.97 137.36 32.99 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.009 1.323 . . . . 0.0 111.298 172.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.38 -23.86 64.71 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.653 -0.655 . . . . 0.0 111.949 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -61.68 -31.76 71.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.768 0.827 . . . . 0.0 112.918 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 55.8 p -64.88 -22.11 66.93 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.0 mt -107.29 -0.34 22.59 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.409 1.884 . . . . 0.0 113.063 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.5 118.5 0.46 Allowed Glycine 0 CA--C 1.539 1.543 0 C-N-CA 126.208 1.861 . . . . 0.0 113.063 -170.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.7 t -75.24 132.84 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.406 1.082 . . . . 0.0 110.767 174.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.43 -174.35 2.51 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.733 1.613 . . . . 0.0 111.494 172.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.848 ' OD1' ' HB2' ' A' ' 1' ' ' MET . 28.1 t0 -139.65 148.82 42.96 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.968 -1.082 . . . . 0.0 113.102 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.92 23.2 75.39 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 123.87 0.747 . . . . 0.0 113.965 -173.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -68.21 165.04 19.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.234 1.414 . . . . 0.0 112.152 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.7 pttm -139.62 142.15 37.07 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 171.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -116.79 121.91 42.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.718 1.207 . . . . 0.0 110.254 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.9 t -96.64 128.97 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.48 0.712 . . . . 0.0 109.875 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.0 mt -111.38 131.54 55.11 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.257 1.023 . . . . 0.0 109.717 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.0 tt -124.91 142.02 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.841 1.256 . . . . 0.0 110.609 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.1 t -132.5 136.48 46.68 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.071 1.348 . . . . 0.0 111.528 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 . . . . . 0 N--CA 1.474 0.746 0 C-N-CA 125.026 1.33 . . . . 0.0 111.463 178.251 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.34 0.114 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -108.84 151.11 26.69 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 120.318 -1.489 . . . . 0.0 113.279 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mt -137.41 134.49 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.986 1.714 . . . . 0.0 109.676 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -93.47 101.44 13.64 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.92 1.288 . . . . 0.0 111.168 174.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 tt -83.49 137.27 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.421 -0.8 . . . . 0.0 110.146 169.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.74 90.33 40.59 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 124.78 1.232 . . . . 0.0 110.464 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -87.64 142.7 5.97 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.467 2.778 . . . . 0.0 112.481 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.91 38.12 0.2 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 125.89 1.676 . . . . 0.0 114.79 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.9 m -139.94 161.49 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 125.767 1.627 . . . . 0.0 112.374 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.3 -122.96 29.85 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.88 0.752 . . . . 0.0 111.91 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.56 -13.24 74.36 Favored Glycine 0 CA--C 1.539 1.571 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 173.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.62 7.0 45.54 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 125.281 1.42 . . . . 0.0 115.831 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.4 m -89.33 154.97 49.16 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 125.399 1.479 . . . . 0.0 113.204 -173.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -64.16 150.6 88.0 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.016 2.477 . . . . 0.0 112.447 169.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mt -137.85 125.96 22.91 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.07 1.748 . . . . 0.0 110.677 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -77.2 114.6 16.18 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.197 0.999 . . . . 0.0 111.325 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.5 mp -114.69 155.82 25.92 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.777 1.631 . . . . 0.0 110.703 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -114.01 133.24 55.63 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.409 1.483 . . . . 0.0 109.701 169.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.04 156.61 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.687 1.195 . . . . 0.0 112.044 -174.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.88 149.08 98.64 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.825 0.85 . . . . 0.0 111.914 173.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.78 -26.38 60.22 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.933 2.422 . . . . 0.0 113.053 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -82.59 12.81 4.21 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.73 1.612 . . . . 0.0 114.463 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.72 113.86 2.47 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.065 -1.022 . . . . 0.0 111.128 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 p -85.24 153.66 22.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.847 0.859 . . . . 0.0 111.536 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.9 t -63.49 -42.08 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.531 -0.731 . . . . 0.0 110.907 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.92 97.06 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.762 0.696 . . . . 0.0 113.226 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.12 -46.98 84.74 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 117.974 0.887 . . . . 0.0 111.742 175.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.76 -47.04 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.589 0.756 . . . . 0.0 111.38 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -56.99 -43.19 81.46 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.895 1.278 . . . . 0.0 111.697 177.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.0 m -65.7 -44.96 84.57 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.686 0.795 . . . . 0.0 111.444 176.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -46.6 87.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.908 0.883 . . . . 0.0 111.653 176.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.09 -51.74 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.219 1.408 . . . . 0.0 111.232 177.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.43 -43.44 96.78 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.799 0.727 . . . . 0.0 112.332 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.66 -43.66 92.89 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.638 0.775 . . . . 0.0 112.823 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.8 ttt -70.18 -36.79 74.9 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.13 0.972 . . . . 0.0 112.848 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.14 -20.41 52.11 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.132 1.373 . . . . 0.0 113.689 176.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? 57.66 19.93 5.91 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.751 2.02 . . . . 0.0 113.825 -171.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 mp -128.96 145.48 56.73 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.76 2.024 . . . . 0.0 110.973 -169.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.87 160.48 45.96 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.606 2.871 . . . . 0.0 113.831 -174.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.33 -5.26 15.5 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 124.02 3.147 . . . . 0.0 114.945 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -71.32 -39.81 71.17 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.736 -1.227 . . . . 0.0 111.715 169.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.7 t -85.97 -49.31 7.94 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.16 -0.962 . . . . 0.0 112.119 173.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.7 m -90.18 127.43 36.11 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.764 0.711 . . . . 0.0 112.093 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -140.37 163.33 33.09 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.758 1.223 . . . . 0.0 113.458 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.4 tp -140.0 136.42 33.73 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.708 2.003 . . . . 0.0 110.639 -170.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.1 p -139.93 155.7 47.03 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.528 1.131 . . . . 0.0 113.084 -178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -149.64 139.68 22.04 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.598 1.959 . . . . 0.0 109.808 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 55.61 29.9 14.4 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.199 1.4 . . . . 0.0 113.969 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.95 13.25 79.15 Favored Glycine 0 CA--C 1.541 1.68 0 C-N-CA 124.785 1.183 . . . . 0.0 114.985 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.3 mmm-85 -123.35 152.73 41.19 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.757 2.023 . . . . 0.0 112.23 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.92 124.01 30.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.738 0.815 . . . . 0.0 109.686 160.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.63 137.04 32.71 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.907 1.283 . . . . 0.0 109.42 174.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -164.51 147.73 9.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.385 1.474 . . . . 0.0 112.036 173.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 56.05 27.21 11.02 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.112 1.765 . . . . 0.0 115.378 175.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -83.96 -16.93 42.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.491 1.116 . . . . 0.0 113.954 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.27 -47.13 0.07 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 129.125 2.97 . . . . 0.0 115.956 -171.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.6 t -152.0 140.38 20.51 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.07 1.348 . . . . 0.0 110.987 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.96 -26.94 67.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.5 0.72 . . . . 0.0 112.153 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -65.3 -27.86 68.91 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.561 1.144 . . . . 0.0 113.364 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.1 t -68.35 -40.51 81.5 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.581 0.753 . . . . 0.0 112.262 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.12 -38.69 22.09 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.526 1.131 . . . . 0.0 112.021 177.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.43 97.91 0.26 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.914 1.721 . . . . 0.0 111.632 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.2 148.98 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.462 1.105 . . . . 0.0 111.735 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.34 -168.6 2.85 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.998 1.719 . . . . 0.0 111.116 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -138.75 149.46 45.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.825 1.25 . . . . 0.0 112.356 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.78 23.63 77.76 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 123.787 0.708 . . . . 0.0 113.87 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -66.92 164.99 16.34 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.93 1.292 . . . . 0.0 112.752 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -136.79 142.85 42.96 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.882 0.873 . . . . 0.0 113.281 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -127.86 125.32 39.48 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.062 1.345 . . . . 0.0 110.335 -175.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.4 126.63 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.604 1.162 . . . . 0.0 109.798 -176.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 tt -124.34 125.05 43.68 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.47 1.108 . . . . 0.0 110.923 -172.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.44 145.15 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.246 1.819 . . . . 0.0 110.275 -169.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.6 t -148.06 150.76 34.51 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.499 1.52 . . . . 0.0 110.941 176.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? . . . . . 0 N--CA 1.475 0.781 0 C-N-CA 125.565 1.546 . . . . 0.0 111.538 -177.008 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.536 ' HG2' ' H ' ' A' ' 2' ' ' LYS . 26.7 ttt . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.536 ' H ' ' HG2' ' A' ' 1' ' ' MET . 58.3 mttm -75.65 140.99 42.87 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.099 -1.0 . . . . 0.0 110.613 162.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.81 159.84 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.056 1.742 . . . . 0.0 109.961 175.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -113.8 139.57 49.02 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.961 1.304 . . . . 0.0 110.36 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 tt -126.82 141.81 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.676 0.79 . . . . 0.0 111.357 174.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 t -124.65 85.36 56.7 Favored Pre-proline 0 N--CA 1.474 0.747 0 C-N-CA 125.547 1.539 . . . . 0.0 109.862 -177.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.07 121.37 5.33 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.289 2.66 . . . . 0.0 111.528 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -80.29 52.77 1.65 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.38 1.472 . . . . 0.0 113.406 -177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -150.45 147.02 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.054 1.342 . . . . 0.0 111.809 -176.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.39 29.18 74.4 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 124.436 1.017 . . . . 0.0 114.958 173.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.49 68.37 1.52 Allowed Glycine 0 CA--C 1.532 1.143 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -167.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.26 137.02 42.85 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.49 1.043 . . . . 0.0 114.372 -170.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.1 m -148.48 152.64 38.86 Favored Pre-proline 0 N--CA 1.474 0.735 0 C-N-CA 126.298 1.839 . . . . 0.0 110.813 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -65.86 143.51 73.63 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.936 2.424 . . . . 0.0 112.45 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.9 tp -139.55 129.0 24.24 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.357 1.463 . . . . 0.0 111.118 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -82.97 144.62 29.86 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.304 1.041 . . . . 0.0 112.783 173.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -152.38 146.97 25.75 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.297 1.439 . . . . 0.0 111.625 168.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -81.42 135.74 35.66 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.739 0.816 . . . . 0.0 111.191 171.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.6 m -134.16 156.56 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.484 1.114 . . . . 0.0 112.279 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.82 152.07 93.81 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 124.382 1.073 . . . . 0.0 112.608 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.09 -23.74 60.32 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.119 2.546 . . . . 0.0 113.279 177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -85.43 10.7 12.12 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.249 1.42 . . . . 0.0 113.739 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.99 155.44 27.5 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.079 0.854 . . . . 0.0 112.515 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.6 m -144.39 135.37 25.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.265 1.426 . . . . 0.0 110.669 -171.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.7 t -61.28 -40.27 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.367 0.667 . . . . 0.0 111.953 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.34 -39.13 97.35 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.431 -0.649 . . . . 0.0 113.37 175.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.69 -37.59 82.52 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 118.342 1.071 . . . . 0.0 112.489 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.48 -44.56 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.543 -0.723 . . . . 0.0 110.37 172.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.2 tmm_? -60.94 -52.61 64.28 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.02 0.928 . . . . 0.0 111.925 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.2 p -64.53 -36.07 83.02 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 118.358 -0.829 . . . . 0.0 112.852 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -58.47 -45.01 89.49 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 119.558 1.072 . . . . 0.0 112.084 172.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 51.9 t -69.82 -42.81 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.082 0.856 . . . . 0.0 111.87 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 88.3 m -56.74 -42.32 79.05 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.908 1.231 . . . . 0.0 112.263 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.19 -41.31 81.61 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.922 0.889 . . . . 0.0 112.626 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 20.2 ttt -71.49 -36.78 71.23 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.897 0.879 . . . . 0.0 113.07 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -77.37 -13.78 59.86 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.075 1.35 . . . . 0.0 113.295 171.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt 55.1 46.39 24.14 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.485 1.914 . . . . 0.0 112.109 -176.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.1 mt -133.14 146.12 59.73 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.424 1.49 . . . . 0.0 112.956 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.18 162.07 43.66 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.974 3.116 . . . . 0.0 113.473 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.48 -7.68 16.81 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 123.833 3.022 . . . . 0.0 114.273 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -75.3 -24.64 57.51 Favored 'General case' 0 CA--C 1.548 0.902 0 O-C-N 120.794 -1.191 . . . . 0.0 113.139 170.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 74.7 p -123.13 0.87 9.11 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.806 1.243 . . . . 0.0 114.204 -174.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.7 m -146.93 125.34 12.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.301 1.441 . . . . 0.0 109.998 172.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -145.36 149.55 34.97 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.734 1.214 . . . . 0.0 113.218 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.571 HD11 ' HB3' ' A' ' 69' ' ' PHE . 47.3 tp -105.13 144.59 31.72 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.129 1.772 . . . . 0.0 111.229 175.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.5 p -131.71 154.6 48.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.003 1.321 . . . . 0.0 111.451 170.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -143.03 125.29 15.49 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.434 1.894 . . . . 0.0 109.479 -174.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt 53.24 31.46 11.67 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.714 1.206 . . . . 0.0 113.351 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.41 -4.58 55.12 Favored Glycine 0 CA--C 1.542 1.769 0 C-N-CA 125.529 1.538 . . . . 0.0 116.094 -175.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -94.41 153.15 18.1 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.771 1.628 . . . . 0.0 111.993 174.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.25 127.67 32.63 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 157.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.5 mt -142.59 151.28 41.36 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.43 1.492 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -154.51 -48.99 0.09 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.369 1.068 . . . . 0.0 113.693 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -83.52 39.13 0.65 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.734 1.614 . . . . 0.0 113.651 -171.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.9 m -72.53 -22.72 60.98 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.844 1.258 . . . . 0.0 113.328 -172.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 63.36 -54.09 0.2 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.71 2.804 . . . . 0.0 115.558 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 40.5 p -160.71 140.8 11.19 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 127.868 2.467 . . . . 0.0 108.853 168.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 mp -73.53 -34.71 65.35 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 119.023 0.829 . . . . 0.0 112.242 171.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.9 tm-20 -65.75 -27.94 68.67 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -173.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.4 m -67.0 -18.23 65.29 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.9 mp -107.87 -42.16 4.78 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.142 1.377 . . . . 0.0 112.155 175.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 151.63 93.86 0.1 Allowed Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.575 1.56 . . . . 0.0 111.771 177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.1 p -76.4 149.39 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.045 0.938 . . . . 0.0 110.994 173.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -141.94 178.56 7.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.477 1.111 . . . . 0.0 113.435 -172.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -97.86 137.53 36.57 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.395 1.878 . . . . 0.0 111.31 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.94 19.6 67.18 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 115.562 0.985 . . . . 0.0 115.562 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -65.09 143.57 57.81 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.581 1.191 . . . . 0.0 111.602 170.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -127.61 132.84 49.72 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -166.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.571 ' HB3' HD11 ' A' ' 45' ' ' LEU . 98.2 m-85 -121.35 141.01 51.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.061 1.744 . . . . 0.0 111.296 -175.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 51.6 t -124.14 122.48 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.979 0.911 . . . . 0.0 109.835 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -112.42 112.02 23.28 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.022 1.329 . . . . 0.0 109.062 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.9 mt -101.5 140.26 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.715 1.606 . . . . 0.0 109.921 -176.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.8 p -133.51 157.37 45.83 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.894 1.277 . . . . 0.0 112.375 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -130.31 149.64 51.9 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.017 2.127 . . . . 0.0 111.475 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.2 t -154.57 155.68 35.21 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.482 1.513 . . . . 0.0 111.088 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.5 t -141.44 140.89 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.153 1.781 . . . . 0.0 110.279 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.358 0 C-N-CA 125.439 1.495 . . . . 0.0 112.587 179.448 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 121.246 0.546 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -82.92 149.71 26.9 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.201 -0.937 . . . . 0.0 110.536 166.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.2 pt -139.85 160.41 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.554 1.942 . . . . 0.0 110.009 169.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -118.88 107.81 14.04 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.872 0.869 . . . . 0.0 111.243 172.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.9 tt -90.13 140.17 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 123.037 0.535 . . . . 0.0 110.933 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 t -125.84 88.94 53.38 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 125.148 1.379 . . . . 0.0 109.899 -175.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -82.41 124.06 4.06 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.448 2.765 . . . . 0.0 112.509 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.19 35.86 0.18 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.87 1.668 . . . . 0.0 114.039 178.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.0 m -79.42 51.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 126.793 2.037 . . . . 0.0 113.315 -171.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.96 53.01 7.39 Favored Glycine 0 CA--C 1.533 1.218 0 O-C-N 121.276 -0.89 . . . . 0.0 112.877 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.97 23.89 36.83 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.405 1.002 . . . . 0.0 114.747 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.19 138.72 45.75 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-N 118.18 0.99 . . . . 0.0 113.554 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.5 p -84.1 155.13 64.04 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 125.427 1.491 . . . . 0.0 112.969 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -62.04 145.15 96.72 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.256 2.637 . . . . 0.0 111.825 170.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.91 127.05 29.91 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.814 1.246 . . . . 0.0 111.392 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -75.53 130.74 39.34 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.724 1.209 . . . . 0.0 111.291 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.94 149.49 41.91 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.611 1.564 . . . . 0.0 111.143 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -85.48 141.8 29.66 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.089 1.356 . . . . 0.0 111.2 169.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.45 142.17 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.482 1.113 . . . . 0.0 112.897 177.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.97 150.32 61.38 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.187 1.395 . . . . 0.0 112.674 176.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.15 -23.58 60.09 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.55 2.833 . . . . 0.0 113.619 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -78.82 0.92 25.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.226 1.41 . . . . 0.0 113.872 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.11 140.23 56.06 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 119.259 0.936 . . . . 0.0 111.972 177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.2 m -119.5 131.96 55.68 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.134 1.374 . . . . 0.0 110.23 -174.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.8 m -61.55 -31.96 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -174.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.64 -37.22 92.33 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 123.776 0.703 . . . . 0.0 113.292 173.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.15 -41.9 73.25 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.214 1.007 . . . . 0.0 111.689 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.46 -45.31 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 123.549 0.739 . . . . 0.0 111.041 175.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -55.36 -49.07 73.23 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.644 1.177 . . . . 0.0 111.239 172.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 90.5 m -65.26 -40.2 93.66 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.226 0.61 . . . . 0.0 111.849 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -59.61 -46.95 87.45 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.252 1.021 . . . . 0.0 111.638 172.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 36.0 t -61.64 -46.92 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.162 0.985 . . . . 0.0 111.865 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.6 m -63.93 -38.49 91.29 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.4 0.68 . . . . 0.0 112.283 177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.26 -41.81 84.95 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.823 0.849 . . . . 0.0 112.421 174.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -66.08 -41.47 90.64 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.329 1.051 . . . . 0.0 112.832 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -85.28 -9.44 57.7 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.79 12.97 1.84 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 127.646 2.379 . . . . 0.0 115.063 -174.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.9 mp -118.66 153.61 52.29 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 126.743 2.017 . . . . 0.0 111.537 -175.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.06 163.87 37.73 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 124.245 3.297 . . . . 0.0 114.235 -173.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -64.91 -14.6 46.05 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.257 2.638 . . . . 0.0 114.026 174.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -68.58 -26.89 65.62 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.345 1.058 . . . . 0.0 113.215 171.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 34.6 p -109.01 -21.4 12.64 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.078 1.351 . . . . 0.0 113.573 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.3 m -126.54 126.03 43.01 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.145 0.978 . . . . 0.0 110.899 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 47.8 ptt85 -141.97 166.25 25.22 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.844 1.258 . . . . 0.0 113.354 -169.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.0 tp -136.93 140.33 42.19 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.869 1.668 . . . . 0.0 111.278 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.8 p -137.29 156.67 47.98 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.181 1.392 . . . . 0.0 112.767 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -152.53 131.92 12.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.441 2.297 . . . . 0.0 110.144 -174.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.35 40.01 17.52 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 125.357 1.463 . . . . 0.0 113.444 174.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.29 8.7 87.62 Favored Glycine 0 CA--C 1.54 1.621 0 C-N-CA 125.132 1.348 . . . . 0.0 116.334 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 -133.89 160.78 36.64 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.707 1.603 . . . . 0.0 112.619 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.41 155.52 29.93 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.274 0.629 . . . . 0.0 110.866 160.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.6 mt -116.86 133.58 55.83 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.55 1.14 . . . . 0.0 111.065 174.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.2 141.65 18.7 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.926 1.29 . . . . 0.0 111.403 -177.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 32.5 t0 55.09 33.58 20.71 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.776 1.63 . . . . 0.0 114.789 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.0 p -83.43 -29.48 28.06 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.565 1.146 . . . . 0.0 113.595 -171.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 61.42 -23.45 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 129.107 2.963 . . . . 0.0 116.979 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.1 p -149.09 161.58 41.68 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.796 2.039 . . . . 0.0 111.25 171.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 65.8 mt -77.01 -20.95 55.37 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.738 -0.601 . . . . 0.0 112.595 164.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -63.67 -36.24 83.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.164 0.986 . . . . 0.0 112.421 176.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.8 m -69.95 -19.2 63.38 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 174.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 97.1 mt -90.11 -24.74 21.02 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.731 1.213 . . . . 0.0 113.48 173.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.97 41.09 72.78 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 123.643 0.64 . . . . 0.0 113.158 -174.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.0 p -55.64 149.19 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.907 1.283 . . . . 0.0 112.22 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.79 151.27 30.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.211 1.004 . . . . 0.0 112.182 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -64.22 128.62 36.58 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.67 0.788 . . . . 0.0 111.195 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.78 8.65 76.09 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.013 1.292 . . . . 0.0 115.858 -176.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -62.08 152.04 33.85 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.665 1.733 . . . . 0.0 113.6 175.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -103.39 154.15 19.72 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.685 1.194 . . . . 0.0 114.179 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -135.78 143.2 45.1 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.119 2.168 . . . . 0.0 109.679 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.9 t -121.7 126.22 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.745 0.818 . . . . 0.0 110.34 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 tt -111.86 122.31 47.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.733 1.613 . . . . 0.0 109.194 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -113.92 142.74 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.722 1.609 . . . . 0.0 110.061 -175.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.7 t -136.87 150.66 48.4 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.092 1.357 . . . . 0.0 112.052 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -127.96 106.67 9.25 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.681 1.993 . . . . 0.0 110.154 -176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.9 m -78.6 76.41 5.1 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.542 1.137 . . . . 0.0 110.829 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.95 -17.9 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.252 0 C-N-CA 125.56 1.553 . . . . 0.0 113.877 179.491 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.913 0.387 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -102.71 152.23 21.46 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.739 1.215 . . . . 0.0 112.315 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -133.44 154.46 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 126.283 1.833 . . . . 0.0 109.608 173.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -98.12 146.26 25.74 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.235 0.614 . . . . 0.0 110.549 161.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.4 tt -123.5 136.74 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 124.473 1.109 . . . . 0.0 109.62 165.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -123.46 78.85 54.46 Favored Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 124.943 1.297 . . . . 0.0 109.359 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -81.56 138.02 10.57 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.882 2.388 . . . . 0.0 112.556 -176.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.29 35.7 0.18 Allowed 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 125.676 1.59 . . . . 0.0 114.394 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.7 m -143.85 160.89 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 126.517 1.927 . . . . 0.0 111.701 -174.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.45 -117.94 12.88 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 123.876 0.75 . . . . 0.0 112.144 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.79 -18.2 72.08 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 123.905 0.764 . . . . 0.0 114.745 174.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.89 11.82 58.74 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-N 118.747 1.273 . . . . 0.0 115.095 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 70.2 p -106.85 160.14 27.37 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.846 2.058 . . . . 0.0 112.765 -168.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.38 137.37 55.36 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.926 2.417 . . . . 0.0 112.076 171.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 mp -124.1 137.09 54.61 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.319 1.448 . . . . 0.0 110.427 167.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -99.82 135.08 41.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.626 1.17 . . . . 0.0 111.844 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.7 mt -142.23 147.61 36.79 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.039 1.736 . . . . 0.0 111.778 -173.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -81.05 144.06 32.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.284 1.034 . . . . 0.0 110.834 166.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.1 p -144.71 145.24 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.777 0.831 . . . . 0.0 112.514 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.05 148.09 91.45 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.537 1.135 . . . . 0.0 112.6 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.84 -23.1 41.81 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.202 2.601 . . . . 0.0 113.182 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -81.91 5.79 17.9 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.443 1.497 . . . . 0.0 113.858 177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.77 140.47 51.5 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.211 -0.931 . . . . 0.0 112.149 177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.6 p -120.05 149.6 41.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.307 1.043 . . . . 0.0 112.109 -175.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.8 m -60.79 -36.06 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.853 0.861 . . . . 0.0 112.519 175.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -65.83 -44.49 91.96 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 123.893 0.759 . . . . 0.0 112.357 177.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.75 -47.72 79.89 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 117.767 0.783 . . . . 0.0 112.06 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.4 t -63.14 -48.11 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.466 0.575 . . . . 0.0 111.316 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -59.71 -48.11 82.98 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.71 0.804 . . . . 0.0 111.66 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 87.5 m -68.62 -36.48 78.7 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.761 -0.587 . . . . 0.0 111.851 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -66.98 -38.78 86.67 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.862 0.865 . . . . 0.0 112.337 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.0 t -56.29 -51.8 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.725 0.81 . . . . 0.0 110.956 167.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.2 m -62.41 -37.18 84.8 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.19 -44.38 84.14 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.024 0.929 . . . . 0.0 112.565 174.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 96.4 mtp -68.63 -39.39 80.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.807 0.843 . . . . 0.0 113.11 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -80.67 -12.56 59.47 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 175.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 58.59 17.43 5.0 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 127.165 2.186 . . . . 0.0 114.162 -173.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 mp -130.04 152.02 79.3 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 127.156 2.183 . . . . 0.0 110.702 -171.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.21 164.74 32.84 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 124.111 3.207 . . . . 0.0 114.115 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.59 -12.28 34.28 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.334 2.689 . . . . 0.0 114.014 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -66.03 -36.84 84.32 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.976 -1.078 . . . . 0.0 112.059 170.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.5 p -90.66 -19.66 23.38 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 89.5 m -136.44 124.83 23.36 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.533 1.515 . . . . 0.0 111.732 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -125.86 157.73 36.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.861 1.665 . . . . 0.0 112.221 -173.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.0 tp -125.98 136.49 53.06 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.445 1.898 . . . . 0.0 111.308 -173.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.0 p -134.37 153.22 52.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.405 1.082 . . . . 0.0 112.543 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -152.26 136.13 16.34 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.186 1.795 . . . . 0.0 110.059 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 ttpt 51.54 33.61 10.86 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.756 1.622 . . . . 0.0 114.362 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.32 19.36 77.47 Favored Glycine 0 CA--C 1.538 1.47 0 C-N-CA 124.125 0.869 . . . . 0.0 115.091 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -129.02 160.96 31.11 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 127.048 2.139 . . . . 0.0 111.24 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -88.58 131.97 34.73 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.696 0.798 . . . . 0.0 110.113 160.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.5 tp -96.94 112.63 24.3 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.148 0.979 . . . . 0.0 110.464 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -154.04 151.14 28.99 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.996 1.318 . . . . 0.0 112.33 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.6 t0 56.18 29.58 14.98 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.928 2.091 . . . . 0.0 115.037 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.0 p -88.36 -20.11 25.75 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 58.09 -64.79 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.87 2.068 . . . . 0.0 114.266 -163.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.7 p -144.01 150.03 37.61 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.16 1.384 . . . . 0.0 111.989 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.51 -30.8 71.61 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.686 0.794 . . . . 0.0 112.631 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.68 -22.51 65.28 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 121.231 -0.918 . . . . 0.0 113.26 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.7 p -69.44 -26.53 64.65 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 172.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 56.6 mt -98.02 -6.35 32.09 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.117 1.767 . . . . 0.0 113.16 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.33 115.39 1.46 Allowed Glycine 0 CA--C 1.536 1.347 0 C-N-CA 126.206 1.86 . . . . 0.0 112.385 -171.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.6 m -74.43 154.45 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.75 1.22 . . . . 0.0 112.684 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -147.81 160.06 43.16 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.317 1.847 . . . . 0.0 110.319 170.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -93.09 147.49 22.82 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.821 0.848 . . . . 0.0 112.485 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.82 30.78 59.07 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 115.068 0.787 . . . . 0.0 115.068 175.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.29 148.34 51.86 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.631 1.215 . . . . 0.0 111.891 173.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -120.74 111.75 17.99 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.367 1.067 . . . . 0.0 111.563 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -94.04 144.23 25.66 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.126 1.37 . . . . 0.0 111.222 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.9 t -124.08 128.34 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.484 1.114 . . . . 0.0 109.664 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.3 tp -115.16 123.21 48.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.026 0.93 . . . . 0.0 110.967 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.4 123.56 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.408 1.483 . . . . 0.0 109.708 -171.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.2 t -111.57 141.19 45.48 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.257 1.023 . . . . 0.0 111.76 176.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.4 mmp_? -81.77 122.64 27.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.557 1.543 . . . . 0.0 110.475 175.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.3 m -65.23 142.85 58.16 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.638 0.775 . . . . 0.0 110.28 169.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.8 p -137.03 139.99 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.632 1.173 . . . . 0.0 111.416 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.19 0 C-N-CA 125.302 1.43 . . . . 0.0 112.496 -176.282 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 mmt . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.668 0.271 . . . . 0.0 111.452 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.88 148.92 27.04 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.651 -1.28 . . . . 0.0 112.298 -179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.22 155.97 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 125.883 1.673 . . . . 0.0 110.434 172.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -111.19 119.36 38.7 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.414 1.086 . . . . 0.0 111.083 169.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 tp -86.98 137.82 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 165.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 t -128.81 77.99 76.82 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 124.718 1.207 . . . . 0.0 109.789 -178.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.09 136.74 10.43 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.317 2.678 . . . . 0.0 112.114 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.46 36.49 0.16 Allowed 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 125.679 1.592 . . . . 0.0 113.463 173.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.6 t -138.32 147.56 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 126.106 1.762 . . . . 0.0 110.641 -170.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.11 -117.71 10.81 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 123.969 0.795 . . . . 0.0 111.967 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.53 -19.58 71.02 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 123.85 0.738 . . . . 0.0 114.519 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.51 3.66 41.38 Favored Glycine 0 CA--C 1.54 1.622 0 C-N-CA 124.87 1.224 . . . . 0.0 115.667 177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 61.0 p -91.31 157.22 42.85 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 126.583 1.953 . . . . 0.0 113.203 -171.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -64.23 145.36 88.7 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.992 2.461 . . . . 0.0 111.784 168.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 tt -137.07 122.48 19.5 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.95 1.3 . . . . 0.0 110.313 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -90.52 137.81 32.06 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.226 1.01 . . . . 0.0 113.017 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.0 mt -144.72 148.17 33.86 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.984 1.714 . . . . 0.0 111.826 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -80.65 138.2 36.39 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.641 1.176 . . . . 0.0 110.382 166.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.4 m -140.0 153.33 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.458 1.103 . . . . 0.0 112.33 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.85 150.49 96.47 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.04 0.936 . . . . 0.0 112.197 175.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.64 -21.01 52.68 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.082 2.521 . . . . 0.0 112.957 174.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.88 15.68 2.15 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.853 1.661 . . . . 0.0 114.015 176.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.18 142.49 54.29 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.163 -0.961 . . . . 0.0 112.128 174.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.3 m -133.56 138.58 46.11 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.241 1.416 . . . . 0.0 111.046 -171.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.9 t -57.49 -47.76 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.339 1.055 . . . . 0.0 112.587 -173.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.6 -38.33 96.22 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.674 -0.515 . . . . 0.0 112.968 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.18 -46.07 78.64 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 117.986 0.893 . . . . 0.0 111.814 175.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -60.8 -49.14 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 123.805 0.842 . . . . 0.0 110.971 176.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.7 ttt85 -62.42 -46.37 88.88 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.264 0.626 . . . . 0.0 111.777 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.6 m -59.62 -43.92 93.63 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.475 0.71 . . . . 0.0 111.51 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -66.32 -37.7 85.98 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.576 0.751 . . . . 0.0 112.469 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 78.5 t -66.02 -46.59 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.502 0.592 . . . . 0.0 111.794 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 96.2 m -58.6 -40.44 83.26 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.501 1.046 . . . . 0.0 112.144 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.72 -41.51 87.8 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.893 0.877 . . . . 0.0 112.715 174.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.6 tpt -68.28 -41.25 81.27 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.515 1.126 . . . . 0.0 112.767 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.444 ' HA ' ' HE3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -74.77 -24.62 58.71 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.511 1.524 . . . . 0.0 113.137 172.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.79 30.25 19.55 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.805 2.042 . . . . 0.0 113.221 -171.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.1 mp -120.32 153.83 56.06 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 126.948 2.099 . . . . 0.0 111.454 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.74 162.54 38.98 Favored 'Trans proline' 0 CA--C 1.546 1.116 0 C-N-CA 123.899 3.066 . . . . 0.0 113.496 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -67.58 -16.22 46.53 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.537 2.825 . . . . 0.0 114.819 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -79.79 -29.6 40.4 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 119.675 1.125 . . . . 0.0 113.613 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.7 p -86.64 9.55 18.31 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.702 1.201 . . . . 0.0 113.69 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 t -135.85 144.81 45.84 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.36 1.464 . . . . 0.0 110.897 176.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -133.52 148.01 51.63 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.505 1.922 . . . . 0.0 110.4 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.3 tp -139.67 121.24 15.19 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.34 1.456 . . . . 0.0 110.563 -169.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.7 m -132.71 141.11 48.42 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.596 1.158 . . . . 0.0 112.342 -169.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -143.75 131.94 21.89 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.779 2.032 . . . . 0.0 110.608 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt 50.14 37.64 15.07 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.008 1.323 . . . . 0.0 113.82 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.18 17.35 79.57 Favored Glycine 0 CA--C 1.541 1.683 0 C-N-CA 124.718 1.151 . . . . 0.0 115.788 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -136.7 154.13 50.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.675 1.99 . . . . 0.0 112.881 -175.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.41 129.27 34.57 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.82 0.848 . . . . 0.0 110.521 165.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.1 130.72 34.84 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.989 0.916 . . . . 0.0 110.223 169.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -162.23 141.94 9.72 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.513 1.525 . . . . 0.0 111.637 176.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 t0 56.55 25.34 9.71 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 115.48 1.659 . . . . 0.0 115.48 172.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.1 p -82.96 -16.03 48.94 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 120.839 -1.163 . . . . 0.0 113.234 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 62.67 -56.1 0.15 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 128.775 2.83 . . . . 0.0 115.02 -171.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 21.5 p -148.93 148.21 29.55 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.344 1.858 . . . . 0.0 111.593 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.69 -25.46 68.22 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.689 0.796 . . . . 0.0 112.991 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -62.01 -27.36 68.82 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.065 -1.022 . . . . 0.0 113.084 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 35.5 m -69.11 -23.93 64.05 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.114 0.966 . . . . 0.0 113.162 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 27.6 mt -93.45 -22.87 18.63 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.238 1.415 . . . . 0.0 112.724 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.53 114.03 3.01 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 126.47 1.986 . . . . 0.0 111.344 -167.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.2 t -72.74 143.18 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.717 1.207 . . . . 0.0 111.314 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -138.55 146.14 41.52 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.549 1.54 . . . . 0.0 110.38 168.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -78.38 147.38 34.14 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.289 -0.882 . . . . 0.0 112.411 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.7 21.81 78.07 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 115.044 0.778 . . . . 0.0 115.044 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -56.98 140.0 50.26 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 118.728 1.264 . . . . 0.0 111.309 170.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -121.44 137.04 54.89 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.856 0.862 . . . . 0.0 112.138 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -119.0 121.87 40.88 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.463 1.505 . . . . 0.0 109.731 -176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.5 t -91.81 130.59 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 123.326 0.65 . . . . 0.0 109.428 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 tp -120.31 123.45 43.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.151 0.98 . . . . 0.0 110.892 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -113.28 129.18 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.411 1.485 . . . . 0.0 110.014 -172.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.6 t -94.37 145.88 24.45 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.497 1.119 . . . . 0.0 111.787 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.55 130.47 34.74 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.633 1.173 . . . . 0.0 110.615 171.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -129.61 -51.11 1.16 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.883 0.873 . . . . 0.0 112.737 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.2 t -73.82 129.98 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.771 0.828 . . . . 0.0 110.131 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.247 0 C-N-CA 126.033 1.778 . . . . 0.0 112.374 -177.559 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.979 0.419 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -121.52 147.45 45.77 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.737 1.215 . . . . 0.0 112.544 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.12 166.44 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.542 1.937 . . . . 0.0 110.265 172.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -128.38 100.78 5.93 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.894 0.878 . . . . 0.0 111.287 -178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.5 tt -86.55 141.8 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 123.77 0.828 . . . . 0.0 111.209 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.6 t -128.84 80.89 71.9 Favored Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 125.491 1.517 . . . . 0.0 109.483 -176.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -73.5 142.7 33.37 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.952 2.434 . . . . 0.0 111.94 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.62 23.29 0.23 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.399 1.48 . . . . 0.0 113.908 174.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.9 p -155.8 160.55 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 127.246 2.218 . . . . 0.0 109.889 -172.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.43 34.81 53.62 Favored Glycine 0 CA--C 1.535 1.292 0 O-C-N 121.389 -0.819 . . . . 0.0 113.998 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 97.33 -9.17 64.89 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.575 1.559 . . . . 0.0 114.887 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.7 -0.44 43.75 Favored Glycine 0 CA--C 1.54 1.598 0 N-CA-C 116.555 1.382 . . . . 0.0 116.555 170.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.4 m -80.38 152.34 73.1 Favored Pre-proline 0 N--CA 1.472 0.629 0 C-N-CA 124.676 1.19 . . . . 0.0 113.053 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -64.43 145.34 87.76 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.067 2.511 . . . . 0.0 111.845 170.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.7 mt -131.68 121.86 24.98 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.503 1.521 . . . . 0.0 110.58 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -88.89 132.77 34.54 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.553 1.141 . . . . 0.0 111.284 178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 mt -149.81 143.49 25.39 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.347 1.059 . . . . 0.0 111.624 -173.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -69.82 150.97 46.28 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.351 0.66 . . . . 0.0 111.98 168.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.3 p -146.37 140.15 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.349 1.06 . . . . 0.0 111.538 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.56 145.27 78.73 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.021 0.928 . . . . 0.0 111.956 177.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.2 -20.88 49.11 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.833 2.355 . . . . 0.0 113.198 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -75.72 -7.18 53.73 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.2 157.76 30.55 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 119.162 0.892 . . . . 0.0 112.847 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.85 145.9 51.82 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.95 1.3 . . . . 0.0 110.885 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.1 t -66.37 -34.05 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 O-C-N 121.373 -0.829 . . . . 0.0 111.295 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.25 -43.7 99.05 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.439 1.018 . . . . 0.0 113.054 173.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -64.87 -45.47 85.88 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.98 0.89 . . . . 0.0 111.717 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.3 t -60.92 -49.3 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.012 0.925 . . . . 0.0 111.99 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.9 ptt85 -64.08 -39.52 94.24 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.123 0.874 . . . . 0.0 112.07 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 93.7 m -62.69 -41.22 98.99 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.596 0.758 . . . . 0.0 111.376 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -60.63 -42.57 97.17 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.708 0.803 . . . . 0.0 112.191 178.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 70.2 t -74.67 -35.74 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.541 0.736 . . . . 0.0 112.559 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 87.1 m -60.25 -45.51 93.01 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.589 -0.694 . . . . 0.0 111.465 170.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.46 -41.1 89.56 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.984 0.914 . . . . 0.0 112.829 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 57.7 ttm -61.69 -43.84 98.09 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.396 1.078 . . . . 0.0 112.849 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -85.94 -6.38 59.07 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 175.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.4 tptm 53.54 53.67 11.21 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 127.059 2.144 . . . . 0.0 112.451 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.7 mt -133.16 148.38 68.98 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.612 1.565 . . . . 0.0 112.164 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -69.49 160.42 49.83 Favored 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 123.563 2.842 . . . . 0.0 112.444 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.07 -26.01 73.43 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.741 2.294 . . . . 0.0 113.13 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -70.09 -3.19 15.41 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.492 -1.38 . . . . 0.0 114.604 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 82.8 p -127.7 14.67 6.99 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.368 1.467 . . . . 0.0 113.075 165.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 m -154.53 110.69 3.23 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.031 1.733 . . . . 0.0 110.868 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.2 mtt-85 -132.15 155.22 48.56 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.557 1.143 . . . . 0.0 112.886 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.0 tp -127.37 131.53 50.33 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.255 1.822 . . . . 0.0 110.596 -174.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.8 p -136.84 152.16 49.95 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.415 1.086 . . . . 0.0 113.371 -175.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -142.26 134.5 27.65 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.575 1.95 . . . . 0.0 110.382 177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 tptm 51.68 33.31 10.68 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.465 1.506 . . . . 0.0 114.191 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.75 10.09 84.67 Favored Glycine 0 CA--C 1.539 1.557 0 C-N-CA 125.285 1.422 . . . . 0.0 115.931 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 96.3 mtt-85 -127.34 149.94 49.82 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.792 1.637 . . . . 0.0 112.678 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.12 88.51 6.55 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.735 1.214 . . . . 0.0 110.844 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.2 mp -65.39 147.55 53.23 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.916 0.886 . . . . 0.0 111.68 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -158.07 -51.05 0.07 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.888 1.275 . . . . 0.0 113.437 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -84.53 40.25 0.78 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.492 1.517 . . . . 0.0 113.295 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.0 m -73.82 -27.26 61.02 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.41 1.084 . . . . 0.0 112.808 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 62.0 -61.92 0.1 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 128.035 2.534 . . . . 0.0 114.776 -174.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 48.4 p -147.29 150.57 35.05 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.217 1.407 . . . . 0.0 111.319 170.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.07 -20.61 62.34 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.122 0.569 . . . . 0.0 112.471 167.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.09 -54.35 39.39 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.575 1.55 . . . . 0.0 112.346 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.3 m -69.27 -28.47 66.34 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 47.9 tp -74.68 -27.84 60.58 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.989 0.916 . . . . 0.0 112.788 173.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.61 54.24 6.12 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.383 0.992 . . . . 0.0 113.042 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.6 p -56.62 151.88 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.633 1.173 . . . . 0.0 112.905 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -131.83 161.07 33.83 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.01 1.324 . . . . 0.0 112.945 -178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -60.95 129.81 43.28 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.099 1.36 . . . . 0.0 112.29 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.46 4.97 59.27 Favored Glycine 0 CA--C 1.535 1.281 0 N-CA-C 115.99 1.156 . . . . 0.0 115.99 171.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -64.68 138.02 58.15 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 119.179 1.49 . . . . 0.0 110.649 168.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -132.98 134.46 44.51 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -167.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -124.32 136.55 54.19 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.698 1.199 . . . . 0.0 111.484 -167.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.8 t -100.73 132.29 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.725 0.81 . . . . 0.0 109.864 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 tt -120.43 103.44 9.19 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.845 0.858 . . . . 0.0 110.299 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -86.71 141.41 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 126.25 1.82 . . . . 0.0 109.867 -176.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.8 t -146.67 156.55 43.27 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.16 0.984 . . . . 0.0 111.899 176.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -140.25 143.88 36.2 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.024 1.33 . . . . 0.0 112.573 -171.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.2 p -141.37 163.02 34.08 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.361 1.864 . . . . 0.0 111.782 -174.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 35.2 m -67.07 154.86 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.314 1.046 . . . . 0.0 112.961 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.266 0 C-N-CA 125.166 1.365 . . . . 0.0 113.571 175.603 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.3 mtmm -101.82 140.06 36.62 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 120.0 -1.688 . . . . 0.0 112.458 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.3 pp -135.83 171.1 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 127.297 2.239 . . . . 0.0 110.399 -178.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.6 mtpt -127.2 149.95 49.75 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.809 1.244 . . . . 0.0 110.962 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.1 tt -129.38 142.47 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.119 0.968 . . . . 0.0 110.777 172.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 t -129.83 77.85 76.12 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 125.292 1.437 . . . . 0.0 109.779 -173.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.84 133.91 15.87 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.163 2.575 . . . . 0.0 111.497 177.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.7 41.47 0.27 Allowed 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 125.253 1.421 . . . . 0.0 113.314 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 37.4 t -139.22 147.28 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 126.031 1.732 . . . . 0.0 110.718 -170.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.13 -119.92 16.37 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 123.898 0.761 . . . . 0.0 111.947 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.34 -18.41 71.43 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 123.684 0.659 . . . . 0.0 114.678 174.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.84 3.19 41.68 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 124.966 1.27 . . . . 0.0 115.748 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.5 p -82.33 155.72 69.14 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.996 1.718 . . . . 0.0 113.363 -174.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -67.34 152.18 79.49 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.302 2.668 . . . . 0.0 112.097 169.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.1 tp -141.31 125.3 17.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.797 1.239 . . . . 0.0 111.759 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -71.08 142.01 50.84 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.21 1.404 . . . . 0.0 112.327 170.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.75 151.78 37.73 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.382 1.473 . . . . 0.0 110.351 174.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -111.68 128.68 56.15 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.776 1.23 . . . . 0.0 110.465 175.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.5 m -140.53 155.1 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.206 1.402 . . . . 0.0 112.483 -165.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.98 150.29 97.64 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 123.82 0.848 . . . . 0.0 111.788 171.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -65.2 -25.34 57.76 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.966 2.444 . . . . 0.0 112.971 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -76.34 12.57 1.17 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.908 1.683 . . . . 0.0 114.728 176.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.55 105.12 0.73 Allowed 'General case' 0 CA--C 1.549 0.911 0 O-C-N 120.916 -1.115 . . . . 0.0 111.917 178.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.0 m -75.61 130.1 38.24 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.476 1.11 . . . . 0.0 111.15 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.9 t -60.93 -35.2 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.994 0.918 . . . . 0.0 112.925 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.59 -40.0 97.23 Favored Glycine 0 CA--C 1.535 1.317 0 O-C-N 121.319 -0.863 . . . . 0.0 113.223 172.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.66 -34.76 77.57 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 117.975 0.887 . . . . 0.0 112.324 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.2 t -60.48 -44.39 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 O-C-N 121.505 -0.747 . . . . 0.0 110.814 172.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -61.42 -54.21 46.47 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.323 173.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 66.4 p -63.17 -34.44 77.63 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.41 1.005 . . . . 0.0 112.853 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -61.06 -47.5 86.09 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.739 0.816 . . . . 0.0 111.751 173.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 91.0 t -66.6 -41.87 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.805 176.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 92.4 m -57.84 -41.87 83.21 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 119.46 1.027 . . . . 0.0 112.087 174.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.51 -41.5 88.77 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.696 0.798 . . . . 0.0 112.849 175.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.5 mtt -67.29 -39.49 86.01 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.04 0.936 . . . . 0.0 113.106 177.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.464 ' HA ' ' HE3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -79.14 -23.22 44.13 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.879 1.272 . . . . 0.0 113.647 176.635 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt 58.78 31.3 21.07 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.419 1.888 . . . . 0.0 113.189 -167.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 mp -114.24 150.58 43.92 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 126.249 1.82 . . . . 0.0 111.035 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -69.54 161.84 44.32 Favored 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.702 2.935 . . . . 0.0 112.726 176.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -65.18 -20.18 62.77 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.22 2.613 . . . . 0.0 113.674 176.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -67.65 -31.56 71.64 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.149 -0.969 . . . . 0.0 113.309 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 47.8 p -94.41 20.17 8.65 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.382 1.473 . . . . 0.0 113.704 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 t -145.68 152.55 39.8 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.334 1.054 . . . . 0.0 112.373 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 88.0 mmt-85 -139.36 145.55 39.15 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.924 1.69 . . . . 0.0 111.283 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.8 tp -134.71 127.9 31.91 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 126.441 1.896 . . . . 0.0 109.834 -174.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.6 p -140.67 155.48 46.48 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.418 1.087 . . . . 0.0 112.772 -178.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -146.41 140.49 26.35 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.101 1.76 . . . . 0.0 110.013 174.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.1 tptt 50.95 34.8 11.17 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.644 1.578 . . . . 0.0 114.035 -177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.87 14.94 81.17 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.757 1.17 . . . . 0.0 115.292 -177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -130.71 145.45 51.94 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.129 1.772 . . . . 0.0 111.739 -173.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.84 119.4 23.86 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.739 0.815 . . . . 0.0 110.655 171.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.1 mp -93.37 135.42 34.62 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.25 1.02 . . . . 0.0 110.212 175.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -160.64 149.7 16.97 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.227 1.811 . . . . 0.0 110.127 175.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 56.18 27.43 11.61 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.601 1.561 . . . . 0.0 114.823 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -73.23 -26.09 60.99 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.52 1.128 . . . . 0.0 113.638 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 61.04 -43.85 0.12 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.73 2.812 . . . . 0.0 115.079 -167.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.8 t -155.05 145.43 22.05 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.121 1.768 . . . . 0.0 110.62 174.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.72 -18.85 65.39 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.671 -0.643 . . . . 0.0 111.938 172.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -64.66 -24.11 67.47 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.033 -1.042 . . . . 0.0 112.772 173.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.7 t -68.25 -36.89 80.15 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.808 0.843 . . . . 0.0 112.283 172.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.4 mt -85.66 -20.67 29.08 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.972 1.309 . . . . 0.0 113.323 175.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 99.64 115.77 3.75 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 126.757 2.123 . . . . 0.0 111.856 -172.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.6 m -77.7 151.86 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.851 1.261 . . . . 0.0 113.364 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.89 163.61 39.77 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.407 1.883 . . . . 0.0 110.755 169.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -90.89 150.23 21.6 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.166 0.987 . . . . 0.0 112.806 172.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.43 11.67 81.67 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.739 1.161 . . . . 0.0 114.804 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -62.19 120.95 11.91 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.531 1.165 . . . . 0.0 110.745 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -106.15 114.87 29.26 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.045 0.938 . . . . 0.0 112.075 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -93.61 125.8 38.42 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.575 1.55 . . . . 0.0 110.545 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.0 t -96.39 133.26 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.724 0.81 . . . . 0.0 109.433 174.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.5 tt -130.37 123.49 30.03 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.851 0.86 . . . . 0.0 111.232 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.4 mm -117.07 122.01 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.112 1.365 . . . . 0.0 110.163 -171.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -81.66 143.35 31.97 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.328 0.651 . . . . 0.0 110.949 167.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -78.12 152.23 32.93 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.753 0.821 . . . . 0.0 110.335 167.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 76.3 p -119.64 165.99 13.76 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.396 1.478 . . . . 0.0 111.501 175.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.4 p -137.14 142.59 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.077 1.351 . . . . 0.0 111.482 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.256 0 C-N-CA 125.565 1.555 . . . . 0.0 112.464 -178.369 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.5 mtt . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -79.76 149.28 31.17 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.16 -0.962 . . . . 0.0 111.559 166.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.2 mp -130.97 140.26 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 126.918 2.087 . . . . 0.0 109.08 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -100.24 110.41 22.66 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.856 1.262 . . . . 0.0 110.951 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.3 tt -90.56 138.47 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.766 -0.584 . . . . 0.0 110.354 171.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.7 t -127.37 81.89 69.24 Favored Pre-proline 0 N--CA 1.472 0.654 0 C-N-CA 125.134 1.373 . . . . 0.0 109.65 -175.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -84.06 135.55 6.52 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.892 2.395 . . . . 0.0 113.02 -177.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.1 37.23 0.25 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.771 1.628 . . . . 0.0 114.109 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.84 157.16 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 125.681 1.593 . . . . 0.0 111.148 -175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.58 -115.48 7.38 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.207 0.908 . . . . 0.0 111.863 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.35 -21.93 70.75 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 123.736 0.684 . . . . 0.0 114.376 174.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.33 23.7 70.22 Favored Glycine 0 CA--C 1.537 1.45 0 CA-C-N 118.539 1.169 . . . . 0.0 114.576 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.9 p -133.14 155.88 80.54 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 125.822 1.649 . . . . 0.0 112.964 -163.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -65.1 138.16 55.39 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.991 2.46 . . . . 0.0 112.564 178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 98.2 mt -131.36 122.8 26.97 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.734 1.614 . . . . 0.0 110.205 175.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -79.71 141.39 36.43 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.709 0.804 . . . . 0.0 111.894 173.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 tp -150.25 144.69 25.75 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.954 1.301 . . . . 0.0 111.229 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -86.05 136.54 33.19 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.98 0.912 . . . . 0.0 111.017 170.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.7 t -142.98 142.53 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.426 1.09 . . . . 0.0 111.019 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.49 152.14 96.5 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.689 1.196 . . . . 0.0 113.192 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -67.07 -20.23 50.58 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.379 2.719 . . . . 0.0 113.492 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -72.02 6.0 2.38 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.87 1.668 . . . . 0.0 114.354 172.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -56.3 131.05 47.04 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.572 1.078 . . . . 0.0 112.496 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.0 m -116.47 133.25 56.23 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.469 1.508 . . . . 0.0 109.798 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.0 t -59.67 -41.0 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.304 0.642 . . . . 0.0 112.155 -175.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.71 -36.54 91.91 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 119.522 -0.599 . . . . 0.0 113.413 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.9 -44.22 73.63 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.381 1.091 . . . . 0.0 111.945 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.3 t -61.66 -47.01 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.591 0.756 . . . . 0.0 111.169 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.4 tmm_? -61.63 -43.55 98.64 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.457 1.103 . . . . 0.0 111.944 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 88.3 m -62.52 -42.6 99.62 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 118.655 0.662 . . . . 0.0 111.696 175.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.67 -43.78 98.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.004 0.921 . . . . 0.0 111.489 176.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.79 -52.86 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.236 1.015 . . . . 0.0 111.504 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 85.1 m -61.06 -35.88 78.11 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.778 0.717 . . . . 0.0 112.599 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.82 -44.25 81.68 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.824 0.849 . . . . 0.0 112.911 173.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 71.7 mtm -68.97 -39.06 79.68 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.527 -0.733 . . . . 0.0 112.928 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -15.63 58.87 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.82 1.248 . . . . 0.0 113.426 176.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? 57.18 32.53 21.87 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 126.597 1.959 . . . . 0.0 112.447 -175.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 32.0 mt -148.42 152.06 37.84 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 126.268 1.827 . . . . 0.0 112.311 -165.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.58 164.03 35.96 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 124.395 3.397 . . . . 0.0 114.44 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.95 -5.21 15.12 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.651 2.901 . . . . 0.0 114.476 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -75.05 -32.39 61.53 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 120.796 -1.19 . . . . 0.0 113.287 168.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 41.7 p -95.15 -20.35 19.33 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.1 m -135.16 130.4 35.33 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.308 1.043 . . . . 0.0 111.055 177.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.9 mmt85 -132.02 159.33 39.09 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.816 1.647 . . . . 0.0 112.598 -173.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.8 tp -127.61 137.0 52.43 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.184 1.794 . . . . 0.0 110.752 -176.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.5 p -132.64 151.45 51.95 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.028 0.931 . . . . 0.0 111.993 172.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -138.3 128.98 26.55 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.005 1.722 . . . . 0.0 109.984 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt 50.28 37.05 14.1 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.114 1.366 . . . . 0.0 114.076 172.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.22 11.49 80.71 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.447 1.499 . . . . 0.0 116.248 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -137.34 155.02 49.91 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.222 1.511 . . . . 0.0 113.59 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.14 99.52 11.57 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.57 1.148 . . . . 0.0 110.249 170.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -66.58 141.28 57.89 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.187 0.995 . . . . 0.0 110.994 176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -166.6 154.48 9.91 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.649 1.58 . . . . 0.0 111.954 173.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.9 t0 57.41 28.72 15.82 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.973 1.709 . . . . 0.0 115.468 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.6 p -84.45 -24.73 29.38 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -174.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 59.49 -46.52 0.08 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 128.287 2.635 . . . . 0.0 115.803 -167.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 2.8 t -151.67 142.71 23.12 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.312 1.445 . . . . 0.0 111.229 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.4 tp -70.04 -22.86 63.04 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.699 0.799 . . . . 0.0 112.645 174.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -67.83 -33.6 75.08 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.085 -1.009 . . . . 0.0 113.168 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.4 t -64.81 -33.89 77.05 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.469 0.708 . . . . 0.0 112.32 174.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 87.0 mt -84.98 -3.98 58.97 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.548 1.539 . . . . 0.0 113.504 173.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.74 113.76 0.49 Allowed Glycine 0 CA--C 1.536 1.397 0 C-N-CA 126.026 1.774 . . . . 0.0 112.825 -170.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 m -70.79 157.56 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.206 1.002 . . . . 0.0 112.196 171.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -138.12 -169.07 2.49 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.084 1.754 . . . . 0.0 110.874 174.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -138.07 150.59 47.04 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.274 1.029 . . . . 0.0 112.58 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.82 21.75 75.22 Favored Glycine 0 CA--C 1.54 1.595 0 C-N-CA 123.32 0.486 . . . . 0.0 113.9 -173.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -60.86 153.34 24.93 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.835 1.254 . . . . 0.0 112.858 176.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -134.41 136.69 43.47 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.094 0.958 . . . . 0.0 113.028 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -125.69 136.13 52.87 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.189 1.795 . . . . 0.0 109.411 -174.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.8 t -117.38 124.21 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.571 0.749 . . . . 0.0 110.079 -175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tp -104.39 125.99 51.09 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.692 0.797 . . . . 0.0 110.332 176.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.5 pt -116.5 146.27 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.348 1.459 . . . . 0.0 110.336 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 14.8 t -139.43 146.89 40.67 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.037 0.935 . . . . 0.0 111.548 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 55.6 ttt-85 -133.12 126.77 32.46 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.331 1.852 . . . . 0.0 110.475 -169.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 74.9 p -73.68 153.55 40.05 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.209 0.604 . . . . 0.0 111.659 173.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.7 t -88.07 99.08 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.651 0.781 . . . . 0.0 109.106 174.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.265 0 C-N-CA 126.083 1.802 . . . . 0.0 113.093 -178.003 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.477 ' HB2' ' OD1' ' A' ' 65' ' ' ASP . 15.8 mmt . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.1 mtmm -86.33 143.23 27.97 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.915 0.886 . . . . 0.0 110.283 162.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.3 157.54 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 126.009 1.723 . . . . 0.0 109.687 172.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -122.45 102.07 7.87 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.085 0.954 . . . . 0.0 110.88 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 15.9 tt -87.26 141.66 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 122.791 0.436 . . . . 0.0 110.71 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.3 t -130.73 81.78 66.47 Favored Pre-proline 0 N--CA 1.47 0.56 0 C-N-CA 125.276 1.43 . . . . 0.0 109.48 -175.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.41 134.22 12.43 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.685 2.257 . . . . 0.0 112.046 178.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.18 40.65 0.21 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 125.024 1.33 . . . . 0.0 113.515 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.2 t -137.97 147.11 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 126.044 1.738 . . . . 0.0 110.814 -170.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.13 -121.55 21.55 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.845 0.736 . . . . 0.0 111.961 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.05 -17.31 71.67 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.671 0.653 . . . . 0.0 114.59 173.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.36 3.34 61.56 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.778 1.18 . . . . 0.0 115.402 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.1 m -72.65 152.13 91.47 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.103 1.361 . . . . 0.0 113.717 -172.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -64.97 152.64 81.67 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.706 2.271 . . . . 0.0 111.81 164.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.3 tp -142.64 124.52 15.16 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.785 1.234 . . . . 0.0 111.323 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -82.77 135.11 35.08 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.951 0.901 . . . . 0.0 111.899 175.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.3 mt -142.7 141.25 31.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.14 1.776 . . . . 0.0 110.761 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -76.78 144.61 39.07 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.626 0.77 . . . . 0.0 111.832 166.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.9 m -142.11 153.79 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.854 1.262 . . . . 0.0 111.452 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.76 150.7 88.69 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.218 0.607 . . . . 0.0 111.692 169.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -65.29 -20.92 62.14 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.781 2.321 . . . . 0.0 112.889 173.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -80.22 7.53 9.21 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.026 1.73 . . . . 0.0 114.185 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.18 117.53 4.5 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.691 1.197 . . . . 0.0 112.963 -174.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.9 m -91.34 141.27 28.94 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.36 1.464 . . . . 0.0 111.684 -176.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.48 -44.22 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 121.556 -0.715 . . . . 0.0 111.986 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.2 -36.83 93.0 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 123.513 0.577 . . . . 0.0 113.681 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.82 -43.67 83.19 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.167 0.983 . . . . 0.0 111.797 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 82.3 t -63.7 -44.81 98.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.854 0.862 . . . . 0.0 111.252 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -64.02 -38.02 89.57 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.286 1.035 . . . . 0.0 111.966 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.0 m -66.34 -44.95 81.85 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.19 0.996 . . . . 0.0 111.423 174.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.0 mmmt -58.17 -45.04 88.2 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.0 0.92 . . . . 0.0 112.139 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.8 t -59.67 -53.24 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.086 0.955 . . . . 0.0 111.112 173.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.3 t -61.08 -41.52 96.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.357 0.663 . . . . 0.0 112.535 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.9 73.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.065 0.946 . . . . 0.0 112.79 176.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.9 ttp -73.42 -22.57 60.19 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -178.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.6 mmpm? -93.23 -15.39 25.94 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.959 1.304 . . . . 0.0 113.688 170.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt 55.71 24.85 7.6 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 127.933 2.493 . . . . 0.0 114.613 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.86 153.97 61.65 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.857 1.663 . . . . 0.0 111.644 -173.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -71.12 156.66 59.25 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.897 3.065 . . . . 0.0 113.243 -175.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.75 -14.5 45.19 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.824 3.016 . . . . 0.0 114.491 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -64.22 -24.99 67.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.824 0.85 . . . . 0.0 113.09 170.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 38.8 p -98.17 -26.86 14.42 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.416 1.087 . . . . 0.0 113.441 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 84.9 m -138.76 116.94 11.8 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.284 1.034 . . . . 0.0 111.61 -177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -109.59 162.84 14.02 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.875 1.67 . . . . 0.0 112.984 -176.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.4 tp -129.66 140.52 51.13 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.039 1.736 . . . . 0.0 111.303 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.4 p -136.26 157.71 46.16 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.597 1.159 . . . . 0.0 112.537 171.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -139.5 131.2 27.36 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.857 2.063 . . . . 0.0 109.789 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? 47.74 37.21 6.66 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.591 1.556 . . . . 0.0 114.485 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.09 14.95 81.76 Favored Glycine 0 CA--C 1.54 1.632 0 N-CA-C 115.715 1.046 . . . . 0.0 115.715 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -134.32 159.85 39.72 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.759 1.623 . . . . 0.0 111.761 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.12 133.16 34.22 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.407 0.683 . . . . 0.0 111.332 169.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.0 mt -86.41 127.55 34.84 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.822 0.849 . . . . 0.0 110.457 168.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.33 131.89 9.52 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.306 1.442 . . . . 0.0 110.541 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.0 t0 55.26 29.18 12.39 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.703 1.601 . . . . 0.0 115.094 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.2 p -84.5 -11.99 55.08 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 120.762 -1.211 . . . . 0.0 113.95 -175.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 63.6 -54.15 0.22 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.893 2.477 . . . . 0.0 115.388 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.1 p -147.33 158.09 43.83 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.312 1.845 . . . . 0.0 111.516 176.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.4 -34.17 77.56 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.721 -0.612 . . . . 0.0 112.066 168.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.6 tm-20 -63.14 -33.54 75.69 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.832 0.853 . . . . 0.0 113.034 -178.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 p -63.75 -27.65 69.34 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 55.4 mt -98.07 4.75 49.17 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.858 1.663 . . . . 0.0 113.17 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.16 100.11 0.76 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.367 1.46 . . . . 0.0 112.141 -172.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.5 p -73.65 150.68 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.869 1.267 . . . . 0.0 111.813 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.69 -171.86 3.33 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.041 1.736 . . . . 0.0 111.041 175.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.477 ' OD1' ' HB2' ' A' ' 1' ' ' MET . 14.2 t0 -121.88 145.2 48.32 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.453 1.101 . . . . 0.0 111.647 174.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.01 20.6 77.5 Favored Glycine 0 CA--C 1.539 1.533 0 CA-C-O 119.705 -0.497 . . . . 0.0 114.333 -174.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -58.47 136.48 57.51 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.432 1.116 . . . . 0.0 111.835 172.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -112.25 140.68 46.76 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -123.66 132.64 53.9 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 126.151 1.781 . . . . 0.0 109.295 -174.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.7 t -123.58 121.3 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 118.719 0.69 . . . . 0.0 110.873 -173.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 tp -96.32 137.72 34.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.379 1.072 . . . . 0.0 110.178 175.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -129.32 125.43 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.485 1.114 . . . . 0.0 109.027 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.7 t -118.1 142.04 47.84 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.711 1.204 . . . . 0.0 112.141 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 -80.79 138.06 36.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.912 1.285 . . . . 0.0 111.478 171.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 23.3 p -71.66 110.35 6.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.884 0.874 . . . . 0.0 110.091 169.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 73.5 t -73.77 120.05 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.509 0.723 . . . . 0.0 109.918 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.163 0 C-N-CA 125.25 1.405 . . . . 0.0 112.595 -177.73 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 121.344 0.592 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -92.75 139.31 30.68 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.652 1.181 . . . . 0.0 111.197 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pp -137.0 162.84 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.773 1.629 . . . . 0.0 110.849 -176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -126.79 138.73 53.4 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.203 1.001 . . . . 0.0 112.153 176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 26.9 mt -121.18 133.91 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.936 1.295 . . . . 0.0 109.096 175.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.23 92.87 37.71 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 124.692 1.197 . . . . 0.0 110.831 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -88.25 130.87 2.5 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.915 2.41 . . . . 0.0 112.493 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.23 29.95 0.12 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.514 1.526 . . . . 0.0 114.507 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.3 m -73.95 73.87 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 126.471 1.908 . . . . 0.0 112.767 -173.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.0 38.91 63.89 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.143 0.878 . . . . 0.0 113.192 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.55 29.46 29.8 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 124.311 0.958 . . . . 0.0 114.289 -174.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.78 141.22 48.1 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 124.622 1.106 . . . . 0.0 114.103 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.9 m -80.03 154.62 75.16 Favored Pre-proline 0 N--CA 1.474 0.739 0 C-N-CA 125.107 1.363 . . . . 0.0 113.418 -176.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -62.89 147.43 94.62 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.075 2.517 . . . . 0.0 111.997 166.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.86 138.03 35.39 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.64 1.576 . . . . 0.0 110.813 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -87.73 140.34 29.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.069 1.348 . . . . 0.0 112.122 175.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.3 mp -140.85 164.94 28.88 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.083 1.753 . . . . 0.0 111.459 175.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -116.39 137.53 52.08 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.52 1.528 . . . . 0.0 110.217 169.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.3 158.99 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.743 1.217 . . . . 0.0 111.879 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.2 149.13 98.62 Favored Pre-proline 0 CA--C 1.551 0.984 0 O-C-N 121.767 -0.583 . . . . 0.0 111.498 170.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.46 -24.32 56.94 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.944 2.429 . . . . 0.0 113.221 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -82.95 33.35 0.44 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.925 1.69 . . . . 0.0 113.638 174.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.41 117.76 5.64 Favored 'General case' 0 CA--C 1.546 0.804 0 O-C-N 121.184 -0.948 . . . . 0.0 111.199 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.2 m -97.46 129.36 44.66 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.732 1.213 . . . . 0.0 110.888 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.8 -44.0 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.917 0.887 . . . . 0.0 112.226 -175.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.46 -36.47 93.42 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.517 0.579 . . . . 0.0 113.51 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.92 -37.98 76.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.38 1.09 . . . . 0.0 112.378 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.7 t -68.65 -43.93 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.276 1.03 . . . . 0.0 111.24 174.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 67.5 ttp85 -63.84 -37.39 87.2 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.022 0.929 . . . . 0.0 112.241 175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.9 m -64.17 -39.77 94.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.661 0.785 . . . . 0.0 111.328 170.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.24 -47.95 83.81 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.872 0.869 . . . . 0.0 111.281 174.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.4 t -56.9 -50.22 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.04 1.336 . . . . 0.0 111.342 174.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.5 t -59.93 -44.71 94.17 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.756 0.822 . . . . 0.0 112.109 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.84 86.17 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.994 0.918 . . . . 0.0 113.177 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.4 mtt -68.64 -42.49 77.94 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.107 0.963 . . . . 0.0 112.748 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.98 -23.28 41.71 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.01 26.24 15.53 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.962 1.705 . . . . 0.0 113.275 -174.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.79 153.91 70.39 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 126.845 2.058 . . . . 0.0 111.317 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.47 163.63 38.16 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 124.293 3.329 . . . . 0.0 114.247 -173.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -64.57 -15.78 51.75 Favored 'Trans proline' 0 CA--C 1.546 1.113 0 C-N-CA 123.421 2.747 . . . . 0.0 113.992 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -67.67 -28.86 68.05 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 121.138 -0.976 . . . . 0.0 113.208 173.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 31.1 p -102.95 -10.16 19.23 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.087 1.355 . . . . 0.0 113.872 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.4 m -148.63 123.49 9.96 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.836 1.254 . . . . 0.0 111.263 172.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -110.49 160.39 16.66 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.718 1.207 . . . . 0.0 113.447 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.6 tp -126.43 132.52 51.46 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.798 2.039 . . . . 0.0 110.391 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.5 p -137.11 158.36 44.62 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.362 1.065 . . . . 0.0 111.966 171.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -133.44 126.58 31.51 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.137 2.175 . . . . 0.0 109.378 -174.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt 51.49 30.66 6.55 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.17 0.988 . . . . 0.0 113.382 -174.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.34 2.28 73.15 Favored Glycine 0 CA--C 1.541 1.674 0 C-N-CA 125.26 1.409 . . . . 0.0 115.958 -174.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.44 146.3 29.68 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.948 2.099 . . . . 0.0 111.357 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.8 122.15 25.68 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.576 -0.703 . . . . 0.0 110.968 169.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.2 mt -83.35 134.17 34.92 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.201 1.0 . . . . 0.0 111.097 171.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -160.38 144.76 14.28 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.456 1.502 . . . . 0.0 110.578 170.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.9 t0 52.69 27.99 5.8 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.778 1.631 . . . . 0.0 115.021 174.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.9 m -83.04 -23.82 33.04 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.078 1.351 . . . . 0.0 112.926 -173.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 61.63 -52.85 0.13 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 128.403 2.681 . . . . 0.0 115.544 -172.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 5.0 t -159.15 142.27 14.5 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.031 1.332 . . . . 0.0 111.641 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.16 -26.75 67.57 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.538 0.735 . . . . 0.0 112.314 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.43 -20.01 64.62 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 119.755 1.161 . . . . 0.0 113.361 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.7 t -74.91 -38.19 61.89 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.112 0.965 . . . . 0.0 112.374 173.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -90.47 -35.73 14.94 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.887 1.275 . . . . 0.0 112.929 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 140.42 87.77 0.13 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.042 1.782 . . . . 0.0 112.267 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.3 p -76.72 147.36 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.011 1.324 . . . . 0.0 112.357 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.19 156.13 37.98 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.894 1.278 . . . . 0.0 112.483 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -67.65 147.09 53.17 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.339 -0.851 . . . . 0.0 111.287 162.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.78 14.32 77.95 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 123.867 0.746 . . . . 0.0 114.493 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -55.4 132.91 49.36 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.729 1.264 . . . . 0.0 110.579 168.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.48 131.95 45.41 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.268 1.027 . . . . 0.0 112.443 -165.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -128.07 132.1 49.06 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.432 1.493 . . . . 0.0 110.637 -169.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.74 133.96 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.166 0.987 . . . . 0.0 110.752 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 tp -109.93 115.47 29.85 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.313 1.045 . . . . 0.0 110.049 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.2 mm -105.32 94.09 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.256 1.023 . . . . 0.0 108.983 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -79.22 152.02 30.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.259 1.424 . . . . 0.0 111.243 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -131.48 139.5 49.35 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.74 1.216 . . . . 0.0 112.197 -177.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.4 m -68.3 143.03 55.36 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.071 1.348 . . . . 0.0 112.365 -172.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 61.2 t -128.65 -49.22 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 124.715 1.206 . . . . 0.0 112.015 177.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.194 0 CA-C-O 118.265 -1.297 . . . . 0.0 113.173 -179.366 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 110.583 -0.154 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -86.13 145.4 27.04 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.179 -1.575 . . . . 0.0 112.944 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.4 mm -136.48 140.12 43.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 127.873 2.469 . . . . 0.0 108.641 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -91.84 140.2 29.91 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.177 0.591 . . . . 0.0 110.596 167.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.6 pt -118.78 139.78 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.888 0.875 . . . . 0.0 110.317 168.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 t -129.95 73.71 81.18 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 124.602 1.161 . . . . 0.0 110.371 -175.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -78.62 134.34 12.22 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.508 2.805 . . . . 0.0 112.014 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.05 35.17 0.2 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.603 1.561 . . . . 0.0 114.545 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.4 m -138.94 161.59 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 126.09 1.756 . . . . 0.0 111.874 -175.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.87 -119.97 18.31 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 123.687 0.661 . . . . 0.0 111.467 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.09 -17.85 74.18 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 123.684 0.659 . . . . 0.0 114.691 172.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.48 2.48 35.01 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.206 1.384 . . . . 0.0 115.229 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 57.6 p -85.63 156.55 58.8 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 126.392 1.877 . . . . 0.0 113.591 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.32 153.08 79.4 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.051 2.5 . . . . 0.0 112.4 170.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.8 tp -143.19 130.04 20.48 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.185 1.394 . . . . 0.0 111.671 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -80.35 134.97 36.1 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.41 1.084 . . . . 0.0 111.967 172.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.4 mt -142.93 149.53 38.55 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.118 1.767 . . . . 0.0 111.409 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -90.58 134.32 34.47 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.502 1.121 . . . . 0.0 110.809 169.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.59 154.64 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.612 1.165 . . . . 0.0 112.299 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.64 152.12 89.35 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.361 1.064 . . . . 0.0 112.585 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.11 -17.98 55.74 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.364 2.709 . . . . 0.0 113.544 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -80.59 4.81 17.3 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.521 1.528 . . . . 0.0 113.928 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.67 125.99 25.81 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.495 1.043 . . . . 0.0 112.565 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 m -94.21 131.27 39.96 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.045 1.338 . . . . 0.0 110.814 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.6 t -60.6 -41.54 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 O-C-N 121.348 -0.845 . . . . 0.0 111.962 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.86 -33.93 88.57 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 123.827 0.727 . . . . 0.0 113.767 175.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.97 -42.66 76.31 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.389 1.095 . . . . 0.0 111.463 174.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.59 -48.03 88.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.77 0.828 . . . . 0.0 110.876 174.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.4 mmm-85 -58.14 -45.99 86.43 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.792 0.837 . . . . 0.0 112.115 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.7 m -60.34 -44.53 95.43 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.332 0.653 . . . . 0.0 111.902 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -42.85 99.44 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.149 0.979 . . . . 0.0 111.568 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 89.0 t -67.18 -47.76 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.589 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 97.8 m -57.67 -42.32 83.31 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.025 1.284 . . . . 0.0 112.087 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.94 -41.18 91.64 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.79 0.836 . . . . 0.0 112.797 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 22.7 ttt -70.85 -41.68 71.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.257 1.023 . . . . 0.0 112.815 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.03 -29.11 63.85 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.762 1.225 . . . . 0.0 112.641 173.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? 68.65 31.75 4.51 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 127.247 2.219 . . . . 0.0 113.208 -173.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mp -128.98 153.65 80.26 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.193 1.797 . . . . 0.0 111.824 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.14 159.62 53.13 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.836 3.024 . . . . 0.0 113.245 -177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -64.51 -15.25 48.91 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.923 3.082 . . . . 0.0 114.408 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -70.23 -25.14 63.24 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.475 1.034 . . . . 0.0 113.031 174.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.4 m -93.46 0.65 56.84 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.962 1.305 . . . . 0.0 113.22 -175.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.0 t -137.34 140.21 41.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.939 1.296 . . . . 0.0 112.056 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -134.16 140.8 46.79 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.72 1.608 . . . . 0.0 110.772 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.4 tp -131.63 129.92 41.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.508 1.523 . . . . 0.0 110.907 -171.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -139.7 153.82 47.33 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.48 1.112 . . . . 0.0 112.948 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -143.72 138.64 29.01 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.263 1.825 . . . . 0.0 110.24 175.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 55.03 30.89 15.04 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.863 1.265 . . . . 0.0 113.777 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.45 18.19 79.28 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 124.786 1.184 . . . . 0.0 114.952 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -134.15 142.78 47.58 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.373 1.869 . . . . 0.0 111.132 -170.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.91 135.55 40.11 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.762 0.825 . . . . 0.0 111.919 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.4 mt -103.91 136.81 42.88 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.486 1.114 . . . . 0.0 110.798 173.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.48 149.65 18.94 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.119 1.368 . . . . 0.0 111.164 171.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.0 t0 54.23 27.67 8.16 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.778 1.631 . . . . 0.0 114.88 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -75.24 -24.88 57.72 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.388 1.075 . . . . 0.0 113.287 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 60.53 -56.01 0.08 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 128.584 2.754 . . . . 0.0 114.898 -169.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.9 p -146.92 133.57 19.91 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.934 1.694 . . . . 0.0 111.205 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.8 mt -65.79 -32.8 74.53 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.871 0.869 . . . . 0.0 112.882 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -62.09 -26.83 68.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.145 0.978 . . . . 0.0 113.383 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.6 m -71.05 -28.15 64.17 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.385 1.074 . . . . 0.0 113.445 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 72.3 mt -99.76 -32.21 11.15 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.74 1.216 . . . . 0.0 112.966 -178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 138.39 81.55 0.09 OUTLIER Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.516 1.532 . . . . 0.0 112.162 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.4 p -70.52 147.07 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.268 1.027 . . . . 0.0 111.633 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -146.36 167.96 22.29 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.619 1.568 . . . . 0.0 111.863 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -106.48 145.69 31.49 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.375 1.47 . . . . 0.0 113.446 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.53 13.45 82.93 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 123.798 0.714 . . . . 0.0 114.463 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -65.03 159.92 22.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.412 1.085 . . . . 0.0 111.796 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.72 130.96 28.44 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.4 m-30 -101.43 138.5 38.36 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.242 1.417 . . . . 0.0 111.093 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.87 134.47 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.263 1.025 . . . . 0.0 109.574 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.0 tt -130.84 125.46 33.7 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.759 0.824 . . . . 0.0 111.514 -177.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.0 mm -113.41 135.78 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.123 1.769 . . . . 0.0 110.476 -170.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.2 t -102.05 143.48 31.84 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.803 1.241 . . . . 0.0 111.346 172.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.06 114.62 27.19 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.626 1.17 . . . . 0.0 111.055 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.2 t -71.98 157.24 38.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.006 0.922 . . . . 0.0 112.338 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 59.6 t -124.61 -46.16 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 125.509 1.524 . . . . 0.0 112.154 -176.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.321 0 CA-C-O 117.862 -1.521 . . . . 0.0 113.976 -178.511 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ttt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 120.657 0.265 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm -68.56 147.52 51.84 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.624 -1.297 . . . . 0.0 111.072 158.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.2 pt -143.95 166.11 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 127.568 2.347 . . . . 0.0 110.165 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -125.69 134.9 51.66 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.062 0.945 . . . . 0.0 111.355 167.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 54.5 mt -121.53 131.03 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.999 1.319 . . . . 0.0 108.669 177.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 p -121.49 98.11 46.48 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 124.563 1.145 . . . . 0.0 110.77 173.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -84.58 144.11 9.98 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.298 2.666 . . . . 0.0 111.38 172.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.34 34.38 0.11 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 125.687 1.595 . . . . 0.0 113.553 173.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.3 t -134.29 144.32 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.263 1.825 . . . . 0.0 110.684 -167.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.24 -113.76 6.21 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 124.05 0.833 . . . . 0.0 112.234 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.73 -20.22 70.05 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 123.984 0.802 . . . . 0.0 114.548 174.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.37 12.86 64.26 Favored Glycine 0 CA--C 1.54 1.606 0 CA-C-N 118.547 1.173 . . . . 0.0 115.47 175.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 71.0 p -111.86 155.97 42.39 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 126.254 1.822 . . . . 0.0 113.003 -167.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.6 145.11 91.3 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.977 2.451 . . . . 0.0 112.317 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.92 129.62 34.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.6 1.56 . . . . 0.0 109.998 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.84 135.21 43.42 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.654 1.181 . . . . 0.0 111.543 173.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.13 168.59 19.38 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.832 1.653 . . . . 0.0 110.602 174.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.2 143.56 49.95 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.909 1.284 . . . . 0.0 111.086 166.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.5 m -141.45 158.12 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.033 1.333 . . . . 0.0 112.109 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.64 149.23 98.35 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 124.238 1.015 . . . . 0.0 112.179 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -67.69 -17.71 47.81 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 123.623 2.882 . . . . 0.0 113.837 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.48 -6.7 59.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.205 1.402 . . . . 0.0 114.136 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.76 141.5 52.74 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 119.471 1.032 . . . . 0.0 111.282 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.9 t -130.83 145.94 52.13 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.365 1.066 . . . . 0.0 111.328 -177.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.2 t -63.24 -35.28 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.439 0.696 . . . . 0.0 111.807 -169.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -61.57 -35.98 91.93 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 121.736 -0.603 . . . . 0.0 113.84 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.89 -41.91 67.41 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.596 1.198 . . . . 0.0 112.045 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.0 t -62.79 -44.44 99.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.561 0.744 . . . . 0.0 110.685 175.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -60.35 -47.16 87.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.373 1.069 . . . . 0.0 111.523 174.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.1 m -59.85 -45.77 91.4 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.937 0.895 . . . . 0.0 111.813 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -60.2 -43.31 96.02 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.705 0.802 . . . . 0.0 112.505 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.51 -41.32 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.777 0.717 . . . . 0.0 112.105 178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 87.5 m -60.53 -37.16 80.3 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.527 1.058 . . . . 0.0 112.31 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.0 77.57 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.252 1.021 . . . . 0.0 113.122 174.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 17.3 mmt -66.83 -38.32 86.21 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.325 -0.859 . . . . 0.0 112.524 173.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 -23.1 58.56 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.991 1.316 . . . . 0.0 113.385 174.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.5 mtpt 51.04 45.02 28.36 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.958 2.103 . . . . 0.0 112.435 -167.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 41.2 mt -136.17 151.34 73.33 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.786 1.634 . . . . 0.0 112.245 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -70.77 162.44 42.58 Favored 'Trans proline' 0 CA--C 1.546 1.085 0 C-N-CA 124.004 3.136 . . . . 0.0 113.526 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.69 -11.58 29.72 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 123.662 2.908 . . . . 0.0 114.305 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -72.07 -32.85 67.44 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.694 1.197 . . . . 0.0 113.123 173.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 60.6 p -105.11 -5.23 20.99 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.156 1.382 . . . . 0.0 113.858 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.0 m -147.63 125.18 11.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.137 1.775 . . . . 0.0 110.077 176.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -140.47 147.19 39.24 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.1 tp -108.85 140.17 42.67 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.587 1.955 . . . . 0.0 111.028 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.9 t -141.88 157.33 45.12 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.263 1.425 . . . . 0.0 111.485 175.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -132.0 129.99 40.83 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.67 1.588 . . . . 0.0 110.359 -174.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 ttpp 51.36 29.06 4.79 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.61 14.84 82.07 Favored Glycine 0 CA--C 1.541 1.709 0 C-N-CA 125.288 1.423 . . . . 0.0 116.09 -175.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.47 129.26 30.81 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.781 1.632 . . . . 0.0 111.267 -177.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.76 131.65 46.83 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.332 0.653 . . . . 0.0 112.501 -175.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.1 mt -131.68 153.9 49.53 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.461 1.504 . . . . 0.0 111.607 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -161.08 -48.83 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.978 1.711 . . . . 0.0 111.268 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -81.54 27.82 0.42 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.688 1.995 . . . . 0.0 114.115 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.8 m -68.09 -27.56 66.59 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.25 1.42 . . . . 0.0 113.277 -172.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 64.5 -63.43 0.17 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.231 2.612 . . . . 0.0 114.895 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 45.6 p -149.08 146.99 27.99 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.249 1.819 . . . . 0.0 110.485 168.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.4 mt -74.08 -27.4 60.88 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.538 -0.726 . . . . 0.0 112.068 171.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -58.53 -36.21 73.51 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.227 1.011 . . . . 0.0 113.079 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.8 p -63.71 -20.01 65.39 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 68.5 mt -105.6 -2.44 23.48 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.034 1.733 . . . . 0.0 113.294 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.26 113.84 0.35 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 125.629 1.585 . . . . 0.0 112.578 -171.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.67 146.04 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.976 1.31 . . . . 0.0 111.676 177.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -145.71 174.74 10.94 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.672 1.589 . . . . 0.0 111.797 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -78.29 162.05 26.8 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.027 0.931 . . . . 0.0 110.903 162.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.67 14.81 81.68 Favored Glycine 0 CA--C 1.536 1.406 0 N-CA-C 115.844 1.098 . . . . 0.0 115.844 174.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -66.59 127.25 31.66 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.852 1.326 . . . . 0.0 110.613 165.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -129.03 130.4 46.56 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.882 1.273 . . . . 0.0 111.981 -166.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -125.51 133.24 52.44 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.798 1.639 . . . . 0.0 111.195 -170.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.6 t -118.1 129.54 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.814 1.245 . . . . 0.0 109.152 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.38 120.57 34.39 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.263 1.025 . . . . 0.0 110.108 -176.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.4 mt -116.19 130.03 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 124.82 1.248 . . . . 0.0 109.12 -172.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.8 p -120.02 158.46 26.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.19 1.396 . . . . 0.0 111.053 177.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -137.1 116.46 12.71 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.433 1.093 . . . . 0.0 111.37 -175.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.9 m -101.28 50.06 0.86 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.099 1.36 . . . . 0.0 110.82 -175.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.9 p -77.39 143.91 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.677 1.191 . . . . 0.0 111.533 178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.272 0 C-N-CA 125.303 1.43 . . . . 0.0 113.82 -179.249 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptm . . . . . 0 N--CA 1.487 1.385 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -86.44 149.61 24.87 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.127 -1.608 . . . . 0.0 111.812 173.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.4 pt -130.74 166.08 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.764 2.025 . . . . 0.0 111.117 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -131.07 112.46 12.91 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.577 1.151 . . . . 0.0 110.079 170.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.3 tt -94.81 139.69 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 122.779 0.432 . . . . 0.0 110.652 175.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 t -126.92 81.43 69.63 Favored Pre-proline 0 N--CA 1.471 0.609 0 C-N-CA 125.247 1.419 . . . . 0.0 109.649 -174.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.53 136.39 12.34 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.474 2.116 . . . . 0.0 112.473 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.83 41.1 0.15 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.133 1.373 . . . . 0.0 113.194 171.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.4 t -135.86 142.66 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.348 1.859 . . . . 0.0 110.35 -169.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.43 -116.5 9.44 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.949 0.785 . . . . 0.0 112.533 175.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.82 -14.9 68.38 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 124.212 0.911 . . . . 0.0 115.081 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.69 7.37 47.66 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 118.885 1.342 . . . . 0.0 115.929 174.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.6 m -94.43 155.48 39.65 Favored Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 125.696 1.598 . . . . 0.0 113.166 -170.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -63.01 147.23 94.74 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.212 2.608 . . . . 0.0 112.18 170.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 tt -138.75 122.61 17.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.414 1.486 . . . . 0.0 110.391 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -82.27 143.39 31.35 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.958 0.903 . . . . 0.0 112.783 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 tp -152.2 153.81 34.55 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.535 1.134 . . . . 0.0 111.657 -177.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -85.22 150.43 24.8 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.374 -0.829 . . . . 0.0 111.338 163.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.5 p -148.16 149.66 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.101 0.961 . . . . 0.0 111.643 174.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.06 149.91 98.23 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 123.992 0.917 . . . . 0.0 112.482 176.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.56 -21.09 46.57 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.278 2.652 . . . . 0.0 113.023 175.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -78.76 16.45 0.87 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.954 1.702 . . . . 0.0 113.648 175.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.35 121.94 10.04 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.391 1.076 . . . . 0.0 112.003 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.6 m -107.83 130.23 55.01 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.283 1.433 . . . . 0.0 109.861 -176.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.1 t -58.94 -42.93 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 123.383 0.673 . . . . 0.0 111.637 -177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -59.77 -37.48 92.51 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.619 1.104 . . . . 0.0 113.578 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.02 -45.12 71.31 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.326 1.063 . . . . 0.0 111.705 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.32 -50.68 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.814 0.846 . . . . 0.0 111.581 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.27 -37.15 86.47 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.683 -0.636 . . . . 0.0 112.468 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.1 m -67.13 -42.03 85.14 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.522 0.601 . . . . 0.0 111.451 175.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -40.2 93.72 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.996 0.919 . . . . 0.0 111.887 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -62.18 -52.54 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.555 1.142 . . . . 0.0 111.502 172.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 88.3 m -62.24 -35.51 79.14 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 118.51 0.596 . . . . 0.0 112.23 -179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.16 -40.64 86.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.404 1.081 . . . . 0.0 112.752 174.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -43.95 87.16 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.726 0.81 . . . . 0.0 112.365 174.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 36' ' ' LYS . 8.0 mmpt? -73.71 -20.48 60.52 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.704 1.202 . . . . 0.0 113.99 177.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? 55.92 27.84 11.69 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.59 1.956 . . . . 0.0 113.075 -170.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.24 154.74 70.25 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 126.486 1.914 . . . . 0.0 111.394 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.69 165.07 33.24 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.425 3.417 . . . . 0.0 114.225 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.34 -17.5 58.14 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.312 2.675 . . . . 0.0 114.091 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -64.64 -28.91 69.93 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.829 -1.169 . . . . 0.0 112.796 173.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.0 p -98.48 -14.05 20.23 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.271 1.428 . . . . 0.0 114.328 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 100.0 m -142.66 117.03 9.61 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 119.899 1.227 . . . . 0.0 111.919 174.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.5 167.74 10.62 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.003 1.721 . . . . 0.0 113.137 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 69' ' ' PHE . 43.8 tp -142.63 136.42 29.11 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.03 1.732 . . . . 0.0 111.372 -173.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.4 p -135.57 158.31 44.69 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.54 1.136 . . . . 0.0 113.213 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -147.62 130.39 16.08 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.3 2.24 . . . . 0.0 110.052 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.1 mmpt? 50.67 31.36 5.75 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.323 1.449 . . . . 0.0 113.78 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.86 7.35 88.37 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 125.01 1.291 . . . . 0.0 115.96 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -120.54 158.97 26.16 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.581 1.552 . . . . 0.0 112.409 176.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.39 127.76 32.5 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.649 0.78 . . . . 0.0 110.534 165.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 34.7 mt -75.46 138.12 41.4 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.376 0.671 . . . . 0.0 110.762 169.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -163.28 142.5 8.46 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.427 1.491 . . . . 0.0 111.464 170.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t0 57.19 21.39 6.52 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 172.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.3 m -70.84 -26.92 63.49 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.857 1.263 . . . . 0.0 112.9 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 63.65 -56.0 0.21 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 128.619 2.767 . . . . 0.0 115.01 -174.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.3 p -145.06 144.46 30.98 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.274 1.429 . . . . 0.0 111.48 170.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.4 -28.54 68.01 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.558 -0.714 . . . . 0.0 112.271 173.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -65.29 -26.87 68.26 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.362 -0.836 . . . . 0.0 113.167 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 33.5 t -63.07 -37.49 87.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.738 0.815 . . . . 0.0 112.614 172.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 49.0 mt -90.68 -10.33 43.55 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.936 1.294 . . . . 0.0 113.689 174.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.51 118.14 2.49 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 126.471 1.986 . . . . 0.0 112.545 -172.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.7 t -73.51 144.89 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.811 1.244 . . . . 0.0 111.219 175.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.06 156.55 38.04 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.635 1.574 . . . . 0.0 110.551 166.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -88.77 146.92 24.73 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.152 -0.967 . . . . 0.0 112.522 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.0 26.59 66.29 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.631 0.613 . . . . 0.0 114.631 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -61.8 140.11 58.27 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.499 1.149 . . . . 0.0 111.869 175.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -119.13 134.23 55.32 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.711 0.804 . . . . 0.0 112.581 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.55 ' HB3' HD11 ' A' ' 45' ' ' LEU . 17.6 m-85 -122.28 138.25 54.56 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.427 1.491 . . . . 0.0 110.755 -174.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.2 t -118.83 123.07 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.591 0.757 . . . . 0.0 110.594 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 tp -97.92 134.97 40.32 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.4 1.08 . . . . 0.0 110.637 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -126.08 111.7 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.719 1.208 . . . . 0.0 109.711 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.4 t -90.74 152.39 20.83 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.83 1.252 . . . . 0.0 111.292 170.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -122.38 121.49 36.78 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.673 1.589 . . . . 0.0 111.004 172.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.8 p -76.3 160.62 29.46 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.655 1.582 . . . . 0.0 112.417 176.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 91.7 t -70.7 -34.87 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.4 1.08 . . . . 0.0 112.222 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 C-N-CA 125.697 1.617 . . . . 0.0 113.401 -179.098 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 121.188 0.518 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -114.05 149.02 36.08 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.195 1.398 . . . . 0.0 111.414 170.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -128.52 155.32 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.865 1.666 . . . . 0.0 110.047 173.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -118.86 93.81 4.23 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.854 1.262 . . . . 0.0 110.22 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.5 tt -79.71 140.47 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 121.783 -0.573 . . . . 0.0 110.743 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.7 t -131.51 82.31 61.97 Favored Pre-proline 0 N--CA 1.472 0.67 0 C-N-CA 125.261 1.425 . . . . 0.0 109.842 -172.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.39 136.45 9.94 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.631 2.22 . . . . 0.0 113.098 -178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.96 39.22 0.18 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.592 1.557 . . . . 0.0 113.564 172.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.6 t -137.99 145.87 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.987 1.715 . . . . 0.0 110.691 -171.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.44 -119.58 17.33 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.054 0.835 . . . . 0.0 112.429 176.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.9 -14.42 67.87 Favored Glycine 0 CA--C 1.539 1.546 0 C-N-CA 124.088 0.851 . . . . 0.0 114.903 175.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 68.27 6.22 46.23 Favored Glycine 0 CA--C 1.541 1.71 0 CA-C-N 118.812 1.306 . . . . 0.0 115.87 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.2 m -90.83 153.57 45.35 Favored Pre-proline 0 N--CA 1.471 0.615 0 C-N-CA 125.369 1.468 . . . . 0.0 113.334 -171.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -66.25 152.98 79.79 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 123.403 2.735 . . . . 0.0 112.646 172.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 63.1 tp -140.1 118.72 12.32 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.427 1.491 . . . . 0.0 111.586 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -69.51 137.56 52.61 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.436 1.094 . . . . 0.0 111.575 169.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 8.3 tp -150.64 136.9 18.6 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.532 1.133 . . . . 0.0 111.51 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.02 143.33 43.6 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.612 0.765 . . . . 0.0 111.626 171.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.17 147.95 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.232 1.013 . . . . 0.0 112.1 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.79 150.89 95.28 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.143 0.977 . . . . 0.0 112.537 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -65.58 -27.12 53.67 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.043 2.496 . . . . 0.0 113.048 176.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -77.35 14.39 0.97 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.398 1.479 . . . . 0.0 114.134 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.13 100.29 0.32 Allowed 'General case' 0 CA--C 1.544 0.732 0 O-C-N 120.844 -1.16 . . . . 0.0 112.212 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.7 t -73.62 148.77 42.54 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.427 1.091 . . . . 0.0 110.858 168.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.6 m -57.75 -31.55 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.85 0.86 . . . . 0.0 112.485 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.33 -41.78 99.37 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 123.576 0.608 . . . . 0.0 112.732 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.2 -44.82 82.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.771 0.828 . . . . 0.0 111.75 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.2 t -62.98 -49.46 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.879 0.871 . . . . 0.0 110.924 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -35.92 78.26 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.853 1.261 . . . . 0.0 112.369 -177.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.6 m -66.79 -45.44 78.44 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.551 0.74 . . . . 0.0 111.435 172.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -63.18 -39.28 94.19 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 118.702 0.683 . . . . 0.0 111.928 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -56.94 -52.0 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.51 1.124 . . . . 0.0 111.385 170.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 51.8 t -60.86 -42.78 98.52 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.123 0.569 . . . . 0.0 112.207 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.23 -40.72 86.37 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.972 0.909 . . . . 0.0 113.254 176.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 3.8 tpp -67.73 -44.07 78.46 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.808 1.243 . . . . 0.0 112.094 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -76.63 -24.03 53.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.691 0.796 . . . . 0.0 113.043 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.3 ttpp 59.67 27.25 16.45 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 127.457 2.303 . . . . 0.0 114.144 -173.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.01 154.49 81.38 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 126.192 1.797 . . . . 0.0 112.033 -175.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.81 159.95 50.98 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 123.904 3.069 . . . . 0.0 113.974 -171.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.57 -10.24 28.46 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.269 3.312 . . . . 0.0 114.978 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -73.46 -21.56 60.41 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 121.195 -0.941 . . . . 0.0 112.601 167.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 22.9 m -108.48 -37.26 6.0 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.018 1.327 . . . . 0.0 112.844 -172.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.2 t -97.52 139.09 33.97 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.69 0.796 . . . . 0.0 111.728 170.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -136.54 154.11 50.81 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.592 1.557 . . . . 0.0 111.476 -177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.8 tp -138.23 132.9 32.5 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.472 1.509 . . . . 0.0 111.217 -171.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.2 p -140.17 155.12 47.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.26 1.024 . . . . 0.0 113.526 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -149.01 131.64 15.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.788 2.035 . . . . 0.0 110.302 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.0 tptt 54.27 29.05 10.04 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.166 1.386 . . . . 0.0 114.319 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.73 3.33 87.11 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.382 1.468 . . . . 0.0 115.562 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -112.55 161.26 16.97 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.821 2.048 . . . . 0.0 111.334 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.03 142.25 28.88 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.61 0.764 . . . . 0.0 110.64 161.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.16 118.82 34.45 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.134 0.974 . . . . 0.0 111.053 172.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.39 145.72 22.97 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.489 1.516 . . . . 0.0 111.109 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 54.63 23.52 4.77 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.589 1.956 . . . . 0.0 116.137 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.8 p -75.94 -24.02 55.46 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 120.818 -1.176 . . . . 0.0 113.69 -176.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 63.79 -40.15 0.21 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 128.739 2.816 . . . . 0.0 115.122 -172.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.5 t -152.22 154.6 36.1 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.188 1.795 . . . . 0.0 111.656 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.66 -25.14 68.08 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.211 1.005 . . . . 0.0 112.899 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.92 -27.84 69.42 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.3 m -65.0 -28.04 69.23 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.994 0.918 . . . . 0.0 112.963 177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.5 mp -96.71 -10.06 27.71 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.468 1.507 . . . . 0.0 112.745 178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.5 28.9 74.07 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.43 1.014 . . . . 0.0 114.468 177.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.8 m -65.97 151.79 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.515 1.126 . . . . 0.0 113.949 -170.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.08 179.07 7.03 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.238 1.415 . . . . 0.0 112.657 173.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -73.58 152.04 40.71 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 121.112 -0.992 . . . . 0.0 111.631 165.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 78.37 29.23 53.82 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 115.856 1.103 . . . . 0.0 115.856 172.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -62.11 155.33 24.54 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.772 1.286 . . . . 0.0 112.263 172.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -125.81 136.62 53.33 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.877 0.871 . . . . 0.0 112.347 173.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -122.23 133.53 54.71 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.855 1.262 . . . . 0.0 110.548 -173.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.9 t -103.24 129.42 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.209 0.603 . . . . 0.0 110.338 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 tp -105.57 131.17 53.29 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.087 0.955 . . . . 0.0 110.572 172.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -115.84 146.32 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.621 1.569 . . . . 0.0 109.53 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.6 t -127.34 164.94 20.69 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.167 1.387 . . . . 0.0 112.085 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -133.43 139.22 46.61 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.964 2.106 . . . . 0.0 110.44 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.6 p -81.65 130.11 34.94 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.417 0.687 . . . . 0.0 110.296 168.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 33.6 m -137.47 16.43 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 125.166 1.386 . . . . 0.0 113.169 -173.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.165 0 C-N-CA 125.821 1.677 . . . . 0.0 112.829 179.784 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 mmt . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.0 140.23 45.34 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 120.469 -1.395 . . . . 0.0 111.145 160.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pp -131.01 166.58 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.657 1.983 . . . . 0.0 110.311 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -120.99 102.66 8.48 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.458 1.103 . . . . 0.0 110.795 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.6 tt -77.84 143.14 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 121.859 -0.525 . . . . 0.0 110.067 173.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.5 79.93 72.61 Favored Pre-proline 0 N--CA 1.471 0.622 0 C-N-CA 124.824 1.249 . . . . 0.0 109.551 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.39 134.27 15.39 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 123.723 2.949 . . . . 0.0 112.32 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.32 28.76 0.15 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 125.558 1.543 . . . . 0.0 114.377 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.1 m -138.39 162.89 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 126.181 1.792 . . . . 0.0 111.699 -176.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.76 -128.78 35.32 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 123.602 0.62 . . . . 0.0 111.806 -175.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.73 -15.1 73.31 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 174.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.74 -1.09 54.85 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 124.97 1.271 . . . . 0.0 115.798 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -71.69 151.79 93.48 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 125.278 1.431 . . . . 0.0 113.195 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -64.17 150.54 88.11 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.716 2.278 . . . . 0.0 111.448 166.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.7 tp -142.8 132.86 24.39 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.252 1.021 . . . . 0.0 111.961 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -78.23 133.85 37.66 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.123 0.969 . . . . 0.0 112.335 177.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mp -139.82 143.6 36.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.479 1.512 . . . . 0.0 110.763 169.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -81.1 136.42 35.92 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.519 0.728 . . . . 0.0 110.26 166.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -141.8 142.67 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.733 0.813 . . . . 0.0 112.154 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.29 147.94 96.48 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.864 0.866 . . . . 0.0 112.498 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.49 -19.61 65.28 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.444 2.763 . . . . 0.0 113.67 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -78.91 4.65 13.55 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.868 1.667 . . . . 0.0 114.659 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.31 124.83 21.5 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 119.568 1.076 . . . . 0.0 112.649 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.2 m -107.89 138.58 43.89 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.557 1.543 . . . . 0.0 111.305 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.0 t -56.62 -47.29 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.023 0.929 . . . . 0.0 112.547 -175.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.5 -41.5 98.71 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 123.429 0.537 . . . . 0.0 112.926 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.13 -45.74 79.99 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.006 0.903 . . . . 0.0 112.139 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.8 t -60.48 -52.84 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.9 0.88 . . . . 0.0 110.849 176.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -62.33 -45.68 92.11 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.903 0.881 . . . . 0.0 111.606 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 84.6 m -61.17 -41.34 96.6 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.359 0.663 . . . . 0.0 111.917 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -63.43 -40.68 97.83 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.003 0.819 . . . . 0.0 112.416 176.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.6 t -67.68 -43.75 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.201 0.91 . . . . 0.0 111.53 174.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 93.9 m -56.88 -43.1 80.93 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.478 1.036 . . . . 0.0 112.081 174.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.33 -39.19 89.09 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.111 0.964 . . . . 0.0 112.803 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.3 tpt -67.83 -39.59 83.87 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.869 0.868 . . . . 0.0 112.496 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -19.02 56.42 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.28 1.432 . . . . 0.0 113.916 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt 58.28 29.05 17.5 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.733 2.013 . . . . 0.0 113.328 -169.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.4 mp -128.08 154.83 78.61 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 126.275 1.83 . . . . 0.0 111.82 -174.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.37 165.33 32.05 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 124.399 3.4 . . . . 0.0 115.102 -171.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -63.15 -15.85 50.69 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.644 2.896 . . . . 0.0 113.928 170.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -68.66 -21.16 64.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.236 1.014 . . . . 0.0 113.136 171.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.9 p -114.86 -38.73 3.86 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.051 1.34 . . . . 0.0 113.183 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 81.7 m -92.84 124.67 37.0 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.29 1.436 . . . . 0.0 111.001 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.3 ttt-85 -149.27 146.22 27.46 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -171.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -112.18 148.08 34.81 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.245 1.818 . . . . 0.0 111.91 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.0 m -143.04 143.15 31.77 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.834 1.654 . . . . 0.0 111.836 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -144.49 133.54 22.75 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.357 1.863 . . . . 0.0 110.635 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? 52.78 30.49 9.05 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.805 1.242 . . . . 0.0 113.488 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.31 16.57 78.73 Favored Glycine 0 CA--C 1.54 1.627 0 C-N-CA 124.852 1.215 . . . . 0.0 115.218 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.8 ttp85 -135.68 155.32 50.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.526 1.93 . . . . 0.0 111.757 -173.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.01 132.32 44.11 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.634 -0.666 . . . . 0.0 111.775 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.35 127.62 37.9 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.58 1.152 . . . . 0.0 109.86 167.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -164.46 147.32 8.94 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.802 1.641 . . . . 0.0 111.162 174.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 56.1 23.96 7.42 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.3 p -75.39 -17.79 60.11 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 120.859 -1.15 . . . . 0.0 113.478 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 61.64 -56.09 0.12 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 128.408 2.683 . . . . 0.0 114.144 -166.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 34.5 p -147.53 157.51 43.59 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.781 1.632 . . . . 0.0 111.048 174.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -66.27 -32.82 74.46 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.459 -0.776 . . . . 0.0 111.304 168.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -63.06 -31.55 72.72 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.407 -0.808 . . . . 0.0 113.074 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.2 t -64.89 -23.88 67.36 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.113 0.965 . . . . 0.0 113.325 175.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 80.4 mt -106.31 -33.31 7.81 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.091 1.357 . . . . 0.0 113.486 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.41 85.9 0.19 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.098 1.808 . . . . 0.0 111.739 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.9 p -72.87 146.93 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.556 1.142 . . . . 0.0 112.181 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -149.85 -179.45 7.15 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.347 1.459 . . . . 0.0 112.178 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -97.68 150.06 21.6 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.807 1.643 . . . . 0.0 111.741 167.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.74 5.14 90.07 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.77 1.176 . . . . 0.0 115.545 176.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -61.23 145.64 50.52 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.357 1.079 . . . . 0.0 110.755 170.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.87 134.2 46.58 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 -171.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -125.1 113.8 18.21 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.417 1.087 . . . . 0.0 110.64 -169.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -83.58 128.9 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.49 0.716 . . . . 0.0 109.704 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.5 tp -113.04 118.37 34.6 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.371 1.468 . . . . 0.0 109.421 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.1 pt -110.27 154.43 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 124.89 1.276 . . . . 0.0 111.993 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.6 t -139.16 165.73 26.38 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.644 1.577 . . . . 0.0 111.298 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.7 ttt85 -153.29 146.17 24.44 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.551 1.541 . . . . 0.0 111.016 -168.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 77.8 p -134.07 -34.81 0.97 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.223 1.009 . . . . 0.0 113.652 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 67.6 t -141.46 139.04 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 125.882 1.673 . . . . 0.0 110.542 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.151 0 C-N-CA 124.627 1.108 . . . . 0.0 115.226 178.963 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -80.68 142.65 33.72 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.049 -1.657 . . . . 0.0 112.476 174.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.9 pt -131.3 162.29 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 127.103 2.161 . . . . 0.0 110.415 170.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -123.88 92.74 3.74 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.035 1.334 . . . . 0.0 110.627 175.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.5 tt -78.71 141.13 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 122.13 -0.356 . . . . 0.0 110.356 174.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.8 t -130.6 79.82 71.32 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.383 1.473 . . . . 0.0 109.426 -174.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.85 137.03 13.75 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.253 1.969 . . . . 0.0 112.509 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.0 41.53 0.16 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.718 1.607 . . . . 0.0 112.63 170.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.4 t -139.14 142.51 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.539 1.936 . . . . 0.0 109.907 -167.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.48 -115.15 7.51 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 123.754 0.692 . . . . 0.0 112.479 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.44 -18.16 71.36 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.127 0.87 . . . . 0.0 114.972 176.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.95 6.45 56.33 Favored Glycine 0 CA--C 1.541 1.68 0 CA-C-N 118.737 1.268 . . . . 0.0 115.627 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.1 p -95.34 158.91 33.89 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 126.485 1.914 . . . . 0.0 113.561 -169.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -65.49 143.25 75.03 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.163 2.575 . . . . 0.0 112.115 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 68.5 mt -131.28 115.83 16.81 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.017 1.727 . . . . 0.0 110.515 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -74.4 125.58 28.83 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.836 0.855 . . . . 0.0 111.238 173.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt -138.17 149.05 45.49 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.606 1.563 . . . . 0.0 111.119 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -97.13 130.3 44.41 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.837 1.255 . . . . 0.0 110.156 174.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.9 149.71 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.922 1.289 . . . . 0.0 112.903 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.11 153.56 88.9 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.8 1.24 . . . . 0.0 112.471 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.13 -25.25 50.95 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.306 2.67 . . . . 0.0 113.635 176.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -80.51 37.57 0.41 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 126.013 1.725 . . . . 0.0 112.985 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.06 67.73 3.96 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.981 1.713 . . . . 0.0 112.622 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 55.9 m -63.76 141.34 58.8 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.683 1.193 . . . . 0.0 112.275 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.1 t -60.07 -44.09 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.072 0.949 . . . . 0.0 112.161 -174.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.98 -36.4 92.18 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.498 0.57 . . . . 0.0 113.231 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.93 -50.33 64.79 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 117.992 0.896 . . . . 0.0 111.796 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.2 p -66.78 -36.86 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 118.867 0.758 . . . . 0.0 112.046 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -59.06 -48.1 82.84 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.475 1.11 . . . . 0.0 111.837 173.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 21.2 m -66.47 -39.9 89.05 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.375 0.67 . . . . 0.0 112.099 175.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -44.48 96.96 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.893 0.877 . . . . 0.0 111.755 176.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.9 t -61.48 -48.33 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.136 1.374 . . . . 0.0 111.362 172.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.6 -44.53 93.36 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.458 0.703 . . . . 0.0 111.967 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.7 -40.49 88.51 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.204 1.002 . . . . 0.0 112.924 175.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.5 ttm -65.76 -43.5 88.69 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.534 1.133 . . . . 0.0 112.232 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -75.38 -29.53 59.87 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.846 1.258 . . . . 0.0 113.394 177.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.2 tptm 57.41 31.29 19.97 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.746 2.018 . . . . 0.0 113.098 -169.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.52 151.16 56.81 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 126.316 1.846 . . . . 0.0 111.082 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.88 159.18 51.19 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.943 3.095 . . . . 0.0 113.594 -173.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.17 -13.07 35.74 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.99 3.127 . . . . 0.0 114.778 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -66.29 -22.25 66.29 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.136 -0.978 . . . . 0.0 113.355 170.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 37.2 p -103.07 -25.84 13.27 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.71 1.204 . . . . 0.0 113.709 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 82.1 m -140.07 126.87 20.6 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.954 1.301 . . . . 0.0 110.928 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.7 ptm180 -134.44 166.61 22.45 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.125 1.37 . . . . 0.0 112.897 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 69' ' ' PHE . 39.4 tp -137.07 135.33 37.41 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.455 1.502 . . . . 0.0 111.497 -168.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 80.5 p -136.49 158.54 44.19 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.491 1.116 . . . . 0.0 112.519 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -139.09 128.73 24.6 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.606 2.363 . . . . 0.0 109.701 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.62 31.97 11.01 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.643 1.177 . . . . 0.0 113.515 178.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.94 8.79 87.63 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 124.945 1.26 . . . . 0.0 115.943 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -122.01 151.1 41.18 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 126.404 1.881 . . . . 0.0 112.261 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.12 126.24 30.52 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.85 -0.531 . . . . 0.0 110.46 165.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.2 mt -74.41 137.65 42.83 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.579 0.752 . . . . 0.0 110.726 170.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.24 140.4 7.5 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.117 1.367 . . . . 0.0 111.335 170.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.0 t0 55.72 26.45 9.43 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.957 1.703 . . . . 0.0 115.191 175.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.9 m -78.03 -15.19 59.13 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.016 1.326 . . . . 0.0 113.732 -171.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 59.4 -70.84 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.601 2.361 . . . . 0.0 114.441 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.2 p -146.38 154.23 41.4 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.158 1.383 . . . . 0.0 111.97 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.22 -20.37 60.88 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.768 -0.583 . . . . 0.0 112.391 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -62.66 -30.72 71.59 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.192 -0.942 . . . . 0.0 112.659 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.0 t -63.59 -24.3 67.74 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.63 0.772 . . . . 0.0 112.762 173.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.4 mt -92.68 -12.42 31.54 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.46 1.504 . . . . 0.0 113.304 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.54 17.15 64.13 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.185 1.374 . . . . 0.0 115.014 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.1 p -76.44 145.0 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.778 1.231 . . . . 0.0 113.424 -169.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.6 -177.29 5.76 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.869 1.667 . . . . 0.0 113.774 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -68.47 164.4 21.21 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.299 1.44 . . . . 0.0 113.214 172.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.83 11.62 60.16 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.587 1.089 . . . . 0.0 115.033 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -62.19 143.83 56.27 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.436 1.118 . . . . 0.0 111.552 171.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -127.18 132.64 50.44 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.101 0.96 . . . . 0.0 112.235 -174.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.459 ' HB3' HD11 ' A' ' 45' ' ' LEU . 6.9 m-85 -125.27 132.61 52.9 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.866 1.266 . . . . 0.0 109.944 -171.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 p -110.73 120.73 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.024 0.829 . . . . 0.0 111.123 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.99 121.11 40.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.954 1.302 . . . . 0.0 109.136 177.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.0 tt -119.7 131.07 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.447 1.099 . . . . 0.0 111.063 -177.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.6 t -114.61 150.87 34.4 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.309 1.844 . . . . 0.0 111.353 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -124.97 126.16 45.03 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.179 1.792 . . . . 0.0 109.959 172.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.2 p -72.21 144.9 48.32 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.216 1.007 . . . . 0.0 111.71 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.5 t -136.36 -39.26 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.869 1.267 . . . . 0.0 112.067 -176.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.222 0 C-N-CA 125.234 1.397 . . . . 0.0 113.309 -178.633 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.28 0.562 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -108.98 141.68 40.74 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.074 1.35 . . . . 0.0 111.331 174.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.0 pt -121.56 163.05 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.07 1.748 . . . . 0.0 110.457 170.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -125.69 105.57 9.09 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.15 0.98 . . . . 0.0 110.875 174.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.4 mt -86.79 137.88 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -126.0 76.25 71.6 Favored Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 124.951 1.3 . . . . 0.0 110.086 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.97 136.59 16.68 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.92 2.413 . . . . 0.0 111.261 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.25 31.91 0.1 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 125.627 1.571 . . . . 0.0 114.173 178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.5 t -139.52 147.67 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 126.62 1.968 . . . . 0.0 109.871 -171.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.5 30.75 70.97 Favored Glycine 0 CA--C 1.537 1.419 0 O-C-N 121.642 -0.661 . . . . 0.0 114.543 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.65 -8.36 40.02 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.615 1.578 . . . . 0.0 115.11 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.32 5.36 76.91 Favored Glycine 0 CA--C 1.54 1.637 0 N-CA-C 116.355 1.302 . . . . 0.0 116.355 170.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.9 m -75.14 150.32 85.41 Favored Pre-proline 0 N--CA 1.475 0.804 0 CA-C-N 118.649 1.225 . . . . 0.0 113.432 -174.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.77 145.7 76.03 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.378 2.719 . . . . 0.0 111.898 169.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.1 mt -131.71 111.72 11.92 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.725 1.61 . . . . 0.0 110.492 178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -79.27 134.22 36.64 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.355 1.062 . . . . 0.0 111.807 176.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 tt -152.43 141.98 21.76 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.347 1.059 . . . . 0.0 112.349 -175.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -80.93 133.92 35.63 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.659 1.184 . . . . 0.0 112.289 177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -139.1 155.51 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.878 1.271 . . . . 0.0 113.01 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.75 152.45 91.31 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.623 1.169 . . . . 0.0 112.271 172.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.02 -19.05 57.85 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.365 2.71 . . . . 0.0 113.419 174.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -78.76 5.77 10.5 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.643 1.577 . . . . 0.0 114.117 176.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.37 130.52 47.11 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 119.391 0.996 . . . . 0.0 112.284 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.9 m -109.7 134.73 51.65 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.47 1.508 . . . . 0.0 110.874 -175.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 70.6 t -60.32 -40.94 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 124.073 0.949 . . . . 0.0 112.31 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.61 -34.93 91.0 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 123.775 0.702 . . . . 0.0 113.5 175.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.87 -43.23 75.79 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.339 1.07 . . . . 0.0 111.645 174.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.9 t -61.27 -46.67 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.005 0.922 . . . . 0.0 111.138 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -56.49 -51.42 68.56 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.542 1.137 . . . . 0.0 111.735 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.4 m -60.16 -42.03 94.08 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.505 0.722 . . . . 0.0 111.818 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.67 -50.76 72.7 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.949 0.9 . . . . 0.0 111.239 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 74.4 t -68.21 -41.37 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.412 0.685 . . . . 0.0 112.132 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 95.9 m -59.67 -40.41 87.7 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.335 0.971 . . . . 0.0 112.202 173.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.57 -41.99 78.95 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.55 0.74 . . . . 0.0 112.77 174.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 84.2 mtp -66.37 -39.73 89.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.353 1.061 . . . . 0.0 112.871 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -84.46 -18.27 36.44 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.718 1.207 . . . . 0.0 113.86 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.2 ttpp 57.75 30.03 18.31 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.457 1.903 . . . . 0.0 113.728 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.92 150.49 43.56 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 126.129 1.771 . . . . 0.0 111.141 -179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.64 159.85 50.75 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 123.713 2.942 . . . . 0.0 112.796 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.07 -9.89 26.67 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 124.007 3.138 . . . . 0.0 115.063 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -80.12 -36.16 35.69 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.193 1.397 . . . . 0.0 113.296 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 34.6 p -85.81 8.13 21.2 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.203 1.401 . . . . 0.0 113.827 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.0 t -144.2 142.72 30.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.679 1.591 . . . . 0.0 111.972 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 46.9 mtt180 -141.02 148.51 40.39 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.465 1.506 . . . . 0.0 112.658 179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.7 tp -127.48 129.41 47.38 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.008 2.123 . . . . 0.0 110.108 -177.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.8 p -140.06 155.52 47.0 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.41 1.084 . . . . 0.0 112.516 177.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -145.0 138.69 26.95 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.168 1.787 . . . . 0.0 110.167 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.3 ttpp 54.13 30.4 12.03 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.935 1.294 . . . . 0.0 114.062 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.96 16.85 80.33 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.037 1.304 . . . . 0.0 115.259 -175.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -134.13 150.86 51.16 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.085 1.754 . . . . 0.0 112.252 -171.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.1 115.95 20.79 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.945 0.898 . . . . 0.0 110.962 172.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.2 mp -86.35 131.96 34.08 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.38 1.072 . . . . 0.0 110.297 171.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.78 149.91 11.45 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.388 1.475 . . . . 0.0 110.903 171.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.7 t0 55.77 27.66 11.13 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.732 1.613 . . . . 0.0 115.073 175.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.6 p -78.85 -22.02 46.72 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.985 1.314 . . . . 0.0 113.523 -179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 62.34 -53.26 0.15 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 128.51 2.724 . . . . 0.0 115.005 -170.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 61.4 p -144.71 152.31 40.22 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.726 1.61 . . . . 0.0 111.599 172.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.7 mt -70.28 -36.27 74.27 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.344 0.658 . . . . 0.0 111.79 172.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.91 -33.67 76.23 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.6 m -68.45 -26.49 65.53 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 66.3 mt -99.29 -26.72 14.07 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.531 1.132 . . . . 0.0 113.471 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 130.76 83.93 0.3 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.839 1.685 . . . . 0.0 111.946 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.68 148.49 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.641 1.177 . . . . 0.0 111.662 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.29 158.26 43.78 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.216 1.406 . . . . 0.0 111.922 176.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -73.35 142.65 47.05 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.336 1.054 . . . . 0.0 111.69 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.91 19.55 78.7 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.414 0.926 . . . . 0.0 115.414 174.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.61 136.94 57.75 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.849 1.324 . . . . 0.0 111.384 171.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -132.9 132.11 41.68 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -172.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -119.7 97.67 5.74 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.251 1.421 . . . . 0.0 110.405 -161.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.65 137.47 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.889 -0.507 . . . . 0.0 110.45 174.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tt -139.47 109.0 6.18 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.623 0.769 . . . . 0.0 110.179 -170.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.3 tt -101.94 142.6 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.998 1.319 . . . . 0.0 111.348 -173.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.4 p -130.29 157.05 43.58 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.22 1.408 . . . . 0.0 110.46 173.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -129.0 137.69 51.5 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.87 0.868 . . . . 0.0 112.172 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.3 p -77.8 -20.02 53.98 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.158 1.383 . . . . 0.0 113.855 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.4 t -118.6 -40.15 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.314 1.446 . . . . 0.0 112.16 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.269 0 C-N-CA 125.314 1.435 . . . . 0.0 112.799 -176.558 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mmt . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 121.347 0.594 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -68.59 148.67 50.17 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.976 0.91 . . . . 0.0 112.28 165.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.4 mm -142.23 143.62 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 128.034 2.534 . . . . 0.0 109.176 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.0 mttp -100.4 144.28 29.58 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.194 0.997 . . . . 0.0 111.056 162.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.7 tt -133.72 134.52 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 124.443 1.097 . . . . 0.0 110.474 167.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.8 p -123.34 103.12 35.84 Favored Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 124.592 1.157 . . . . 0.0 110.679 175.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -92.89 140.69 1.89 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.721 2.28 . . . . 0.0 112.255 176.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -77.17 48.36 0.61 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 125.463 1.505 . . . . 0.0 113.522 178.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.6 p -154.34 155.3 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.437 1.495 . . . . 0.0 111.529 -172.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.93 -112.4 4.64 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.704 0.669 . . . . 0.0 112.671 174.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.13 -19.85 72.43 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 124.082 0.848 . . . . 0.0 114.799 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 61.24 32.85 82.18 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-N 118.782 1.291 . . . . 0.0 114.448 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.0 t -144.68 145.6 28.84 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.163 1.385 . . . . 0.0 112.103 -162.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -60.51 140.38 91.07 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.526 2.818 . . . . 0.0 113.096 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.0 tp -124.9 134.06 52.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.343 1.857 . . . . 0.0 110.44 175.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -82.79 135.05 35.08 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.676 0.791 . . . . 0.0 110.752 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.3 mt -142.21 175.09 10.02 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.873 2.069 . . . . 0.0 110.872 179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -136.41 134.6 37.94 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.613 1.565 . . . . 0.0 109.962 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.4 m -136.03 155.19 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.136 0.974 . . . . 0.0 113.0 -173.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.24 149.87 73.33 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 123.853 0.861 . . . . 0.0 111.675 169.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -64.93 -21.64 63.74 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.287 2.658 . . . . 0.0 112.865 172.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -74.06 -0.94 18.03 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.925 1.69 . . . . 0.0 114.134 176.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.66 121.18 10.38 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 119.287 0.948 . . . . 0.0 111.814 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.0 p -86.16 150.73 24.2 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.773 0.829 . . . . 0.0 111.502 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 67.3 t -64.39 -36.6 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.812 -0.555 . . . . 0.0 110.647 173.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -57.35 -51.4 57.86 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 124.083 0.849 . . . . 0.0 112.74 176.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.75 93.13 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 118.004 0.902 . . . . 0.0 112.865 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.5 t -63.93 -47.29 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 121.833 -0.542 . . . . 0.0 111.013 175.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -63.18 -42.4 99.37 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.273 1.029 . . . . 0.0 112.074 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 69.8 p -69.63 -38.16 77.1 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 118.329 -0.843 . . . . 0.0 112.582 177.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.8 mtpt -61.95 -43.97 97.74 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.898 1.226 . . . . 0.0 111.844 172.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.2 t -61.53 -48.27 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 118.832 0.742 . . . . 0.0 111.477 175.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 42.3 t -59.24 -44.57 92.36 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.938 0.895 . . . . 0.0 111.876 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.63 -40.93 80.12 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.255 1.022 . . . . 0.0 112.951 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 59.3 ttp -71.35 -41.04 70.26 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.14 1.376 . . . . 0.0 112.989 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -82.51 -14.59 54.71 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 174.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp 58.34 29.93 18.86 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.708 2.003 . . . . 0.0 112.995 -177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.2 mt -141.02 147.92 49.81 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.877 1.671 . . . . 0.0 112.378 -168.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.95 161.05 47.4 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.222 3.281 . . . . 0.0 114.582 -171.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -66.05 -16.01 50.73 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.763 2.975 . . . . 0.0 114.71 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -67.58 -45.49 75.4 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.946 -1.096 . . . . 0.0 111.756 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.2 t -88.36 -22.59 23.72 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.195 1.398 . . . . 0.0 112.955 -174.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.6 m -127.82 119.12 25.0 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.453 1.501 . . . . 0.0 112.204 -178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -133.06 160.9 35.84 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.345 1.858 . . . . 0.0 113.202 -173.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 42.1 tp -134.94 138.86 44.45 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.785 2.034 . . . . 0.0 110.854 -172.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.3 m -139.22 146.09 40.06 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.43 1.492 . . . . 0.0 111.388 -176.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -142.56 134.6 27.26 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.499 1.519 . . . . 0.0 110.226 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 tptm 52.91 32.69 13.0 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.159 1.383 . . . . 0.0 113.407 -176.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.45 14.53 74.7 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 124.495 1.045 . . . . 0.0 115.34 -176.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.41 141.95 51.71 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.685 1.994 . . . . 0.0 111.4 -174.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.45 125.84 31.54 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.874 0.87 . . . . 0.0 110.348 167.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.0 mp -82.13 138.66 34.71 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.684 0.794 . . . . 0.0 110.354 172.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 136.76 6.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.725 1.61 . . . . 0.0 110.289 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 28.3 t0 55.61 26.92 9.75 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 125.577 1.551 . . . . 0.0 114.471 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.4 m -78.19 -29.39 48.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.839 1.256 . . . . 0.0 113.782 -169.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 62.24 -36.59 0.12 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 128.692 2.797 . . . . 0.0 117.554 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 3.2 t -156.01 146.29 21.6 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.292 1.437 . . . . 0.0 111.123 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.27 -18.13 64.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.882 0.873 . . . . 0.0 112.86 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -68.35 -19.95 64.68 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 171.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.1 t -69.46 -41.1 76.65 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.968 0.907 . . . . 0.0 112.017 178.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.8 mp -82.47 -14.56 54.84 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.843 1.257 . . . . 0.0 112.82 170.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.99 37.25 91.98 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.475 1.036 . . . . 0.0 113.364 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.6 m -64.56 152.97 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.313 1.045 . . . . 0.0 113.802 -168.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -84.86 -178.38 6.83 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 125.197 1.399 . . . . 0.0 112.965 174.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -80.34 153.07 28.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.609 1.163 . . . . 0.0 112.231 165.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.6 26.12 61.65 Favored Glycine 0 CA--C 1.538 1.469 0 N-CA-C 115.351 0.9 . . . . 0.0 115.351 173.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -61.55 156.46 19.59 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.278 1.039 . . . . 0.0 112.769 175.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -124.7 108.66 12.23 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.175 1.39 . . . . 0.0 111.132 -178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -93.58 144.71 25.12 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.272 1.429 . . . . 0.0 110.998 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.0 m -124.47 133.49 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.139 0.976 . . . . 0.0 110.767 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.58 131.98 56.49 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.439 1.096 . . . . 0.0 110.781 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.64 136.59 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 125.948 1.699 . . . . 0.0 108.936 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.0 t -142.8 129.05 19.88 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.859 0.864 . . . . 0.0 111.408 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.1 mmt-85 -86.37 159.55 19.35 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.851 1.66 . . . . 0.0 112.325 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.0 p -70.73 155.06 41.24 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.386 1.075 . . . . 0.0 111.675 169.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 32.0 m -130.76 157.01 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.407 1.483 . . . . 0.0 111.862 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.176 0 C-N-CA 125.457 1.503 . . . . 0.0 112.991 -178.207 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ttt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -130.07 153.07 48.83 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.39 1.476 . . . . 0.0 111.917 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.4 pp -133.1 158.82 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 126.8 2.04 . . . . 0.0 110.807 173.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -103.42 147.88 26.58 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.587 1.555 . . . . 0.0 110.036 164.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.2 tt -135.93 135.38 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.148 0.979 . . . . 0.0 110.396 169.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.6 p -128.26 96.75 30.27 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.82 1.248 . . . . 0.0 111.042 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -81.74 138.96 10.86 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.342 2.695 . . . . 0.0 111.683 170.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.98 40.31 0.15 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.586 1.554 . . . . 0.0 112.968 170.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.3 t -138.73 144.38 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.364 1.866 . . . . 0.0 110.037 -169.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.95 -112.4 4.79 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.965 0.793 . . . . 0.0 112.141 175.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.83 -16.8 68.62 Favored Glycine 0 CA--C 1.539 1.572 0 C-N-CA 124.223 0.916 . . . . 0.0 115.046 175.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 64.55 20.71 66.15 Favored Glycine 0 CA--C 1.54 1.596 0 CA-C-N 118.747 1.274 . . . . 0.0 115.362 171.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.4 m -129.35 153.58 80.55 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 125.6 1.56 . . . . 0.0 112.962 -164.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.92 146.19 82.14 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.293 2.662 . . . . 0.0 113.384 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.4 mt -132.5 138.4 47.54 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.418 1.887 . . . . 0.0 111.094 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -78.75 135.67 37.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.987 1.315 . . . . 0.0 111.87 172.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mp -142.96 150.8 40.17 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.882 1.273 . . . . 0.0 111.925 169.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -85.38 143.92 28.34 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.963 0.905 . . . . 0.0 110.471 160.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.7 m -144.17 148.96 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.503 1.521 . . . . 0.0 110.994 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.72 149.9 88.38 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.69 0.796 . . . . 0.0 111.658 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.42 -19.03 61.31 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.02 2.48 . . . . 0.0 112.927 171.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -77.92 -0.74 28.7 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 126.029 1.732 . . . . 0.0 114.441 171.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.06 142.66 56.48 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 119.415 1.007 . . . . 0.0 111.055 172.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -122.11 152.01 40.33 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.412 1.085 . . . . 0.0 111.411 -175.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -60.94 -32.91 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 121.566 -0.709 . . . . 0.0 112.433 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -64.9 -50.26 59.0 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 123.96 0.791 . . . . 0.0 111.917 173.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.4 -40.11 95.42 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.091 0.956 . . . . 0.0 112.73 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.1 t -63.02 -49.6 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 O-C-N 121.661 -0.649 . . . . 0.0 110.525 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -63.36 -45.33 91.69 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 121.566 -0.709 . . . . 0.0 112.467 -177.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.5 p -67.75 -37.61 82.38 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.479 1.036 . . . . 0.0 112.161 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -58.1 -47.19 83.98 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 119.265 0.939 . . . . 0.0 111.024 172.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.9 t -63.44 -47.35 92.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.325 1.05 . . . . 0.0 111.414 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 93.8 m -61.63 -41.83 98.04 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.24 85.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.839 0.856 . . . . 0.0 113.113 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.5 ttt -66.64 -41.18 88.69 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.283 1.033 . . . . 0.0 112.486 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.471 ' HA ' ' HE3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -74.9 -24.21 58.49 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.434 1.094 . . . . 0.0 113.352 172.584 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt 59.09 28.51 17.81 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.385 2.274 . . . . 0.0 113.912 -167.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.9 mp -116.35 155.44 48.44 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.14 1.776 . . . . 0.0 111.634 -177.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.69 157.72 60.7 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 123.52 2.813 . . . . 0.0 112.437 178.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.48 -25.34 63.06 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.402 2.735 . . . . 0.0 114.406 -173.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -71.64 -17.59 62.25 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.696 1.134 . . . . 0.0 113.634 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.2 m -84.45 -1.04 55.02 Favored 'General case' 0 N--CA 1.48 1.042 0 O-C-N 120.684 -1.26 . . . . 0.0 112.993 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.3 t -136.13 158.01 45.45 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.49 1.516 . . . . 0.0 112.244 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 87.0 mmt-85 -141.79 140.12 32.94 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.029 1.732 . . . . 0.0 111.2 176.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.5 tp -113.31 130.84 56.15 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.433 1.893 . . . . 0.0 110.143 173.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.3 p -136.8 155.63 49.57 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.956 0.902 . . . . 0.0 112.428 172.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -151.74 135.13 16.06 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.303 1.841 . . . . 0.0 110.11 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.92 35.96 20.54 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.215 1.406 . . . . 0.0 113.353 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.83 15.91 79.44 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 124.48 1.038 . . . . 0.0 115.212 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -129.58 151.9 49.69 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.643 1.977 . . . . 0.0 111.637 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.08 135.26 38.59 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.862 -0.524 . . . . 0.0 109.673 160.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.7 tp -107.98 115.89 30.96 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.899 0.88 . . . . 0.0 109.865 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -150.1 141.13 22.97 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.915 1.286 . . . . 0.0 111.613 -169.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 26.6 t0 54.95 26.46 7.96 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.864 1.665 . . . . 0.0 114.836 174.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.4 p -75.28 -26.52 58.83 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.133 1.373 . . . . 0.0 113.005 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 64.04 -46.7 0.28 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 129.015 2.926 . . . . 0.0 114.892 -172.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -152.94 139.01 18.21 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.35 1.86 . . . . 0.0 111.588 175.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.91 -37.36 87.4 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.877 0.871 . . . . 0.0 111.994 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -65.58 -18.19 65.14 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.9 m -75.61 -27.14 58.35 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.134 0.974 . . . . 0.0 113.15 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.37 -39.8 8.62 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.858 1.263 . . . . 0.0 112.036 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 145.67 93.32 0.14 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.518 1.532 . . . . 0.0 111.459 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.2 p -75.04 147.49 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.338 1.055 . . . . 0.0 111.75 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -147.09 164.82 31.82 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.458 1.503 . . . . 0.0 111.837 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -94.88 146.09 24.46 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.816 1.246 . . . . 0.0 112.841 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 79.03 19.46 72.51 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 123.86 0.743 . . . . 0.0 114.8 176.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.31 144.04 54.62 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.458 1.129 . . . . 0.0 111.498 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.25 110.96 17.62 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.674 1.19 . . . . 0.0 111.534 -177.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -92.47 131.66 37.44 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.787 1.235 . . . . 0.0 111.353 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -109.57 127.2 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.283 1.033 . . . . 0.0 110.298 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.8 mp -113.28 121.16 43.59 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.71 1.604 . . . . 0.0 110.357 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.0 mm -114.93 125.38 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.902 1.281 . . . . 0.0 109.903 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.8 t -98.24 155.95 16.94 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.503 1.121 . . . . 0.0 111.622 172.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -116.05 139.02 50.7 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.192 1.397 . . . . 0.0 111.187 171.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 3.6 m -140.49 -53.55 0.5 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.142 0.977 . . . . 0.0 111.989 176.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.2 p -83.07 -27.44 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.431 1.092 . . . . 0.0 112.983 177.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.208 0 C-N-CA 125.603 1.573 . . . . 0.0 113.886 179.581 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.848 ' HB2' ' OD1' ' A' ' 65' ' ' ASP . 26.3 mmt . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 121.668 0.747 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.26 141.17 32.38 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.464 1.506 . . . . 0.0 111.045 174.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.4 mt -128.22 141.98 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.786 1.634 . . . . 0.0 109.803 176.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt -105.55 102.23 11.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.862 1.265 . . . . 0.0 110.25 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.4 pt -78.92 143.51 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 O-C-N 121.436 -0.79 . . . . 0.0 110.326 175.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.9 t -130.61 80.18 70.57 Favored Pre-proline 0 N--CA 1.474 0.774 0 C-N-CA 124.907 1.283 . . . . 0.0 109.847 -175.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.55 131.46 16.17 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.021 2.481 . . . . 0.0 112.256 175.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.44 41.07 0.18 Allowed 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 124.878 1.271 . . . . 0.0 112.749 167.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.9 t -138.91 145.49 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 126.503 1.921 . . . . 0.0 110.202 -169.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.72 -121.19 22.97 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 123.721 0.677 . . . . 0.0 111.858 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.21 -18.27 72.95 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 123.952 0.787 . . . . 0.0 114.935 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.09 -0.8 57.98 Favored Glycine 0 CA--C 1.542 1.763 0 C-N-CA 124.981 1.276 . . . . 0.0 115.769 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.7 m -73.92 153.43 88.94 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 125.523 1.529 . . . . 0.0 113.793 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -63.55 149.37 91.18 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 122.729 2.286 . . . . 0.0 111.467 163.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 tt -141.4 127.07 19.04 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.881 1.272 . . . . 0.0 111.311 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -85.38 128.89 34.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.827 1.251 . . . . 0.0 112.581 -174.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.9 mt -141.7 146.17 35.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.561 1.544 . . . . 0.0 112.439 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -84.7 146.33 27.48 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.144 0.977 . . . . 0.0 111.112 163.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.6 m -143.6 157.87 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.291 1.436 . . . . 0.0 111.201 174.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.36 151.95 96.89 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 123.646 0.778 . . . . 0.0 111.824 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -65.99 -20.49 57.46 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.149 2.566 . . . . 0.0 113.027 173.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -83.98 22.16 1.21 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.482 1.913 . . . . 0.0 113.083 175.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.76 108.98 2.28 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.531 -1.355 . . . . 0.0 111.578 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.2 m -77.92 129.97 36.0 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.402 1.081 . . . . 0.0 110.954 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.1 t -57.57 -44.9 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.028 0.931 . . . . 0.0 111.719 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.24 -35.64 91.86 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.48 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.75 -42.31 77.72 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.883 1.342 . . . . 0.0 112.037 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.4 t -61.0 -49.05 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.448 0.699 . . . . 0.0 110.527 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -62.71 -41.66 99.25 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.513 0.725 . . . . 0.0 111.583 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.1 m -62.41 -42.0 99.11 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.651 0.78 . . . . 0.0 111.591 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -58.58 -45.64 88.61 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.359 0.981 . . . . 0.0 111.733 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 83.1 t -63.34 -47.16 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.938 0.895 . . . . 0.0 111.376 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 83.2 m -63.24 -39.9 95.9 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.067 0.547 . . . . 0.0 112.4 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.44 -39.47 77.79 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.297 1.039 . . . . 0.0 112.719 177.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 63.9 ttp -67.1 -40.44 86.92 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.148 0.979 . . . . 0.0 112.159 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -83.02 -10.42 58.76 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 173.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 58.38 25.15 12.51 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 127.29 2.236 . . . . 0.0 114.418 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 mp -131.98 155.0 81.89 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 126.326 1.85 . . . . 0.0 112.169 -174.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.48 162.54 41.96 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 124.305 3.337 . . . . 0.0 114.215 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -63.67 -16.75 56.6 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 124.194 3.263 . . . . 0.0 114.792 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -66.01 -26.65 67.63 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.026 -1.047 . . . . 0.0 112.434 170.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 26.2 m -91.23 -36.59 13.83 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.492 0.717 . . . . 0.0 112.407 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 33.3 m -130.21 126.76 38.16 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.245 1.018 . . . . 0.0 112.162 -171.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -131.46 161.8 31.69 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.844 1.658 . . . . 0.0 112.997 -168.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.7 tp -129.29 134.54 47.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 127.473 2.309 . . . . 0.0 110.654 -174.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.2 p -138.52 156.8 47.19 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.724 1.21 . . . . 0.0 113.033 174.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -147.68 132.76 18.25 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.269 1.828 . . . . 0.0 110.447 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm 52.05 40.58 28.75 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.226 1.41 . . . . 0.0 113.374 173.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.49 9.17 84.57 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 125.167 1.365 . . . . 0.0 115.723 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 65.3 mtp180 -127.6 152.08 48.1 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.457 1.903 . . . . 0.0 111.958 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.36 128.06 34.57 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.034 0.934 . . . . 0.0 110.116 166.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 84.2 mt -86.35 140.56 29.93 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.829 0.852 . . . . 0.0 110.988 174.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -162.69 152.76 16.25 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.853 1.661 . . . . 0.0 111.331 171.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 53.91 19.89 2.16 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.629 1.972 . . . . 0.0 116.239 171.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.4 m -75.91 -29.95 58.6 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.008 1.323 . . . . 0.0 112.576 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 62.46 -53.94 0.15 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 128.006 2.523 . . . . 0.0 115.475 -175.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 49.5 p -140.97 137.36 32.99 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.009 1.323 . . . . 0.0 111.298 172.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.38 -23.86 64.71 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.653 -0.655 . . . . 0.0 111.949 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -61.68 -31.76 71.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.768 0.827 . . . . 0.0 112.918 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 55.8 p -64.88 -22.11 66.93 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 57.0 mt -107.29 -0.34 22.59 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.409 1.884 . . . . 0.0 113.063 176.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.5 118.5 0.46 Allowed Glycine 0 CA--C 1.539 1.543 0 C-N-CA 126.208 1.861 . . . . 0.0 113.063 -170.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.7 t -75.24 132.84 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.406 1.082 . . . . 0.0 110.767 174.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -105.43 -174.35 2.51 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.733 1.613 . . . . 0.0 111.494 172.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.848 ' OD1' ' HB2' ' A' ' 1' ' ' MET . 28.1 t0 -139.65 148.82 42.96 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.968 -1.082 . . . . 0.0 113.102 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 74.92 23.2 75.39 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 123.87 0.747 . . . . 0.0 113.965 -173.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -68.21 165.04 19.19 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.234 1.414 . . . . 0.0 112.152 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.7 pttm -139.62 142.15 37.07 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 171.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -116.79 121.91 42.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.718 1.207 . . . . 0.0 110.254 178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.9 t -96.64 128.97 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.48 0.712 . . . . 0.0 109.875 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.0 mt -111.38 131.54 55.11 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.257 1.023 . . . . 0.0 109.717 175.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.0 tt -124.91 142.02 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.841 1.256 . . . . 0.0 110.609 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.1 t -132.5 136.48 46.68 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.071 1.348 . . . . 0.0 111.528 -177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -78.55 143.05 36.88 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.026 1.33 . . . . 0.0 111.463 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 82.7 m -72.53 114.09 10.28 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.789 -0.569 . . . . 0.0 110.031 174.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.0 p -74.75 -27.12 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.351 1.06 . . . . 0.0 113.145 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.192 0 C-N-CA 125.893 1.711 . . . . 0.0 113.366 179.597 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.34 0.114 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -108.84 151.11 26.69 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 120.318 -1.489 . . . . 0.0 113.279 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.9 mt -137.41 134.49 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.986 1.714 . . . . 0.0 109.676 -179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -93.47 101.44 13.64 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.92 1.288 . . . . 0.0 111.168 174.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 tt -83.49 137.27 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.421 -0.8 . . . . 0.0 110.146 169.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -130.74 90.33 40.59 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 124.78 1.232 . . . . 0.0 110.464 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -87.64 142.7 5.97 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 123.467 2.778 . . . . 0.0 112.481 179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.91 38.12 0.2 Allowed 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 125.89 1.676 . . . . 0.0 114.79 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 28.9 m -139.94 161.49 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 125.767 1.627 . . . . 0.0 112.374 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.3 -122.96 29.85 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.88 0.752 . . . . 0.0 111.91 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.56 -13.24 74.36 Favored Glycine 0 CA--C 1.539 1.571 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 173.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.62 7.0 45.54 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 125.281 1.42 . . . . 0.0 115.831 176.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.4 m -89.33 154.97 49.16 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 125.399 1.479 . . . . 0.0 113.204 -173.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -64.16 150.6 88.0 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.016 2.477 . . . . 0.0 112.447 169.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mt -137.85 125.96 22.91 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 126.07 1.748 . . . . 0.0 110.677 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -77.2 114.6 16.18 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.197 0.999 . . . . 0.0 111.325 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.5 mp -114.69 155.82 25.92 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.777 1.631 . . . . 0.0 110.703 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -114.01 133.24 55.63 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.409 1.483 . . . . 0.0 109.701 169.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.04 156.61 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.687 1.195 . . . . 0.0 112.044 -174.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.88 149.08 98.64 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 123.825 0.85 . . . . 0.0 111.914 173.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.78 -26.38 60.22 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.933 2.422 . . . . 0.0 113.053 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -82.59 12.81 4.21 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.73 1.612 . . . . 0.0 114.463 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.72 113.86 2.47 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.065 -1.022 . . . . 0.0 111.128 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 p -85.24 153.66 22.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.847 0.859 . . . . 0.0 111.536 -178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 66.9 t -63.49 -42.08 94.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 121.531 -0.731 . . . . 0.0 110.907 174.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.92 97.06 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.762 0.696 . . . . 0.0 113.226 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.12 -46.98 84.74 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 117.974 0.887 . . . . 0.0 111.742 175.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.76 -47.04 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.589 0.756 . . . . 0.0 111.38 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -56.99 -43.19 81.46 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.895 1.278 . . . . 0.0 111.697 177.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.0 m -65.7 -44.96 84.57 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.686 0.795 . . . . 0.0 111.444 176.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.87 -46.6 87.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.908 0.883 . . . . 0.0 111.653 176.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.09 -51.74 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.219 1.408 . . . . 0.0 111.232 177.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 53.2 t -60.43 -43.44 96.78 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.799 0.727 . . . . 0.0 112.332 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.66 -43.66 92.89 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.638 0.775 . . . . 0.0 112.823 176.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 24.8 ttt -70.18 -36.79 74.9 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.13 0.972 . . . . 0.0 112.848 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.14 -20.41 52.11 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.132 1.373 . . . . 0.0 113.689 176.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.7 mmpt? 57.66 19.93 5.91 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 126.751 2.02 . . . . 0.0 113.825 -171.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 mp -128.96 145.48 56.73 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.76 2.024 . . . . 0.0 110.973 -169.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.87 160.48 45.96 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.606 2.871 . . . . 0.0 113.831 -174.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.33 -5.26 15.5 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 124.02 3.147 . . . . 0.0 114.945 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -71.32 -39.81 71.17 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.736 -1.227 . . . . 0.0 111.715 169.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.7 t -85.97 -49.31 7.94 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 121.16 -0.962 . . . . 0.0 112.119 173.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 71.7 m -90.18 127.43 36.11 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.764 0.711 . . . . 0.0 112.093 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -140.37 163.33 33.09 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.758 1.223 . . . . 0.0 113.458 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.4 tp -140.0 136.42 33.73 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.708 2.003 . . . . 0.0 110.639 -170.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.1 p -139.93 155.7 47.03 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.528 1.131 . . . . 0.0 113.084 -178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -149.64 139.68 22.04 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.598 1.959 . . . . 0.0 109.808 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 55.61 29.9 14.4 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.199 1.4 . . . . 0.0 113.969 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.95 13.25 79.15 Favored Glycine 0 CA--C 1.541 1.68 0 C-N-CA 124.785 1.183 . . . . 0.0 114.985 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.3 mmm-85 -123.35 152.73 41.19 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.757 2.023 . . . . 0.0 112.23 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.92 124.01 30.56 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.738 0.815 . . . . 0.0 109.686 160.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -92.63 137.04 32.71 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.907 1.283 . . . . 0.0 109.42 174.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -164.51 147.73 9.04 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.385 1.474 . . . . 0.0 112.036 173.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 56.05 27.21 11.02 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.112 1.765 . . . . 0.0 115.378 175.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -83.96 -16.93 42.34 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.491 1.116 . . . . 0.0 113.954 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.27 -47.13 0.07 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 129.125 2.97 . . . . 0.0 115.956 -171.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.6 t -152.0 140.38 20.51 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.07 1.348 . . . . 0.0 110.987 176.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.5 tp -65.96 -26.94 67.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.5 0.72 . . . . 0.0 112.153 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -65.3 -27.86 68.91 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.561 1.144 . . . . 0.0 113.364 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.1 t -68.35 -40.51 81.5 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.581 0.753 . . . . 0.0 112.262 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.12 -38.69 22.09 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.526 1.131 . . . . 0.0 112.021 177.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.43 97.91 0.26 Allowed Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.914 1.721 . . . . 0.0 111.632 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.2 148.98 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.462 1.105 . . . . 0.0 111.735 176.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -143.34 -168.6 2.85 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.998 1.719 . . . . 0.0 111.116 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -138.75 149.46 45.06 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.825 1.25 . . . . 0.0 112.356 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 71.78 23.63 77.76 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 123.787 0.708 . . . . 0.0 113.87 -175.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -66.92 164.99 16.34 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.93 1.292 . . . . 0.0 112.752 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -136.79 142.85 42.96 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.882 0.873 . . . . 0.0 113.281 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -127.86 125.32 39.48 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.062 1.345 . . . . 0.0 110.335 -175.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.1 t -105.4 126.63 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.604 1.162 . . . . 0.0 109.798 -176.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 tt -124.34 125.05 43.68 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.47 1.108 . . . . 0.0 110.923 -172.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.44 145.15 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 126.246 1.819 . . . . 0.0 110.275 -169.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.6 t -148.06 150.76 34.51 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.499 1.52 . . . . 0.0 110.941 176.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -122.27 134.68 54.68 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.565 1.546 . . . . 0.0 111.538 -177.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 22.3 p -71.92 148.08 46.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.443 1.097 . . . . 0.0 112.484 176.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.0 t -71.2 -34.35 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.283 1.033 . . . . 0.0 111.977 178.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.181 0 C-N-CA 125.725 1.631 . . . . 0.0 113.141 179.766 . . . . . . . . 0 0 . 1 stop_ save_